Sentence,class,file
"Long-Term Outcomes Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 47GA, et al.",OADS,/arxiv_data1/oa_pdf/1e/af/ymj-54-41.PMC3521267.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 108Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.108 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):108-115, 2013 Long-Term Outcomes of Chemoradiation   for Anal Cancer Patients Hun Jin Kim,1 Jung Wook Huh,1 Chang Hyun Kim,1 Sang Woo Lim,1  Taek-Keun Nam,2 Hyeong Rok Kim,1 and Young Jin Kim1 Departments of 1Surgery and 2Radiation Oncology, Chonnam National University Hwasun Hospital and Medical School, Jeollanam-do, Korea.",Non-OADS,/arxiv_data1/oa_pdf/2b/54/ymj-54-108.PMC3521268.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The aim of this study was to evaluate long-term oncologic outcomes af - ter concurrent chemoradiation treatment for anal cancer.",Non-OADS,/arxiv_data1/oa_pdf/2b/54/ymj-54-108.PMC3521268.pdf
"Chemoradiation in Anal Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 109Of the 50 patients, 49 received concurrent chemoradio - therapy.",Non-OADS,/arxiv_data1/oa_pdf/2b/54/ymj-54-108.PMC3521268.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 110tient with Fournier’s gangrene was offered salvage APR,  and the remaining patients were treated with conservative  treatment and they showed favorable results.",Non-OADS,/arxiv_data1/oa_pdf/2b/54/ymj-54-108.PMC3521268.pdf
"Chemoradiation in Anal Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 11185% and 81%, respectively ( p=0.076) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/2b/54/ymj-54-108.PMC3521268.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 112strategy for anal cancer.,Non-OADS,/arxiv_data1/oa_pdf/2b/54/ymj-54-108.PMC3521268.pdf
"Chemoradiation in Anal Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 113survival in the current research; the 5-year OS, DFS, LRFS,  and colostomy-free survival (CFS) were 84.2%, 72.7%,  69.9%, and 71.3%, respectively.",Non-OADS,/arxiv_data1/oa_pdf/2b/54/ymj-54-108.PMC3521268.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 114unfavorable influence on survival than did the tumor diam - eter for patients with anal cancer.,Non-OADS,/arxiv_data1/oa_pdf/2b/54/ymj-54-108.PMC3521268.pdf
Chemoradiation in Anal Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 11515.,Non-OADS,/arxiv_data1/oa_pdf/2b/54/ymj-54-108.PMC3521268.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 215Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.215 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):215-219, 2013 Degeneration of Leiomyoma in Patients Referred for Uterine  Fibroid Embolization: Incidence, Imaging Features and   Clinical Characteristics Seung Chul Han, Man-Deuk Kim, Dae Chul Jung, Myungsu Lee, Mu Sook Lee, Sung Il Park,  Jong Yun Won, Do Yun Lee, and Kwang Hun Lee  Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/cd/2b/ymj-54-215.PMC3521269.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Imaging features and clinical characteristics of degenerated leiomyoma  in patients referred for uterine fibroid embolization (UFE) were analyzed to assess  the incidence of degenerated leiomyoma.",Non-OADS,/arxiv_data1/oa_pdf/cd/2b/ymj-54-215.PMC3521269.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 216HD/HDx; GE Healthcare, Waukesha, WI, USA) of the pel - vis.",Non-OADS,/arxiv_data1/oa_pdf/cd/2b/ymj-54-215.PMC3521269.pdf
Degeneration of Leiomyoma in Patients Referred for Uterine Artery Embolization Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 217from 7.3 cm to 6.7 cm at follow-up.,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/ymj-54-215.PMC3521269.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 218data were abdominal pain including acute onset of pain,  menorrhagia, and bulk-related symptoms.",Non-OADS,/arxiv_data1/oa_pdf/cd/2b/ymj-54-215.PMC3521269.pdf
Degeneration of Leiomyoma in Patients Referred for Uterine Artery Embolization Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 219Ontario Uterine Fibroid Embolization Trial.,Non-OADS,/arxiv_data1/oa_pdf/cd/2b/ymj-54-215.PMC3521269.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 131Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.131 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):131-138, 2013 Circumferential Resection Margin Involvement in Stage III Rectal  Cancer Patients Treated with Curative Resection Followed by  Chemoradiotherapy: A Surrogate Marker for Local Recurrence?",Non-OADS,/arxiv_data1/oa_pdf/2b/fc/ymj-54-131.PMC3521270.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Circumferential resection margin (CRM) involvement is a well-known  predictor for poor prognosis in rectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/2b/fc/ymj-54-131.PMC3521270.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 132from the aorta at its root.,Non-OADS,/arxiv_data1/oa_pdf/2b/fc/ymj-54-131.PMC3521270.pdf
"Impact of CRM on Prognosis in Stage III Rectal Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 133Statistical analysis All statistical analyses were performed using SPSS soft - ware, version 18.0 (SPSS, Chicago, IL, USA).",Non-OADS,/arxiv_data1/oa_pdf/2b/fc/ymj-54-131.PMC3521270.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 134nomatosis were significantly higher in the CRM-positive  group than in the CRM-negative group (25.3% vs. 10.8%;  p=0.001, and 6.3% vs. 1.9%; p=0.043, respectively) (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/2b/fc/ymj-54-131.PMC3521270.pdf
"Impact of CRM on Prognosis in Stage III Rectal Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 135adjuvant chemoradiotherapy, CRM involvement proved to  be an independent adverse prognostic factor.",Non-OADS,/arxiv_data1/oa_pdf/2b/fc/ymj-54-131.PMC3521270.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 136ther evidence to the report of Hall, et al.13 In our study, the  median time to diagnosis of systemic recurrence from the rence.",Non-OADS,/arxiv_data1/oa_pdf/2b/fc/ymj-54-131.PMC3521270.pdf
Impact of CRM on Prognosis in Stage III Rectal Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 137recurrence-free and systemic recurrence-free survival.,Non-OADS,/arxiv_data1/oa_pdf/2b/fc/ymj-54-131.PMC3521270.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 138lowing total mesorectal excision and adjuvant chemoradiotherapy  in patients with rectal cancer.,Non-OADS,/arxiv_data1/oa_pdf/2b/fc/ymj-54-131.PMC3521270.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 204Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.204 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):204-208, 2013 Comparison of Natural Drainage Group and   Negative Drainage Groups after Total Thyroidectomy:  Prospective Randomized Controlled Study Seung Hoon Woo,1,2 Jin Pyeong Kim,1 Jung Je Park,1 Hyun Seok Shim,1 Sang Ha Lee,1  Ho Joong Lee,1 Seong Jun Won,1 Hee Young Son,3 Rock Bum Kim,4 and Young-Ik Son5 Departments of 1Otolaryngology and 2Institute of Health Sciences, Gyeongsang National University, Jinju; 3Department of Otolaryngology, Thyroid/Head & Neck Cancer Center of the Dongnam-Institute of Radiological & Medical Sciences (DIRAMS), Busan; 4Dong-A University Hospital, Regional Cardiocerebrovascular Center, Busan; 5Department of Otorhinolaryngology-Head and Neck Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/fb/4f/ymj-54-204.PMC3521271.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The aim of this study was to compare a negative pressure drain with a  natural drain in order to determine whether a negative pressure drainage tube  causes an increase in the drainage volume.",Non-OADS,/arxiv_data1/oa_pdf/fb/4f/ymj-54-204.PMC3521271.pdf
Comparison with Natural Drainage Group and Negative Drainage Group after Total Thyroidectomy Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 205clinic with thyroid papillary carcinoma were enrolled in  this study (Fig.,Non-OADS,/arxiv_data1/oa_pdf/fb/4f/ymj-54-204.PMC3521271.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 206two groups were identical.,OADS,/arxiv_data1/oa_pdf/fb/4f/ymj-54-204.PMC3521271.pdf
Comparison with Natural Drainage Group and Negative Drainage Group after Total Thyroidectomy Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 207creases the discomfort of patients and their guardians.,Non-OADS,/arxiv_data1/oa_pdf/fb/4f/ymj-54-204.PMC3521271.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 208Our results suggest that in the cases of total thyroidecto - my only, the drainage volume tended to be smaller than that  of conventional surgery where drainage tubes were installed.",Non-OADS,/arxiv_data1/oa_pdf/fb/4f/ymj-54-204.PMC3521271.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 116Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.116 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):116-122, 2013 Usefulness of Carcinoembryonic Antigen for Monitoring   Tumor Progression during Palliative Chemotherapy   in Metastatic Colorectal Cancer Gangmi Kim, Eun-Joo Jung, Chun-Geun Ryu, and Dae-Yong Hwang Department of Surgery, Konkuk University Medical Center, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/3a/d0/ymj-54-116.PMC3521272.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To evaluate the efficacy of carcinoembryonic antigen (CEA) measure - ment for monitoring tumor progression during palliative chemotherapy in meta - static colorectal cancer.",Non-OADS,/arxiv_data1/oa_pdf/3a/d0/ymj-54-116.PMC3521272.pdf
"CEA in Colorectal Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 117ed over 120 minutes as a mixed infusion, followed by a bo - lus of 5-FU (400 mg/m2, i.v.)",Non-OADS,/arxiv_data1/oa_pdf/3a/d0/ymj-54-116.PMC3521272.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 118which also demonstrated an absolute increase of at least 5  mm, taking as reference the smallest sum observed.",OADS,/arxiv_data1/oa_pdf/3a/d0/ymj-54-116.PMC3521272.pdf
"CEA in Colorectal Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 119for predicting complete or partial response (CR+PR, deter - mined by CT) were 29.2% and 95.8%, respectively; the di - agnostic accuracy of CA 19-9 measurement for predicting  response (CR+PR, by CT) was 62.5%.",Non-OADS,/arxiv_data1/oa_pdf/3a/d0/ymj-54-116.PMC3521272.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 120evaluations have been generally performed using imaging  studies, such as CT scans or MRI, according to World Health  Organization (WHO) response criteria8 or the RECIST cri - teria.2 Further to imaging modalities, tumor markers could  be used if they are proved to accurately reflect tumor re - sponses.",Non-OADS,/arxiv_data1/oa_pdf/3a/d0/ymj-54-116.PMC3521272.pdf
"CEA in Colorectal Cancer Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 121progression was very low in the initially normal CEA group,  while it was comparatively high in the initially elevated  CEA group (20.0% vs. 66.7%).",Non-OADS,/arxiv_data1/oa_pdf/3a/d0/ymj-54-116.PMC3521272.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 122ative chemotherapy for advanced colorectal cancer: a multicentre  randomised trial.,Non-OADS,/arxiv_data1/oa_pdf/3a/d0/ymj-54-116.PMC3521272.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 62Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.62 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):62-70, 2013 Implication of Early Lymphocyte Recovery after Allogeneic  Hematopoietic Stem Cell Transplantation in Children   with Leukemia Dong Kyun Han, Hee Jo Baek, So Yeon Kim, Tai Ju Hwang, and Hoon Kook   Department of Pediatrics, Environmental Health Center for Childhood Leukemia and Cancer, Chonnam National University Hwasun Hospital,   Chonnam National University Medical School, Hwasun, Korea.",Non-OADS,/arxiv_data1/oa_pdf/6e/dd/ymj-54-62.PMC3521273.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The repopulating lymphocytes after allogeneic hematopoietic stem cell  transplantation have an important role not only on the prevention of serious infec - tions in the early transplantation period, but also on the killing of residual leukemic  cells by graft-versus-leukemia effect.",Non-OADS,/arxiv_data1/oa_pdf/6e/dd/ymj-54-62.PMC3521273.pdf
"Lymphocyte Recovery after HSCT in Pediatric Leukemia Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 63D+21 and +30 leukocyte counts, both the total and differ - ential counts, were collected from the medical records and  hospital electronic database.",OADS,/arxiv_data1/oa_pdf/6e/dd/ymj-54-62.PMC3521273.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 64blood (UCB), 12; BM+PBSC, 1.",Non-OADS,/arxiv_data1/oa_pdf/6e/dd/ymj-54-62.PMC3521273.pdf
Lymphocyte Recovery after HSCT in Pediatric Leukemia Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 65Statistical analysis The χ2 test was used to compare nominal variables and the  t-test was used to compare numerical variables between the  two groups.,Non-OADS,/arxiv_data1/oa_pdf/6e/dd/ymj-54-62.PMC3521273.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 66patients died of non-relapse causes, with a cumulative inci - dence of TRM of 18.5%.",Non-OADS,/arxiv_data1/oa_pdf/6e/dd/ymj-54-62.PMC3521273.pdf
"Lymphocyte Recovery after HSCT in Pediatric Leukemia Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 67the Low at D+30 (72% vs. 53%, p=0.065) (Table 4) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/6e/dd/ymj-54-62.PMC3521273.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 68(HR 2.2, p=0.01) and had an inferior 3-year EFS (30% vs.  57%, p=0.0001).",Non-OADS,/arxiv_data1/oa_pdf/6e/dd/ymj-54-62.PMC3521273.pdf
"Lymphocyte Recovery after HSCT in Pediatric Leukemia Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 69of Clinical Medicine, and Environmental Health Center for  Childhood Leukemia and Cancer.",Non-OADS,/arxiv_data1/oa_pdf/6e/dd/ymj-54-62.PMC3521273.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 70transplantation.,Non-OADS,/arxiv_data1/oa_pdf/6e/dd/ymj-54-62.PMC3521273.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 55Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.55 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):55-61, 2013 Differential Association of Adiposity Measures   with Heart Rate Variability Measures in Koreans Sang Hoon Yi,1 Kayoung Lee,2 Dong-Gu Shin,3 Jun Su Kim,2 and Hee-Cheol Kim4  1School of Computer Aided Science & Institute of Basic Science, Inje University, Gimhae; 2Department of Family Medicine, Busan Paik Hospital,  Inje University College of Medicine, Busan; 3Cardiovascular Division, Yeungnam University Hospital, Daegu;  4School of Computer Engineering & Ubiquitous Healthcare Research Center, Inje University, Gimhae, Korea.",Non-OADS,/arxiv_data1/oa_pdf/12/04/ymj-54-55.PMC3521274.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Although obesity has been associated with imbalances in cardiac auto - nomic nervous system, it is unclear whether there are differential relationships be - tween adiposity measures and heart rate variability (HRV) measures.",Non-OADS,/arxiv_data1/oa_pdf/12/04/ymj-54-55.PMC3521274.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 56raw ECG signals were recorded for 10 minutes in the  morning and in the overnight fasting state while each sub - ject lays quietly.,Non-OADS,/arxiv_data1/oa_pdf/12/04/ymj-54-55.PMC3521274.pdf
"Adiposity and Heart Rate V ariability Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 57der or adjusting for age, gender, and CV risk factors.",Non-OADS,/arxiv_data1/oa_pdf/12/04/ymj-54-55.PMC3521274.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 58tions with HRV indices (RMSSD, LF, and pNN50 for WHR  and RMSSD, HF, and pNN50 for PBF).",OADS,/arxiv_data1/oa_pdf/12/04/ymj-54-55.PMC3521274.pdf
"Adiposity and Heart Rate V ariability Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 59activity and higher parasympathetic activity compared with  non-obese controls.2 Similarly, a decrease in HRV was found  in morbidly obese group compared with controls in 80 wom - en, and significant associations between metabolic and hor - monal factors and HRV measures disappeared after adjust - ing for body fat mass.5 It has also been suggested that HRV  is reversible.",Non-OADS,/arxiv_data1/oa_pdf/12/04/ymj-54-55.PMC3521274.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 60arity.,Non-OADS,/arxiv_data1/oa_pdf/12/04/ymj-54-55.PMC3521274.pdf
Adiposity and Heart Rate V ariability Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 6112.,Non-OADS,/arxiv_data1/oa_pdf/12/04/ymj-54-55.PMC3521274.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 81Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.81 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):81-86, 2013 Effects of Post Biopsy Digital Rectal Compression on Improving  Prostate Cancer Staging Using Magnetic Resonance Imaging   in Localized Prostate Cancer Kyung Kgi Park,1 Mun Su Chung,2 Soo Yoon Chung,3 Joo Hee Kim,4 and Byung Ha Chung5 Departments of 1Urology and 3Radiology, Yongin Severance Hospital, Yonsei University College of Medicine, Yongin; 2Department of Urology, Uijeongbu St. Mary’ s Hospital, The Catholic University of Korea, Uijeongbu; Departments of 4Radiology and 5Urology, Gangnam Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/c1/8a/ymj-54-81.PMC3521275.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To evaluate the effectiveness of digital rectal-compression immediately  after transrectal prostate biopsy (P-bx) for improving the accuracy of prostate  cancer (PCa) staging.",Non-OADS,/arxiv_data1/oa_pdf/c1/8a/ymj-54-81.PMC3521275.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 82warfarin, prostate biopsy was delayed until the Internation - al Normalized Ratio had been corrected to less than 1.5.",Non-OADS,/arxiv_data1/oa_pdf/c1/8a/ymj-54-81.PMC3521275.pdf
Effect of Post-Biopsy Rectal Compression on Accurate Staging in PCa Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 83viewed the pathology and radiology scoring results.,Non-OADS,/arxiv_data1/oa_pdf/c1/8a/ymj-54-81.PMC3521275.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 84onstrate show low signal intensity within the peripheral  zone on T2-weighted images.1-3  In a patient who is diagnosed with PCa via a prostate bi - opsy, post-biopsy hemorrhaging is a major factor that inter - feres with accurate MR image interpretation.",Non-OADS,/arxiv_data1/oa_pdf/c1/8a/ymj-54-81.PMC3521275.pdf
"Effect of Post-Biopsy Rectal Compression on Accurate Staging in PCa Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 85Even if the most similar MRI and pathology sections were  selected, there were still some inconsistencies between pa - thology and radiology sections.",Non-OADS,/arxiv_data1/oa_pdf/c1/8a/ymj-54-81.PMC3521275.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 86imaging.,Non-OADS,/arxiv_data1/oa_pdf/c1/8a/ymj-54-81.PMC3521275.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 262Case Reporthttp://dx.doi.org/10.3349/ymj.2013.54.1.262 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):262-264, 2013 A Case of Immunoglobulin E Mediated Anaphylaxis   to Levodropropizine  Kyung Hee Park,1,2 Il Seon Yun,1,2 Soo-Young Choi,2 Jae-Hyun Lee,1,2  Chein-Soo Hong,1,2 and Jung-Won Park1,2 1Division of Allergy and Immunology, Department of Internal Medicine, 2Institute of Allergy, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/5a/5b/ymj-54-262.PMC3521276.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.We experienced a case of immunoglobulin E (IgE) mediated anaphylaxis to levo - dropropizine.",Non-OADS,/arxiv_data1/oa_pdf/5a/5b/ymj-54-262.PMC3521276.pdf
IgE Mediated Anaphylaxis to Levodropropizine  Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 263of levodropropizine.,Non-OADS,/arxiv_data1/oa_pdf/5a/5b/ymj-54-262.PMC3521276.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 264SA measurement.,Non-OADS,/arxiv_data1/oa_pdf/5a/5b/ymj-54-262.PMC3521276.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 189Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.189 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):189-196, 2013 Renal Manifestations in 2007 Korean Patients   with Behçet’s Disease Sung Bin Cho,1 Jihyun Kim,1 Shin-Wook Kang,2 Tae-Hyun Yoo,2 Zhenlong Zheng,1,3  Suhyun Cho,1 Hye Sun Lee,4 and Dongsik Bang1 1Department of Dermatology and Cutaneous Biology Research Institute;  2Division of Nephrology, Department of Internal Medicine, BK21 Project for Medical Science,  Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/f0/d5/ymj-54-189.PMC3521277.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Behçet’s disease (BD) theoretically affects all sizes and types of blood  vessels and results in multi-organ involvement.",Non-OADS,/arxiv_data1/oa_pdf/f0/d5/ymj-54-189.PMC3521277.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 190pyelogram, ultrasonographic examination of the abdomen  and pelvis, cytologic examination of the urine, and lab tests  including complement levels and the quantitative evalua - tion of serum immunoglobulins.",Non-OADS,/arxiv_data1/oa_pdf/f0/d5/ymj-54-189.PMC3521277.pdf
Renal Behçet’s Disease Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 191patient (3.5%).,Non-OADS,/arxiv_data1/oa_pdf/f0/d5/ymj-54-189.PMC3521277.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 192CRP (p=0.12).,Non-OADS,/arxiv_data1/oa_pdf/f0/d5/ymj-54-189.PMC3521277.pdf
"Renal Behçet’s Disease Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 193(58.3%) had arthritis, and 3 patients (25%) had ocular in - volvement.",Non-OADS,/arxiv_data1/oa_pdf/f0/d5/ymj-54-189.PMC3521277.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 194nal BD patients were determined to be amyloidosis (n=108;  42.7%), glomerulonephritis (n=88; 34.8%), renal macro - scopic/microscopic vascular disease (n=55; 21.7%), and in - terstitial nephritis (n=5; 2.0%).",Non-OADS,/arxiv_data1/oa_pdf/f0/d5/ymj-54-189.PMC3521277.pdf
"Renal Behçet’s Disease Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 195through the inhibition of enhanced monocyte chemotactic  protein-1 and intercellular adhesion molecule-1 expres - sion.3,16 However, routine administration of colchicine for  BD patients with hematuria, proteinuria, or biopsy-proven  glomerular lesions requires further investigation.",Non-OADS,/arxiv_data1/oa_pdf/f0/d5/ymj-54-189.PMC3521277.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 196shi Y .,Non-OADS,/arxiv_data1/oa_pdf/f0/d5/ymj-54-189.PMC3521277.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 28Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.28 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):28-33, 2013 Evaluation of the Effect of Hemoglobin or Hematocrit Level on  Dural Sinus Density Using Unenhanced Computed Tomography Seung Young Lee,1 Sang-Hoon Cha,1 Sung-Hyun Lee,2 and Dong-Ick Shin2 Departments of 1Radiology and 2Neurology, College of Medicine, Chungbuk National University, Cheongju, Korea.",Non-OADS,/arxiv_data1/oa_pdf/32/fb/ymj-54-28.PMC3521278.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To identify the relationship between hemoglobin (Hgb) or hematocrit  (Hct) level and dural sinus density using unenhanced computed tomography  (UECT).",Non-OADS,/arxiv_data1/oa_pdf/32/fb/ymj-54-28.PMC3521278.pdf
"The Effect of Hgb and Hct Level on Dural Sinus Density Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 29roview 5.3 (Infinitt Co., Seoul, Korea) Picture Archiving and  Communication System by one neuroradiologist to elimi - nate inter-operator variability.",OADS,/arxiv_data1/oa_pdf/32/fb/ymj-54-28.PMC3521278.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 30correlation analysis and independent sample t-test using  SPSS 12.0 (SPSS company, Chicago, IL, USA) were per - formed.",OADS,/arxiv_data1/oa_pdf/32/fb/ymj-54-28.PMC3521278.pdf
"The Effect of Hgb and Hct Level on Dural Sinus Density Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 31er, DST often presents with highly variable symptoms, so  UECT is usually the first imaging modality for most of  them.",Non-OADS,/arxiv_data1/oa_pdf/32/fb/ymj-54-28.PMC3521278.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 32female patients had a history of chronic disease such as liv - er cirrhosis or chronic renal failure and none presented with  active bleeding.,Non-OADS,/arxiv_data1/oa_pdf/32/fb/ymj-54-28.PMC3521278.pdf
"The Effect of Hgb and Hct Level on Dural Sinus Density Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 33mann H, et al.",OADS,/arxiv_data1/oa_pdf/32/fb/ymj-54-28.PMC3521278.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 197Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.197 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):197-203, 2013 Transmesocolic Approach for Left Side Laparoscopic   Pyeloplasty: Comparison with Laterocolic Approach   in the Initial Learning Period Hyun Ho Han,1 Won Sik Ham,1 Jang Hwan Kim,1 Chang Hee Hong,2  Young Deuk Choi,1 Sang Won Han,1 and Byung Ha Chung2 1Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul; 2Department of Urology, Yonsei University College of Medicine, Gangnam Severance Hospital, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/9c/e5/ymj-54-197.PMC3521279.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  To evaluate the outcome of transmesocolic (TMC) laparoscopic pyelo - plasty compared with conventional laterocolic procedure for surgeons with limited  experience.",Non-OADS,/arxiv_data1/oa_pdf/9c/e5/ymj-54-197.PMC3521279.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 198(86%), and the mean age of all patients was 26.5 years  (range: 2-76 years).",OADS,/arxiv_data1/oa_pdf/9c/e5/ymj-54-197.PMC3521279.pdf
"Transmesocolic Laparoscopic Pyeloplasty, Initial Experience Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 199out through the urethra.",Non-OADS,/arxiv_data1/oa_pdf/9c/e5/ymj-54-197.PMC3521279.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 200ference was not statistically significant (20.4±19.2 years vs.  31.8±22.3 years, p=0.423).",OADS,/arxiv_data1/oa_pdf/9c/e5/ymj-54-197.PMC3521279.pdf
"Transmesocolic Laparoscopic Pyeloplasty, Initial Experience Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 201cal difficulties and stiff learning curve of this complex re - constructive surgery1,9,13 Early reports indicate significantly  longer operation time than that of the open procedure.",Non-OADS,/arxiv_data1/oa_pdf/9c/e5/ymj-54-197.PMC3521279.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 202it may be thicker, which would cause troublesome bleeding  during dissection.",Non-OADS,/arxiv_data1/oa_pdf/9c/e5/ymj-54-197.PMC3521279.pdf
"Transmesocolic Laparoscopic Pyeloplasty, Initial Experience Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 20315.",Non-OADS,/arxiv_data1/oa_pdf/9c/e5/ymj-54-197.PMC3521279.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 183Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.183 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):183-188, 2013 Influence of Infliximab on Cytokines Network and Markers   of Bone Remodeling in Rheumatoid Arthritis Patients Izabela Korczowska,1 Jan Krzysztof Lacki,2 and Pawel Hrycaj1   1Department of Rheumatology and Clinical Immunology, University of Medical Sciences in Poznan, Poznan; 2Public Health Department, University of Zielona Gora, Zielona Gora, Poland .",Non-OADS,/arxiv_data1/oa_pdf/b5/85/ymj-54-183.PMC3521280.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Our aim was to determine the effects of infliximab on bone mineral  metabolism in rheumatoid arthritis (RA) patients and analyze the relationship be - tween inflammatory markers of acute phase thought to play a major role in bone  remodeling.",Non-OADS,/arxiv_data1/oa_pdf/b5/85/ymj-54-183.PMC3521280.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 184um supplements.,Non-OADS,/arxiv_data1/oa_pdf/b5/85/ymj-54-183.PMC3521280.pdf
"Infliximab and Bone Remodeling in Rheumatoid Arthritis Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 185patients who were treated with infliximab revealed signifi - cant decrease in the level of BGP ( p<0.01), NTx ( p<0.01)  and Dpd ( p<0.01) after 12 months, compared to the results  before treatment.",Non-OADS,/arxiv_data1/oa_pdf/b5/85/ymj-54-183.PMC3521280.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 186BGP levels, in RA patients who were treated with inflix - imab.",Non-OADS,/arxiv_data1/oa_pdf/b5/85/ymj-54-183.PMC3521280.pdf
Infliximab and Bone Remodeling in Rheumatoid Arthritis Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 187Rheumatol Suppl 1994;100:21-30.,Non-OADS,/arxiv_data1/oa_pdf/b5/85/ymj-54-183.PMC3521280.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 18822.,Non-OADS,/arxiv_data1/oa_pdf/b5/85/ymj-54-183.PMC3521280.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 1Review Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.1 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):1-14, 2013 The Role of Pharmacoethnicity in the Development of Cytotoxic  and Molecular Targeted Drugs in Oncology Nagahiro Saijo Executive Officer, Japanese Society of Medical Oncology, Tokyo, Japan.",OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.The effective and toxic ranges of anticancer drugs are very narrow and, in some  cases, inverted.",Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
"Nagahiro Saijo Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 2tively, as well as sorafenib against liver cancer, pharmaco - ethnic differences induced by differences in environmental  and local medical practices have also been noted in addi - tion to differences in pharmacogenomics (Table 1).",Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
Pharmacoethnicity for Oncology Drugs Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 3was 225 mg/m2 in the JMTO and SWOG trials and 200  mg/m2 in the FACS trial.,Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
Nagahiro Saijo Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 4These results suggested the need for 1) consideration of dif - ferent patient characteristics and outcomes amongst patients  receiving identical therapy.,Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
"Pharmacoethnicity for Oncology Drugs Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 5pared gefitinib vs. carboplatin/paclitaxel in clinically selected  patients, included patients from 9 Asian countries including  China, Japan, Hong Kong, the Philippines, Singapore, Tai - wan and Thailand, accruing 1217 patients within 18  months.39 Patient selection in the IP ASS trial was, however,  performed based solely on clinical factors such as adenocar -ISEL trial using gefitinib produced negative results34 while  the BR-21 trial using erlotinib produced positive results.29 If  the ISEL population was subdivided into Asians and Cau - casians, gefitinib was shown to only be effective against  Asian patients (Fig.",Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
"Nagahiro Saijo Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 6erlotinib were conducted in China (OPTIMAL)42 and Europe  (EURTAC).43 All four of these trials produced similar results  (Table 5), suggesting that the biological character of EGFR  mutated NSCLC was similar in East Asians and Caucasians  despite differences in mutation frequencies.",Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
"Pharmacoethnicity for Oncology Drugs Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 7that, among the patients who died as a result of ILD, 31.6%  had received gefitinib and 27.9% undergone chemotherapy,  respectively.",Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
Nagahiro Saijo Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 8ceived treatment with an EGFR-TKI (17% vs. 61%) after  the first line chemotherapy.,Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
Pharmacoethnicity for Oncology Drugs Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 95.3 months).,Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
"Nagahiro Saijo Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 10cellular carcinoma, as more than 70% of the Japanese pa - tients were infected with hepatitis C virus and more than  70% of Korean patients were infected with hepatitis B vi - rus.",Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
"Pharmacoethnicity for Oncology Drugs Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 11ence more frequent and profound neutropenia despite re - ceiving the same treatment doses, schedules and same phar - macokinetics.",Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
Nagahiro Saijo Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 12only be identified from the prospective analyses of patients  of a homogeneous background.,Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
"Pharmacoethnicity for Oncology Drugs Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 13(‘Iressa’, ZD1839) in Japanese patients with solid malignant tu - mors.",Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
Nagahiro Saijo Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 14Pulmonary drug toxicity: radiologic and pathologic manifesta - tions.,Non-OADS,/arxiv_data1/oa_pdf/52/42/ymj-54-1.PMC3521281.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 231Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.231 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):231-237, 2013 The Influence of the Severity of Chronic Virus-Related   Liver Disease on Propofol Requirements   during Propofol-Remifentanil Anesthesia Jian Wu,1 Su-Qin Huang,1 Qing-Lian Chen,1 and Shu-Sen Zheng2 1Department of Anesthesiology, 2Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery,  First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.",Non-OADS,/arxiv_data1/oa_pdf/18/80/ymj-54-231.PMC3521282.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  The purpose of this study was to investigate the influence of chronic vi - rus-related liver disease severity on propofol requirements.",Non-OADS,/arxiv_data1/oa_pdf/18/80/ymj-54-231.PMC3521282.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 232dard physiological monitors including electrocardiography  and pulse oximetry were placed.,Non-OADS,/arxiv_data1/oa_pdf/18/80/ymj-54-231.PMC3521282.pdf
Propofol Requirements and Chronic Liver Disease Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 233ty were made for measurement data.,OADS,/arxiv_data1/oa_pdf/18/80/ymj-54-231.PMC3521282.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 234icantly different between the groups ( p<0.05), with group C  having the lowest requirement (2.2 µg/mL).",Non-OADS,/arxiv_data1/oa_pdf/18/80/ymj-54-231.PMC3521282.pdf
"Propofol Requirements and Chronic Liver Disease Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 235by Xu, et al.,7 who reported a C 95 for effect-site concentra - tion of 3.2 µg/mL, with 95% confidence intervals of 3.1-3.3  µg/mL, for a healthy Chinese population.",Non-OADS,/arxiv_data1/oa_pdf/18/80/ymj-54-231.PMC3521282.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 236warrant further investigation.,Non-OADS,/arxiv_data1/oa_pdf/18/80/ymj-54-231.PMC3521282.pdf
Propofol Requirements and Chronic Liver Disease Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 23722.,Non-OADS,/arxiv_data1/oa_pdf/18/80/ymj-54-231.PMC3521282.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 265Case Reporthttp://dx.doi.org/10.3349/ymj.2013.54.1.265 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):265-268, 2013 Two Cases of Mushroom Poisoning   by Podostroma Cornu-Damae Jin Young Ahn,1* Soon Ja Seok,2* Je Eun Song,1 Jung Ho Choi,1 Sang Hoon Han,1  Jun Yong Choi,1 Chang Oh Kim,1 Young Goo Song,1 and June Myung Kim1 1Department of Internal Medicine, Yonsei University College of Medicine, Seoul; 2Agricultural Microbiology Team, National Academy of Agricultural Science, Rural Development Administration, Suwon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/3a/e4/ymj-54-265.PMC3521283.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Podostroma cornu-damae  is a rare fungus that houses a fatal toxin in its fruit body.",Non-OADS,/arxiv_data1/oa_pdf/3a/e4/ymj-54-265.PMC3521283.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 266On hospital day (HD) 2, the patient’s high temperature  was sustained and pancytopenia was aggravated with a  WBC count of 90/μL (ANC 20/μL), Hb of 6.3 g/dL, and a  platelet count of 5000/μL, despite the administration of  granulocyte-colony stimulating factor and a transfusion of  packed red blood cell and platelet concentrate.",Non-OADS,/arxiv_data1/oa_pdf/3a/e4/ymj-54-265.PMC3521283.pdf
"Poisoning by Podostroma Cornu-Damae Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 267tratoxin H 13’-acetate, satratoxin H, roridin E, and veruca - rin J.",Non-OADS,/arxiv_data1/oa_pdf/3a/e4/ymj-54-265.PMC3521283.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 268REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/3a/e4/ymj-54-265.PMC3521283.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 71Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.71 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):71-80, 2013 Prevalence, Incidence, and Factor Concentrate Usage   Trends of Hemophiliacs in Taiwan Tsu-Chiang Tu,1,2 Wen-Shyong Liou,3,4 Tsui-Yun Chou,5 Tsung-Kun Lin,2 Chuan-Fang Lee,2  Jye-Daa Chen,2 Thau-Ming Cham,1 and Mei-Ing Chung1 1School of Pharmacy, Kaohsiung Medical University, Kaohsiung; 2Department of Pharmacy Practice, Tri-Service General Hospital, Taipei; 3Department of Pharmacy, Taichung Veterans General Hospital, Taichung; 4College of Pharmacy, China Medical University, Taichung;  5The Hemophilia Care and Research Center, Tri-Service General Hospital, Taipei, Taiwan.",Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Hemophilia A and B (HA, HB) are the most common X-linked inherit - ed bleeding disorders.",Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 72tients are able to obtain treatment with factor concentrates.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
"Factor Usage Trends of Hemophiliacs in Taiwan  Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 73version 11.0 (StataCorp LP , Lakeway, TX, USA).15 RESULTS   General population characteristics Fig.",OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 74annual prevalence (per 100000 males) was 6.7±0.1 for HA,  1.2±0.1 for HB, and 7.9±0.1 for HA+HB.",OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Factor Usage Trends of Hemophiliacs in Taiwan  Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 75based on disease type of hemophilia are shown in Table 3.,OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 76(104078).,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Factor Usage Trends of Hemophiliacs in Taiwan  Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 77general male population.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 78pitals in 2003 to 44 hospitals in 2007.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Factor Usage Trends of Hemophiliacs in Taiwan  Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 79A better designed and patient-centered registry system  could empower more detailed information collection and  subsequent analysis.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Available at: http://wfh.org/2/docs/Publications/Di - agnosis_and_Treatment/Guidelines_Mng_Hemophilia.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Available at: http://www.nhi.gov.tw/Resource/ webdata/Attach_13792_2_cherishing.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
"Available at: http://www.nhi.gov.tw/Re - source/webdata/13767_1_NHI%20IN%20TAIWAN%20the use of FVIII and FIX (IUs per capita) recombinant con - centrates-to-plasma-derived concentrates, respectively, in  2007.",Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 80fid=BFFEE6AB018CFAF8.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Available at: http://www2.cdc.gov.tw/public/Data/8121710212971.,OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Available at:http://www.cdc.gov.tw/english/info.aspx?treeid=0 0ed75d6c887bb27&nowtreeid=1d256e6c8b243c1d&tid=1E0691 878D687950.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Available at: http://www.who.int/ healthinfo/paper31.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Available at:  http://www.doh.gov.tw/CHT2006/DisplayStatisticFile.aspx?d=  73104&s=1.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Available at:  http://www.ukhcdo.org/docs/AnnualReports/2009/Annual%20 Report%202009%20slides.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Available at: http://fhs.mcmaster.ca/ chr/pdf/09/CHRVIII090413.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Avail - able at: http://www1.wfh.org/2/docs/Publications/Statistics/FF- 10_Prevalence_HemophiliaB.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Available at: http://fhs.mcmaster.ca/ chr/pdf/09/CHRIX090413.pdf.,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
Available at: http://www.cdc.gov.tw/downloadfile.aspx?,Non-OADS,/arxiv_data1/oa_pdf/00/05/ymj-54-71.PMC3521284.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 48Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.48 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):48-54, 2013 Reference Diameters of the Abdominal Aorta and   Iliac Arteries in the Korean Population Jin Hyun Joh,1 Hyung-Joon Ahn,2 and Ho-Chul Park1 1Department of Surgery, Kyung Hee University Hospital at Gangdong, School of Medicine, Kyung Hee University, Seoul; 2Department of Surgery, Kyung Hee University Hospital, School of Medicine, Kyung Hee University, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/08/01/ymj-54-48.PMC3521285.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  It is important to know the normal diameter of artery throughout the body  so that clinicians are able to determine when an artery becomes aneurysmal.",Non-OADS,/arxiv_data1/oa_pdf/08/01/ymj-54-48.PMC3521285.pdf
"Reference Diameters of Abdominal Aorta and Iliac Arteries Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 49function impairment, and enquired about their surgical his - tory.",Non-OADS,/arxiv_data1/oa_pdf/08/01/ymj-54-48.PMC3521285.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 50RESULTS   One thousand two hundred and twenty-nine people were  enrolled in our screening project.,Non-OADS,/arxiv_data1/oa_pdf/08/01/ymj-54-48.PMC3521285.pdf
"Reference Diameters of Abdominal Aorta and Iliac Arteries Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 51DISCUSSION There are 3 modalities for aortic diameter measurement: ul - trasonography (US), computed tomography (CT), and family history of AAA, men aged 65 to 75 years old who  have smoked at least 100 cigarettes throughout their life.",Non-OADS,/arxiv_data1/oa_pdf/08/01/ymj-54-48.PMC3521285.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 52was about 30% between the ages of 25 and 71 years.,Non-OADS,/arxiv_data1/oa_pdf/08/01/ymj-54-48.PMC3521285.pdf
"Reference Diameters of Abdominal Aorta and Iliac Arteries Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 53agement of patients with peripheral arterial disease (lower extremi - ty, renal, mesenteric, and abdominal aortic): a collaborative report  from the American Association for V ascular Surgery/Society for  V ascular Surgery, Society for Cardiovascular Angiography and In - terventions, Society for V ascular Medicine and Biology, Society of  Interventional Radiology, and the ACC/AHA Task Force on Prac - tice Guidelines (Writing Committee to Develop Guidelines for the  Management of Patients With Peripheral Arterial Disease): en - dorsed by the American Association of Cardiovascular and Pulmo - nary Rehabilitation; National Heart, Lung, and Blood Institute; So - ciety for V ascular Nursing; TransAtlantic Inter-Society Consensus;  and V ascular Disease Foundation.",Non-OADS,/arxiv_data1/oa_pdf/08/01/ymj-54-48.PMC3521285.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 54aneurysm in a cohort of more than 3 million individuals.,Non-OADS,/arxiv_data1/oa_pdf/08/01/ymj-54-48.PMC3521285.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 258Case Reporthttp://dx.doi.org/10.3349/ymj.2013.54.1.258 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):258-261, 2013 Thoracic Endovascular Aortic Repair with the Chimney  Technique for Blunt Traumatic Pseudoaneurysm of the Aortic  Arch in a No-Option Patient Won Ho Kim,1* Jin Ho Choi,2* Sang Hyun Park,1 Yu Jeong Choi,1 Kyung Tae Jeong,1  Sun Chang Park,1 and Sahng Lee1  Divisions of 1Cardiology and 2Chest Surgery, Eulji University Hospital, Eulji University School of Medicine, Daejeon, Korea.",Non-OADS,/arxiv_data1/oa_pdf/05/10/ymj-54-258.PMC3521286.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.A 42-year-old man was involved in a motor vehicle collision.",Non-OADS,/arxiv_data1/oa_pdf/05/10/ymj-54-258.PMC3521286.pdf
"Chimney Technique, Pseudoaneurysm Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 259tail catheter via right femoral access in the ascending aorta,  a Thoracic SEAL stent graft (S&G Bio Tech CO., Seong - nam, Korea) made of 34-30 mm tapered diameter and 110  mm length was deployed.",Non-OADS,/arxiv_data1/oa_pdf/05/10/ymj-54-258.PMC3521286.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 260ostium.,Non-OADS,/arxiv_data1/oa_pdf/05/10/ymj-54-258.PMC3521286.pdf
"Chimney Technique, Pseudoaneurysm Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 2618.",Non-OADS,/arxiv_data1/oa_pdf/05/10/ymj-54-258.PMC3521286.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 209Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.209 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):209-214, 2013 Incidence of Venous Air Embolism during Myomectomy:   The Effect of Patient Position Jiwon An,1 Seo Kyung Shin,1 Ja-Young Kwon,2 and Ki Jun Kim1 1Department of Anesthesiology and Pain Medicine, Anesthesia and Pain Research Institute and 2Department of Obstetrics and Gynecology, Yonsei University College of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/0a/cc/ymj-54-209.PMC3521287.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  V enous air embolism (V AE) is characterized by the entrainment of air or  exogenous gases from broken venous vasculature into the central venous system.",Non-OADS,/arxiv_data1/oa_pdf/0a/cc/ymj-54-209.PMC3521287.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 210ing.,Non-OADS,/arxiv_data1/oa_pdf/0a/cc/ymj-54-209.PMC3521287.pdf
"V enous Air Embolism during Myomectomy Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 211fined as a sudden decrease of more than 20 mm Hg in the  mean arterial blood pressure from the measurement taken 5  minutes prior, an acute fall of pulse oximetric saturation be - low 90%, and/or a sudden decrease of PETCO 2 above 2 mm  Hg from the baseline value.",Non-OADS,/arxiv_data1/oa_pdf/0a/cc/ymj-54-209.PMC3521287.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 212ed no V AE.,Non-OADS,/arxiv_data1/oa_pdf/0a/cc/ymj-54-209.PMC3521287.pdf
V enous Air Embolism during Myomectomy Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 213was significantly lower than that in the supine group with - out fluctuation of vital signs.,Non-OADS,/arxiv_data1/oa_pdf/0a/cc/ymj-54-209.PMC3521287.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 214myomectomy.,Non-OADS,/arxiv_data1/oa_pdf/0a/cc/ymj-54-209.PMC3521287.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 34Original Articlehttp://dx.doi.org/10.3349/ymj.2013.54.1.34 pISSN: 0513-5796, eISSN: 1976-2437         Yonsei Med J 54(1):34-40, 2013 Adjunctive Cilostazol versus High Maintenance Dose   of Clopidogrel in Patients with Hyporesponsiveness   to Chronic Clopidogrel Therapy Ga Yeon Lee,1 Joo-Yong Hahn,1 Soo-Youn Lee,2 Hee-Jin Kim,2 Jun Hyung Kim,1 Sang-Yup Lee,1  Young Bin Song,1 Seung-Hyuk Choi,1 Jin-Ho Choi,1 and Hyeon-Cheol Gwon1  Departments of 1Medicine and 2Laboratory Medicine & Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.",Non-OADS,/arxiv_data1/oa_pdf/a8/20/ymj-54-34.PMC3521288.pdf
"© Copyright: Yonsei University College of Medicine 2013 This is an Open Access article distributed under the  terms of the Creative Commons Attribution Non- Commercial License (http://creativecommons.org/  licenses/by-nc/3.0) which permits unrestricted non- commercial use, distribution, and reproduction in any  medium, provided the original work is properly cited.Purpose:  Whether addition of cilostazol is superior to increasing dose of clopido - grel in patients with hyporesponsiveness to chronic clopidogrel therapy is un - known.",Non-OADS,/arxiv_data1/oa_pdf/a8/20/ymj-54-34.PMC3521288.pdf
"Cilostazol for Clopidogrel Hyporesponsiveness Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 35ization after DES implantation was similar in both groups,  30 (29-33) days in group A and 30 (24-32) days in group B  (p=0.324).",Non-OADS,/arxiv_data1/oa_pdf/a8/20/ymj-54-34.PMC3521288.pdf
Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 36dogrel.,Non-OADS,/arxiv_data1/oa_pdf/a8/20/ymj-54-34.PMC3521288.pdf
Cilostazol for Clopidogrel Hyporesponsiveness Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 37among 35 patients (28.6%) in the group B showed follow- up percent inhibition of PRU less than 30% at 4 weeks after  the 1st randomization.,Non-OADS,/arxiv_data1/oa_pdf/a8/20/ymj-54-34.PMC3521288.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 38ness or resistance to clopidogrel.1 Since hypo-responsive - ness to clopidogrel has been reported to be associated with  adverse clinical outcomes,8,9 finding more effective regimen  in the patients with hyporesponsiveness to clopidogrel has  evoked great interests.",Non-OADS,/arxiv_data1/oa_pdf/a8/20/ymj-54-34.PMC3521288.pdf
Cilostazol for Clopidogrel Hyporesponsiveness Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 39life of clopidogrel and cilostazol.,Non-OADS,/arxiv_data1/oa_pdf/a8/20/ymj-54-34.PMC3521288.pdf
"Yonsei Med J   http://www.eymj.org   Volume 54   Number 1   January 2013 40dogrel: clinical implications, management, and future perspec - tives.",Non-OADS,/arxiv_data1/oa_pdf/a8/20/ymj-54-34.PMC3521288.pdf
"(advance access), http://eurheartj.oxfordjou rnals.org/content/early/2011/11/21/eurheartj.ehr409.extract .",Non-OADS,/arxiv_data1/oa_pdf/80/aa/3291.PMC3521298.pdf
http://www.summitmd.com/pdf/pdf/1430_Safety_4_TakayukiOkamura.pdf   11.,Non-OADS,/arxiv_data1/oa_pdf/80/aa/3291.PMC3521298.pdf
"Cybernet Systems Co , Ltd., “Free 3D DICOM viewer INTAGE Realia” ( 2010 ),  http://kgt.cybernet.co.jp/viz/realia/english/intage_realia.html .",Non-OADS,/arxiv_data1/oa_pdf/80/aa/3291.PMC3521298.pdf
"Global Industry Analysts, Inc. , “Coronary stents - a global strategic business report ( 2011 ),”  http://www.strategyr.com/Coronary_Stents_Market_Report.asp .",Non-OADS,/arxiv_data1/oa_pdf/80/aa/3291.PMC3521298.pdf
"Imalux, “Products,” http://www.imalux.com/products.htm .",Non-OADS,/arxiv_data1/oa_pdf/10/a1/3346.PMC3521301.pdf
We applied this new method to analyze a complex numerical phantom and both the phantom data and the improved code are available as open-source software at http://mcx.sourceforge.net/mmc/.,OADS,/arxiv_data1/oa_pdf/86/79/3223.PMC3521306.pdf
"J.Pommier,“SimpleSSEandSSE2optimizedsin,cos,logandexp”(2007),http://gruntthepeon.free.fr/ssemath/.",OADS,/arxiv_data1/oa_pdf/86/79/3223.PMC3521306.pdf
The updated source code and benchmark dataset is provided on our website athttp://mcx.sourceforge.net/mmc/.,OADS,/arxiv_data1/oa_pdf/86/79/3223.PMC3521306.pdf
"“CUDA Toolkit 3.1 Downloads,” http://developer.nvidia.com/cuda -toolkit- 31-downloads .",Non-OADS,/arxiv_data1/oa_pdf/38/72/3067.PMC3521307.pdf
"E xpress  17(25), 23037 –23043  (2009 ),  http://www.opticsinfobase.org/abstract.cfm?URI=oe -17-25-23037 .",Non-OADS,/arxiv_data1/oa_pdf/7e/d8/3332.PMC3521308.pdf
"S. Prahl , “Optical absorption of hemoglobin” ( 1998 ), tabulated molar extinction coefficient for hemoglobin in  water using data from W. B. Gratzer, Medical Research Council Labs, Holly Hill, London, UK and N. Kollias,  Wellman Laboratories, Harvard Medical School, Boston, MA, USA, at  http://omlc.ogi.edu/spectra/hemoglobin/index.html .",OADS,/arxiv_data1/oa_pdf/7e/d8/3332.PMC3521308.pdf
"SUROS , “New method for breast cancer diagnosis ,” 2003 , http://www2.prnewswire.com/cgi - bin/stories.pl?A CCT=104&STORY=/www/story/11 -25-2003/0002065545&EDATE= .",Non-OADS,/arxiv_data1/oa_pdf/e2/53/3211.PMC3521310.pdf
"Asahi Spectra, “MAX -302 xenon light source 300W technical information,”  http://www.gmp.ch/htmlarea/pdf/asahi_ pdf/max302techinfo.pdf .",Non-OADS,/arxiv_data1/oa_pdf/e2/53/3211.PMC3521310.pdf
"Texas Instruments , “IVC102 precision switched integrator transimpedance amplifier,”  http://www.ti.com/product/ivc102 .",Non-OADS,/arxiv_data1/oa_pdf/e2/53/3211.PMC3521310.pdf
"PICAXE microcontroller, available from http://www.pi caxe.com/ .",Non-OADS,/arxiv_data1/oa_pdf/e2/53/3211.PMC3521310.pdf
"R. Shellock and D. Services, Inc., and F. G.  Shellock , “Monitoring patients in the MRI environment,” ( 2012 ),  http://www.mrisafety.com/safety_article.asp?subject=40 .",Non-OADS,/arxiv_data1/oa_pdf/79/b5/3325.PMC3521315.pdf
"Natural Science Forum, “Relative humidity of human exhaled breath,” July 3, 2004 ,  http://www.natscience.com/Uwe/Forum.aspx/bio/233/Relative -humidity -of-human- exhaled -breath .",Non-OADS,/arxiv_data1/oa_pdf/79/b5/3325.PMC3521315.pdf
"S. Prahl , “Mie Scattering Calculator,” http://omlc.ogi.edu/calc/mie_calc.html .",OADS,/arxiv_data1/oa_pdf/bb/cf/3250.PMC3521317.pdf
"Joseph’s Healthcare Hamilton, West 5th Campus, Hamilton, ON DOI:http://dx.doi.org/10.5770/cgj.15.39ORIGINAL RESEARCH © 2012 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/fa/0e/cgj-15-80.PMC3521320.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/fa/0e/cgj-15-80.PMC3521320.pdf
Avail - able from: http://www.statcan.gc.ca/pub/82-003-x/2010001/ article/11131-eng.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fa/0e/cgj-15-80.PMC3521320.pdf
Available at: http://www.health.gov.on.ca/en/ news/bulletin/2010/20101130.aspx .,Non-OADS,/arxiv_data1/oa_pdf/fa/0e/cgj-15-80.PMC3521320.pdf
"Basran, md, frcpc3,  A. Maria Chung, md, frcpc4,  Pamela G. Jarrett, md, frcpc5, José A. Morais, md, frcpc6, Eileen Peters, md7, Kenneth J. Rockwood, md, frcpc5,  Philip D. St. John, md, mph, frcpc8, Anne L. Sclater, md, frcpc9, Timothy Stultz, md10, Sarah Woolmore-Goodwin,  ba (spec hons ), msc2  1Division of Geriatric Medicine, University of Calgary, Calgary, AB; 2Division of Geriatric Medicine, University of Western  Ontario, London, ON; 3Division of Geriatric Medicine, University of Saskatchewan, Saskatoon, SK; 4Division of Geriatric  Medicine, University of British Columbia, Vancouver, BC; 5Division of Geriatric Medicine, Dalhousie University, Halifax,  NS; 6Division of Geriatric Medicine, McGill University, Montreal, PQ; 7Frame Lake Community Health Clinic, Yellowknife,  Northwest Territories; 8Division of Geriatric Medicine, University of Manitoba, Winnipeg, MB; 9Department of Medicine,  Memorial University, St. John’s, NL; 10Provincial Geriatric Program, Health PEI, Summerside, PEI DOI:http://dx.doi.org/10.5770/cgj.15.41CliniCal Pra CtiCe Guidelines/Consensus statements © 2012 Author(s).",Non-OADS,/arxiv_data1/oa_pdf/1d/1a/cgj-15-68.PMC3521321.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/1d/1a/cgj-15-68.PMC3521321.pdf
Source: 2010 - Statistics Canada (accessed 28/11/2011 - http://www.statcan.gc.ca/ pub/91-520-x/2010001/tablesectlist-listetableauxsect-eng.htm ).,OADS,/arxiv_data1/oa_pdf/1d/1a/cgj-15-68.PMC3521321.pdf
b  Number of specialists in geriatric medicine who are Fellows of the RCPSC (data base accessed 28/11/2011 - http://rcpsc.medical.org/dof/ index_e.php ).,Non-OADS,/arxiv_data1/oa_pdf/1d/1a/cgj-15-68.PMC3521321.pdf
The counts exclude physicians in postgraduate training and those over  the age of 80 (data base accessed 22/02/2012 - http://www.cma.ca/index.php?ci_id=16959&la_id=1 ).,OADS,/arxiv_data1/oa_pdf/1d/1a/cgj-15-68.PMC3521321.pdf
Available from: http://www.caper.ca/census _ book_2011/toc_en.php .,OADS,/arxiv_data1/oa_pdf/1d/1a/cgj-15-68.PMC3521321.pdf
Available from:  http://www.caper.,Non-OADS,/arxiv_data1/oa_pdf/1d/1a/cgj-15-68.PMC3521321.pdf
Available from:  http://www.carms.ca/eng/ operations_R4reports_e.shtml  33.,OADS,/arxiv_data1/oa_pdf/1d/1a/cgj-15-68.PMC3521321.pdf
Available from: http://www.cma.ca/bleak-job-outlook-specialties  34.,Non-OADS,/arxiv_data1/oa_pdf/1d/1a/cgj-15-68.PMC3521321.pdf
Available from: http://www.newyorker.com/reporting/2007/04/30/070430fa_fact_ gawande 46.,Non-OADS,/arxiv_data1/oa_pdf/1d/1a/cgj-15-68.PMC3521321.pdf
DOI:http://dx.doi.org/10.5770/cgj.15.42SYSTEMIC REVIEW/META-ANAL YSIS © 2012 Author(s).,Non-OADS,/arxiv_data1/oa_pdf/62/c9/cgj-15-85.PMC3521322.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial   No-Derivative license (http://creativecommons.org/licenses/by-nc-nd/2.5/ca/), which permits unrestricted non-commercial use and distribution, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/62/c9/cgj-15-85.PMC3521322.pdf
"For a more thorough description of the methods, see the Regional Geriatric Program of Eastern Ontario’s report titled “A Scop - ing Interpretive Review of Literature on Perspectives and Practices of Primary Care Physicians Vis-à-vis Diagnosis and Management of Community Living Older Persons with De - mentia” available at http://www.cgjonline.ca/cgj/templates/images/RGPEOFullReport.pdf.",Non-OADS,/arxiv_data1/oa_pdf/62/c9/cgj-15-85.PMC3521322.pdf
"(23,26,27,47,48,56) For a detailed presentation of the evidence on the practices of PCP, see the Regional Geriatric Program of Eastern Ontario’s report titled “A Scoping Interpretive Review of Literature on Perspectives and Practices of Primary Care Physicians Vis-à-vis Diagnosis and Management of Community Liv - ing Older Persons with Dementia” available at http://www.cgjonline.ca/cgj/templates/images/RGPEOFullReport.pdf.",Non-OADS,/arxiv_data1/oa_pdf/62/c9/cgj-15-85.PMC3521322.pdf
"For a comprehensive discussion of other barriers, see the Regional Geriatric Program of Eastern Ontario’s report titled “A Scoping Interpretive Review of Literature on Perspectives and Practices of Primary Care Physicians Vis-à-vis Diagno - sis and Management of Community Living Older Persons with Dementia” available at http://www.cgjonline.ca/cgj/templates/images/RGPEOFullReport.pdf.",Non-OADS,/arxiv_data1/oa_pdf/62/c9/cgj-15-85.PMC3521322.pdf
"For a more detailed discussion of various intervention studies, see the Regional Geriatric Program of Eastern Ontario’s report titled “A Scoping Inter - pretive Review of Literature on Perspectives and Practices of Primary Care Physicians Vis-à-vis Diagnosis and Manage - ment of Community Living Older Persons with Dementia” available at http://www.cgjonline.ca/cgj/templates/images/RGPEOFullReport.pdf.",Non-OADS,/arxiv_data1/oa_pdf/62/c9/cgj-15-85.PMC3521322.pdf
Dr.	Ken	Madden Editor-in-Chief Canadian Geriatrics JournalA Little Bittle of Geriatrics... DOI:http://dx.doi.org/10.5770/cgj.15.53EDITORIAL ©	2012	Author(s).,Non-OADS,/arxiv_data1/oa_pdf/c3/a4/cgj-15-67.PMC3521323.pdf
"This	is	an	Open	Access	article	distributed	 under	the	terms	of	the	Creative	Commons	 Attribution	 Non-Commercial 	  No-Derivative	 license	(http://creativecommons.org/licenses/by-nc-nd/2.5/ca/),	 which	permits	unrestricted	 non-commercial	 use	and	distribution,	 provided	the	original	work	is	properly	cited.",Non-OADS,/arxiv_data1/oa_pdf/c3/a4/cgj-15-67.PMC3521323.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/9a/kes350.PMC3521445.pdf
http://www.medicine.manchester.ac.uk/ images/File/ESI_07_malig_form.pdf.,Non-OADS,/arxiv_data1/oa_pdf/34/9a/kes350.PMC3521445.pdf
http://ons.gov.,Non-OADS,/arxiv_data1/oa_pdf/34/9a/kes350.PMC3521445.pdf
"http://apps.who.int/classifications/apps/icd/ic-d10online/ (12 June 2010, date last accessed).",OADS,/arxiv_data1/oa_pdf/34/9a/kes350.PMC3521445.pdf
"39, 2008. http://ons.gov.uk/on- s/publications/re-reference-tables.html?edition=tcm% 3A77-198611 (11 July 2011, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/34/9a/kes350.PMC3521445.pdf
http://www.ons.gov.,Non-OADS,/arxiv_data1/oa_pdf/34/9a/kes350.PMC3521445.pdf
"39, 2008. http://ons.gov.",Non-OADS,/arxiv_data1/oa_pdf/34/9a/kes350.PMC3521445.pdf
( http://www.cdc.gov/nccdphp/dnpa/ physical/stats/leisure_time.htm ).,Non-OADS,/arxiv_data1/oa_pdf/7b/26/kws336.PMC3521479.pdf
Two months after publication it is available to the pub - lic under an Attribution–Noncommercial–Share Alike 3.0 Unported Creative  Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/39/26/4663.PMC3521674.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/29/b0/4664.PMC3521675.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/62/35/4668.PMC3521676.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7d/1a/4679.PMC3521677.pdf
"Gene Ontology analysis Age-dependent insoluble proteins were submitted to the DAVID  Bioinformatics Databases Functional Annotation Tool v6.7 (National  Institute of Allergy and Infectious Diseases, National Institutes of  Health; http://david.abcc.ncifcrf.gov/).",OADS,/arxiv_data1/oa_pdf/7d/1a/4679.PMC3521677.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/74/5f/4689.PMC3521678.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4d/56/4701.PMC3521679.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/11/1a/4713.PMC3521680.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/87/9e/4725.PMC3521681.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d8/ca/4739.PMC3521682.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9e/0d/4751.PMC3521683.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/38/f8/4766.PMC3521684.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/2b/4b/4778.PMC3521685.pdf
Two months after publi - cation it is available to the public under an Attribution–Noncommercial–Share  Alike 3.0 Unported Creative Commons License (http://creativecommons.org/ licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/d8/d8/4786.PMC3521686.pdf
"Cep170  is widely expressed in diverse cell types  (Novartis Gene Atlas, http://biogps.org) and  can act as a potent activator of Kif2b de - polymerase based on the work presented  here.",Non-OADS,/arxiv_data1/oa_pdf/d8/d8/4786.PMC3521686.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/3b/a9/4796.PMC3521687.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/98/26/4807.PMC3521688.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f5/0e/4820.PMC3521689.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/3c/50/4833.PMC3521690.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/ by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7c/c2/4849.PMC3521691.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/00/23/4864.PMC3521692.pdf
"Yan Cheng Editor-in-Chief, SpermatogenesisLetter from the editor c. Yan c heng the Mary M. Wohlford Laboratory for Male c ontraceptive r esearch; c enter for Biomedical r esearch; t he Population c ouncil; New York, NY USA Correspondence to: C. Yan Cheng; Email: y-cheng@popcbr.rockefeller.edu Submitted: 10/18/12; Accepted: 10/18/12DOI: http://dx.doi.org/10.4161/spmg.22648",Non-OADS,/arxiv_data1/oa_pdf/df/9d/spmg-2-237.PMC3521744.pdf
"Spermatogenesis 2:4, 238-244; October/November/December 2012; © 2012 Landes Bioscience viewS , cOmmeNtarieS  & OpiNiONS 238 Spermatogenesis volume 2 issue 4Keywords:  in vitro spermatogenesis,  organ culture, spermatogonial stem cells,  infertility, germ cells, stem cells, trans - plantation Abbreviations:  siRNA, small interfer - ing RNA; ISCI, intracytoplasmic sperm  injection; ROSI, round spermatid injec - tion; SSCs, spermatogonial stem cells; iPS cell, induced pluripotent stem cell; IVF, in vitro fertilization; KSR, knock - out serum replacement; PGCs, primor - dial germ cells Submitted: 08/11/12Accepted: 09/03/12http://dx.doi.org/10.4161/spmg.22069 *Correspondence to: Miles F. Wilkinson;   Email: mfwilkinson@ucsd.eduThe generation of functional sperm  in vitro has been a goal for almost a  century.",Non-OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Proc Natl Acad Sci USA 2006; 103:9524-9; PMID:16740658; http://dx.doi.org/10.1073/ pnas.0603332103.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Genes Dev 2006; 20:147-52; PMID:16418481; http://dx.doi.org/10.1101/ gad1367806.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Nature 1981; 293:55-7; PMID:7266658;  http://dx.doi.org/10.1038/293055a0.,Non-OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Cell 2005; 120:369-82;  PMID:15707895; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
JAMA 2009; 302:2127-34; PMID:19920237;  http://dx.doi.org/10.1001/jama.2009.1689.,Non-OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Cell 2004; 119:1001-12; PMID:15620358; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Hum Mol Genet 2011; 20:752-62;  PMID:21131292; http://dx.doi.org/10.1093/hmg/ddq520.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Stem Cells 2009; 27:783-95; PMID:19350678;  http://dx.doi.org/10.1002/stem.13.,Non-OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Hum Reprod 2001;  16:513-6; PMID:11228222; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Nat Rev Genet 2002; 3:137- 44; PMID:11836507; http://dx.doi.org/10.1038/ nrg733.16.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Biol Reprod 2005; 72:985-91; PMID:15601913; http://dx.doi.org/10.1095/biolre - prod.104.036400.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Nature  2004; 427:148-54; PMID:14668819; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Nature 2009; 462:222-5; PMID:19865085;  http://dx.doi.org/10.1038/nature08562.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Biol Reprod 2010; 83:261-7;  PMID:20393168; http://dx.doi.org/10.1095/biolre - prod.110.083899.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Nat Commun 2011; 2:472; PMID:21915114; http://dx.doi.org/10.1038/ncomms1478.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Nat Med 2000; 6:29-34; PMID:10613820; http://dx.doi.org/10.1038/71496.,Non-OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Biol Reprod 2002; 67:712-7; PMID:12193376; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Proc Natl Acad Sci USA 2002; 99:7524- 9; PMID:12032316; http://dx.doi.org/10.1073/ pnas.072207299.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Theriogenology 2010; 73:129-38;  PMID:19837451; http://dx.doi.org/10.1016/j.therio - genology.2009.07.028.References 1.,Non-OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Semin Cell Dev Biol 1998;  9:411-6; PMID:9813187; http://dx.doi.org/10.1006/ scdb.1998.0203.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Nature  2011; 471:504-7; PMID:21430778; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Nature 1937; 139:413; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Exp Cell Res 1964; 36:19-27; PMID:14222741; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
J Reprod Fertil 1965; 9:243-8; PMID:14273758;  http://dx.doi.org/10.1530/jrf.0.0090243.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Am J Anat 1963; 112:35-51;  PMID:14021715; http://dx.doi.org/10.1002/ aja.1001120103.,Non-OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Proc Natl Acad Sci USA 1983; 80:3377- 81; PMID:6407012; http://dx.doi.org/10.1073/ pnas.80.11.3377.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Cell  1993; 75:997-1006; PMID:7504588; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Proc Natl Acad Sci USA 1994; 91:5533- 7; PMID:8202522; http://dx.doi.org/10.1073/ pnas.91.12.5533.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Science 2002; 297:392-5; PMID:12077424; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
Lancet 1999; 353:555-6; PMID:10028987; http://dx.doi.org/10.1016/S0140-6736(98)04784-9.,OADS,/arxiv_data1/oa_pdf/6d/b6/spmg-2-238.PMC3521745.pdf
"The seminiferous tubules in  *Correspondence to: Stefan Schlatt and Joachim Wistuba;   Email: stefan.schlatt@ukmuenster.de and joachim.wistuba@ukmuenster.de Submitted: 07/26/12; Revised: 08/27/12; Accepted: 08/27/12http://dx.doi.org/10.4161/spmg.21983Many previous studies have aimed at spermatogenesis of male  murine germ cells in vitro, but no efficient system has been established yet that covers the entire process of mammalian  spermatogenesis in a culture dish permanently.",Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Proc Natl Acad Sci USA 1915;  1:220-2; PMID:16575981; http://dx.doi.org/10.1073/ pnas.1.4.220.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Endocrinology 1964; 74:788- 92; PMID:14168569; http://dx.doi.org/10.1210/ endo-74-5-788.3.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Mol Hum Reprod 2009; 15:521-9; PMID:19561342;  http://dx.doi.org/10.1093/molehr/gap052.4.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
J Androl 2008; 29:312-29;  PMID:18046051; http://dx.doi.org/10.2164/jan-drol.107.002857.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
J Androl 2011; 32:271-81;  PMID:20930193; http://dx.doi.org/10.2164/jan- drol.110.010322.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Science 2002; 296:2174-6;  PMID:12077400; http://dx.doi.org/10.1126/sci- ence.1071607.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Biol Reprod 2007; 76:43-7; PMID:17005941;  http://dx.doi.org/10.1095/biolreprod.106.054999.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Ann N Y Acad Sci 2007; 1120:152- 67; PMID:18184913; http://dx.doi.org/10.1196/ annals.1411.015.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Fertil  Steril 2007; 87:824-33; PMID:17239867; http://dx.doi.org/10.1016/j.fertnstert.2006.09.015.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Biol Reprod 2001; 65:873-8; PMID:11514353; http://dx.doi.org/10.1095/biolre- prod65.3.873.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Biomaterials  2006; 27:2845-53; PMID:16430959; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
J Immunol Methods 2000; 244:49-58;  PMID:11033018; http://dx.doi.org/10.1016/S0022- 1759(00)00253-2.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
J Exp Med 1975; 142:877- 86; PMID:1080792; http://dx.doi.org/10.1084/ jem.142.4.877.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Biomaterials 2005; 26:3587-96;  PMID:15621249; http://dx.doi.org/10.1016/j.bioma- terials.2004.09.046.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Environ Res 2003; 91:95-103; PMID:12584010;  http://dx.doi.org/10.1016/S0013-9351(02)00019-1.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Endocr Dev 2009; 15:101-34; PMID:19293606; http://dx.doi.org/10.1159/000207612.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
J Reprod  Fertil 1965; 9:243-8; PMID:14273758; http://dx.doi.org/10.1530/jrf.0.0090243.23.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Endocrinology 1983; 112:1150-2; PMID:6822207;  http://dx.doi.org/10.1210/endo-112-3-1150.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Exp Cell Res 1966; 44:443-52;  PMID:5337205; http://dx.doi.org/10.1016/0014- 4827(66)90451-4.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Biol Reprod  2004; 70:625-31; PMID:14585812; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Hum Reprod 1998; 13(10):2772-81; PMID:9804229; http://dx.doi.org/10.1093/humrep/13.10.2772.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Hum Reprod 1999; 14:1287-93; PMID:10325279; http://dx.doi.org/10.1093/hum- rep/14.5.1287.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Hum Reprod  2002; 17:161-72; PMID:11756382; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Fertil Steril 2003; 79(Suppl 1):795-801;  PMID:12620493; http://dx.doi.org/10.1016/S0015- 0282(02)04833-1.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
J Mol Endocrinol  2004; 33:729-42; PMID:15591031; http://dx.doi.org/10.1677/jme.1.01493.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Proc Natl Acad Sci USA 1983; 80:3377- 81; PMID:6407012; http://dx.doi.org/10.1073/ pnas.80.11.3377.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Theriogenology  2006; 65:288-98; PMID:15964619; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Biol Reprod 1996; 55:227-35; PMID:8828824; http://dx.doi.org/10.1095/biolreprod55.2.227.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Theriogenology  2011; 76:607-14; PMID:21529912; http://dx.doi.org/10.1016/j.theriogenology.2011.03.011.5.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Reproduction 2008; 136:459-69;  PMID:18660385; http://dx.doi.org/10.1530/REP-08- 0241.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Nature  2011; 471:504-7; PMID:21430778; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Asian J Androl  2012; 14:285-93; PMID:22057383; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Nat Commun 2011; 2:472; PMID:21915114; http://dx.doi.org/10.1038/ncomms1478.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Microsc Res Tech 2009; 72:580-5; PMID:19263493;  http://dx.doi.org/10.1002/jemt.20699.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Mol Cell  Endocrinol 2008; 288:95-103; PMID:18485583;  http://dx.doi.org/10.1016/j.mce.2008.04.012.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Biol Reprod 2010; 83:951-7;  PMID:20702852; http://dx.doi.org/10.1095/biolre- prod.109.082800.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
J Androl 2006; 27:611- 8; PMID:16582408; http://dx.doi.org/10.2164/jan- drol.05207.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Science 2000; 287:1489-93; PMID:10688798; http://dx.doi.org/10.1126/science.287.5457.1489.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Anat Rec 1971; 169:533-57; PMID:5550532;  http://dx.doi.org/10.1002/ar.1091690306.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Biol Reprod 1989; 41:571-7; PMID:2695173; http://dx.doi.org/10.1095/biolreprod41.4.571.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Dev Growth Differ 2008; 50:623-32; PMID:18657168; http://dx.doi.org/10.1111/j.1440- 169X.2008.01060.x.,Non-OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
Exp Cell Res 1959; 16:118-47; PMID:13639945; http://dx.doi.org/10.1016/0014- 4827(59)90201-0.,OADS,/arxiv_data1/oa_pdf/a7/64/spmg-2-245.PMC3521746.pdf
"7-9 Furthermore, there is increasing evidence that paternal  health cues can be passed to the next generation with male age associated with an increase in autistic spectrum disorders 10 and  *Correspondence to: Michelle Lane; Email: michelle.lane@adelaide.edu.au Submitted: 05/17/12; Revised: 07/04/12; Accepted: 07/04/12http://dx.doi.org/10.4161/spmg.21362Male obesity in reproductive-age men has nearly tripled in the  past 30 years and coincides with an increase in male infertility worldwide.",Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Gastroenterol Clin North Am 2010; 39:1- 7; PMID:20202574; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Hum Reprod Update  2011; 17:667-83; PMID:21546379; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril 2011; 96:843-7; PMID:21839433;  http://dx.doi.org/10.1016/j.fertnstert.2011.07.356.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Mol Cell Endocrinol  2006; 250:66-9; PMID:16412557; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril 2004; 81:349-54; PMID:14967372; http://dx.doi.org/10.1016/j.fertnstert.2003.06.026.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril  2010; 93:2222-31; PMID:19261274; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Androl  2006; 27:450-2; PMID:16339454; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Reprod  Biomed Online 2009; 19:660-70; PMID:20021714; http://dx.doi.org/10.1016/j.rbmo.2009.07.001.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Androl 2012; 33:53-8; PMID:21273503;  http://dx.doi.org/10.2164/jandrol.110.012120.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Andrologia  2011; 43:121-8; PMID:21382066; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Endocrinol 2010; 205:117-31; PMID:20144980;  http://dx.doi.org/10.1677/JOE-10-0025.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril 2008; 90:619-26;  PMID:18068160; http://dx.doi.org/10.1016/j.fertn- stert.2007.07.1292.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril 2010; 94:610-8; PMID:19328465; http://dx.doi.org/10.1016/j.fertnstert.2009.01.142.24.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Am J Physiol Endocrinol Metab  2012; 302:E768-80; PMID:22252945; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Int J Androl  2011; 34:402-10; PMID:20649934; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril 2011; 95:1349-53;  PMID:21047633; http://dx.doi.org/10.1016/j.fertn- stert.2010.09.038.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Biol Reprod 2010; 82:96-104; PMID:19696015; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Epigenomics 2010; 2:539- 49; PMID:22121973; http://dx.doi.org/10.2217/ epi.10.33.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Eur J  Nutr 2002; 41:132-8; PMID:12111051; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Am J Clin  Nutr 2009; 89:551-7; PMID:19106237; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Reprod Biol Endocrinol 2011; 9:32; PMID:21396114;  http://dx.doi.org/10.1186/1477-7827-9-32.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Reprod Fertil Dev 2011; 23:929- 39; PMID:21871212; http://dx.doi.org/10.1071/RD10326.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Assist Reprod Genet 2012;  PMID:22692280; http://dx.doi.org/10.1007/s10815- 012-9801-3.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Int J Androl 2008; 31:518-26;  PMID:17822420; http://dx.doi.org/10.1111/j.1365- 2605.2007.00803.x.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Nat Rev Urol 2010; 7:153-61;  PMID:20157305; http://dx.doi.org/10.1038/nru- rol.2010.6.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Mol Psychiatry 2011; 16:1203-12; PMID:21116277;  http://dx.doi.org/10.1038/mp.2010.121.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Methods Mol Biol 2009; 472:103-37;  PMID:19107431; http://dx.doi.org/10.1007/978-1- 60327-492-0_5.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Am J  Clin Nutr 2010; 92:946-53; PMID:20702606; http://dx.doi.org/10.3945/ajcn.2010.29477.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Nature 2010; 467:963-6; PMID:20962845; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Hum Reprod  2012; 27:1391-400; PMID:22357767; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Reprod  Biomed Online 2011; 23:490-9; PMID:21856228;  http://dx.doi.org/10.1016/j.rbmo.2011.06.010.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Hum Reprod 2008; 23:878-84; PMID:18281684; http://dx.doi.org/10.1093/humrep/den017.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Hum Reprod  2007; 22:2488-93; PMID:17636282; http://dx.doi.org/10.1093/humrep/dem139.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Hum Reprod 2007; 22:1634-7; PMID:17344224; http://dx.doi.org/10.1093/humrep/ dem035.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril  2011; 95:1700-4; PMID:21145051; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Urology 2010; 76:851-6;  PMID:20430424; http://dx.doi.org/10.1016/j.urol- ogy.2010.01.055.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Assist  Reprod Genet 2010; 27:539-44; PMID:20635132;  http://dx.doi.org/10.1007/s10815-010-9439-y.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Nat Rev Urol 2011; 8:86-94;  PMID:21243017; http://dx.doi.org/10.1038/nru-rol.2010.230.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Nature  1996; 382:250-2; PMID:8717038; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Endocrinology 1998; 139:4652-62; PMID:9794477;  http://dx.doi.org/10.1210/en.139.11.4652.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Eur J Endocrinol  1999; 140:468-73; PMID:10229915; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Endocrinology 1999; 140:4939- 47; PMID:10537117; http://dx.doi.org/10.1210/ en.140.11.4939.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Lancet 1996; 348:159-61; PMID:8684156; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
JAMA 1968; 204:290- 7; PMID:5694622; http://dx.doi.org/10.1001/ jama.1968.03140170006002.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Reproduction 2008; 136:73-84;  PMID:18390691; http://dx.doi.org/10.1530/REP-08- 0036.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Mol Hum Reprod 2008; 14:1-8;  PMID:18175790; http://dx.doi.org/10.1093/molehr/ gam089.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril  2011; 95:1025-30; PMID:21122845; http://dx.doi.org/10.1016/j.fertnstert.2010.11.006.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Fam Plann Reprod Health Care 2002; 28:211-3; PMID:12419067; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Ann Biomed Eng  2011; 39:664-73; PMID:20976556; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Br J Urol 1981; 53:55-61;  PMID:7470804; http://dx.doi.org/10.1111/j.1464- 410X.1981.tb03129.x.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Reprod Biol Endocrinol 2007; 5:15;  PMID:17448228; http://dx.doi.org/10.1186/1477- 7827-5-15.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Reprod Fertil 1998; 114:179-94; PMID:10070346;  http://dx.doi.org/10.1530/jrf.0.1140179.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Reprod Fertil Dev 2006; 18:647-53; PMID:16930511;  http://dx.doi.org/10.1071/RD05022.68.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Endocrinology 1990; 127:1470- 6; PMID:2201538; http://dx.doi.org/10.1210/endo- 127-3-1470.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Neuroendocrinol 1998; 10:785-92;  PMID:9792330; http://dx.doi.org/10.1046/j.1365- 2826.1998.00264.x.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Diabetes 2009; 58:2027-31; PMID:19581420; http://dx.doi.org/10.2337/ db09-0031.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Hypertens  Res 2010; 33:587-91; PMID:20339372; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Clin Endocrinol (Oxf) 2007; 66:440-6; PMID:17302881; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Semin Reprod Med 2002; 20:277-84; PMID:12428207; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Med Hypotheses 1999; 52:49-51; PMID:10342671;  http://dx.doi.org/10.1054/mehy.1997.0624.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Clin Endocrinol Metab  1980; 51:1128-32; PMID:7419688; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Med Hypotheses 2008; 70:358- 60; PMID:17825496; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Dtsch Med Wochenschr  2011; 136:541-5; PMID:21387213; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Endocrinology 1997; 138:1190-3; PMID:9048626;  http://dx.doi.org/10.1210/en.138.3.1190.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Science 1997; 275:88-90; PMID:8974400;  http://dx.doi.org/10.1126/science.275.5296.88.54.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Arch Androl  2006; 52:97-102; PMID:16443585; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril 2010; 94:581-4; PMID:19423100;  http://dx.doi.org/10.1016/j.fertnstert.2009.03.085.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril 2004; 82:863- 70; PMID:15482761; http://dx.doi.org/10.1016/j.fertnstert.2004.03.056.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Clin Endocrinol Metab 1985; 14:89-124;  PMID:3926355; http://dx.doi.org/10.1016/S0300-595X(85)80066-9.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Anat Rec  1993; 235:547-59; PMID:8385423; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Cell Tissue Res 1993; 274:153- 61; PMID:8242704; http://dx.doi.org/10.1007/ BF00327996.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Nat Genet 1997;  15:201-4; PMID:9020850; http://dx.doi.org/10.1038/ ng0297-201.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Androl 2008; 29:251- 9; PMID:18222914; http://dx.doi.org/10.2164/jan- drol.107.003731.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Diabet Med 1998; 15:473-9; PMID:9632121;  http://dx.doi.org/10.1002/(SICI)1096- 9136(199806)15:6<473::AID-DIA607>3.0.CO;2-L.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Androl 2005; 26:741- 8; PMID:16291969; http://dx.doi.org/10.2164/jan- drol.05063.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Andrologia 2005; 37:69-71; PMID:16026427;  http://dx.doi.org/10.1111/j.1439-0272.2005.00656.x.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Cell Biochem 2008; 104:1570- 9; PMID:18393352; http://dx.doi.org/10.1002/ jcb.21756.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Microsc Res Tech 2009; 72:536- 51; PMID:19283828; http://dx.doi.org/10.1002/ jemt.20697.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Nature 2004; 429:154;  PMID:15141202; http://dx.doi.org/10.1038/429154a.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Mol Med (Berl) 2009; 87:735-48; PMID:19466390;  http://dx.doi.org/10.1007/s00109-009-0485-9.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Biochem Biophys Res  Commun 2005; 330:690-4; PMID:15809052; http://dx.doi.org/10.1016/j.bbrc.2005.03.032.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Hum Reprod 2011; 26:3401-12; PMID:21989093; http://dx.doi.org/10.1093/humrep/ der329.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Gene 2005; 357:83-94; PMID:16111837; http://dx.doi.org/10.1016/j.gene.2005.06.019.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Nat Struct Mol Biol 2008; 15:259- 67; PMID:18311153; http://dx.doi.org/10.1038/ nsmb.1391.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Carcinogenesis 2010; 31:1110-5;  PMID:19959559; http://dx.doi.org/10.1093/carcin/ bgp300.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Nature 2006; 441:469-74; PMID:16724059; http://dx.doi.org/10.1038/nature04674.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Biol T race Elem Res 2012; 147:251-60; PMID:22207218;  http://dx.doi.org/10.1007/s12011-011-9308-2.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Reprod  Health 2011; 8:24; PMID:21849026; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Alcohol Clin Exp Res 2009; 33:1615-27;  PMID:19519716; http://dx.doi.org/10.1111/j.1530- 0277.2009.00993.x.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Alcohol Clin Exp  Res 2002; 26:347-51; PMID:11923587; http://dx.doi.org/10.1111/j.1530-0277.2002.tb02544.x.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Reprod Toxicol 2011; 31:507-12; PMID:21382472; http://dx.doi.org/10.1016/j.repro- tox.2011.02.009.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Front Genet 2012; 3:10; PMID:22371710;  http://dx.doi.org/10.3389/fgene.2012.00010.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Am J Clin Nutr 2011; 93:897S- 900; PMID:21289222; http://dx.doi.org/10.3945/ ajcn.110.001933.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
FEBS J  2010; 277:599-604; PMID:20015078; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Biochemistry 1977; 16:4074- 80; PMID:911755; http://dx.doi.org/10.1021/ bi00637a021.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Science 1987; 236:962- 4; PMID:3576213; http://dx.doi.org/10.1126/sci- ence.3576213.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
PLoS Genet 2008; 4:e1000116;  PMID:18584034; http://dx.doi.org/10.1371/journal.pgen.1000116.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Syst Biol Reprod Med  2010; 56:44-61; PMID:20170286; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Eur J Cell Biol  2000; 79:950-60; PMID:11152286; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Biol Reprod 2004; 70:910-8;  PMID:14645105; http://dx.doi.org/10.1095/biolre- prod.103.022541.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Androl 2006; 27:890-8; PMID:16870950; http://dx.doi.org/10.2164/jandrol.106.000703.99.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Asian J Androl  2011; 13:195-6; PMID:21186371; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Acta Paediatr Suppl 2004;  93:26-33; PMID:15702667; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Genome  Res 2010; 20:1623-8; PMID:21041414; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Curr Opin Cell Biol 2007; 19:257-65; PMID:17467256; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Cell 2011; 146:1029-41; PMID:21925323;  http://dx.doi.org/10.1016/j.cell.2011.08.016.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Epigenetics  2011; 6:1354-61; PMID:22048249; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
J Assist  Reprod Genet 2009; 26:537-44; PMID:19876730;  http://dx.doi.org/10.1007/s10815-009-9346-2.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Asian J Androl 2011; 13:342- 6; PMID:21196940; http://dx.doi.org/10.1038/ aja.2010.160.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Reproduction 2011; 141:749-57;  PMID:21389080; http://dx.doi.org/10.1530/REP-11-0008.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril 2009;  91(Suppl):2253-63; PMID:18778817; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril  2010; 93:2222-31; PMID:19261274; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Reprod Biomed Online  2011; 23:717-23; PMID:22019618; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Aging Male  2010; 13:155-8; PMID:20059435; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Andrologia  2011; 43:286-91; PMID:21486403; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril 2008; 90:2222-5;  PMID:18178190; http://dx.doi.org/10.1016/j.fertn- stert.2007.10.011.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril 2009; 92:1016-7; PMID:19243747;  http://dx.doi.org/10.1016/j.fertnstert.2008.12.093.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Fertil Steril 2010; 94:581-4;  PMID:19423100; http://dx.doi.org/10.1016/j.fertn- stert.2009.03.085.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Hum Reprod 2009; 24:1561-8;  PMID:19351657; http://dx.doi.org/10.1093/humrep/ dep075.145.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Reprod  Biomed Online 2012; 24:206-10; PMID:22196889;  http://dx.doi.org/10.1016/j.rbmo.2011.10.014.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Metabolism 1982; 31:871-5;  PMID:6811834; http://dx.doi.org/10.1016/0026- 0495(82)90175-5.,Non-OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Hum Reprod 2005; 20:208-15;  PMID:15567884; http://dx.doi.org/10.1093/humrep/ deh569.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
Arch Androl  2005; 51:299-304; PMID:16036638; http://dx.doi.org/10.1080/01485010590919701.,OADS,/arxiv_data1/oa_pdf/97/66/spmg-2-253.PMC3521747.pdf
"The ES is a very important structure between Sertoli cells or Sertoli cells and germ cells during spermatogenesis, which is promi - nently identified at the blood-testis barrier (BTB, also known as  *Correspondence to: Hsiao Chang Chan; Email: hsiaocchan@cuhk.edu.hk Submitted: 07/25/12; Revised: 08/28/12; Accepted: 08/29/12http://dx.doi.org/10.4161/spmg.22014CD147, also named basigin (Bsg) or extracellular matrix ( eCM)  metalloproteinase inducer ( eMMP riN), is a highly glycosylated  protein first identified as a tumor cell surface molecule.",Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
FEBS  Lett 1998; 441:88-92; PMID:9877171; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
J Biol Chem 1997; 272:24-7; PMID:8995219; http://dx.doi.org/10.1074/jbc.272.1.24.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Biochimie 2005; 87:361-8; PMID:15781323; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
BMC  Cancer 2009; 9:337; PMID:19775453; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
J Cell Sci 2005; 118:2649- 60; PMID:15928045; http://dx.doi.org/10.1242/ jcs.02408.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
J Biol Chem  2012; 287:4759-72; PMID:22130661; http://dx.doi.org/10.1074/jbc.M111.277699.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Cell Biol Int 2009; 33:199- 206; PMID:19059491; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
BMC  Cancer 2012; 12:115; PMID:22443116; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Hepatology 2011; 54:2012-24; PMID:21809360; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Oncogene 2011; 30:4410- 27; PMID:21532623; http://dx.doi.org/10.1038/ onc.2011.149.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
J Physiol 1999; 517:633-42; PMID:10358105;  http://dx.doi.org/10.1111/j.1469-7793.1999.0633s.x.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Dev Neurosci 2004; 26:380-7; PMID:15855767;  http://dx.doi.org/10.1159/000082280.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Int J  Cancer 2000; 88:21-7; PMID:10962435; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Front  Biosci 2008; 13:5571-9; PMID:18508606; http://dx.doi.org/10.2741/3100.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Biochem J 2008; 409:311-20; PMID:17760565;  http://dx.doi.org/10.1042/BJ20070374.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
J Biol Chem 2001; 276:46870- 7; PMID:11591720; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Histopathology  2009; 54:677-87; PMID:19438743; http://dx.doi.org/10.1111/j.1365-2559.2009.03280.x.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Arterioscler Thromb Vasc Biol 2001; 21:1104-17; PMID:11451738; http://dx.doi.org/10.1161/ hq0701.093685.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Biochem Biophys Res Commun 1982; 109:1026-34; PMID:6297481; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Anat Sci Int 2003;  78:1-16; PMID:12680465; http://dx.doi.org/10.1046/ j.0022-7722.2003.00034.x.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Biochim Biophys Acta  2008; 1778:692-708; PMID:18068662; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Mol Endocrinol 2000; 14:682-99; PMID:10809232;  http://dx.doi.org/10.1210/me.14.5.682.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Urol Int  2010; 85:216-20; PMID:20530960; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Mol Reprod Dev  2006; 73:1061-72; PMID:16700071; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Reproduction 2011; 141:139-50; PMID:21148286; http://dx.doi.org/10.1530/REP-10- 0232.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Biol Reprod 2012; 86:186; PMID:22495890;  http://dx.doi.org/10.1095/biolreprod.111.097097.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Hum Reprod Update 2004; 10:349- 69; PMID:15192055; http://dx.doi.org/10.1093/ humupd/dmh026.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Adv Exp Med Biol 2008; 636:234-54;  PMID:19856171; http://dx.doi.org/10.1007/978-0- 387-09597-4_13.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Mol  Cell Endocrinol 2010; 315:49-56; PMID:19682538;  http://dx.doi.org/10.1016/j.mce.2009.08.004.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Exp Mol Pathol 2007; 83:283- 95; PMID:17945211; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
EMBO J 2000; 19:3896- 904; PMID:10921872; http://dx.doi.org/10.1093/emboj/19.15.3896.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Genomics 1996; 37:273- 80; PMID:8938438; http://dx.doi.org/10.1006/ geno.1996.0560.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Eur J Immunol 1997; 27:671- 8; PMID:9079808; http://dx.doi.org/10.1002/ eji.1830270315.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Cancer Sci  2011; 102:1287-92; PMID:21443647; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Anticancer Drugs  2010; 21:861-7; PMID:20700044; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Cancer Lett 2009; 276:189-95; PMID:19097686; http://dx.doi.org/10.1016/j.can- let.2008.11.010.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Biochem Biophys Res Commun 2008; 374:111- 6; PMID:18616931; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Int Immunol 2006; 18:1159-69;  PMID:16740601; http://dx.doi.org/10.1093/intimm/ dxl050.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Cell Death Differ  2012; PMID:22595757; http://dx.doi.org/10.1038/ cdd.2012.60.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
J Clin Endocrinol Metab 2007; 92:3292-304;  PMID:17504903; http://dx.doi.org/10.1210/jc.2007- 0367.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Philos T rans R Soc Lond  B Biol Sci 2010; 365:1501-15; PMID:20403866;  http://dx.doi.org/10.1098/rstb.2009.0124.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Immunity  2005; 22:355-70; PMID:15780992; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Oncogene 2003; 22:9030-40; PMID:14663481;  http://dx.doi.org/10.1038/sj.onc.1207116.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
J Surg Oncol 2005; 92:337-43;  PMID:16299808; http://dx.doi.org/10.1002/ jso.20424.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
J Biol Chem 2006; 281:7260- 70; PMID:16407291; http://dx.doi.org/10.1074/jbc.M509868200.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Biochem Biophys Res Commun  2005; 331:851-8; PMID:15865941; http://dx.doi.org/10.1016/j.bbrc.2005.03.189.58.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
FEBS Lett 2004; 563:129-34;  PMID:15063736; http://dx.doi.org/10.1016/S0014- 5793(04)00281-9.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Curr Top Dev Biol 2005; 71:263-96;  PMID:16344108; http://dx.doi.org/10.1016/S0070- 2153(05)71008-5.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Crit Rev Biochem Mol Biol 2009;  44:245-63; PMID:19622063; http://dx.doi.org/10.1080/10409230903061207.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Proc Natl Acad Sci USA  2008; 105:8950-5; PMID:18579774; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Biol Reprod  2004; 70:945-64; PMID:14645107; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Curr  Top Dev Biol 2008; 80:57-92; PMID:17950372;  http://dx.doi.org/10.1016/S0070-2153(07)80002-0.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
J Biol Chem 2006;  281:16799-813; PMID:16617054; http://dx.doi.org/10.1074/jbc.M601618200.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Neurochem Int 2010; 56:67- 76; PMID:19751784; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Eur J Pediatr 2009; 168:705-10;  PMID:18795327; http://dx.doi.org/10.1007/s00431- 008-0828-5.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Mol Reprod Dev 2002; 63:47-54; PMID:12211060;  http://dx.doi.org/10.1002/mrd.10128.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
J Clin Endocrinol Metab 2003; 88:6063-72; PMID:14671212; http://dx.doi.org/10.1210/jc.2003- 030457.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Dev Biol 1998; 194:152- 65; PMID:9501026; http://dx.doi.org/10.1006/ dbio.1997.8819.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Mol Hum Reprod 2011; 17:405-14;  PMID:21343160; http://dx.doi.org/10.1093/molehr/gar013.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Arch  Histol Cytol 1998; 61:405-15; PMID:9990424;  http://dx.doi.org/10.1679/aohc.61.405.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Reproduction  2002; 123:435-44; PMID:11882021; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Anat Histol Embryol 1999; 28:205-13;  PMID:10458027; http://dx.doi.org/10.1046/j.1439- 0264.1999.00194.x.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Biol Reprod 2004; 70:993-1000; PMID:14645104; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Biol Reprod 2005; 72:985-91;  PMID:15601913; http://dx.doi.org/10.1095/biolre- prod.104.036400.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Cell Stem Cell 2008; 3:533-42;  PMID:18983968; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Hum Reprod 2012; 27:1568-76;  PMID:22451502; http://dx.doi.org/10.1093/humrep/ des050.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Cell Death Differ  2006; 13:1614-8; PMID:16485031; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
Oncogene 2001; 20:4601-12; PMID:11498783;  http://dx.doi.org/10.1038/sj.onc.1204484.,OADS,/arxiv_data1/oa_pdf/f5/fd/spmg-2-264.PMC3521748.pdf
"www.landesbioscience.com Spermatogenesis 273Spermatogenesis 2:4, 273-278; October/November/December 2012; © 2012 Landes Bioscience RepOR t Review  Review *Correspondence to: Marc Goldstein; Email: mgoldst@med.cornell.edu Submitted: 09/25/12; Accepted: 10/18/12http://dx.doi.org/10.4161/spmg.22591Introduction Worldwide, it is estimated that approximately 6% of married  couples rely solely on vasectomy for contraception.1 In the United  States, the prevalence of vasectomy among married couples is 7% to 10%, and increases with age such that 18% of men have undergone a vasectomy by age 45.",Non-OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
J Urol 2001; 166:1178- 80; PMID:11490318; http://dx.doi.org/10.1016/ S0022-5347(05)65941-1.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
J Urol 1998; 159:827- 30; PMID:9474160; http://dx.doi.org/10.1016/ S0022-5347(01)63744-3.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Hum Reprod 2008; 23:1698- 707; PMID:18482993; http://dx.doi.org/10.1093/ humrep/den181.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
J Androl 2010; 31:573-83;  PMID:20378925; http://dx.doi.org/10.2164/jan- drol.109.009860.,Non-OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Fertil Steril  1997; 67:133-41; PMID:8986698; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Fertil Steril 2002; 77:516-9; PMID:11872205;  http://dx.doi.org/10.1016/S0015-0282(01)03219-8.,Non-OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Fertil Steril 2004; 81:1371-4;  PMID:15136104; http://dx.doi.org/10.1016/j.fertn- stert.2003.09.066.11.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Biol Reprod 1990; 43:34- 45; PMID:2393691; http://dx.doi.org/10.1095/biolre- prod43.1.34.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Clin Anat  2000; 13:185-94; PMID:10797625; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Biol  Reprod 2001; 64:720-7; PMID:11159378; http://dx.doi.org/10.1095/biolreprod64.2.720.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
J Androl 2011; 32:686-97; PMID:21441430;  http://dx.doi.org/10.2164/jandrol.110.012575.,Non-OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
J Assist Reprod Genet 2011; 28:391- 7; PMID:21327499; http://dx.doi.org/10.1007/ s10815-011-9544-6.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
J Urol 2010; 183:662-5; PMID:20018311;  http://dx.doi.org/10.1016/j.juro.2009.10.010.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Biol Reprod 1989; 41:163-73;  PMID:2804205; http://dx.doi.org/10.1095/biolre- prod41.1.163.References 1.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Hum Reprod 2008; 23:2043- 9; PMID:18556680; http://dx.doi.org/10.1093/hum- rep/den200.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Urology 2006; 68:9- 14; PMID:16806411; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
"J Urol  2006; 176:232-6, discussion 236; PMID:16753407;  http://dx.doi.org/10.1016/S0022-5347(06)00507-6.",OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
BJU Int 2003; 91:839-44;  PMID:12780844; http://dx.doi.org/10.1046/j.1464- 410X.2003.04227.x.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Urol Clin North Am  2009; 36:295-305; PMID:19643232; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Urol Clin North Am 2009; 36:359-73; PMID:19643238; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Int J  Androl 1996; 19:33-8; PMID:8698536; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
BJU Int 2005; 96:598-601;  PMID:16104917; http://dx.doi.org/10.1111/j.1464- 410X.2005.05691.x.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
Nat Clin Pract Urol 2006; 3:381- 91; PMID:16835626; http://dx.doi.org/10.1038/ ncpuro0524.32.,Non-OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
J Urol 1998; 159:188-90; PMID:9400469; http://dx.doi.org/10.1016/S0022-5347(01)64053-9.29.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
J Urol 2004; 171:304- 6; PMID:14665900; http://dx.doi.org/10.1097/01.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
J Urol  2009; 181:264-9; PMID:19013620; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/84/25/spmg-2-273.PMC3521749.pdf
"www.landesbioscience.com Spermatogenesis 279Spermatogenesis 2:4, 279-284; October/November/December 2012; © 2012 Landes Bioscience MethODS  & techNOLOgieS MethODS  & techNOLOgieS  MethODS  & techNOLOgieS *Correspondence to: Craig A. Harrison; Email: craig.harrison@princehenrys.org Submitted: 04/10/12; Revised: 09/21/12; Accepted: 10/10/12http://dx.doi.org/10.4161/spmg.22516Introduction The somatic Sertoli cell of the testis provides structural and  nutritional support to germ cells in the process of spermatogen - esis.",Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Endocrinology 1975; 96:897-89; PMID:1120478;  http://dx.doi.org/10.1210/endo-96-4-879.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Endocrinology 1975; 96:618- 24; PMID:163729; http://dx.doi.org/10.1210/endo- 96-3-618.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Proc Natl Acad Sci USA  2009; 106:10213-8; PMID:19509333; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Reprod  Biol Endocrinol 2008; 6:29; PMID:18620581; http://dx.doi.org/10.1186/1477-7827-6-29.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Reproduction  2009; 137:361-70; PMID:18955374; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Bioessays 2007; 29:441-51; PMID:17450594; http://dx.doi.org/10.1002/ bies.20561.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Cell  Res 2012; 22:208-18; PMID:22064700; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
J Endocrinol 2006; 189:381- 95; PMID:16648304; http://dx.doi.org/10.1677/ joe.1.06634.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Reproduction  2007; 133:1169-79; PMID:17636171; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
T ransplantation 2010; 90:1352- 7; PMID:21197711; http://dx.doi.org/10.1097/ TP .0b013e3181ffb9d2.,OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Neurotox Res 2003; 5:443- 50; PMID:14715448; http://dx.doi.org/10.1007/ BF03033174.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Nat Med 1997; 3:1129-32; PMID:9334725; http://dx.doi.org/10.1038/nm1097- 1129.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Med Hypotheses 2011; 77:35-42;  PMID:21454019; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Reproduction  2011; 141:151-61; PMID:21084571; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Endocrinology  2010; 151:2911-22; PMID:20357222; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Hum Gene Ther 2005; 16:1241- 6; PMID:16259557; http://dx.doi.org/10.1089/ hum.2005.16.1241.,OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Endocrinology  1999; 140:1262-71; PMID:10067852; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Spermatogenesis 2012; 2:1-5;  PMID:22553484; http://dx.doi.org/10.4161/ spmg.19885.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Nat Methods 2007; 4:721-6; PMID:17694064;  http://dx.doi.org/10.1038/nmeth1079.,OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Spermatogenesis 2012;  2:23-31; PMID:22553487; http://dx.doi.org/10.4161/ spmg.19119.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Reproduction 2010; 139:495-504;  PMID:19995832; http://dx.doi.org/10.1530/REP-09-0384.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Endocrinology 2009; 150:2481-90; PMID:19106224;  http://dx.doi.org/10.1210/en.2008-1048.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Endocrinology  2011; 152:1670-83; PMID:21325043; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
J Virol  2000; 74:10074-80; PMID:11024136; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Hum Gene Ther 2001; 12:1103-8; PMID:11399231; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Nat Protoc 2006; 1:241-5; PMID:17406239; http://dx.doi.org/10.1038/ nprot.2006.37.,OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Nucleic Acids Res 1991; 19:408; PMID:2014181;  http://dx.doi.org/10.1093/nar/19.2.408.,Non-OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
Nucleic Acids Res 1991;  19:4293; PMID:1870982; http://dx.doi.org/10.1093/ nar/19.15.4293.,OADS,/arxiv_data1/oa_pdf/11/a4/spmg-2-279.PMC3521750.pdf
"www.landesbioscience.com Spermatogenesis 285Spermatogenesis 2:4, 285-293; October/November/December 2012; © 2012 Landes Bioscience RepOR t RepOR t  RepOR t *Correspondence to: C. Yan Cheng; Email: Y-Cheng@popcbr.rockefeller.edu Submitted: 09/15/12; Revised: 10/08/12; Accepted: 10/11/12http://dx.doi.org/10.4161/spmg.22536Introduction Cadmium is one of the few environmental toxicants that has sig - nificant adverse side-effects in humans, in particular men’s repro - ductive health.",Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Endocr Rev 2009; 30:119-32; PMID:19176467;  http://dx.doi.org/10.1210/er.2008-0025.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
J Biol Chem 2005; 280:25029-47; PMID:15870075;  http://dx.doi.org/10.1074/jbc.M501049200.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Endocrinology 2003; 144:3114-29; PMID:12810568; http://dx.doi.org/10.1210/ en.2002-0167.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Mol  Cell Endocrinol 1992; 89:127-40; PMID:1284490;  http://dx.doi.org/10.1016/0303-7207(92)90219-V. 41.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Proc Natl Acad Sci USA 2011; 108:19623- 8; PMID:22106313; http://dx.doi.org/10.1073/ pnas.1111414108.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Int J Biochem Cell Biol  2010; 42:1864-75; PMID:20713173; http://dx.doi.org/10.1016/j.biocel.2010.08.004.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Int J Biochem Cell Biol 2010; 42:975-86; PMID:20188849; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Int J Biochem Cell Biol  2009; 41:2302-14; PMID:19497385; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
J  Cell Sci 2004; 117:783-98; PMID:14734653; http://dx.doi.org/10.1242/jcs.00900.18.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Proc Natl Acad Sci USA 2011; 108:19719-24; PMID:22095132; http://dx.doi.org/10.1073/ pnas.1113021108.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
J Neurochem  2004; 90:743-9; PMID:15255953; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
J Endocrinol  2011; 209:337-51; PMID:21471187; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Gastroenterology 1997; 113:332-40; PMID:9207295;  http://dx.doi.org/10.1016/S0016-5085(97)70112-4.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Nat Genet 2004;  36:40-5; PMID:14702039; http://dx.doi.org/10.1038/ ng1285.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Am J Physiol Lung Physiol 2008; 294:L1127- 36; http://dx.doi.org/10.1152/ajplung.00057.2008.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
T rends  Pharmacol Sci 2011; 32:99-106; PMID:21168226;  http://dx.doi.org/10.1016/j.tips.2010.11.007.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Biol Reprod  2008; 78:445-54; PMID:18057314; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
FASEB J  2011; 25:1244-53; PMID:21191089; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Endocrinology  2003; 144:371-87; PMID:12488366; http://dx.doi.org/10.1210/en.2002-220786.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Endocrinology 2001; 142:1865-77; PMID:11316752;  http://dx.doi.org/10.1210/en.142.5.1865.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Toxicol Appl Pharmacol  2009; 238:240-9; PMID:19236889; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Spermatogenesis  2011; 1:283-90; PMID:22332111; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Spermatogenesis 2011; 1:2-13; PMID:21866273;  http://dx.doi.org/10.4161/spmg.1.1.13971.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Environ Health Perspect  2010; 118:1676-84; PMID:20716508; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
T rends  Pharmacol Sci 2011; 32:290-9; PMID:21324536;  http://dx.doi.org/10.1016/j.tips.2011.01.001.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Syst  Biol Reprod Med 2010; 56:147-67; PMID:20377313;  http://dx.doi.org/10.3109/19396360903582216.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Pharmacol Rev 2012; 64:16-64; PMID:22039149; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Biochim  Biophys Acta 1999; 1451:93-100; PMID:10446391;  http://dx.doi.org/10.1016/S0167-4889(99)00077-4.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Toxicol  Appl Pharmacol 2003; 189:180-95; PMID:12791303;  http://dx.doi.org/10.1016/S0041-008X(03)00130-3.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Pharmacol Ther  2007; 114:74-93; PMID:17316817; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Crit Rev Toxicol  2011; 41:75-82; PMID:21073263; http://dx.doi.org/1 0.3109/10408444.2010.529104.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Epigenetics 2011; 6:820- 7; PMID:21610324; http://dx.doi.org/10.4161/ epi.6.7.16250.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Toxicol Appl Pharmacol  2010; 248:71-88; PMID:20708025; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Int J Mol Sci  2011; 12:9576-95; PMID:22272150; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Spermatogenesis 2011; 1:121-2; PMID:22319660;  http://dx.doi.org/10.4161/spmg.1.2.16606.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Exp Cell Res 2010; 316:2945- 60; PMID:20682309; http://dx.doi.org/10.1016/j.yexcr.2010.07.018.54.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Philos T rans R Soc Lond B Biol Sci 2010; 365:1517-35; PMID:20403867; http://dx.doi.org/10.1098/ rstb.2009.0235.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Endocr Rev 2001; 22:289-318; PMID:11399746; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
J Pharmacol Exp Ther 2012; 342:510- 9; PMID:22588260; http://dx.doi.org/10.1124/ jpet.112.192344.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
J Pharmacol Exp Ther 2012; 340:96- 108; PMID:21990609; http://dx.doi.org/10.1124/ jpet.111.186916.47.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Biol Reprod 1993;  49:840-9; PMID:8218650; http://dx.doi.org/10.1095/ biolreprod49.4.840.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Proc Natl Acad Sci USA 2010; 107:11399-404; PMID:20534521; http://dx.doi.org/10.1073/ pnas.1001077107.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Endocrinology 2006; 147:5624-33;  PMID:16973730; http://dx.doi.org/10.1210/en.2006-0138.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Proc Natl Acad Sci USA 2005; 102:16696-700; PMID:16275920; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Adv Exp Med Biol 2008; 636:212-33; PMID:19856170; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Endocrinology 2001; 142:1878-88;  PMID:11316753; http://dx.doi.org/10.1210/ en.142.5.1878.,Non-OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
Proc Natl Acad Sci USA 2009; 106:9298- 303; PMID:19470647; http://dx.doi.org/10.1073/ pnas.0813113106.,OADS,/arxiv_data1/oa_pdf/da/15/spmg-2-285.PMC3521751.pdf
"Spermatogenesis 2:4, 294-303; October/November/December 2012; © 2012 Landes Bioscience RepOR t 294 Spermatogenesis Volume 2 Issue 4 RepOR t *Correspondence to: Dolores D. Mruk; Email: mruk@popcbr.rockefeller.edu Submitted: 09/03/12; Revised: 10/10/12; Accepted: 10/16/12http://dx.doi.org/10.4161/spmg.22602Introduction Spermatogenesis is an extremely complex cellular process that  produces approximately 150 million sperm daily in an aver - age healthy male, and it takes place within the seminiferous epithelium under the regulation of several factors, including testosterone, follicle stimulating hormone (FSH), luteinizing hormone (LH) and estradiol 17 β.",Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Philos T rans R Soc Lond B Biol Sci 2010; 365:1517- 35; PMID:20403867; http://dx.doi.org/10.1098/ rstb.2009.0235.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Biochim Biophys Acta 2011; 1812:1616- 29; PMID:21914474; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Anat Rec 1978; 190:99- 111; PMID:626419; http://dx.doi.org/10.1002/ ar.1091900109.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Pharmacol Rev 2012; 64:16-64; PMID:22039149; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Endocr Rev 2004; 25:747-806;  PMID:15466940; http://dx.doi.org/10.1210/er.2003- 0022.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Am J  Anat 1977; 148:313-28; PMID:857632; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Nat Rev Mol Cell Biol 2010; 11:366- 78; PMID:20414258; http://dx.doi.org/10.1038/ nrm2889.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
J Cell Sci 2012; PMID:22976294; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
J Mol Med (Berl) 1996; 74:13- 33; PMID:8834767; http://dx.doi.org/10.1007/ BF00202069.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
J Biol Chem 1999; 274:28978- 82; PMID:10506145; http://dx.doi.org/10.1074/ jbc.274.41.28978.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Proc Natl Acad Sci USA 1995; 92:5808- 12; PMID:7541137; http://dx.doi.org/10.1073/ pnas.92.13.5808.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Endocrinology  1993; 133:389-96; PMID:8319585; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Dev Biol  2009; 327:48-61; PMID:19103189; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Exp Cell Res 2007; 313:1373-92; PMID:17359973;  http://dx.doi.org/10.1016/j.yexcr.2007.01.017.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Endocrinology  2003; 144:371-87; PMID:12488366; http://dx.doi.org/10.1210/en.2002-220786.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
J Endocrinol 2006; 190:313-29; PMID:16899565;  http://dx.doi.org/10.1677/joe.1.06781.26.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Endocrinology 1986; 118:480-8; PMID:3080306;  http://dx.doi.org/10.1210/endo-118-2-480.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Reprod  Domest Anim 2011; 46:1050-60; PMID:21457361;  http://dx.doi.org/10.1111/j.1439-0531.2011.01783.x.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
J  Cell Physiol 1996; 168:123-33; PMID:8647906;  http://dx.doi.org/10.1002/(SICI)1097- 4652(199607)168:1<123::AID-JCP15>3.0.CO;2-8.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Mol Cell Endocrinol 1994; 104:213-27; PMID:7988748; http://dx.doi.org/10.1016/0303- 7207(94)90124-4.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Biol Reprod 1992; 47:568-72;  PMID:1391343; http://dx.doi.org/10.1095/biolre - prod47.4.568.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Biol Reprod  1994; 51:843-51; PMID:7849186; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
J Biol Chem  2000; 275:15006-13; PMID:10748199; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Eur J Biochem  1996; 239:239-47; PMID:8706726; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
J Biol Chem 2008; 283:17391-405; PMID:18413312; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
T rends Immunol 2003; 24:327-34;  PMID:12810109; http://dx.doi.org/10.1016/S1471- 4906(03)00117-0.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Annu Rev Pathol 2011; 6:323-44;  PMID:21073340; http://dx.doi.org/10.1146/annurev- pathol-011110-130224.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Oncogene 2002; 21:5213-23; PMID:12149643;  http://dx.doi.org/10.1038/sj.onc.1205684.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Cancer Res 2007; 67:4227-35;  PMID:17483334; http://dx.doi.org/10.1158/0008-5472.CAN-06-3928.50.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Cytokine Growth Factor Rev 2009; 20:329-38;  PMID:19651533; http://dx.doi.org/10.1016/j.cytog- fr.2009.07.007.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
J Reprod Immunol 1993; 23:63- 72; PMID:8429525; http://dx.doi.org/10.1016/0165- 0378(93)90027-F .,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Endocrinology 1999; 140:3054- 62; PMID:10385397; http://dx.doi.org/10.1210/ en.140.7.3054.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
J Biol Chem 1998; 273:7566-71; PMID:9516459; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Nat Rev Mol Cell Biol 2007; 8:221-33; PMID:17318226;  http://dx.doi.org/10.1038/nrm2125.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Circ Res 2003; 92:827-39;  PMID:12730128; http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
J Cell Sci 2009; 122:3015- 24; PMID:19692588; http://dx.doi.org/10.1242/ jcs.034561.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
J Biol Chem  2002; 277:26340-50; PMID:12004057; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Biol Reprod  2004; 70:945-64; PMID:14645107; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Nature 1959;  184:249-51; PMID:13831896; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
J Reprod Fertil 1974; 36:439- 40; PMID:4819326; http://dx.doi.org/10.1530/ jrf.0.0360439.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
J Biol Chem 2005; 280:26160-8; PMID:15901740; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Mol Cell Endocrinol 2003; 201:1-12; PMID:12706288; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Biochim Biophys Acta 2010; 1803:142-50;  PMID:19409422; http://dx.doi.org/10.1016/j.bbam - cr.2009.04.011.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Eur J Cell Biol 2012; 91:889-95;  PMID:22939226; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Cell Adh Migr 2011; 5:187-98;  PMID:21258212; http://dx.doi.org/10.4161/ cam.5.2.14773.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Cell Motil Cytoskeleton  2009; 66:865-73; PMID:19437513; http://dx.doi.org/10.1002/cm.20380.,Non-OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
Biol Reprod 2008; 78:445-54; PMID:18057314; http://dx.doi.org/10.1095/biolre- prod.107.064501.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
FASEB J 2011; 25:1244-53; PMID:21191089; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/75/34/spmg-2-294.PMC3521752.pdf
"Spermatogenesis 2:4, 304-304; October/November/December 2012; © 2012 Landes Bioscience EDit Or’S cOrNEr 304 Spermatogenesis Volume 2 issue 4 LEttEr t O thE  EDit Or Testin and its emerging modulatory role  in systemic carcinogenesis Shailendra  Kapoor Private Practice; c hicago, i L USA Correspondence to: Shailendra Kapoor; Email: shailendrakapoor@yahoo.com Submitted: 10/09/12; Accepted: 11/01/12DOI: http://dx.doi.org/10.4161/spmg.22744I read with great interest the recent article by Mruk et al.1  Testin may suppress tumor growth in a number of systemic  malignancies.",Non-OADS,/arxiv_data1/oa_pdf/92/c0/spmg-2-304.PMC3521753.pdf
Spermatogenesis 2011; 1:137-46; PMID:22319662;   http://dx.doi.org/10.4161/spmg.1.2.16449.,Non-OADS,/arxiv_data1/oa_pdf/92/c0/spmg-2-304.PMC3521753.pdf
Arch Otolaryngol Head Neck Surg 2009; 135:254-60; PMID:19289703;  http://dx.doi.org/10.1001/archoto.2008.560.,Non-OADS,/arxiv_data1/oa_pdf/92/c0/spmg-2-304.PMC3521753.pdf
Mol Cancer 2010; 9:190; PMID:20626849;   http://dx.doi.org/10.1186/1476-4598-9-190.,Non-OADS,/arxiv_data1/oa_pdf/92/c0/spmg-2-304.PMC3521753.pdf
"www.landesbioscience.com Spermatogenesis 305Spermatogenesis 2:4, 305-305; October/November/December 2012; © 2012 Landes Bioscience authOrS ’  reSpONSe authOr reSpONSe Rat and mouse testicular testin is different from  the human tumor suppressor gene TESTIN (Tes ) Authors’ response to the letter of Dr. S. Kapoor Dolores D. Mruk and C. Yan Cheng the Mary M. Wohlford Laboratory for Male Contraceptive r esearch; Center for Biomedical r esearch; p opulation Council; New York, NY u Sa Correspondence to: Dolores D. Mruk and C. Yan Cheng; Email: mruk@popcbr.rockefeller.edu and Y-Cheng@popcbr.rockefeller.edu Submitted: 10/01/12; Accepted: 11/01/12DOI: http://dx.doi.org/10.4161/spmg.22790In response to the Letter to the Editor from Dr. Shailendra  Kapoor with regard to a paper previously published on testin in Spermatogenesis , 1 we wish to clarify some misinformation on  this protein in the literature.",Non-OADS,/arxiv_data1/oa_pdf/bc/47/spmg-2-305.PMC3521754.pdf
Spermatogenesis 2011; 1:137-46; PMID:22319662;   http://dx.doi.org/10.4161/spmg.1.2.16449.,Non-OADS,/arxiv_data1/oa_pdf/bc/47/spmg-2-305.PMC3521754.pdf
Biol Reprod 1995; 52:340-55; PMID:7711203;   http://dx.doi.org/10.1095/biolreprod52.2.340.,Non-OADS,/arxiv_data1/oa_pdf/bc/47/spmg-2-305.PMC3521754.pdf
Biol Reprod 2003; 68:1376-86; PMID:12606342;   http://dx.doi.org/10.1095/biolreprod.102.011205.,OADS,/arxiv_data1/oa_pdf/bc/47/spmg-2-305.PMC3521754.pdf
Biol Reprod 1994; 51:843-51; PMID:7849186;   http://dx.doi.org/10.1095/biolreprod51.5.843.,Non-OADS,/arxiv_data1/oa_pdf/bc/47/spmg-2-305.PMC3521754.pdf
J Biol Chem 1997; 272:6499-509; PMID:9045675;   http://dx.doi.org/10.1074/jbc.272.10.6499.,OADS,/arxiv_data1/oa_pdf/bc/47/spmg-2-305.PMC3521754.pdf
J Biol Chem 1998; 273:21040-53; PMID:9694856;   http://dx.doi.org/10.1074/jbc.273.33.21040.,OADS,/arxiv_data1/oa_pdf/bc/47/spmg-2-305.PMC3521754.pdf
Biol Reprod 2000; 63:1648-60; PMID:11090432;   http://dx.doi.org/10.1095/biolreprod63.6.1648.,Non-OADS,/arxiv_data1/oa_pdf/bc/47/spmg-2-305.PMC3521754.pdf
Biochem Biophys Res Commun 1993; 191:224-31;  PMID:8447824; http://dx.doi.org/10.1006/bbrc.1993.1206.,OADS,/arxiv_data1/oa_pdf/bc/47/spmg-2-305.PMC3521754.pdf
Genomics 2000; 68:1-12; PMID:10950921;   http://dx.doi.org/10.1006/geno.2000.6272.,OADS,/arxiv_data1/oa_pdf/bc/47/spmg-2-305.PMC3521754.pdf
Eur J Immunol 2003; 33:2964-73; PMID:14579264;   http://dx.doi.org/10.1002/eji.200324149.,Non-OADS,/arxiv_data1/oa_pdf/bc/47/spmg-2-305.PMC3521754.pdf
"This is an Open Access article distributed under the terms of the Creative Commons   Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/),   which permits unrestricted non-commercial use, distribution, and reproduction in any medium,   provided the original work is properly cited.The British Sign Language Versions of the Patient Health  Questionnaire, the Generalized Anxiety Disorder 7-Item Scale, and the Work and Social Adjustment Scale Katherine D. Rogers*, Alys Young, Karina Lovell, Malcolm Campbell, Paul R.  Scott, Sarah Kendal University of Manchester Received July 4, 2012; revisions received October 19, 2012; accepted October 19, 2012 The present study is aimed to translate 3 widely used clinical  assessment measures into British Sign Language (BSL), to pilot the BSL versions, and to establish their validity and reli- ability.",Non-OADS,/arxiv_data1/oa_pdf/9f/55/ens040.PMC3521778.pdf
Retrieved from http://www.bsmhd.,Non-OADS,/arxiv_data1/oa_pdf/9f/55/ens040.PMC3521778.pdf
Retrieved from http://www.cspsychiatr.cz/detail.php?stat=312120 Journal of Deaf Studies and Deaf Education 18:1 January 2013,Non-OADS,/arxiv_data1/oa_pdf/9f/55/ens040.PMC3521778.pdf
Retrieved from http://www.iapt.nhs.uk/equalities/british-sign-language-bsl/ Improving Access to Psychological Therapies.,Non-OADS,/arxiv_data1/oa_pdf/9f/55/ens040.PMC3521778.pdf
"Retrieved from http://www.iapt.nhs.uk/equalities/translations/ Kroenke, K., Spitzer, R. L., & Williams, J.",Non-OADS,/arxiv_data1/oa_pdf/9f/55/ens040.PMC3521778.pdf
"2011;66 (12):2099-104, http://dx.doi.org/10.1590/S1807-59322011001200016.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(6):965-72, http://dx.doi.org/ 10.1590/S1807-59322011000600008.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(9):1591-6, http://dx.doi.org/10.1590/S1807-59322011000900015.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(7):1203-8, http://dx.doi.org/10.1590/S1807-59322011000700014.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(3):465-8, http://dx.doi.org/10.1590/S1807-59322011000300018.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(5):919-22, http://dx.doi.org/10.1590/S1807-59322011000500034.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2010;65(1):53-60, http://dx.doi.org/10.1590/S1807- 59322010000100009.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(6):1097-100, http://dx.doi.org/10.1590/ S1807-59322011000600030.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(6):1073-9, http://dx.doi.org/10.1590/S1807-59322011000600026.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2010;65(4):407-15, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(10):1747- 55, http://dx.doi.org/10.1590/S1807-59322011001000013.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(1):163-5, http://dx.doi.org/10.1590/S1807-59322011000100028.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(8):1401-6, http://dx.doi.org/10.1590/S1807-59322011000800016.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(11):1879-86, http://dx.doi.org/10.1590/S1807-59322011001100006.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(7):1171-5, http://dx.doi.org/10.1590/S1807-59322011000700008.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2010;65(11):1189-95, http://dx.doi.org/10.1590/ S1807-59322010001100023.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2010;65(12):1229-37, http://dx.doi.org/10.1590/S1807- 59322010001200003.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2010;65(12):1285-90, http://dx.doi.org/10.1590/S1807-59322010001200010.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2010;65(6):569-73, http://dx.doi.org/10.1590/ S1807-59322010000600002.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(6):997- 1002, http://dx.doi.org/10.1590/S1807-59322011000600013.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(6):949-53, http://dx.doi.org/10.1590/S1807-59322011000600005.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2010;65(11):1087-92, http://dx.doi.org/10.1590/S1807-59322010001100005.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(8):1485-8, http://dx.doi.org/10.1590/S1807-59322011000800030.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2010;65(9):825-9, http://dx.doi.org/ 10.1590/S1807-59322010000900002.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(10):1681-9, http://dx.doi.org/10.1590/S1807-59322011001000004.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2010;65(8):799-802, http://dx.doi.org/10.1590/S1807-59322010000800010.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(6):1021-5, http://dx.doi.org/10.1590/ S1807-59322011000600017.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2010;65(11):1133-7, http://dx.doi.org/ 10.1590/S1807-59322010001100014.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(12):2013-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(2):189-95, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(12):2071-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(2):261-6, http://dx.doi.org/10.1590/S1807-59322011000200014.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(1):17-20, http://dx.doi.org/10.1590/S1807- 59322011000100004.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(12):2055-61, http://dx.doi.org/10.1590/ S1807-59322011001200010.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2011;66(6):933-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/35/58/cln-67-12-1353.PMC3521794.pdf
"2002;58(6):911-6, http://dx.doi.org/10.1212/ WNL.58.6.911.Table 2 - Polysomnographic findings.",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2010;29(1):36-42, http://dx.doi.org/10.1159/000255972.",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2006;37(4):967-72, http://dx.doi.org/ 10.1161/01.STR.0000208215.49243.c3.",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2008;168(3):297-301, http://dx.doi.org/10.1001/archinternmed.2007.70.",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2004;24(2):267-72, http://dx.doi.org/10.1183/ 09031936.04.00061503.",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2000;118(4):1018-24, http://dx.doi.org/10.1378/chest.118.4.1018.",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2008;39(9):2511-4, http://dx.doi.org/10.1161/STROKEAHA.107.513572.",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2008;30(6):645-8, http://dx.doi.org/10.1179/174313208X289598.",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2009;27(2):119-22, http://dx.doi.org/10.1159/000177918.",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2006;13(2):198-200, http://dx.doi.org/10.1111/j.1468-1331.",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2006;77(10):1143-9, http://dx.doi.org/10.1136/jnnp.2005.",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2009;27(2):183-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2008;30(6):645-8, http://dx.doi.org/10.1179/174313208X289598.",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2011;12(3):262-6, http://dx.doi.org/10.1016/j.sleep.",OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"1996;63(5):283-7, http://dx.doi.org/10.1159/ 000196561.Positional sleep apnea after stroke Camilo MR et al.CLINICS 2012;67(12):1357-1360 1360",Non-OADS,/arxiv_data1/oa_pdf/42/df/cln-67-12-1357.PMC3521795.pdf
"2004;34(13):929-38, http://dx.doi.org/10.2165/ 00007256-200434130-00004.",Non-OADS,/arxiv_data1/oa_pdf/78/d9/cln-67-12-1361.PMC3521796.pdf
"2008;18(1):19-24, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/78/d9/cln-67-12-1361.PMC3521796.pdf
"2007;26(2):214-8, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/78/d9/cln-67-12-1361.PMC3521796.pdf
"2010;29(6):1011-22, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/78/d9/cln-67-12-1361.PMC3521796.pdf
"2007;99(4):379-85, http://dx.doi.org/10.1007/s00421-006-0357-8.",Non-OADS,/arxiv_data1/oa_pdf/78/d9/cln-67-12-1361.PMC3521796.pdf
"2010;38(4):824-8, http://dx.doi.org/10.1177/ 0363546509354056.",Non-OADS,/arxiv_data1/oa_pdf/78/d9/cln-67-12-1361.PMC3521796.pdf
"2006;96(6):659-64, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/78/d9/cln-67-12-1361.PMC3521796.pdf
"2002;83(2):224-8, http://dx.doi.org/10.1053/apmr.2002.28032.",Non-OADS,/arxiv_data1/oa_pdf/78/d9/cln-67-12-1361.PMC3521796.pdf
"2008;22(5):1429-33, http://dx.doi.org/10.1519/JSC.0b013e31818202db.",Non-OADS,/arxiv_data1/oa_pdf/78/d9/cln-67-12-1361.PMC3521796.pdf
"2011;12(4):194-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/78/d9/cln-67-12-1361.PMC3521796.pdf
"2011;39(11):2347-54, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/78/d9/cln-67-12-1361.PMC3521796.pdf
"2003;18(1):126-32, http://dx.doi.org/ 10.1093/ndt/18.1.126.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2004;19(1):95-9, http://dx.doi.org/10.1093/ ndt/gfg423 3.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"1993;328(17):1230-5, http://dx.doi.org/10.1056/NEJM199304293281704.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2002;52(1):16-23, http://dx.doi.org/ 10.1055/s-2002-19662.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2011;26(3):1058-65, http://dx.doi.org/10.1093/ ndt/gfq476.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2007;3(4):1091-4, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2005;37(5):2072-6, http://dx.doi.org/10.1016/j.transproceed.2005.03.084.11.",OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2009;29(6):493-500, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2008;40(1):203-10, http://dx.doi.org/10.1007/s11255-007-9188-8.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2008;40(4):1151-8, http://dx.doi.org/10.1007/s11255-008-9469-x.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2007;63(6):591-7, http://dx.doi.org/ 10.1016/j.jpsychores.2007.06.007.",OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2002;53(3):737-40, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2007;57(1):52, http://dx.doi.org/10.1590/S0034-709420 07000100006.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2007;22(10):3028-33, http://dx.doi.org/10.1093/ ndt/gfm309.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2005;20(1):194-8, http://dx.doi.org/10.1093/ndt/ gfh604.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2009;18(9):1185-93, http://dx.doi.org/10.1007/s11136-009-9536-5.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2008;40(3):785- 91, http://dx.doi.org/10.1007/s11255-008-9359-2.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2007;39(4):1095-7, http://dx.doi.org/10.1016/j.transproceed.",OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2007;39(4):1082-4, http://dx.doi.org/10.1016/ j.transproceed.2007.03.088.",OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2007;39(4):1074-8, http://dx.doi.org/10.1016/j.transproceed.2007.04.002.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2010;23(5):484-92, http://dx.doi.org/10.1111/j.1432-2277.2009.01003.x.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2010;66(4):828-38, http://dx.doi.org/10.1111/j.1365-2648.2009.05243.x.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2001;38(3):443-64, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"1998;32(1):93-100, http://dx.doi.org/10.1053/ajkd.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"2002;16(2):113-21, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6f/0f/cln-67-12-1365.PMC3521797.pdf
"Nat Rev Cancer 2002;2(1):38-47, http://dx.doi.org/10.1038/nrc704.",Non-OADS,/arxiv_data1/oa_pdf/ec/aa/cln-67-12-1373.PMC3521798.pdf
"2006;441(7092):437-43, http://dx.doi.org/10.1038/nature04871.",Non-OADS,/arxiv_data1/oa_pdf/ec/aa/cln-67-12-1373.PMC3521798.pdf
"2012;148(3):399-408, http://dx.doi.org/10.1016/j.cell.2012.01.021.",OADS,/arxiv_data1/oa_pdf/ec/aa/cln-67-12-1373.PMC3521798.pdf
"2007;26(2):341-52, http://dx.doi.org/10.1007/ s10555-007-9059-x.",Non-OADS,/arxiv_data1/oa_pdf/ec/aa/cln-67-12-1373.PMC3521798.pdf
"2001;85(6):881-90, http://dx.doi.org/10.1054/bjoc.2001.2018.8.",Non-OADS,/arxiv_data1/oa_pdf/ec/aa/cln-67-12-1373.PMC3521798.pdf
"2004;10(16):5566-71, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ec/aa/cln-67-12-1373.PMC3521798.pdf
"2004;111(1):43-50, http://dx.doi.org/10.1002/ijc.20052.",Non-OADS,/arxiv_data1/oa_pdf/ec/aa/cln-67-12-1373.PMC3521798.pdf
"2009;10(Suppl 1):S17-23, http://dx.doi.org/10.3816/CLC.2009.s.003.",Non-OADS,/arxiv_data1/oa_pdf/ec/aa/cln-67-12-1373.PMC3521798.pdf
"2006;355(24):2542-50, http://dx.doi.org/10.1056/ NEJMoa061884.",Non-OADS,/arxiv_data1/oa_pdf/ec/aa/cln-67-12-1373.PMC3521798.pdf
"2005;6(5):299-303, http://dx.doi.org/10.3816/CLC.2005.n.009.",Non-OADS,/arxiv_data1/oa_pdf/ec/aa/cln-67-12-1373.PMC3521798.pdf
"2005;49(3):325-35, http://dx.doi.org/10.1016/j.lungcan.2005.03.036.",OADS,/arxiv_data1/oa_pdf/ec/aa/cln-67-12-1373.PMC3521798.pdf
"2009;32(2): 142-9, http://dx.doi.org/10.1159/ 000184747.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2008;39(2):292-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"1995;274(13):1017-25, http://dx.doi.org/10.1001/ jama.1995.03530130023023.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2007;38(3):967–73, http://dx.doi.org/ 10.1161/01.STR.0000258112.14918.24.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2007;38(3):948-54, http://dx.doi.org/10.1161/01.STR.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2010;41(10):2254-8, http://dx.doi.org/10.1161/STROKEAHA.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2010;41(8):1836-40, http://dx.doi.org/10.1161/STROKEAHA.110.584904.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2010;41(11):2559-67, http://dx.doi.org/ 10.1161/STROKEAHA.110.592071.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2011;32(7):1269–73, http://dx.doi.org/10.3174/ajnr.A2494.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2011;42(7):1929-35, http://dx.doi.org/10.1161/STROKEAHA.110.608976.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2011;3 Suppl 1:A1-39, http://dx.doi.org/10.1136/neurintsurg-2011-010097.2.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2011;32(6):1078-81, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2011;153(8):1625-31, http://dx.doi.org/ 10.1007/s00701-011-0999-0.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2011;32(7):1245-8, http://dx.doi.org/10.3174/ajnr.A2505.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2012;19(1):39- 43, http://dx.doi.org/10.1016/j.jocn.2011.06.015.",OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2012;4(1):62- 6, http://dx.doi.org/10.1136/jnis.2010.004051.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2012;83(1):117-8, http://dx.doi.org/10.1136/jnnp.2010.225573.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2012;54(2):147-54, http://dx.doi.org/10.1007/s00234-010-0835-x.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2005;36(7):1432-8, http://dx.doi.org/ 10.1161/01.STR.0000171066.25248.1d.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2008;39(4):1205-12, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"1999;282(21):2003-11, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b6/08/cln-67-12-1379.PMC3521799.pdf
"2006;12(9):1310-6, http://dx.doi.org/10.1002/lt.20894.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2010;30(2):208-14, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2009; 24(Suppl 3):S93-6, http://dx.doi.org/10.1111/j.1440-1746.2009.06078.x.5.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2001;72(4):666-70, http://dx.doi.org/10.1097/00007890- 200108270-00018.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"1991;14(6):1102-8, http://dx.doi.org/10.1002/hep.1840140626.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"1996;24(6):1422-7, http://dx.doi.org/10.1002/hep.510240620.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"1997;16(2):43-55, http://dx.doi.org/10.1016/S0261-5614(97)80022-2.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"1997;25(3):652-7, http://dx.doi.org/10.1002/hep.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2008;63(3):357-62, http://dx.doi.org/10.1590/S1807-59322008000300012.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2011;27(2):133-7, http://dx.doi.org/10.1016/j.nut.2010.06.001.",OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2008;27(1):72-6, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2010;65(11):1087- 92, http://dx.doi.org/10.1590/S1807-59322010001100005.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2011;66(1):57-64, http://dx.doi.org/10.1590/S1807-59322011000100011.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2000;30(4):361-7, http://dx.doi.org/10.1097/00005176- 200004000-00003.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2002;5(3):297-307, http://dx.doi.org/10.1097/00075197-200205000-00010.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2008;51(5):626-8, http://dx.doi.org/10.1002/pbc.21697.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2000;70(9):1347-52, http://dx.doi.org/ 10.1097/00007890-200011150-00014.CLINICS 2012;67(12):1387-1392 Anthropometric evaluation liver transplantation Zamberlan P et al.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2000;19(2):101-7, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2002;21(1):73-7, http://dx.doi.org/10.1054/clnu.2001.0508.32.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"1997;3(5):532-7, http://dx.doi.org/10.1002/lt.500030509.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
"2011;35(4):445-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/14/7d/cln-67-12-1387.PMC3521800.pdf
The primer pairs used to amplify the coding exons and exon/intron boundaries of GATA5 using polymerase chain reaction (PCR) were designed as pre- viously described using Primer 3 software (http://frodo.wi.,OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"Alignment of multiple GATA5 protein sequences Multiple GATA5 protein sequences across various species were aligned using the online program MUSCLE, Version 3.6 (http://www.ncbi.nlm.nih.gov/).",OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
The two variants were not observed in the 400 control alleles nor were they found in the NCBI SNP database (http://www.ncbi.nlm.nih.gov/SNP).,Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2004;110(9):1042-6, http://dx.doi.org/10.1161/ 01.CIR.0000140263.20897.42.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2012;67(6):543-6, http://dx.doi.org/10.6061/clinics/2012(06)01.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2012;67(4):305-11, http://dx.doi.org/10.6061/ clinics/2012(04)02.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"1998;989(10):946-52, http://dx.doi.org/10.1161/01.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"1991;22(8):983-8, http://dx.doi.org/10.1161/01.STR.22.8.983.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"1978;28(10):973-7, http://dx.doi.org/10.1212/WNL.28.10.973.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2011;13(10):1375-85, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2003;41(12):2185-92, http://dx.doi.org/10.1016/S0735- 1097(03)00465-0.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2010;49(22):2385-91, http://dx.doi.org/10.2169/ internalmedicine.49.4130.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2010;304(20):2263-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2004;291(23):2851-5, http://dx.doi.org/10.1001/jama.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2011;89(4):692-700, http://dx.doi.org/10.1093/cvr/cvq381.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2009;6(12):1818-24, http://dx.doi.org/10.1016/j.hrthm.2009.07.011.",OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2004;63(2):196- 207, http://dx.doi.org/10.1016/j.cardiores.2004.03.025.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2010;53(4):201-3, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2011;412(19-20):1825-30, http://dx.doi.org/10.1016/j.cca.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"Mol Biol Rep. 2012;39(8):8127- 35, http://dx.doi.org/10.1007/s11033-012-1660-6.",OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2012;155(3):494-6, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2007;134(1):189-98, http://dx.doi.org/10.1242/dev.02720.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2012;157(2):305-7, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"1999;10(10):993-9, http://dx.doi.org/ 10.1007/s003359901146.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"1998;339(10):659-66, http://dx.doi.org/10.1056/NEJM199809033391003.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2011;13(10):1394-400, http://dx.doi.org/10.1093/europace/eur145.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2007;101(9):902-9, http://dx.doi.org/10.1161/CIRCRESAHA.107.161182.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2007;100(3):354-62, http://dx.doi.org/10.1161/ 01.RES.0000258019.74591.b3.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2002;39(11):807-11, http://dx.doi.org/10.1136/jmg.39.11.807.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"2006;14(12):1313-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/62/24/cln-67-12-1393.PMC3521801.pdf
"1997;12(3):456-63, http://dx.doi.org/10.1359/jbmr.1997.12.3.456.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"1997;7(1):36-8, http://dx.doi.org/10.1007/ BF01623457.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2001;30(5):371-3, http://dx.doi.org/10.1093/ageing/30.5.371.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2011;22(2):711-9, http://dx.doi.org/10.1007/s00198-010-1258-6.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2001;12(2):85-90, http://dx.doi.org/10.1007/ s001980170138.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2005;76(4):235-42, http://dx.doi.org/10.1007/s00223- 004-2222-2.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"1988;10(4):283-96, http://dx.doi.org/10.1016/0378-5122(88)90064-3.15.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2001;12(11):903- 8, http://dx.doi.org/10.1007/ s001980170017.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2010;85(9):806-13, http://dx.doi.org/10.4065/mcp.2010.0082.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2004;15(1):80-5, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2009;62(1):85-90, http://dx.doi.org/10.1016/j.maturitas.2008.10.012.",OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2003;289(19):2560-72, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2008;43(6):1115-21, http://dx.doi.org/ 10.1016/j.bone.2008.08.106.",OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2006;9(1):31-6, http://dx.doi.org/10.1016/j.jocd.2006.05.005.",OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2004;15(12):975-80, http://dx.doi.org/10.1007/ s00198-004-1633-2.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"1993;36(6):750-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2000;11(7):577-82, http://dx.doi.org/10.1007/s001980070078.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2003;11(2):209-16, http://dx.doi.org/10.1038/oby.2003.33.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2003;14(8):677-82, http://dx.doi.org/10.1007/ s00198-003-1423-2.",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2010;66(2):206- 11, http://dx.doi.org/10.1016/j.maturitas.2010.03.009.",OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2012;23(8):2141-50, http://dx.doi.org/10.1007/ s00198-011-1856-y.Vertebral fractures and quality of life Lopes JB et al.CLINICS 2012;67(12):1401-1406 1406",Non-OADS,/arxiv_data1/oa_pdf/6b/ac/cln-67-12-1401.PMC3521802.pdf
"2004;17(4):337-49, http://dx.doi.org/10.1111/j.1365-277X.2004.00533.x.",Non-OADS,/arxiv_data1/oa_pdf/86/70/cln-67-12-1407.PMC3521803.pdf
"2005;294(19):2455-64, http://dx.doi.org/10.1001/jama.294.",Non-OADS,/arxiv_data1/oa_pdf/86/70/cln-67-12-1407.PMC3521803.pdf
"2005;45:1379-87, http://dx.doi.org/10.1016/j.jacc.",OADS,/arxiv_data1/oa_pdf/86/70/cln-67-12-1407.PMC3521803.pdf
"2009;12(9A):1644-7, http://dx.doi.org/10.1017/ S1368980009990498.",Non-OADS,/arxiv_data1/oa_pdf/86/70/cln-67-12-1407.PMC3521803.pdf
"2011;108 (11):1523-9, http://dx.doi.org/10.1016/j.amjcard.2011.07.008.",OADS,/arxiv_data1/oa_pdf/86/70/cln-67-12-1407.PMC3521803.pdf
"2011;8(1):32, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/86/70/cln-67-12-1407.PMC3521803.pdf
"2011;49(3):188-94, http://dx.doi.org/10.3164/jcbn.11-02.",Non-OADS,/arxiv_data1/oa_pdf/86/70/cln-67-12-1407.PMC3521803.pdf
"2007;88:suppl1, http://dx.doi.org/10.1590/S0066-782X2007000700002.",Non-OADS,/arxiv_data1/oa_pdf/86/70/cln-67-12-1407.PMC3521803.pdf
"2005;7(2):102-9, http://dx.doi.org/10.1111/j.1524-6175.",Non-OADS,/arxiv_data1/oa_pdf/86/70/cln-67-12-1407.PMC3521803.pdf
BMI classification - WHO http://apps.who.int/bmi/index.jsp?intro Page=intro_3.html.,OADS,/arxiv_data1/oa_pdf/86/70/cln-67-12-1407.PMC3521803.pdf
"1999;99:779-85, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/86/70/cln-67-12-1407.PMC3521803.pdf
"2011;269:150-9, http://dx.doi.org/10.1111/j.",Non-OADS,/arxiv_data1/oa_pdf/86/70/cln-67-12-1407.PMC3521803.pdf
"2010;65:99-106, http://dx.doi.org/10.1590/S1807- 59322010000100015.",Non-OADS,/arxiv_data1/oa_pdf/86/70/cln-67-12-1407.PMC3521803.pdf
"2005;173:1256-61, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/02/16/cln-67-12-1415.PMC3521804.pdf
"1992;267:1077-82, http://dx.doi.org/10.1001/jama.1992.03480080047025.",Non-OADS,/arxiv_data1/oa_pdf/02/16/cln-67-12-1415.PMC3521804.pdf
"2010;58(3):384-97, http://dx.doi.org/10.1016/j.eururo.2010.06.005.",Non-OADS,/arxiv_data1/oa_pdf/02/16/cln-67-12-1415.PMC3521804.pdf
"2011;185(4):1374-8, http://dx.doi.org/10.1016/j.juro.2010.11.086.",OADS,/arxiv_data1/oa_pdf/02/16/cln-67-12-1415.PMC3521804.pdf
"2001;39(2):151-8, http://dx.doi.org/10.1159/000052430.",Non-OADS,/arxiv_data1/oa_pdf/02/16/cln-67-12-1415.PMC3521804.pdf
"1998;33(5):476–80, http://dx.doi.org/10.1159/000019638.",Non-OADS,/arxiv_data1/oa_pdf/02/16/cln-67-12-1415.PMC3521804.pdf
"2004;64(2):306–10, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/02/16/cln-67-12-1415.PMC3521804.pdf
"2009;12(1):57-60, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/02/16/cln-67-12-1415.PMC3521804.pdf
"2004;73(3):193-7, http://dx.doi.org/10.1159/000080826.",Non-OADS,/arxiv_data1/oa_pdf/02/16/cln-67-12-1415.PMC3521804.pdf
"2011;37(3):380-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/02/16/cln-67-12-1415.PMC3521804.pdf
"2006;6:14, http://dx.doi.org/ 10.1186/1471-2490-6-14.",Non-OADS,/arxiv_data1/oa_pdf/02/16/cln-67-12-1415.PMC3521804.pdf
"Curr Urol Rep. 2011;12(4):265–73, http://dx.doi.org/10.1007/s11934-011-0193-1.",Non-OADS,/arxiv_data1/oa_pdf/02/16/cln-67-12-1415.PMC3521804.pdf
"2008;22(4):713-8, http://dx.doi.org/10.1089/end.",Non-OADS,/arxiv_data1/oa_pdf/02/16/cln-67-12-1415.PMC3521804.pdf
"1988;11(1):21-32, http://dx.doi.org/ 10.1002/mus.880110106.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2010;33(10):2285- 93, http://dx.doi.org/10.2337/dc10-1303.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"1993;16(7):757-68, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2005;28(4):956-62, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2010;33(1):207-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"1998;17(4):25-33, http://dx.doi.org/10.1109/51.687960.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2009;52(1):42-7, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2003;16(9):1257-62, http://dx.doi.org/10.1515/JPEM.2003.16.9.1257.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"1990;1:121-38, http://dx.doi.org/10.1177/1358836X9000100204.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2001;24(8):1468-75, http://dx.doi.org/10.2337/diacare.24.8.1468.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2001;3(1):29-50, http://dx.doi.org/10.1089/152091501750220000.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2007;30(10):2613-18, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2003;26(5):1553-79, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2003;52(7):815- 20, http://dx.doi.org/10.1016/S0026-0495(03)00095-7.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2000;23(11):1686-93, http://dx.doi.org/10.2337/diacare.23.11.1686.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2003;27(6):646-61, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
/http://www.measurementexperts.org/ instrument/instrument_reviews.asp?detail=66.,OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2006;5(4):250-60, http://dx.doi.org/10.1177/1534734606293481.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"1993;10:820-4, http://dx.doi.org/10.1111/j.1464-5491.1993.tb00173.x.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2006;114:153-9, http://dx.doi.org/10.1055/s-2006-924083.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"1992;15(11):1509-16, http://dx.doi.org/10.2337/diacare.15.11.1509.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"Associac ¸a˜oM e´dica Brasileira e Conselho Federal de Medicina, 2005. http://www.projetodiretrizes.org.br/4_ volume/09-Diabetesm.pdf.Thermography in diabetic neuropathy Balbinot LF et al.CLINICS 2012;67(12):1419-1425 1424",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2001;54(2):115- 28, http://dx.doi.org/10.1016/S0168-8227(01)00278-9.",OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2011;66(7):1259-66, http://dx.doi.org/10.1590/S1807-59322011000700023.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2004;127(Pt 7):1593-605, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/6c/b7/cln-67-12-1419.PMC3521805.pdf
"2003;84(1):90-5, http://dx.doi.org/10.1053/apmr.2003.50004.",Non-OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2003;84(1):17-22, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2006;150(2):261-5, http://dx.doi.org/10.5507/ bp.2006.038.",Non-OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2010;14(3);183-92, http://dx.doi.org/10.1590/S1413-35552010000300003.",Non-OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2000;81(4):484-9, http://dx.doi.org/10.1053/mr.2000.",Non-OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2003;17(2):136-41, http://dx.doi.org/10.1016/S0966-6362(02)00161-3.",Non-OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2006;30(12):1750-7, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2007;26(1):32-8, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2009;17(10):1951-6, http://dx.doi.org/10.1038/oby.2009.82.",Non-OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2009;52(8):977-86, http://dx.doi.org/10.1080/00140130902777636.",Non-OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2002;17:666-77, http://dx.doi.org/10.1016/S0268-0033(02)00107-9.",OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2009;19(6):e513-9, http://dx.doi.org/10.1016/j.jelekin.2008.10.007.",OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2000;9(8):865-72, http://dx.doi.org/10.1089/152460900750020892.",Non-OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2009;27(4):549-54, http://dx.doi.org/10.1002/jor.20661.",Non-OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"2001;28(6):624-33, http://dx.doi.org/10.1080/ 03014460110047946.",Non-OADS,/arxiv_data1/oa_pdf/86/06/cln-67-12-1433.PMC3521807.pdf
"1988;84(2):155-61, http://dx.doi.org/10.1007/BF00421050.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"2004;44:239-67, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"2001;305(1):75- 80, http://dx.doi.org/10.1016/S0009-8981(00)00422-8.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"2000;21(3):361-70, http://dx.doi.org/10.1093/carcin/21.3.361.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"2004;88:219-24, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"2002;16(5):461-6, http://dx.doi.org/10.1002/ptr.1015.19.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"2000;55(6):280-5, http://dx.doi.org/10.1093/gerona/55.6.B280.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"1997;170(1-2):131-8, http://dx.doi.org/10.1023/A:1006853419214.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"2011;8(1):42, http://dx.doi.org/ 10.1186/1743-7075-8-42.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"1997;35(3):273-82, http://dx.doi.org/10.1016/ S0162-3109(96)00150-6.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"1987;161(2):559-66, http://dx.doi.org/10.1016/0003-2697(87)90489-1.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"2000;742(2):315-25, http://dx.doi.org/10.1016/S0378- 4347(00)00174-2.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"2003 5;785(2):337-44, http://dx.doi.org/10.1016/S1570-0232(02)00956-X.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"1981;103(4):1245-53, http://dx.doi.org/10.1016/ 0006-291X(81)90256-4.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"1988;5(5-6):335- 9, http://dx.doi.org/10.1016/0891-5849(88)90105-0.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"2002;22(1-2):55-64, http://dx.doi.org/10.1016/S0271-5317(01)00371-2.",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"1998;24(9):1477-84, http://dx.doi.org/10.1016/S0891- 5849(98)00025-2.Piper betle modulates antioxidant enzymes Aliahmat NS et al.CLINICS 2012;67(12):1447-1454 1454",Non-OADS,/arxiv_data1/oa_pdf/c5/77/cln-67-12-1447.PMC3521809.pdf
"2001;21(4):517-24, http://dx.doi.org/10.1055/s-2001-19032.2.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"2000;35(5):717-20, http://dx.doi.org/10.1053/jpsu.2000.6034.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"1985;20:693-5, http://dx.doi.org/10.1016/S0022-3468(85)80026-9.",OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"1997;32(7):1103-7, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"2005;40(2):327-30, http://dx.doi.org/ 10.1016/j.jpedsurg.2004.10.017.",OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"2007;42(8):1324-8, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"1997;26(6):1363-71, http://dx.doi.org/10.1016/S0168-8278 (97)80473-4.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"1996;31(2-3):183-93, http://dx.doi.org/10.1016/ 0162-3109(95)00048-8.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"2003;18(4):437-44, http://dx.doi.org/10.1046/j.1440-1746.2003.03004.x.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"2009;13(1):81-7, http://dx.doi.org/10.1111/j.1399- 3046.2008.00947.x.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"1979;28(7):1063-6, http://dx.doi.org/10.1016/0006- 2952(79)90304-6.20.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"1997;29:181-96, http://dx.doi.org/10.1016/S0306-3623 (96)00314-X.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"2006;58:488-520, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"2007;76:481-511, http://dx.doi.org/10.1146/annurev.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"2000;32:14-15, http://dx.doi.org/10.1016/S0168-8278(00)80436-5.",OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"2002;7:d496-503, http://dx.doi.org/10.2741/ kinnman.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"2006;130(4):1270-82, http://dx.doi.org/10.1053/j.gastro.2005.12.034.CLINICS 2012;67(12):1455-1461 Portal fibrogenesis and biliary obstruction Andrade WC et al.",Non-OADS,/arxiv_data1/oa_pdf/2e/04/cln-67-12-1455.PMC3521810.pdf
"2004;32(5 Suppl):S313-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2011;216(3):302-8, http://dx.doi.org/10.1016/j.imbio.",OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2010;215(6):435- 42, http://dx.doi.org/10.1016/j.imbio.2009.09.002.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2002;17(4):286-92, http://dx.doi.org/10.1097/ 00024382-200204000-00008.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2010;33(2): 126-36, http://dx.doi.org/10.1007/ s10753-009-9166-7.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2000;14(3):265-9; discussion 9-70, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2010;47(16):2587-93, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2006;32(1):80-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2009;38(5):507-14, http://dx.doi.org/10.1097/MPA.0b013e31819fef75.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2010;37(1):35-9, http://dx.doi.org/10.1111/ j.1440-1681.2009.05220.x.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2000;14(5):503-8, http://dx.doi.org/10.1097/00024382- 200014050-00002.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2001;50(2):206-12, http://dx.doi.org/10.1097/00005373-200102000-00004.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2000;14(3):409-14; discussion 414-5, http://dx.doi.org/10.1097/00024382-200014030-00029.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2012;37(3):268- 75, http://dx.doi.org/10.1097/SHK.0b013e31823f152f.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"1995;96(5):2339-47, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"1999;126(2):378-83, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2000;48(1):45-8, http://dx.doi.org/10.1097/ 00005373-200001000-00008.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2011;35(6):560-6, http://dx.doi.org/10.1097/SHK.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2006;173(1):84-90, http://dx.doi.org/10.1164/rccm.200507-1118OC.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2006;34(4):1073-9, http://dx.doi.org/10.1097/01.CCM.0000206470.47721.8D.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2001;29(2):380-4, http://dx.doi.org/10.1097/00003246- 200102000-00029.",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2000;6(2):164-70, http://dx.doi.org/10.1038/72262.The role of hypertonic saline solution in inflammation Theobaldo MC et al.CLINICS 2012;67(12):1463-1468 1468",Non-OADS,/arxiv_data1/oa_pdf/8a/7c/cln-67-12-1463.PMC3521811.pdf
"2008;29(24):2959-71, http://dx.doi.org/10.1093/eurheartj/ehn387.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2005;40(4):229-42, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2005;98(4):1154-62, http://dx.doi.org/10.1152/ japplphysiol.00164.2004.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2003;289(1):76-9, http://dx.doi.org/10.1001/jama.289.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2006;18(12):1241- 5, http://dx.doi.org/10.1097/01.meg.0000243872.86949.95.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2010;47(10):829-39, http://dx.doi.org/10.1007/ s13312-010-0142-y.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2006;42:105-17, http://dx.doi.org/10.1042/bse0420105.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2006;24(3):585-99, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2008;16(10):2217-22, http://dx.doi.org/10.1038/oby.2008.339.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2007;40(1):23-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2009;379(2):605-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2009;12(2):153- 64, http://dx.doi.org/10.1080/13697130802447074.24.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2008;59(3):259-67, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2009;34(6):1079-86, http://dx.doi.org/10.1139/H09- 116.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2008;24(2):177-86, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2001;130(1):21-7, http://dx.doi.org/10.1016/S1095-6433(01)00362-2.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2004;29(1):16-31, http://dx.doi.org/10.1139/h04- 002.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2005;73(1):9-15, http://dx.doi.org/10.1016/j.plefa.2005.04.010.",OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2003;89(6):603-11, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2007;37(1):31-46, http://dx.doi.org/10.2165/ 00007256-200737010-00003.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2011;3(1):18-24, http://dx.doi.org/10.4330/ wjc.v3.i1.18.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2010;9:109, http://dx.doi.org/10.1186/1476- 511X-9-109.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"1999;274(45):31868-74, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2007;16(4):388-95, http://dx.doi.org/10.1111/j.1365-2869.2007.00614.x.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2010;43(5):467-75, http://dx.doi.org/10.1590/S0100-879X2010007500030.",Non-OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2010;316(2):129-39, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/af/15/cln-67-12-1469.PMC3521812.pdf
"2003;160(11):2063-5, http://dx.doi.org/10.1176/appi.ajp.160.11.2063.",Non-OADS,/arxiv_data1/oa_pdf/7b/86/cln-67-12-1479.PMC3521813.pdf
"2010;35(2):581-90, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7b/86/cln-67-12-1479.PMC3521813.pdf
"2010;36(1):71-93, http://dx.doi.org/10.1093/schbul/sbp116.",Non-OADS,/arxiv_data1/oa_pdf/7b/86/cln-67-12-1479.PMC3521813.pdf
"2007;30(3):511-33, http://dx.doi.org/10.1016/j.psc.2007.04.001.",OADS,/arxiv_data1/oa_pdf/7b/86/cln-67-12-1479.PMC3521813.pdf
"2006;163(12):2090-5, http://dx.doi.org/10.1176/appi.ajp.163.12.2090.",Non-OADS,/arxiv_data1/oa_pdf/7b/86/cln-67-12-1479.PMC3521813.pdf
"2009;113(1):49-55, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7b/86/cln-67-12-1479.PMC3521813.pdf
"2006;3(1):10-21, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7b/86/cln-67-12-1479.PMC3521813.pdf
"2007;22(5):267-75, http://dx.doi.org/10.1016/j.eurpsy.2007.02.005.Treatment response in schizophrenia Kayo M et al.CLINICS 2012;67(12):1479-1482 1482",Non-OADS,/arxiv_data1/oa_pdf/7b/86/cln-67-12-1479.PMC3521813.pdf
"1959;79(1):85-93, http://dx.doi.org/10.1001/archsurg.1959.0432 0070089015.",Non-OADS,/arxiv_data1/oa_pdf/aa/82/cln-67-12-1483.PMC3521814.pdf
"1948;127(2):193-206, http://dx.doi.org/10.1097/ 00000658-194802000-00001.",Non-OADS,/arxiv_data1/oa_pdf/aa/82/cln-67-12-1483.PMC3521814.pdf
"1963;87:230-8, http://dx.doi.org/10.1001/archsurg.1963.01310140038010.",Non-OADS,/arxiv_data1/oa_pdf/aa/82/cln-67-12-1483.PMC3521814.pdf
"2007;22(11):3097- 101, http://dx.doi.org/10.1093/ndt/gfm430.",Non-OADS,/arxiv_data1/oa_pdf/aa/82/cln-67-12-1483.PMC3521814.pdf
"1998;98(8):642-7, http://dx.doi.org/10.1161/01.CIR.98.7.642.",Non-OADS,/arxiv_data1/oa_pdf/aa/82/cln-67-12-1483.PMC3521814.pdf
"2004;45(4):637-45, http://dx.doi.org/10.1536/jhj.45.637.",Non-OADS,/arxiv_data1/oa_pdf/aa/82/cln-67-12-1483.PMC3521814.pdf
"2005;46(3):557-62, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/aa/82/cln-67-12-1483.PMC3521814.pdf
"1997;20(5):353-8, http://dx.doi.org/10.1007/s002709900167.",Non-OADS,/arxiv_data1/oa_pdf/aa/82/cln-67-12-1483.PMC3521814.pdf
"2006;108(3):1037-44, http://dx.doi.org/10.1182/blood-2005-12-4916.",Non-OADS,/arxiv_data1/oa_pdf/54/fa/cln-67-12-1487.PMC3521815.pdf
"2006;30(1):9-16, http://dx.doi.org/10.1016/j.leukres.2005.05.019.",OADS,/arxiv_data1/oa_pdf/54/fa/cln-67-12-1487.PMC3521815.pdf
"Br J Haematol 2007; 139(5):701-8, http://dx.doi.org/10.1111/j.1365-2141.2007.06865.x.",Non-OADS,/arxiv_data1/oa_pdf/54/fa/cln-67-12-1487.PMC3521815.pdf
"2008;22(6):1175-83, http://dx.doi.org/10.1038/leu.2008.49.",Non-OADS,/arxiv_data1/oa_pdf/54/fa/cln-67-12-1487.PMC3521815.pdf
"2012;97(6):895- 902, http://dx.doi.org/10.3324/haematol.2011.057158.",Non-OADS,/arxiv_data1/oa_pdf/54/fa/cln-67-12-1487.PMC3521815.pdf
"2004;45(6):1279-83, http://dx.doi.org/10.1080/10428190310001638869.Table 2 - Previous reports of MDS and B-chronic lymphoproliferative disorders .",Non-OADS,/arxiv_data1/oa_pdf/54/fa/cln-67-12-1487.PMC3521815.pdf
"2002;43(1):191- 3, http://dx.doi.org/10.1080/10428190210205.",Non-OADS,/arxiv_data1/oa_pdf/54/fa/cln-67-12-1487.PMC3521815.pdf
"1997;21(7):619-21, http://dx.doi.org/10.1016/S0145- 2126(97)00017-9.",Non-OADS,/arxiv_data1/oa_pdf/54/fa/cln-67-12-1487.PMC3521815.pdf
"Br J Haematol 2007;139(5):701-8, http://dx.doi.org/10.1111/j.1365-2141.2007.06865.x.",Non-OADS,/arxiv_data1/oa_pdf/54/fa/cln-67-12-1487.PMC3521815.pdf
"2006;30(4):507- 10, http://dx.doi.org/10.1016/j.leukres.2005.08.025.",OADS,/arxiv_data1/oa_pdf/54/fa/cln-67-12-1487.PMC3521815.pdf
"2009;94(4):496-506, http://dx.doi.org/10.3324/ haematol.13612.",Non-OADS,/arxiv_data1/oa_pdf/54/fa/cln-67-12-1487.PMC3521815.pdf
"2008;93(1):151-2, http://dx.doi.org/10.3324/haematol.11822.",Non-OADS,/arxiv_data1/oa_pdf/54/fa/cln-67-12-1487.PMC3521815.pdf
"2008;32(1):5-17, http://dx.doi.org/10.1016/j.leukres.2007.04.020.CLINICS 2012;67(12):1487-1491 MDS and monoclonal B-cell lymphocytosis Sandes AF et al.",OADS,/arxiv_data1/oa_pdf/54/fa/cln-67-12-1487.PMC3521815.pdf
"2011;103(10):546-8, http://dx.doi.org/10.4321/S1130-0108 2011001000009.",Non-OADS,/arxiv_data1/oa_pdf/ba/1e/cln-67-12-1493.PMC3521816.pdf
"Gastroenterology 2011;140(3):e7-8, http://dx.doi.org/10.1053/j.gastro.",Non-OADS,/arxiv_data1/oa_pdf/ba/1e/cln-67-12-1493.PMC3521816.pdf
"2008;28(3):352-4, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/ba/1e/cln-67-12-1493.PMC3521816.pdf
"2010;30(3):277-80, http://dx.doi.org/10.3109/01443610903576282.",Non-OADS,/arxiv_data1/oa_pdf/ba/1e/cln-67-12-1493.PMC3521816.pdf
"2008;14(45):6975-80, http://dx.doi.org/10.3748/ wjg.14.6975.",Non-OADS,/arxiv_data1/oa_pdf/ba/1e/cln-67-12-1493.PMC3521816.pdf
"2008; 28(3):259-60, http://dx.doi.org/10.1080/01443610802042993.",Non-OADS,/arxiv_data1/oa_pdf/ba/1e/cln-67-12-1493.PMC3521816.pdf
"1984;120(4):484-9, http://dx.doi.org/10.1001/archderm.1984.016504000660 14.",Non-OADS,/arxiv_data1/oa_pdf/97/ee/cln-67-12-1497.PMC3521817.pdf
"2006;26(12):1154-7, http://dx.doi.org/ 10.1007/s00296-006-0152-1.",Non-OADS,/arxiv_data1/oa_pdf/97/ee/cln-67-12-1497.PMC3521817.pdf
"1996;21(1):65-6, http://dx.doi.org/10.1111/j.1365-2230.1996.tb00018.x.",Non-OADS,/arxiv_data1/oa_pdf/97/ee/cln-67-12-1497.PMC3521817.pdf
"1989;96(1):215-6, http://dx.doi.org/10.1378/ chest.96.1.215.",Non-OADS,/arxiv_data1/oa_pdf/97/ee/cln-67-12-1497.PMC3521817.pdf
"1981;62(3):169-73, http://dx.doi.org/10.1016/0041-3879(81)90002-7.",Non-OADS,/arxiv_data1/oa_pdf/97/ee/cln-67-12-1497.PMC3521817.pdf
"1996;63(5):292- 7, http://dx.doi.org/10.1159/000196563.",Non-OADS,/arxiv_data1/oa_pdf/97/ee/cln-67-12-1497.PMC3521817.pdf
"1999; 3(5):300-3, http://dx.doi.org/10.1016/S1092-9134(99)80026-4.",Non-OADS,/arxiv_data1/oa_pdf/97/ee/cln-67-12-1497.PMC3521817.pdf
"Arch Intern Med 1985;145(3):554-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/97/ee/cln-67-12-1497.PMC3521817.pdf
"Lancet 1991;338(8763):364-6, http://dx.doi.org/10.1016/ 0140-6736(91)90492-8.",Non-OADS,/arxiv_data1/oa_pdf/97/ee/cln-67-12-1497.PMC3521817.pdf
"2007;18(4):377- 80, http://dx.doi.org/10.1097/MBC.0b013e3280d942b4.",Non-OADS,/arxiv_data1/oa_pdf/97/ee/cln-67-12-1497.PMC3521817.pdf
"2005;76(6):1023-33, http://dx.doi.org/10.1086/430842.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"1977;113(12):1674-7, http://dx.doi.org/10.1001/archderm.1977.01640120042005.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"1999;135(10):1195-202, http://dx.doi.org/10.1001/archderm.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"2007;175(10):1044-53, http://dx.doi.org/10.1164/rccm.200610-1483OC.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"2008;32(5):1316-20, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"2007;131(2):624-7, http://dx.doi.org/10.1378/chest.06-0559.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"2006;61(3):259-66, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"2008;32(5):1399-403, http://dx.doi.org/10.1183/ 09031936.00132007.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"2008;102(8):e73-85, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"2006;354(24):2621-2, http://dx.doi.org/10.1056/NEJMc053410.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"2011;37(4):424-30, http://dx.doi.org/10.1590/S1806-37132011000400003.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"1997;28(9):1071-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"1994;370(6484):61-5, http://dx.doi.org/10.1038/370061a0.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"2002;11(3):295-9, http://dx.doi.org/10.1097/ 00041552-200205000-00005.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"2009;103(1):124-9, http://dx.doi.org/10.1016/j.rmed.2008.07.017.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"2003;28(4):504-11, http://dx.doi.org/10.1165/rcmb.2002- 0124OC.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"2002;39(12):906-12, http://dx.doi.org/10.1136/jmg.39.12.906.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"2011;79(4):345-54, http://dx.doi.org/10.1111/j.1399-0004.2010.",Non-OADS,/arxiv_data1/oa_pdf/b5/04/cln-67-12-1501.PMC3521818.pdf
"1990;27(11):701-6, http://dx.doi.org/10.1136/jmg.27.11.701.",Non-OADS,/arxiv_data1/oa_pdf/f0/9f/cln-67-12-1505.PMC3521819.pdf
"1994;24(6):392- 406, http://dx.doi.org/10.1007/BF02011904.",Non-OADS,/arxiv_data1/oa_pdf/f0/9f/cln-67-12-1505.PMC3521819.pdf
"2010;1192:269-77, http://dx.doi.org/10.1111/j.1749-6632.2009.05244.x.",Non-OADS,/arxiv_data1/oa_pdf/f0/9f/cln-67-12-1505.PMC3521819.pdf
"2011;129(5):497-502, http://dx.doi.org/10.1007/s00439-011-0947-3.",Non-OADS,/arxiv_data1/oa_pdf/f0/9f/cln-67-12-1505.PMC3521819.pdf
"2009;374(9698):1351-63, http://dx.doi.org/10.1016/S0140-6736 (09)61069-2.2.",Non-OADS,/arxiv_data1/oa_pdf/66/33/cln-67-12-1511.PMC3521820.pdf
"2011;306(15):1659, http://dx.doi.org/10.1001/jama.2011.1471.",Non-OADS,/arxiv_data1/oa_pdf/66/33/cln-67-12-1511.PMC3521820.pdf
"2011;37(5):824-30, http://dx.doi.org/10.1007/s00134-011-2158-8.",Non-OADS,/arxiv_data1/oa_pdf/66/33/cln-67-12-1511.PMC3521820.pdf
"2002;48(6):612-9, http://dx.doi.org/10.1097/ 00002480-200211000-00007.",Non-OADS,/arxiv_data1/oa_pdf/66/33/cln-67-12-1511.PMC3521820.pdf
"2009;23(6):886-92, http://dx.doi.org/10.1053/j.jvca.2009.08.006.",Non-OADS,/arxiv_data1/oa_pdf/66/33/cln-67-12-1511.PMC3521820.pdf
"2011;68(12):1543-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/66/33/cln-67-12-1511.PMC3521820.pdf
"2011;14(3):423- 6, http://dx.doi.org/10.1007/s12028-011-9516-9.",Non-OADS,/arxiv_data1/oa_pdf/66/33/cln-67-12-1511.PMC3521820.pdf
"2009;23(7):1419-27, http://dx.doi.org/10.1007/s00464-009- 0463-x.",Non-OADS,/arxiv_data1/oa_pdf/d9/a4/cln-67-12-1519.PMC3521822.pdf
"2010;20(5):469-71, http://dx.doi.org/10.1089/lap.2009.",Non-OADS,/arxiv_data1/oa_pdf/d9/a4/cln-67-12-1519.PMC3521822.pdf
"2005;24(3):466-77, http://dx.doi.org/10.1016/j.clnu.2005.02.002.",OADS,/arxiv_data1/oa_pdf/d9/a4/cln-67-12-1519.PMC3521822.pdf
"2008;10(5):336- 40, http://dx.doi.org/10.1080/13651820802276622.",Non-OADS,/arxiv_data1/oa_pdf/d9/a4/cln-67-12-1519.PMC3521822.pdf
"2008;18(11):1492-94, http://dx.doi.org/10.1007/s11695-008-9649-x.",Non-OADS,/arxiv_data1/oa_pdf/d9/a4/cln-67-12-1519.PMC3521822.pdf
"2010;24(9):2236-40, http://dx.doi.org/10.1007/s00464-010-0940-2.",Non-OADS,/arxiv_data1/oa_pdf/d9/a4/cln-67-12-1519.PMC3521822.pdf
"2009;13(8):1520-3, http://dx.doi.org/ 10.1007/s11605-009-0869-8.",Non-OADS,/arxiv_data1/oa_pdf/d9/a4/cln-67-12-1519.PMC3521822.pdf
"2011;25(10):3222-7, http://dx.doi.org/10.1007/s00464-011-1697-y.",Non-OADS,/arxiv_data1/oa_pdf/d9/a4/cln-67-12-1519.PMC3521822.pdf
"2006;1:51, http://dx.doi.org/10.1186/1750-1172-1-51.",Non-OADS,/arxiv_data1/oa_pdf/57/dc/cln-67-12-1523.PMC3521823.pdf
"2012;19(3):278-86, http://dx.doi.org/10.5603/CJ.2012.0050.",Non-OADS,/arxiv_data1/oa_pdf/57/dc/cln-67-12-1523.PMC3521823.pdf
"1995;35(2):116-20, http://dx.doi.org/10.1002/ccd.1810350207.",Non-OADS,/arxiv_data1/oa_pdf/57/dc/cln-67-12-1523.PMC3521823.pdf
"2001; 20(6):1255-7, http://dx.doi.org/10.1016/S1010-7940(01)00998-8.",Non-OADS,/arxiv_data1/oa_pdf/57/dc/cln-67-12-1523.PMC3521823.pdf
"2001;22(1):58-61, http://dx.doi.org/10.1097/00000433-200103000-00011.CLINICS 2012;67(12):1523-1525 Fistula in pregnancy Roscani MG et al.",Non-OADS,/arxiv_data1/oa_pdf/57/dc/cln-67-12-1523.PMC3521823.pdf
"2003;120(4):556-73, http://dx.doi.org/10.1046/j.1365-2141.",Non-OADS,/arxiv_data1/oa_pdf/9f/01/cln-67-12-1527.PMC3521824.pdf
"2006;11(3):139-46, http://dx.doi.org/10.1080/10245330600667583.",Non-OADS,/arxiv_data1/oa_pdf/9f/01/cln-67-12-1527.PMC3521824.pdf
"2008;3:249-77, http://dx.doi.org/10.1146/annurev.",Non-OADS,/arxiv_data1/oa_pdf/9f/01/cln-67-12-1527.PMC3521824.pdf
"2004;103(11):4043-9, http://dx.doi.org/10.1182/blood-2003-11-4035.",Non-OADS,/arxiv_data1/oa_pdf/9f/01/cln-67-12-1527.PMC3521824.pdf
"2010;182(2):230-6, http://dx.doi.org/10.1164/rccm.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2004;23(5):527-31, http://dx.doi.org/10.1016/j.healun.2003.07.003.",OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2003;167(11):1483-9, http://dx.doi.org/10.1164/rccm.2203034.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2005;171(11):1312-6, http://dx.doi.org/10.1164/rccm.200409-1243OC.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2011;184(2):159-71, http://dx.doi.org/10.1164/rccm.201101-0134CI.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"1999;116(1):187-94, http://dx.doi.org/ 10.1378/chest.116.1.187.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2002;121(6):1876-82, http://dx.doi.org/10.1378/chest.121.6.1876.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2011;306(15):1659-68, http://dx.doi.org/10.1001/jama.2011.1471.CLINICS 2012;67(12):1529-1532 ECMO for PDG after lung transplantation Peˆ go-Fernandes PM et al.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2009;64(10):1025-30, http://dx.doi.org/10.1590/S1807-5932 2009001000014.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2009;64(10):1015-24, http://dx.doi.org/ 10.1590/S1807-59322009001000013.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"1979;242(20):2193-6, http://dx.doi.org/10.1001/jama.1979.03300200023016.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2011;37(5):824-30, http://dx.doi.org/10.1007/s00134-011-2158-8.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2011;37(9):1447-57, http://dx.doi.org/ 10.1007/s00134-011-2301-6.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2009;374(9698):1351-63, http://dx.doi.org/10.1016/S0140-6736 (09)61069-2.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2009;55(3):255-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2011;66(9):1659-61, http://dx.doi.org/10.1590/S1807-59322011000900027.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2007;31(3):462-7, http://dx.doi.org/10.1016/j.ejcts.2006.11.050.",OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2001;25(8):607-12, http://dx.doi.org/10.1046/j.1525- 1594.2001.025008607.x.",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2007;26(5):472-7, http://dx.doi.org/10.1016/j.healun.2007.01.031.",OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"2012;67(10):1157-63, http://dx.doi.org/10.6061/clinics/ 2012(10)07.ECMO for PDG after lung transplantation Peˆ go-Fernandes PM et al.CLINICS 2012;67(12):1529-1532 1532",Non-OADS,/arxiv_data1/oa_pdf/c9/86/cln-67-12-1529.PMC3521825.pdf
"4 1, No.11,Nov2012, pp.1-9 Review article 1 Available at: http://ijph.tums.ac.ir Environmental Factors Inducing Human Cancers N Parsa National Institutes of Health, Bethesda, MD, USA *Corresponding Author: Email:nzparsa@yahoo.com (Received 11 Jun 2012; accepted 21 Oct 2012) Introduction Current biological mechanisms of cancer suggest that all cancers are originated from both environ - ment and genetics, meaning that there are multiple external factors combined with internal genetic changes will lead to human cancers.",Non-OADS,/arxiv_data1/oa_pdf/cb/45/ijph-41-1.PMC3521879.pdf
Parsa:Environmental Factors Inducing Human … Available at: http://ijph.tums.ac.ir 2to change a normal cell to a cancer cell.,Non-OADS,/arxiv_data1/oa_pdf/cb/45/ijph-41-1.PMC3521879.pdf
"4 1, No.11,Nov2012, pp.1-9 3 Available at: http://ijph.tums.ac.irwell.",Non-OADS,/arxiv_data1/oa_pdf/cb/45/ijph-41-1.PMC3521879.pdf
"Parsa:Environmental Factors Inducing Human … Available at: http://ijph.tums.ac.ir 4cancer linked inherited syndromes, two cases of rare cancers in the same family and family history of multipl icity of primary tumors (11).",Non-OADS,/arxiv_data1/oa_pdf/cb/45/ijph-41-1.PMC3521879.pdf
"4 1, No.11,Nov2012, pp.1-9 5 Available at: http://ijph.tums.ac.irtion is the major cause of non -melanoma skin cancers, which are by far the most common malignancies in human populations.",Non-OADS,/arxiv_data1/oa_pdf/cb/45/ijph-41-1.PMC3521879.pdf
Parsa:Environmental Factors Inducing Human … Available at: http://ijph.tums.ac.ir 6marketing.,Non-OADS,/arxiv_data1/oa_pdf/cb/45/ijph-41-1.PMC3521879.pdf
"4 1, No.11,Nov2012, pp.1-9 7 Available at: http://ijph.tums.ac.irdigestion and absorption, followed by mental changes and coma.",Non-OADS,/arxiv_data1/oa_pdf/cb/45/ijph-41-1.PMC3521879.pdf
Parsa:Environmental Factors Inducing Human … Available at: http://ijph.tums.ac.ir 8as the driving force in initiating tumor develop - ment and progression.,Non-OADS,/arxiv_data1/oa_pdf/cb/45/ijph-41-1.PMC3521879.pdf
"4 1, No.11,Nov2012, pp.1-9 9 Available at: http://ijph.tums.ac.ir17.Reimer KJ, Koch I, Cullen, WR (2010).",Non-OADS,/arxiv_data1/oa_pdf/cb/45/ijph-41-1.PMC3521879.pdf
Ac - cessed at http://www.cancer.org/Cancer/Colonan - dRectumCancer/DetailedGuide/index .,Non-OADS,/arxiv_data1/oa_pdf/cb/45/ijph-41-1.PMC3521879.pdf
"4 1, No.11,Nov2012, pp.10-18 Original Article 10 Available at: http://ijph.tums.ac.ir HBV Subgenotype C2 Infection, A1762T/G1764A Mutations May Contribute To Hepatocellular Carcinoma with Cirrhosis in South east China Yueming Chen, Daojun Yu, Weiying Zhang, Chunning Qiu, Guoqian Xiang, Weijian Dai, Shenghai Wu, *Xianjun Wang Dept.",Non-OADS,/arxiv_data1/oa_pdf/ce/4b/ijph-41-10.PMC3521880.pdf
":HBV Subgenotype C2 Infection, A1762T/G1764A Mutations … 11 Available at: http://ijph.tums.ac.irG1862T, G1896A and G1899A nucleotide acid substitution.",Non-OADS,/arxiv_data1/oa_pdf/ce/4b/ijph-41-10.PMC3521880.pdf
"4 1, No.11,Nov2012, pp.10-18 Available at: http://ijph.tums.ac.ir 12USA), the reagent kits provided by DaAn Gene Diagnostic Co., Ltd of SUN YAT -SEN University (Guangzhou, China) with a lower limit of detec - tion of 500 copies/mL.",Non-OADS,/arxiv_data1/oa_pdf/ce/4b/ijph-41-10.PMC3521880.pdf
":HBV Subgenotype C2 Infection, A1762T/G1764A Mutations … 13 Available at: http://ijph.tums.ac.irP=0.002 for HCC vs.CHB; respectively) and A1762T/G1764A mutations (57.33% vs.41.25%, P=0.005 for LC vs.CHB; 58.97% vs.41.25%, P=0.002 for HCC vs.CHB; respect ively) weremore often detected in LC and HCC patients than in CHB patients, but there were no differences in both variants between LC and HCC patients (Ta - ble 1).",Non-OADS,/arxiv_data1/oa_pdf/ce/4b/ijph-41-10.PMC3521880.pdf
"4 1, No.11,Nov2012, pp.10-18 Available at: http://ijph.tums.ac.ir 14more frequently than in those without cirrhosis (65.42%vs.34.58%,P=0.016 for subgenotype C2;66.30%vs.33.70%,P=0.009 for the mutations; respectively) (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/ce/4b/ijph-41-10.PMC3521880.pdf
":HBV Subgenotype C2 Infection, A1762T/G1764A Mutations … 15 Available at: http://ijph.tums.ac.irLC and HCC with cirrhosis for subgenotype C2 infection were similar to that for the mutations in the patients with CHB, but the risks of ad vanced liver diseases for these two variants in combi - nation (OR=2.662, 95%CI=1.593 -4.460,P=0.001 for LCvsCHB; OR=3.837, 95%CI=2.131 -6.930,P=0.001 for HC C with cirrho sisvsCHB; respe c- tively) were seemed to higher than that for uni - variant (Table 4).",Non-OADS,/arxiv_data1/oa_pdf/ce/4b/ijph-41-10.PMC3521880.pdf
"4 1, No.11,Nov2012, pp.10-18 Available at: http://ijph.tums.ac.ir 16DNA level showed obviously higher in the p a- tients with advanced liver disease.",Non-OADS,/arxiv_data1/oa_pdf/ce/4b/ijph-41-10.PMC3521880.pdf
":HBV Subgenotype C2 Infection, A1762T/G1764A Mutations … 17 Available at: http://ijph.tums.ac.irpredicting these diseases, but all no helpful for predicting HCC development in LC patients.",Non-OADS,/arxiv_data1/oa_pdf/ce/4b/ijph-41-10.PMC3521880.pdf
"4 1, No.11,Nov2012, pp.10-18 Available at: http://ijph.tums.ac.ir 1811.Chen J, Yin J, Tan X, Zhang H,Zhang H, ChenB, et al(2007).",Non-OADS,/arxiv_data1/oa_pdf/ce/4b/ijph-41-10.PMC3521880.pdf
"41, No.11,Nov2012, pp.102-103 Letter to the Editor 102 Available at: http://ijph.tums.ac.ir Validity of Evaluation Approaches for Outbreak Detection Methods in Syndromic Surveillance Systems M Karami Dept.",Non-OADS,/arxiv_data1/oa_pdf/e5/8b/ijph-41-102.PMC3521881.pdf
103 Available at: http://ijph.tums.ac.ir(2004).,Non-OADS,/arxiv_data1/oa_pdf/e5/8b/ijph-41-102.PMC3521881.pdf
"4 1, No.11,Nov2012, pp.19-26 Original Article 19 Available at: http://ijph.tums.ac.ir Predictors of Non -Uptake of Human Immunodeficiency Virus Testing by Tuberculosis Public Primary Patients in Three Districts, SouthAfrica *K Peltzer1, 2, G Mchunu1, B Tutshana1, P Naidoo1, 3, G Matseke1, J Louw1 1.HIV/STI and TB (HAST) Research Programme, Human Sciences Research Council, Pretoria, Durban and Cape Town, South Africa 2.Dept.",Non-OADS,/arxiv_data1/oa_pdf/89/18/ijph-41-19.PMC3521882.pdf
":Predictors of Non -Uptake of Human Immunodeficiency Virus … Available at: http://ijph.tums.ac.ir 20South African national tuberculosis management guidelines, TB clients should be strongly advised to have an HIV test; ideally the offer of an HIV test should take place soon after initiation of TB treatment, as the morbidity and mortality of co - infected patients are the highest in the first two months of treatment (1).",Non-OADS,/arxiv_data1/oa_pdf/89/18/ijph-41-19.PMC3521882.pdf
"4 1, No.11,Nov2012, pp.19-26 21 Available at: http://ijph.tums.ac.irlevel (3 items), symptoms of alcohol dependence (3 items), and problems associated with alcohol use (4 items).",Non-OADS,/arxiv_data1/oa_pdf/89/18/ijph-41-19.PMC3521882.pdf
":Predictors of Non -Uptake of Human Immunodeficiency Virus … Available at: http://ijph.tums.ac.ir 22Marital status (N=4632, 268 missing) Not married Married/cohabitating Separated/divorced/widowed2954 (91.0) 881 (90.5) 233 (86.0)291(9.0) 92 (9.5) 38 (14.0) Education(N=4818, 82 missing) Grade 7 or less Grade 8-11 Grade 12 or more1091 (88.9) 3004 (90.9) 124 (89.9)136 (11.1) 299 (9.1) 14 (10.1) Poverty index (N=4620, 280 missing) Low Medium High1447 (91.8) 1972 (90.4) 637(87.0)130 (8.2) 209 (9.6) 95 (13.0) Residence(N=4827, 73 missing) Urban Rural Informal settlement2786 (89.5) 793 (93.7) 649 (90.1)327 (10.5) 53 (6.3) 71 (9.9) Perceived health status (N=4833, 67 missing) Excellent/very good Good Fair/poor764(87.0) 1483 (91.1) 1997 (91.5)114 (13.0) 144 (8.9) 186 (8.5) TB treatment status (N=4835, 65 missing) New TB Retreatment1009 (92.0) 3228 (89.9)363 (10.1) 88 (8.0) Current tobacco use (N=4735, 165 missing) Yes No1097 (87.4) 3064 (91.7)158(12.6) 278 (8.3) Hazardous or harmful alcohol use (N=4808, 92 missing) Yes No984 (88.6) 3271 (91.0)122 (11.4) 325 (9.0) Severe psychological distress (N=4845, 55 missing) Yes No1017 (88.1) 2988 (91.3)138 (11.9) 283 (8.7) Sexually active in the past 3 months (N=4585, 315 missing) Yes No2013 (88.8) 2018 (62.1)255 (11.2) 174 (7.9) Last sexual partner (N=4453, 447 missing) HIV negative or unknown HIV positive2754 (87.3) 1168 (98.9)402 (12.7) 13 (1.1) Sex without condom use occasions (past 3 months) (N=2632) 0-2 times 3-20 21-41+ times1387 (90.9) 607 (86.7) 257 (81.6)139 (9.1) 93 (13.3) 58 (18.4) Sex with condom use occasions (past 3 months) (N=2623) 0-2 times 3-20 21-41+ times1059 (87.0) 725(90.0) 461 (90.0)158 (13.0) 81 (10.0) 51 (10.0) Unprotected last sex (N=4287, 613 missing) Yes No2140 (93.4) 1660 (88.0)152 (6.6) 226 (12.0) 1N do not add up to the total due to missing valuesTable 1: Cond…",Non-OADS,/arxiv_data1/oa_pdf/89/18/ijph-41-19.PMC3521882.pdf
"4 1, No.11,Nov2012, pp.19-26 23 Available at: http://ijph.tums.ac.irHIV testing characteristics Those who got tested for HIV gave as major reasons to get tested “I was feeling sick” (50.6%) and “I wanted to know my HIV status” (33%) (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/89/18/ijph-41-19.PMC3521882.pdf
":Predictors of Non -Uptake of Human Immunodeficiency Virus … Available at: http://ijph.tums.ac.ir 24Gender Female Male1.00 2.01 (1.63 -2.47)***1.00 1.96 (1.39 -2.75)*** Marital status Not married Married/cohabitating Separated/divorced/widowed1.00 1.06 (0.83 -1.36) 1.66 (1.15 -2.38)**1.00 0.87 (0.60 -1.26) 1.63 (0.84 -3.14) Education Grade 7or less Grade 8-11 Grade 12 or more1.00 0.80 (0.64 -0.99)* 0.91 (0.51 -1.62)1.00 1.11 (0.75 -1.64) 1.35 (0.61 -3.02) Poverty index Low Medium High1.00 1.18 (0.94 -1.48) 1.66 (1.25 -2.20)***1.00 1.13 (0.79 -1.62) 1.44 (0.91 -2.26) Residence Urban Rural Informal settlement1.00 0.60 (0.42 -0.77)*** 0.93 (0.71 -1.22)1.00 0.79 (0.50 -1.32) 0.85 (0.50 -1.32) Perceived health status Excellent/very good Good Fair/poor1.00 0.65 (0.50 -0.85)*** 0.62 (0.49 -0.80)***1.00 0.78 (0.53 -1.15) 0.88 (0.60 -1.29) TBtreatment status New TB Retreatment1.00 1.29 (1.01 -1.65)*1.00 0.97 (0.67 -1.40) Substance use Current tobacco use 1.59 (1.29 -1.95)*** 1.04 (0.74 -1.47) Hazardous or harmful alcohol use 1.30 (1.04 -1.61)* 0.94 (0.66 -1.35) Severe psychological distress 1.43 (1.16 -1.78)*** 1.40 (1.00 -1.95)* Sexual (risk) behaviour Sexually active in the past 3 months 1.47 (1.20 -1.80)*** 1.48 (0.79 -2.77) Sex without condom use occasions 1.14 (1.08 -1.21)*** 1.14 (1.07 -1.22)*** Last sexual partner HIV positive HIV negative or unknown1.00 13.12 (7.52 -22.88)***1.00 16.96 (6.90 -41.65)*** aUsing “enter” LR selection of variables bFor Hosmer and Lemeshow Chi -square 16.17, df 8, 0.040; Cox and Snell R20.08; Nagelkerke R20.16 *P<0.05; ** P<0.01; *** P<0.001 Discussion The study found among a large sample of tuberculosis public primary care patients that 9.6% had not tested for HIV within one month of TB treatment.",Non-OADS,/arxiv_data1/oa_pdf/89/18/ijph-41-19.PMC3521882.pdf
"4 1, No.11,Nov2012, pp.19-26 25 Available at: http://ijph.tums.ac.irshould engage with patients about their fear of HIV-positivity, TB -HIV coinfection, emotional concerns and stigma.",Non-OADS,/arxiv_data1/oa_pdf/89/18/ijph-41-19.PMC3521882.pdf
":Predictors of Non -Uptake of Human Immunodeficiency Virus … Available at: http://ijph.tums.ac.ir 266.Ayenew A ,Leykun A,Colebunders R ,Deribew A (2010).",Non-OADS,/arxiv_data1/oa_pdf/89/18/ijph-41-19.PMC3521882.pdf
"4 1, No.11,Nov2012, pp.27-33 Original Article 27 Available at: http://ijph.tums.ac.ir Biodiversity of Keratinophilic Fungal Flora in University Campus, Jaipur, India Neetu Jain, Meenakshi Sharma Laboratory of Microbiology, Dept.",Non-OADS,/arxiv_data1/oa_pdf/82/94/ijph-41-27.PMC3521883.pdf
":Biodiversity of Keratinophilic Fungal Flora … Available at: http://ijph.tums.ac.ir 28which it is proposed, should be utilized for the recycling of keratin in soil and may be exploited for their biotechnological potential in industry.",Non-OADS,/arxiv_data1/oa_pdf/82/94/ijph-41-27.PMC3521883.pdf
"4 1, No.11,Nov2012, pp.27-33 29 Available at: http://ijph.tums.ac.irTable 1:Keratinophilic fungal flora of University Campus T. rubrumT.",Non-OADS,/arxiv_data1/oa_pdf/82/94/ijph-41-27.PMC3521883.pdf
":Biodiversity of Keratinophilic Fungal Flora … Available at: http://ijph.tums.ac.ir 30Among all these fungal species Microsporum audoui- nii(0.52%),Cladosporium sp.",Non-OADS,/arxiv_data1/oa_pdf/82/94/ijph-41-27.PMC3521883.pdf
"4 1, No.11,Nov2012, pp.27-33 31 Available at: http://ijph.tums.ac.irthe capital of Rajasthan, is a highly populated city.",Non-OADS,/arxiv_data1/oa_pdf/82/94/ijph-41-27.PMC3521883.pdf
:Biodiversity of Keratinophilic Fungal Flora … Available at: http://ijph.tums.ac.ir 32ben (29).,Non-OADS,/arxiv_data1/oa_pdf/82/94/ijph-41-27.PMC3521883.pdf
"4 1, No.11,Nov2012, pp.34-43 Original Article 34 Available at: http://ijph.tums.ac.ir IsaMass Prevention and Control Program for Pandemic (H1N1) 2009 Good Value for Money?",Non-OADS,/arxiv_data1/oa_pdf/1f/9d/ijph-41-34.PMC3521884.pdf
":Is A Mass Prevention and Control Program for Pandemic … 35 Available at: http://ijph.tums.ac.ireconomics, to handle public health emergencies or major infectious disease in a more economical way and to allot and use the limited health resource rationally so as to Improve the efficiency in the use of health resources in the future, it was very necessary to conduct a health economic evaluation on the H1N1 influenza prevention and control program, especially the cost -benefit analysis.",Non-OADS,/arxiv_data1/oa_pdf/1f/9d/ijph-41-34.PMC3521884.pdf
"4 1, No.11,Nov2012, pp.34-43 Available at: http://ijph.tums.ac.ir 36any measures for the prevention and control.4 The counterfactual scenarios like this: In the trend that H1N1 may spread around the world, if no measures were taken to prevent and control H1N1 in Hubei province, it would natural spo - radic even the outbreak around the province.",Non-OADS,/arxiv_data1/oa_pdf/1f/9d/ijph-41-34.PMC3521884.pdf
"The data about con - firmed cases, deaths and others came from the official website of U.S. governme nt (url: http://www.flu.gov/individualfamily/about/h1n 1/estimates_2009_h1n1.html).",OADS,/arxiv_data1/oa_pdf/1f/9d/ijph-41-34.PMC3521884.pdf
:Is A Mass Prevention and Control Program for Pandemic … 37 Available at: http://ijph.tums.ac.irBenefit data The data of treatment cost saved per capita in di - rect benefit calculation was the same with those for diagnosed patient in cost data.,OADS,/arxiv_data1/oa_pdf/1f/9d/ijph-41-34.PMC3521884.pdf
"4 1, No.11,Nov2012, pp.34-43 Available at: http://ijph.tums.ac.ir 38Table 1: The direct and indirect treatment costs for diagnosed patients Type of costsPer capita costs(RMB)Total costs(RMB) The direct treat ment costs — 8,423,400 Inpatient cases 6416.16 4,876,300 Outpatient cases 1652.11 3,547,100 Indirect treatment costs — 3,910,200 Inpatient cases 4790.80 3,641,000 Outpatient cases 125.40 269,200 Total — 12,333,600 The average direct and indirect costs for each inpatient were 11206.96 RMB among them the direct costs were 6416.16 RMB while the indirect costs were 4790.8 RMB.",Non-OADS,/arxiv_data1/oa_pdf/1f/9d/ijph-41-34.PMC3521884.pdf
:Is A Mass Prevention and Control Program for Pandemic … 39 Available at: http://ijph.tums.ac.irThe mean positive rate was 8.53%.,Non-OADS,/arxiv_data1/oa_pdf/1f/9d/ijph-41-34.PMC3521884.pdf
"4 1, No.11,Nov2012, pp.34-43 Available at: http://ijph.tums.ac.ir 40Table 5: The total costs for H1N1 influenza prevention and control in Hubei MeasuresMean costs(RMB)Total costs(thousand RMB)Percentage (%) Direct and indirect cost of treatment for diagnosed patients _ 12,334 4.65 Medical observation for clinically diagnosed patients at home 468.00 1,233 0.47 Isolated observation for close contacts _ 9,030 3.41 Detection for influenza cases _ 4,120 1.55 Influenza surveillance network laboratories 106.29 14,880 5.61 Vaccine purchase and vaccination 26.25 118,140 44.57 Other costs besides vaccine allocated by Hubei Finance _ 15,630 5.90 Other costs allocated by local Finance _ 70,000 26.41 Costs of other associated units _ 19,720 7.44 Total _ 265,087 100 The effect of prevention and control Analysis of the epidemic of H1N1 influenza in USA Up to December 16th2009, 246 thousand people In USA were infected by H1N1 influenza, with 11,160 death cases.",Non-OADS,/arxiv_data1/oa_pdf/1f/9d/ijph-41-34.PMC3521884.pdf
":Is A Mass Prevention and Control Program for Pandemic … 41 Available at: http://ijph.tums.ac.irrates of diagnosed cases and clinically diagnosed cases and their costs in Hubei in 2009, the directbenefit could be estimated to be 328350100 RMB Yuan (Table 6).",Non-OADS,/arxiv_data1/oa_pdf/1f/9d/ijph-41-34.PMC3521884.pdf
"4 1, No.11,Nov2012, pp.34-43 Available at: http://ijph.tums.ac.ir 42Table8:Outcome of total benefit Types of benefitBenefit(thousand RMB)(%) Direct bene fit 328,350.1 23.60 Indirect benefit 1,063,109.5 76.40 Total 1,391,459.6 100 Cost-effectiveness ratio During the period from April 25th in 2009 to De - cember 31st in 2009, the total costs of H1N1 in - fluenza prevention and control were 265 million RMB while the total benefit were 1,391 million RMB, its net benefit was 1,126 million RMB, the cost-effectiveness ratio was 1 ：5.25.",Non-OADS,/arxiv_data1/oa_pdf/1f/9d/ijph-41-34.PMC3521884.pdf
":Is A Mass Prevention and Control Program for Pandemic … 43 Available at: http://ijph.tums.ac.irConclusion In conclusion, when humans face similar infec - tious diseases such as influenza A H1N1, it is an effective way to control the spread of infectious diseases by devoting the necessary human, ma - terial and financial resources and taking strict measures against infectious disease prevention and control in the first time.",Non-OADS,/arxiv_data1/oa_pdf/1f/9d/ijph-41-34.PMC3521884.pdf
"4 1, No.11,Nov2012, pp.44-53 Original Article 44 Available at: http://ijph.tums.ac.ir The Effects of Sleep and Touch Therapy on Symptoms of Fibromyalgia and Depression *BC Demirbağ1, B Erci2 1.Dept.",Non-OADS,/arxiv_data1/oa_pdf/ab/90/ijph-41-44.PMC3521885.pdf
Demirbağ & Erci :The Effects of Sleep and Touch Therapy … 45 Available at: http://ijph.tums.ac.irmigraine/headaches and gastrointestinal problems are the most common symptoms for FMS (6 -17).,Non-OADS,/arxiv_data1/oa_pdf/ab/90/ijph-41-44.PMC3521885.pdf
"44-53 Available at: http://ijph.tums.ac.ir 46formed a second time using the face -to-face inter- view technique, which ended the interaction with the patients.",Non-OADS,/arxiv_data1/oa_pdf/ab/90/ijph-41-44.PMC3521885.pdf
Demirbağ & Erci :The Effects of Sleep and Touch Therapy … 47 Available at: http://ijph.tums.ac.irstatements in this scale were created on the basis of the statements of the patients under treatment.,Non-OADS,/arxiv_data1/oa_pdf/ab/90/ijph-41-44.PMC3521885.pdf
"44-53 Available at: http://ijph.tums.ac.ir 48Table 1:The distribution of the pa tients in terms of their personal characteristics Patient CharacteristicsControl GroupTouch+Music+Aroma Group (TMA)Sleep+Music+Aroma Group (SMA) n(%) n (%) n (%) Marital Status Married 45(83.3) 40 (75.5) 40 (75.5) 6(11.1) 10 (16.9) 10 (16.9) Widow 3(5.6) 4 (7.6) 4 (7.6) Level of Education Illiterate 7(13.0) 7 (13.0) 5 (9.3) Literate 8(14.8) 7 (13.0) 5 (9.3) Primary School 23(42.6) 20 (37.0) 19 (35.2) Secondary School 5(9.2) 2 (3.8) 11 (20.4) High School 9(16.7) 13 (24.0) 8 (14.7) University 2(3.7) 5 (9.2) 6 (11.1) Employment Status Housewife 43(79.5) 38 (70.4) 43 (79.4) Worker 5(9.3) 1 (1.9) 3 (5.6) Civil Servant 4(7.4) 6 (11.2) 2 (3.8) Student 1(1.9) 3 (5.6) 3 (5.6) Retired 1(1.9) 1 (1.9) 3 (5.6) Social Security Social Insurance Institution 26(48.1) 28 (51.8) 28 (51.8) Retirement Fund of Civil Servants14(25.9) 11 (20.4) 12 (22.2) Social Security Organiza - tion for the Self -employed11(20.4) 13 (24.1) 11 (20.4) Green Card 3(5.6) 2 (3.7) 3 (5.6) Duration of Illness 1-5 months 11(20.4) 13 (24.1) 13 (24.1) 6-10 months 2(3.7) 2 (3.7) 7 (13.0) 11months -2years 20(37.0) 17 (31.5) 16 (29.5) 3-7 years 14(25.9) 13 (24.1) 9 (16.7) above 8 years 7(13.0) 9 (16.6) 9 (16.7) X ±SS X ±SS X ±SS Monthly Income 875±3.77 963±4.80 876±4.27 Age 42.96±11.45 42.74±11.89 41.70±12.15 A look into the between -groups comparison of the Fibromyalgia Symptom Form post -tests in the Control, TMA and SMA Groups shows that there was a significant difference in terms of the va - riables of morning tiredness (X2=35.49,P<0.05), exhaustion (X2=10.12, P<0.05), re stless sleep (X2=6.37,P<0.05), tiredness after low -effort jobs (X2=8.56,P<0.05), feeling like crying (X2=8.99,P<0.05), and bowel complaints (X2=24.31, P<0.05), while there was no significant difference in terms of the variables of morning stiffness (X2=3.85), sleeplessness (X2=3.39), pain (X2=2.42), headache (X2=0.34), being easily dis - tracted during activity (X2=315), and exaggerated reactions to things (X2=7.85) (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/ab/90/ijph-41-44.PMC3521885.pdf
"Demirbağ & Erci :The Effects of Sleep and Touch Therapy … 49 Available at: http://ijph.tums.ac.irTable 2:The between -groups comparison of the f ibromyalgia symptom form pre -testsin the control, tma and sma groups *Significant at the P<0.05 level Table 3:The between -groups comparison of the fibromyalgia symptom form post -tests in the control, tma and sma groupsSymptomsPre-test Points Control TMA SMA X2df*P Yes No Yes No Yes No Morning Fatiguen54 -54 -54 - (%)(100) -(100) -(100) - Morning Stiffnessn39 15 35 19 39 15 0.932>0.05 (%)(72.2) (27.8) (64.6) (35.2) (72.2) (27.8) Exhaustionn40 14 47 7 41 13 3.202>0.05 (%)(74.1) (25.9) (87.0) (13.0) (75.9) (24.1) Restless sleepn44 10 48 6 44 10 1.462>0.05 (%)(81.5) (18.5) (88.9) (11.1) (81.5) (18.5) Sleeplessnessn43 11 42 11 39 15 0.892>0.05 (%)(79.6) (20.4) (77.8) (20.4) (72.2) (27.8) Painn54 -54 -54 - (%)(100) -(100) -(100) - Headachen33 21 42 12 32 22 0.952>0.05 (%)(61.1) (38.9) (77.8) (22.2) (59.3) (40.7) After low-effort worksn46 8 45 9 46 8 0.932>0.05 (%)(85.2) (14.8) (83.3) (16.7) (85.2) (14.8) Quick distraction of concentration during any activityn31 23 36 18 27 273.092>0.05 (%)(57.4) (42.6) (66.7) (33.3) (50.0) (50.0) Exaggeration in reac- tions to thingsn33 19 24 29 29 24 5.912>0.05 (%)(61.1) (35.2) (44.4) (53.7) (53.7) (44.4) Feeling like cryingn26 28 19 35 20 34 2.122>0.05 (%)(48.1) (51.9) (35.2) (64.8) (37.0) (63.0) Complaints from the bowelsn27 27 26 28 24 30 0.342>0.05 (%)(50) (50)(48.1) (51.9) (44.4) (55.6) SymptomsPost-Test Points X2df*P Control TMA SMA YesNoYesNoYesNo Morning Fatiguen4864311441035.496<0.05 (%)(88.9)(11.1)(79.6)(20.4)(81.5)(18.5) Morning Stiffnessn3618243034203.852>0.05 (%)(66.7)(33.3)(44.4)(55.6)(63.0)(37.0) Exhaustionn40143321371710.122<0.05 (%)(74.1)(25.9)(61.1)(38.9)(68.5)(31.5)",Non-OADS,/arxiv_data1/oa_pdf/ab/90/ijph-41-44.PMC3521885.pdf
"44-53 Available at: http://ijph.tums.ac.ir 50*Significant at the P<0.05 level After the intervention, according to the One -way AnovaTest, a statistically significant difference was observed between the control group and the study groups for BDI [TMA (Before: 22.01±5.3,After: 14.52±3.7); SMA (Before: 24.81±5.1, After: 20.16±4.9); Control (Before: 23.73±4.4, After: 21.05±2.6)] (Table 4 ).",Non-OADS,/arxiv_data1/oa_pdf/ab/90/ijph-41-44.PMC3521885.pdf
"Demirbağ & Erci :The Effects of Sleep and Touch Therapy … 51 Available at: http://ijph.tums.ac.irWhen the preferences for music types (maqam ) in the study groups are examined, it can be seen that in the TMA group, 44.4% preferred the Uşak ma - qam, 27.8% the Rast, 16.7% the Hüseyni and 11.1% the Saba maqam.",Non-OADS,/arxiv_data1/oa_pdf/ab/90/ijph-41-44.PMC3521885.pdf
"44-53 Available at: http://ijph.tums.ac.ir 52have shown that if patients are permitted to choose their favorite music, this contributes to their recovery (40).",Non-OADS,/arxiv_data1/oa_pdf/ab/90/ijph-41-44.PMC3521885.pdf
"Demirbağ & Erci :The Effects of Sleep and Touch Therapy … 53 Available at: http://ijph.tums.ac.ir13.Oliver K, Franks MH, Cronan TA (2004).",Non-OADS,/arxiv_data1/oa_pdf/ab/90/ijph-41-44.PMC3521885.pdf
"4 1, No.11,Nov2012, pp.54-58 Original Art icle 54 Available at: http://ijph.tums.ac.ir Construction of Knowledge, Attitude and Practice Questionnaire for Assessing Plagiarism *J Poorolajal1, P Cheraghi2, A Doosti Irani3, Z Cheraghi3, M Mirfakhraei3 1.Research Center for Health Sciences and Dep t.of Epidemiology & Biostatistics, School of Public Health, Hamadan Univer sity of Medical Sciences, Hamadan, Iran 2.Dept.",Non-OADS,/arxiv_data1/oa_pdf/4d/20/ijph-41-54.PMC3521886.pdf
":Construction of Knowledge, Attitude and Practice Questionnaire … 55 Available at: http://ijph.tums.ac.irUsing the internet has facilitated the copying of people's works and ideas.",Non-OADS,/arxiv_data1/oa_pdf/4d/20/ijph-41-54.PMC3521886.pdf
"4 1, No.11,Nov2012, pp.54-58 Available at: http://ijph.tums.ac.ir 56chancellors' domain including Treatment services, Health services ,Education , and Research & Tech - nology.",Non-OADS,/arxiv_data1/oa_pdf/4d/20/ijph-41-54.PMC3521886.pdf
":Construction of Knowledge, Attitude and Practice Questionnaire … 57 Available at: http://ijph.tums.ac.irTable 2:Linear regression analysis assessing the effect of knowledge and attitude on plagiarism commision Variable Coefficient Standard Error 95% CI Pvalue Knowledge -0.13 0.05 -0.22-0.04 0.005 Constant 2.63 0.69 1.273.99<0.001 Attitude -0.16 0.03 -0.22-0.10<0.001 Constant 4.65 0.75 3.186.13<0.001 According to this results, plagiarism commission decreased 13% per one unitincrease in score of knowledge (P=0.005).The impact of attitude on committing plagiarism was stronger, so that pla- giarism commis sion decreased 16%perone unit increase in the score of attitude(P<0.001).",OADS,/arxiv_data1/oa_pdf/4d/20/ijph-41-54.PMC3521886.pdf
"4 1, No.11,Nov2012, pp.54-58 Available at: http://ijph.tums.ac.ir 58about56%among medical students (10).Another studywas conducted by Bilic -Zulle on 198 medical students in Croatia reported that 83% of the st u- dents had plagiarized at least once (5).",Non-OADS,/arxiv_data1/oa_pdf/4d/20/ijph-41-54.PMC3521886.pdf
"2012 [cited January 12, 2012]; Available from: http://www.plagiarism.org.",Non-OADS,/arxiv_data1/oa_pdf/4d/20/ijph-41-54.PMC3521886.pdf
"Massachusetts: Merriam -Webster Inc; 2012 [cited Janyary 12, 2012]; Available from: http://www.merri am-webster.com.",Non-OADS,/arxiv_data1/oa_pdf/4d/20/ijph-41-54.PMC3521886.pdf
"4 1, No.11,Nov2012, pp.59-66 Original Article 59 Available at: http://ijph.tums.ac.ir Effect of Oral Carbohydrate Intake on Labor Progress: Randomized Controlled Trial R Rahmani1, Z Khakbazan2, *P Yavari2, 3, M Granmayeh2, L Yavari4 1.Faculty of Nursing and Midwifery, Gonabad University of Medical Sciences, Razavi Khorasan, Iran 2.Faculty of Nursing and Midwifery, Tehran University of Medical Sciences, Tehran, Iran 3.Dept.",Non-OADS,/arxiv_data1/oa_pdf/b0/61/ijph-41-59.PMC3521887.pdf
":Effect of Oral Carbo hydrate Intake on Labor Progres … Available at: http://ijph.tums.ac.ir 60providing hydration, nutrition, and comfort, self - regulating intake decreases a women's stress level and provides her with a feeling of control.''",Non-OADS,/arxiv_data1/oa_pdf/b0/61/ijph-41-59.PMC3521887.pdf
"4 1, No.11,Nov2012, pp.59-66 61 Available at: http://ijph.tums.ac.irpermission to women in labor to eat small amount of carbohydrate would influence the out - come of labor and to increase the chance of vomiting and subsequent risk of pulmonary aspiration.",Non-OADS,/arxiv_data1/oa_pdf/b0/61/ijph-41-59.PMC3521887.pdf
":Effect of Oral Carbo hydrate Intake on Labor Progres … Available at: http://ijph.tums.ac.ir 62pain.Neonate heart rates in first and second stage were assessed by external electronic fetal heart monitoring .One minute, five minute Apgar scores, and birth weight were recorded at delivery.",Non-OADS,/arxiv_data1/oa_pdf/b0/61/ijph-41-59.PMC3521887.pdf
"4 1, No.11,Nov2012, pp.59-66 63 Available at: http://ijph.tums.ac.irTable 2:Maternal and neonatal outcomes for study groups VARIABLECarbohydrates (n = 87)Control (n = 90)Pvalue Duration of active phase of labor (hour) Mean (SD) 3.3 (1.2) 3.4(1.3) 0.3 Duration of second stage of labor (min) Mean (SD) 12.6 (5.7) 19.7 (7.3) 0.04* Duration of third stage of labor (min) Mean (SD) 4.3 (3) 5 (4.5) 0.1 Type of delivery (%) Spontaneous vaginal Instrumental vaginal Caesarean section97.7 2.3 096.7 2.2 1.10.9 Frequency of vomiting (%) 1 time 2 times70 3080 200.7 Volume of vomiting (ml) Mean (SD) 188 (51.0) 178 (72.5) 0.7 Infant's Birth Weight (g) Mean (SD) 3119.5 (262.6) 3183.5 (350.5) 0.2 N Neonate Heart Rate in 1ststage 120-160 beat/min 137.9(3.4) 137.1(4.2) 0.1 N  Neonate Heart Rate in 2ndstage 100-140 BPM 117.9(6.7) 116.3(8.9) 0.2 Apgar scores 1 min Mean (SD) 8.9 (0.3) 8.9 (0.3) 0.5 Apgar scores 5 min Mean (SD) 10 (0.6) 9.53 (0.7) 0.8 There were no significant differences between groups by Mann-Whitney *Statistically significant differences with control group ( Mann-Whitney) Discussion The purpose of this study was to determine if oral carbohydrate intake during labor decreased the duration of labor and type of delivery, maternal and neonatal outcomes.",Non-OADS,/arxiv_data1/oa_pdf/b0/61/ijph-41-59.PMC3521887.pdf
:Effect of Oral Carbo hydrate Intake on Labor Progres … Available at: http://ijph.tums.ac.ir 64and on delivery outcomes in low -risk nulliparous women between 30 and 40 weeks gestation (12).,Non-OADS,/arxiv_data1/oa_pdf/b0/61/ijph-41-59.PMC3521887.pdf
"4 1, No.11,Nov2012, pp.59-66 65 Available at: http://ijph.tums.ac.irConclusions In summary, for low -risk women with 3 -4 cm cervical dilatation, intake of dates or orange juice during active labor could decrease the length of second stage of labor phase.",Non-OADS,/arxiv_data1/oa_pdf/b0/61/ijph-41-59.PMC3521887.pdf
"ACOG, Available from: (http://www.acog.org/About_ACOG/Ne ws_Room/News_Releases/2009 , accessed 25 August 2012).",Non-OADS,/arxiv_data1/oa_pdf/b0/61/ijph-41-59.PMC3521887.pdf
:Effect of Oral Carbo hydrate Intake on Labor Progres … Available at: http://ijph.tums.ac.ir 66and Ashurst.,Non-OADS,/arxiv_data1/oa_pdf/b0/61/ijph-41-59.PMC3521887.pdf
"4 1, No.11,Nov2012, pp.67-71 Original Article 67 Available at: http://ijph.tums.ac.ir Causes of New Cases of Major Thalassemia in Sistan and Balouchis tan Province in South -East of Iran E Miri-Moghaddam1, 2, *M Naderi3, S Izadi4, MA Mashhadi5 1.Genetics of Non -Communicable Disease Research Center, Zahedan University of Medical Sciences, (ZUMS), Zahedan -Iran 2.Dept.of Genetics, Faculty of Medicine, ZUMS, Zahedan -Iran 3.Dept.",Non-OADS,/arxiv_data1/oa_pdf/9a/fb/ijph-41-67.PMC3521888.pdf
":Causes of New Cases of Major Thalassemia … Available at: http://ijph.tums.ac.ir 68increase of iron, in turn, damages tissues and creates numerous problems for the patient (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/9a/fb/ijph-41-67.PMC3521888.pdf
"4 1, No.11,Nov2012, pp.67-71 69 Available at: http://ijph.tums.ac.irdistricts of the province.",Non-OADS,/arxiv_data1/oa_pdf/9a/fb/ijph-41-67.PMC3521888.pdf
":Causes of New Cases of Major Thalassemia … Available at: http://ijph.tums.ac.ir 70Meanwhile, of the couples who had been diag - nosed to be minor thalessemic and introduced to PND Center, 50.9% did not refer to the center due to lack of awareness about the gestational age, unwillingness of husband and relatives, and lack of awareness about the importance of the issue.",Non-OADS,/arxiv_data1/oa_pdf/9a/fb/ijph-41-67.PMC3521888.pdf
"4 1, No.11,Nov2012, pp.67-71 71 Available at: http://ijph.tums.ac.irfamiliar with Balouch culture (over 90% of pa - tients 6.",Non-OADS,/arxiv_data1/oa_pdf/9a/fb/ijph-41-67.PMC3521888.pdf
"4 1, No.11,Nov2012, pp.72-77 Original Article 72 Available at: http://ijph.tums.ac.ir Seroepidemiology of Crimean Congo Hemorrhagic Fever in Slaughterhouse Workers in North Eastern Iran S Chinikar1, A Hezareh Moghadam2, SM J Parizadeh2, M Moradi1, N Bayat5, 3, M Zeinali4, *E Mostafavi3 1.Laboratory of Arboviruses and Viral Haemorrhagic Fevers (National Reference Laboratory), Pasteur Institute of Iran, Postal Code: 1316943551, Tehran, Iran.",Non-OADS,/arxiv_data1/oa_pdf/5d/7f/ijph-41-72.PMC3521889.pdf
":Seroepidemiology of Crimean Congo Hemorrhagic Fever … 73 Available at: http://ijph.tums.ac.irmost areas of Africa, the southern parts of Russia and the Balkans in Europe (3).",Non-OADS,/arxiv_data1/oa_pdf/5d/7f/ijph-41-72.PMC3521889.pdf
"4 1, No.11,Nov2012, pp.72-77 Available at: http://ijph.tums.ac.ir 74into the study.",Non-OADS,/arxiv_data1/oa_pdf/5d/7f/ijph-41-72.PMC3521889.pdf
:Seroepidemiology of Crimean Congo Hemorrhagic Fever … 75 Available at: http://ijph.tums.ac.irof twelve samples).,Non-OADS,/arxiv_data1/oa_pdf/5d/7f/ijph-41-72.PMC3521889.pdf
"4 1, No.11,Nov2012, pp.72-77 Available at: http://ijph.tums.ac.ir 76or slaughterhouse workers (16).",Non-OADS,/arxiv_data1/oa_pdf/5d/7f/ijph-41-72.PMC3521889.pdf
:Seroepidemiology of Crimean Congo Hemorrhagic Fever … 77 Available at: http://ijph.tums.ac.irSystem of Crimean Congo Haemorrhagic Fever in Iran.,Non-OADS,/arxiv_data1/oa_pdf/5d/7f/ijph-41-72.PMC3521889.pdf
"4 1, No.11,Nov2012, pp.78-84 Original Article 78 Available at: http://ijph.tums.ac.ir The Effect of Support Group Method on Quality of Life in Post-menopausal Women M Yazdkhasti1,*M Keshavarz2,ES Merghaati Khoei3, AF Hosseini4, S ESmaeilzadeh5, M Amiri Pebdani6, H Jafarzadeh7 1.Dept.",Non-OADS,/arxiv_data1/oa_pdf/b1/79/ijph-41-78.PMC3521890.pdf
:The Effect of Support Group Method on Quality of Life … 79 Available at: http://ijph.tums.ac.irIntroduction Health is the fundamental rights of every human being and improvement of educational methods is a public duty (1).,Non-OADS,/arxiv_data1/oa_pdf/b1/79/ijph-41-78.PMC3521890.pdf
"4 1, No.11,Nov2012, pp.78-84 Available at: http://ijph.tums.ac.ir 80less than 30 (kg/m2) and not employed in any health systems.",Non-OADS,/arxiv_data1/oa_pdf/b1/79/ijph-41-78.PMC3521890.pdf
":The Effect of Support Group Method on Quality of Life … 81 Available at: http://ijph.tums.ac.irof (respectively) vasomotor and psychosocial, physical and sexual dimensions.",Non-OADS,/arxiv_data1/oa_pdf/b1/79/ijph-41-78.PMC3521890.pdf
"4 1, No.11,Nov2012, pp.78-84 Available at: http://ijph.tums.ac.ir 82Table 2:Comparison of mean & SD of QOL score before and three months after intervention in test and control groups Groups Support group Statistics Result TestControl groupStatistics Result TestBefore Mean±S.DAfter Mean±S.DBefore Mean±S.DAfter Mean±S.DDimensions Vasomotor 19.92±3.74 14.94±4.24 *Z=6.053 P=0.001 18.32±5.90 18.00±5.62 t= 0.97P=0.34 Psychosocial 38.7±10.91 28.63±10.21 **t=9.708P=0.001 34.60±12 34.14±11.53 t=0.58P=0.56 Physical 79.03±18.89 57.19±14.55 t=15.320 P=0.00170.55±20.86 70.22±20.59 t=0.479P=0.63 Sexual 16.44±5.07 12.54±5.45 t=8.745 P=0.001 16.19±5.14 16.03±5.74 t=0.44P=0.66 QOL 153.76±38.61 113.30±34.45 t=17.056 P=0.001139.6±43.09 138.36±35.17 t=0.88P=0.38 * Wlicoxon test results ** Independent t -test results Discussion This survey demonstrated the positive impact of 10-week consecutive structural program by using support group on quality of life and symptoms of menopause (vasomotor and psychosocial, physical, sexual dimensions).",Non-OADS,/arxiv_data1/oa_pdf/b1/79/ijph-41-78.PMC3521890.pdf
Available from: http://www.euro.who.int/Document/E88 086.pdf.,Non-OADS,/arxiv_data1/oa_pdf/b1/79/ijph-41-78.PMC3521890.pdf
"4 1, No.11,Nov2012, pp.78-84 Available at: http://ijph.tums.ac.ir 848.Rotem M, Kushnir T, Levine Ebrenfeld M. A psycho-Educational program for improv - ing women's Attitudes and coping with menopause symptoms (2005).",Non-OADS,/arxiv_data1/oa_pdf/b1/79/ijph-41-78.PMC3521890.pdf
Available from: http://www.euro.who.int/Document/E88 086.pdf .,Non-OADS,/arxiv_data1/oa_pdf/b1/79/ijph-41-78.PMC3521890.pdf
"Available from : http://hdl.handle.net/1951/41486 11.Satoh T, Ohashi K (2005).",OADS,/arxiv_data1/oa_pdf/b1/79/ijph-41-78.PMC3521890.pdf
"Available from: http://www.ebiblioteka.lt/resursai/LMA/ Acta%20medica%20Lituanica/A -152.pdf15.Hey-Chung C, Ying -Fen T,Shing F, Yaw Wang S (2001).",OADS,/arxiv_data1/oa_pdf/b1/79/ijph-41-78.PMC3521890.pdf
"4 1, No.11,Nov2012, pp.85-91 Original Article 85 Available at: http://ijph.tums.ac.ir Risk Management Status of Waste Anesthetic Gases Using ECRI Institute Standards S Asefzadeh1,AR Raeisi2, *A Mousavi3 1.Research Center for Social Determinants of Health, Qazvin University of Medical Sciences, Qazvin, Iran 2.Educational Planning, Health Management, and Economic Research Center (HMERC), Isfahan University of Medical Sciences, Isfahan, Iran 3.Health Services Administration, Qazvin University of Medical Sciences, Qazvin, Iran *Corresponding Author: Email:rose_mp7@yahoo.com (Received 23Mar2012; accepted 12Aug2012) Introduction All operating -room personnel are continuously exposed to trace concentrations of anesthesia agents.",Non-OADS,/arxiv_data1/oa_pdf/88/70/ijph-41-85.PMC3521891.pdf
":Risk Management Status of Waste Anesthetic Gases … Available at: http://ijph.tums.ac.ir 86Waste anesthetic gases including both nitrous oxide and halogenated anesthetics (halothane, enflurane, isoflurane, desflurane, sevoflurane, and methoxyflurane) that over -exposure of them, may produce health effects and hazards to operating - room personnel.",Non-OADS,/arxiv_data1/oa_pdf/88/70/ijph-41-85.PMC3521891.pdf
"4 1, No.11,Nov2012, pp.85-91 87 Available at: http://ijph.tums.ac.irfor data collection was a structured standard checklist that had been developed by ECRI insti - tute (Emergency Care Research Institute) in November 2007 (17).",OADS,/arxiv_data1/oa_pdf/88/70/ijph-41-85.PMC3521891.pdf
:Risk Management Status of Waste Anesthetic Gases … Available at: http://ijph.tums.ac.ir 88Table 2:The percentile of WAGs risk manage - ment status in Isfahan teaching hospitals Grade No (%)N/I (%)Yes (%) Hospitals 501931 A 422533 B 641125 C 67825 D 561628 Total Classification of hospital based on the predeter - mined standards showed that the mean of com - pliance standards is higher in Ahospital than other hospitals.,Non-OADS,/arxiv_data1/oa_pdf/88/70/ijph-41-85.PMC3521891.pdf
:Risk Management Status of Waste Anesthetic Gases … Available at: http://ijph.tums.ac.ir 88Table 2:The percentile of WAGs risk manage - ment status in Isfahan teaching hospitals Grade No (%)N/I (%)Yes (%) Hospitals 501931 A 422533 B 641125 C 67825 D 561628 Total Classification of hospital based on the predeter - mined standards showed that the mean of com - pliance standards is higher in Ahospital than other hospitals.,Non-OADS,/arxiv_data1/oa_pdf/88/70/ijph-41-85.PMC3521891.pdf
:Risk Management Status of Waste Anesthetic Gases … Available at: http://ijph.tums.ac.ir 88Table 2:The percentile of WAGs risk manage - ment status in Isfahan teaching hospitals Grade No (%)N/I (%)Yes (%) Hospitals 501931 A 422533 B 641125 C 67825 D 561628 Total Classification of hospital based on the predeter - mined standards showed that the mean of com - pliance standards is higher in Ahospital than other hospitals.,Non-OADS,/arxiv_data1/oa_pdf/88/70/ijph-41-85.PMC3521891.pdf
"4 1, No.11,Nov2012, pp.85-91 89 Available at: http://ijph.tums.ac.irquential surgeries.",Non-OADS,/arxiv_data1/oa_pdf/88/70/ijph-41-85.PMC3521891.pdf
:Risk Management Status of Waste Anesthetic Gases … Available at: http://ijph.tums.ac.ir 90In the all of considered hospitals on ly28% of standards complied with predetermined standards .,Non-OADS,/arxiv_data1/oa_pdf/88/70/ijph-41-85.PMC3521891.pdf
Available from: http://www.osha.gov/dts/osta/anesthetic - gases/in ex.html.,OADS,/arxiv_data1/oa_pdf/88/70/ijph-41-85.PMC3521891.pdf
"4 1, No.11,Nov2012, pp.85-91 91 Available at: http://ijph.tums.ac.iranesthetic gases, monitoring strategies, and correlations between nitrous oxide levels and health symptoms.",Non-OADS,/arxiv_data1/oa_pdf/88/70/ijph-41-85.PMC3521891.pdf
Available from :http://www.ecri.org .,Non-OADS,/arxiv_data1/oa_pdf/88/70/ijph-41-85.PMC3521891.pdf
Available from: http://www.ecri.org.uk/about -ecri.htm/.,Non-OADS,/arxiv_data1/oa_pdf/88/70/ijph-41-85.PMC3521891.pdf
Available from : http://www.asahq.org/ Newslet- ters/1997/05_97/Trace_Gases.html.,OADS,/arxiv_data1/oa_pdf/88/70/ijph-41-85.PMC3521891.pdf
"4 1, No.11,Nov2012, pp.92-97 Original Article 92 Available at: http://ijph.tums.ac.ir Increased Nuchal Translucency and Pregnancy Outcome ATahmasebpour1,*N Baradaran Rafiee2, S Ghaffari3, A Jamal2 1.Iranian Fetal Medicine Foundation, Tehran, Iran 2.Dept.",Non-OADS,/arxiv_data1/oa_pdf/96/04/ijph-41-92.PMC3521892.pdf
:Increased Nuchal Translucency and Pregnancy … 93 Available at: http://ijph.tums.ac.ircause severe anxiety in parents.,Non-OADS,/arxiv_data1/oa_pdf/96/04/ijph-41-92.PMC3521892.pdf
"4 1, No.11,Nov2012, pp.92-97 Available at: http://ijph.tums.ac.ir 94Table 2:Pregnancy outcome of 149 fetuses with increased NT in relation to degree of NT enlargement Adverse outcome [n (%)] NT(mm) nFetal lossHydrops Structural abnormalitiesMaternal request(TOP)Total  APO Live birth, no defects 95th centile -3.4821(1) 0 9(10) 1(1) 11(13) 71(86) 3.5-4.4 432(4) 1(2) 2(4) 3(7) 7(16) 35(81) 4.5-5.4 70 0 1(14) 4(57) 5(57) 2(28) 5.5-6.4 83(37) 0 0 4(50) 7(87) 1(12) ≥ 6.5 191(11) 1(11) 1(11) 5(55) 8(88) 1(11) Total 1497(4.6) 2(1.3) 13(8) 17(11) 39 (26) 110(74) NT, nuchal translucency; APO, adverse pregnancy outcome; TOP, termination of pregnancy The most common fetal malformation was heart defects.",Non-OADS,/arxiv_data1/oa_pdf/96/04/ijph-41-92.PMC3521892.pdf
:Increased Nuchal Translucency and Pregnancy … 95 Available at: http://ijph.tums.ac.ir Fig.1:Outcome of 186 fetuses with NT ≥ 95 percentile Discussion Approximately 20% of screened women in our study had abnormal karyotype that is in agreement with Kagan et al.,Non-OADS,/arxiv_data1/oa_pdf/96/04/ijph-41-92.PMC3521892.pdf
"4 1, No.11,Nov2012, pp.92-97 Available at: http://ijph.tums.ac.ir 96higher rate of TOP based on maternal request in group with NT ≥3.5, but the overall rate of APO was proportional to the degree of NT enlargement.",Non-OADS,/arxiv_data1/oa_pdf/96/04/ijph-41-92.PMC3521892.pdf
":Increased Nuchal Translucency and Pregnancy … 97 Available at: http://ijph.tums.ac.ir7.Nicolaides K H, Azar G, Byrne D, Mansur C, Marks K (1992).",Non-OADS,/arxiv_data1/oa_pdf/96/04/ijph-41-92.PMC3521892.pdf
"4 1, No.11,Nov2012, pp.98-101 Short Communication 98 Available at: http://ijph.tums.ac.ir Avicenna the First to Describe Diseases Which May Be Prevented By Exercise *MB Siahpoosh1, M Ebadiani1, GhR Shah Hosseini2, MMIsfahani1, A Nikbakht Nasrabadi3, H Dadgostar4 1.Dept.of Traditional Medicine, Tehran University of Medical Sciences, Tehran, Iran 2.Dept.",Non-OADS,/arxiv_data1/oa_pdf/1f/14/ijph-41-98.PMC3521893.pdf
":Avicenna the First to Describe Diseases … 99 Available at: http://ijph.tums.ac.irwhich, according to Avicenna’s viewpoint, could be prevented by exercise but how exercise pre - vents from diseases is not the aim of this study.",Non-OADS,/arxiv_data1/oa_pdf/1f/14/ijph-41-98.PMC3521893.pdf
"4 1, No.11,Nov2012, pp.98-101 Available at: http://ijph.tums.ac.ir 100Discussion Study’s data indicate that according to Avicenna’s teaching there are several diseases caused due to physical inactivity.",Non-OADS,/arxiv_data1/oa_pdf/1f/14/ijph-41-98.PMC3521893.pdf
:Avicenna the First to Describe Diseases … 101 Available at: http://ijph.tums.ac.irMedical Sciences for its collaboration.,Non-OADS,/arxiv_data1/oa_pdf/1f/14/ijph-41-98.PMC3521893.pdf
Avail - able: http://onlineqda.hud.ac.uk/Intro_QDA/w hat_is_qda.php .,Non-OADS,/arxiv_data1/oa_pdf/1f/14/ijph-41-98.PMC3521893.pdf
" Work, Health and Wellbeing  Dame Carol BLACK  Expert Medical Adviser on Health and Work to the Department of Health, lately National Director for Health and Work, London, UKpISSN : 2093-7911 eISSN : 2093-7997Saf Health Work 2012;3:241-2    |    http://dx.doi.org/10.5491/SHAW.2012.3.4.241 Received:  October 5, 2012  Accepted:  October 9, 2012  Available online:  November 30, 2012 Correspondence to: Dame Carol BLACK Health Improvement & Protection Directorate, Department of Health 704 Wellington House, 133-155 Waterloo Road, London SE1 8UG, UK E-mail: profblack@btinternet.comDuring the past decade we have become more aware of im - portant relationships between health and work.",Non-OADS,/arxiv_data1/oa_pdf/1b/79/shaw-3-241.PMC3521922.pdf
"In some in - stances, of course, this is a natural consequence of the severity of illness or disability, but in many cases it is a result of inade - Copyright © 2012 by Safety and Health at Work (SH@W) This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted   non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Editorial",Non-OADS,/arxiv_data1/oa_pdf/1b/79/shaw-3-241.PMC3521922.pdf
" Toxic Encephalopathy  Yangho KIM1 and Jae Woo KIM2  1Department of Occupational and Environmental Medicine, Ulsan University Hospital, University of Ulsan College of Medicine, Ulsan 2Department of Neurology, Dong-A University, College of Medicine, Busan, KoreapISSN : 2093-7911 eISSN : 2093-7997Saf Health Work 2012;3:243-56    |    http://dx.doi.org/10.5491/SHAW.2012.3.4.243 Received:  September 17, 2012  Revised:  November 4, 2012 Accepted:  November 4, 2012  Available online:  November 30, 2012 Correspondence to: Yangho KIM Department of Occupational and Environmental Medicine Ulsan University Hospital, University of Ulsan College of Medicine  877, Bangeojinsunhwan-doro, Dong-gu, Ulsan 682-714, Korea Tel: +82-52-250-7281, Fax: +82-52-250-7289E-mail: yanghokm@ulsan.ac.krThis article schematically reviews the clinical features, diagnostic approaches to, and toxicological implications of toxic encepha - lopathy.",Non-OADS,/arxiv_data1/oa_pdf/97/9f/shaw-3-243.PMC3521923.pdf
"The review focuses on the most significant occupational causes of toxic encephalopa - Copyright © 2012 by Safety and Health at Work (SH@W) This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted   non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review",Non-OADS,/arxiv_data1/oa_pdf/97/9f/shaw-3-243.PMC3521923.pdf
" Occupational Neurotoxic Diseases in   Taiwan  Chi-Hung LIU1, Chu- Yun HUANG2 and Chin-Chang HUANG1,3  1Department of Neurology, Chang Gung Memorial Hospital, Taoyuan,  2Division of Clinical Pharmacy, Graduate Institute of Pharmacy, Taipei Medical University, Taipei,  3Chang Gung University, College of Medicine, Taoyuan, TaiwanpISSN : 2093-7911 eISSN : 2093-7997Saf Health Work 2012;3:257-67    |    http://dx.doi.org/10.5491/SHAW.2012.3.4.257 Received:  August 27, 2012  Revised:  September 24, 2012 Accepted:  September 24, 2012  Available online:  November 30, 2012 Correspondence to: Chin-Chang HUANG Department of Neurology, Chang Gung Memorial Hospital and Chang Gung University, College of Medicine 199, Tung-Hwa North Road, Taipei, Taiwan Tel: +886-3-3281200, ext.",Non-OADS,/arxiv_data1/oa_pdf/be/e6/shaw-3-257.PMC3521924.pdf
"Copyright © 2012 by Safety and Health at Work (SH@W) This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted   non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Review",Non-OADS,/arxiv_data1/oa_pdf/be/e6/shaw-3-257.PMC3521924.pdf
" Mercury Exposure among   Garbage Workers in Southern Thailand  Somsiri DECHARAT  Department of Industrial Hygiene and Health Science, Faculty of Health and Sport Science, Thaksin University, Phattalung, ThailandpISSN : 2093-7911 eISSN : 2093-7997Saf Health Work 2012;3:268-77    |    http://dx.doi.org/10.5491/SHAW.2012.3.4.268 Received:  April 25, 2012  Revised:  November 13, 2012 Accepted:  November 13, 2012  Available online:  November 30, 2012 Correspondence to: Somsiri DECHARAT Department of Industrial Hygiene and Health Science   Faculty of Health and Sport Science,Thaksin University   222 Papayom District, Phattalong Province 93110, ThailandTel: +66 (0)74-693997 ext.",Non-OADS,/arxiv_data1/oa_pdf/56/92/shaw-3-268.PMC3521925.pdf
"The  Copyright © 2012 by Safety and Health at Work (SH@W) This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted   non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article",Non-OADS,/arxiv_data1/oa_pdf/56/92/shaw-3-268.PMC3521925.pdf
" Typology of ROII Patterns on   Cluster Analysis in Korean Enterprises  Young Sun KIM, Oh Jun KWON, Ki Sik KIM and Kyung Yong RHEE  Occupational Safety and Health Research Institute, Korea Occupational Safety and Health Agency, Incheon, KoreapISSN : 2093-7911 eISSN : 2093-7997Saf Health Work 2012;3:278-86    |    http://dx.doi.org/10.5491/SHAW.2012.3.4.278 Received:  June 25, 2012  Revised:  August 21, 2012 Accepted:  August 21, 2012  Available online:  November 30, 2012 Correspondence to: Kyung Yong RHEE Occupational Safety and Health Research Institute Korea Occupational Safety and Health Agency 478 Munemi-ro, Bupyeong-gu, Incheon 403-711, Korea Tel: +82-32-5100-900, Fax: +82-32-518-0866E-mail: rheeky@hanmail.netObjectives:  Authors investigated the pattern of the rate of occupational injuries and illnesses (ROII) at the level of enterprises  in order to build a network for exchange of experience and knowledge, which would contribute to workers’ safety and health  through safety climate of workplace.",Non-OADS,/arxiv_data1/oa_pdf/73/b5/shaw-3-278.PMC3521926.pdf
"Traditional measures to prevent occupational injuries and  illnesses separately analyzed people, technology, and the work context by means of focusing on sociological, technological,  Copyright © 2012 by Safety and Health at Work (SH@W) This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted   non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article",Non-OADS,/arxiv_data1/oa_pdf/73/b5/shaw-3-278.PMC3521926.pdf
" Evaluation of Waist Circumference   Cut-off Values as a Marker for Fatty Liver   among Japanese Workers  Naomi ABE1, Sumihisa HONDA2 and Doosub JAHNG1  1Kyushu Institute of Technology, Graduate School of Life Science & Systems Engineering, Fukuoka,  2Nagasaki University, Graduate School of Biomedical Sciences, Nagasaki, JapanpISSN : 2093-7911 eISSN : 2093-7997Saf Health Work 2012;3:287-93    |    http://dx.doi.org/10.5491/SHAW.2012.3.4.287 Received:  June 15, 2012  Revised:  October 18, 2012 Accepted:  October 18, 2012  Available online:  November 30, 2012 Correspondence to: Naomi ABE Kyushu Institute of Technology, Graduate School of Life Science & Systems Engineering   2-4 Hibikino, Wakamatsu-ku, Kitakyushu, Fukuoka 808-0196, Japan Tel: +81-93-695-6138, Fax: +81-93-695-6138E-mail: abe-naomi@umin.ac.jp An abstract of this paper was presented at the 67th annual meeting  of the Japanese Society of Public Health (November 2008, Fukuoka).Objectives:  Metabolic syndrome has received attention as a risk factor for cardiovascular disease, with particular importance at - tached to visceral fat accumulation, which is associated with lifestyle-related diseases and is strongly correlated with waist circum - ference.",Non-OADS,/arxiv_data1/oa_pdf/aa/d3/shaw-3-287.PMC3521927.pdf
"Together with growing knowledge of the concept of meta - bolic syndrome, the relationship between visceral fat accumula - Copyright © 2012 by Safety and Health at Work (SH@W) This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted   non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Original Article",Non-OADS,/arxiv_data1/oa_pdf/aa/d3/shaw-3-287.PMC3521927.pdf
Avail - able from: http://www.mhlw.go.jp/bunya/shakaihosho/iryouseido01/info03a.html.,Non-OADS,/arxiv_data1/oa_pdf/aa/d3/shaw-3-287.PMC3521927.pdf
" Investigating the Time Lag Effect   between Economic Recession and Suicide Rates in  Agriculture, Fisheries, and Forestry Workers in Korea  Jin-Ha YOON1,3, Washington JUNGER2, Boo-Wook KIM1,  Young-Joo KIM3 and Sang-Baek KOH3  1Occupational Lung Disease Institute, Korea Workers’ Compensation and Welfare Service, Ansan, Korea 2Institute of Social Medicine, State University of Rio de Janeiro, Rio de Janeiro, Brazil 3Institute of Occupational and Environmental Medicine, Wonju College of Medicine, Yonsei University, Wonju, KoreapISSN : 2093-7911 eISSN : 2093-7997Saf Health Work 2012;3:294-7    |    http://dx.doi.org/10.5491/SHAW.2012.3.4.294 Received:  July 16, 2012  Revised:  August 27, 2012 Accepted:  August 27, 2012  Available online:  November 30, 2012 Correspondence to: Jin-Ha YOON Occupational Lung Disease Institute Korea Workers’ Compensation & Welfare Services 87, Guryong-ro, Sangnok-gu, Ansan 426-858, Korea Tel: +82-31-5001-818, Fax: +82-31-5001-811E-mail: flyinyou@gmail.comPrevious studies on the vast increase in suicide mortality in Southeast Asia have indicated that suicide rates increase in parallel with a rise in unemployment or during periods of economic recession.",Non-OADS,/arxiv_data1/oa_pdf/7e/01/shaw-3-294.PMC3521928.pdf
"Copyright © 2012 by Safety and Health at Work (SH@W) This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted   non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Short Communication",Non-OADS,/arxiv_data1/oa_pdf/7e/01/shaw-3-294.PMC3521928.pdf
"Challenges and   Opportunities for Raising Health and   Safety Awareness among a Multinational Workforce  in the United Arab Emirates  Tom LONEY1, Robert Fletcher COOLING1,2 and Tar-Ching AW1   1Institute of Public Health, College of Medicine and Health Sciences, United Arab Emirates University, Al Ain,  2Parsons Brinckerhoff Middle East Limited, Dubai, United Arab EmiratespISSN : 2093-7911 eISSN : 2093-7997Saf Health Work 2012;3:298-304    |    http://dx.doi.org/10.5491/SHAW.2012.3.4.298 Received:  August 28, 2012  Revised:  November 8, 2012 Accepted:  November 8, 2012  Available online:  November 30, 2012 Correspondence to: Tom LONEY Institute of Public Health, College of Medicine and Health Sciences   United Arab Emirates University  PO Box 17666, Al Ain, United Arab Emirates Tel: +971-3-713-7487, Fax: +971-3-767-2022E-mail: tom.loney@uaeu.ac.aeThe United Arab Emirates (UAE) has experienced tremendous economic and industrial growth in the petroleum, airline, maritime and construction sectors, especially since the discovery of oil reserves.",Non-OADS,/arxiv_data1/oa_pdf/84/30/shaw-3-298.PMC3521929.pdf
"Generally, there is a distinct  Copyright © 2012 by Safety and Health at Work (SH@W) This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted   non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Short Communication",Non-OADS,/arxiv_data1/oa_pdf/84/30/shaw-3-298.PMC3521929.pdf
"Available from: http://www.mol.gov.ae/newcontrol - panel2010/Attachments/public/Distribution%20of%20Workers%20Enrolled%20in%20the%20Ministry%20of%20Labour%20by%20Economic%20Activity,%202010.png.",Non-OADS,/arxiv_data1/oa_pdf/84/30/shaw-3-298.PMC3521929.pdf
Available from: http://haad-height.ae/.,OADS,/arxiv_data1/oa_pdf/84/30/shaw-3-298.PMC3521929.pdf
"   Correction to: Roles of Participatory Action-oriented   Programs in Promoting Safety and Health at Work  Kazutaka KOGI  Institute for Science of Labour, Kawasaki, JapanpISSN : 2093-7911 eISSN : 2093-7997Saf Health Work 2012;3:305    |    http://dx.doi.org/10.5491/SHAW.2012.3.4.305 Copyright © 2012 by Safety and Health at Work (SH@W) This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted   non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Erratum Correction to: Saf Health Work 2012;3:155-65                            http://dx.doi.org/10.5491/SHAW.2012.3.3.155 In the original publication, the author’s first name has been inverted with surname.",Non-OADS,/arxiv_data1/oa_pdf/cf/a4/shaw-3-305.PMC3521930.pdf
"Il Ju Choi Center for Gastric Cancer, National Cancer Center, Goyang, KoreaOpen Access Received: September 27, 2012    Revised: October 22, 2012 Accepted: October 22, 2012 Correspondence:  Il Ju Choi Center for Gastric Cancer, National Cancer Center, 323 Ilsan-ro, Ilsandong-gu,  Goyang 410-769, Korea Tel: +82-31-920-2282, Fax: +82-31-920-1520, E-mail:  cij1224@ncc.re.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.341  See “United Rapid Urease Test Is Superior than Separate Test in Detecting Helicobacter pylori  at the Gastric Antrum and  Body Sepcimens” by Sung Woon Moon, Tae Hyo Kim, Hyeon Sik Kim, et al., on page 392-396",Non-OADS,/arxiv_data1/oa_pdf/08/9c/ce-45-341.PMC3521931.pdf
"The proper direction in acute angulations was determined by COMMENTARY Tips for Successful Endoscopic Retrograde   Cholangiopancreatography in Patients with Billroth II Gastrectomy Seok Ho Dong Division of Gastroenterology, Department of Internal Medicine, Kyung Hee University School of Medicine, Seoul, KoreaOpen Access Received: October 10, 2012    Revised: October 30, 2012 Accepted: October 30, 2012 Correspondence:  Seok Ho Dong Division of Gastroenterology, Department of Internal Medicine, Kyung Hee  University School of Medicine, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul  130-701, KoreaTel: +82-2-958-8200, Fax: +82-2-968-1848, E-mail:  gidrdong@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.343 See “Usefulness of Forward-Viewing Endoscope for Endoscopic Retrograde Cholangiopancreatography in Patients with  Billroth II Gastrectomy” by Jong Won Byun, Jae Woo Kim, Se Y ong Sung, et al., on page 397-403",Non-OADS,/arxiv_data1/oa_pdf/0a/4e/ce-45-343.PMC3521932.pdf
"In addi - tion, higher AMR and AAMR than previous tandem colonos - copy even in the patients with a well-prepared colon may be COMMENTARY Inadequate Bowel Preparation Increases Missed Polyps Hyung Wook Kim Department of Internal Medicine, Pusan National University School of Medicine, Yangsan, KoreaOpen Access Received: September 11, 2012    Revised: October 2, 2012 Accepted: October 2, 2012 Correspondence:  Hyung Wook Kim Department of Internal Medicine, Pusan National University School of Medi - cine, 49 Busandaehak-ro, Yangsan 626-815, Korea Tel: +82-55-360-1534, Fax: +82-55-360-1536 E-mail:  mdkhwook@gmail.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.345 See “The Effect of the Bowel Preparation Status on the Risk of Missing Polyp and Adenoma during Screening Colonoscopy:  A Tandem Colonoscopic Study” Sung Noh Hong, In Kyung Sung, Jeong Hwan Kim, et al., on page 404-411",Non-OADS,/arxiv_data1/oa_pdf/05/e5/ce-45-345.PMC3521933.pdf
"Key Words :  Endoscopic submucosal dissection; Animal models; Training; Globalization; UniversalizationOpen Access Received: August 23, 2012    Revised: September 5, 2012 Accepted: September 5, 2012 Correspondence:  Chang-Il Kwon Digestive Disease Center, Bundang CHA Hospital, CHA University College  of Medicine, 59 Yatap-ro, Bundang-gu, Seongnam 463-712, Korea Tel: +82-31-780-5220, Fax: +82-31-780-5219, E-mail:  endoscopy@cha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.347FOCUSED REVIEW SERIES: Globalization and Universalization of ESD",Non-OADS,/arxiv_data1/oa_pdf/8c/c4/ce-45-347.PMC3521934.pdf
"Key Words :  Endoscopic submucosal dissection; Animal models; TrainingOpen Access Received: August 30, 2012    Revised: October 11, 2012 Accepted: October 11, 2012 Correspondence:  Adolfo Parra-Blanco Department of Gastroenterology, Pontificia Universidad Católica de Chile, Mar - coleta 367, Santiago 833-0024, Chile Tel: +56-2-3543820, Fax: +56-2-6397780 E-mail:  aparrab@med.puc.cl cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.350FOCUSED REVIEW SERIES: Globalization and Universalization of ESD",Non-OADS,/arxiv_data1/oa_pdf/8d/37/ce-45-350.PMC3521935.pdf
"Key Words :  Endoscopic submucosal dissection; Endoscopic submucosal dissection training; Ex vivo  model; In vivo  modelOpen Access Received: August 23, 2012    Revised: September 5, 2012 Accepted: September 5, 2012 Correspondence:  Joo Y oung Cho Institute for Digestive Research, Digestive Disease Center, Soonchunhyang  University Hospital, Soonchunhyang University College of Medicine, 59 Dae - sagwan-ro, Y ongsan-gu, Seoul 140-743, Korea Tel: +82-2-709-9202, Fax: +82-2-709-9696, E-mail:  schcjy@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.358FOCUSED REVIEW SERIES: Globalization and Universalization of ESD",Non-OADS,/arxiv_data1/oa_pdf/e7/ba/ce-45-358.PMC3521936.pdf
"Key Words :  Endoscopic submucosal dissection; Gastro intestinal neoplasms; Quality control; Dissection level; Vessel networkOpen Access Received: July 3, 2012    Revised: August 24, 2012 Accepted: September 4, 2012 Correspondence:  Takashi Toyonaga Department of Endoscopy, Kobe University Hospital, 7-5-1 Kusunoki-cho,  Chuo-ku, Kobe 650-0017, Japan Tel: +81-78-382-6305, Fax: +81-78-382-6309 E-mail:  toyonaga@med.kobe-u.ac.jp cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.362FOCUSED REVIEW SERIES: Globalization and Universalization of ESD",Non-OADS,/arxiv_data1/oa_pdf/64/da/ce-45-362.PMC3521937.pdf
"Key Words :  Endoscopic submucosal dissection; Stomach neoplasms; Counterattraction; Surgical instrumentsOpen Access Received: August 22, 2012    Revised: October 11, 2012 Accepted: October 14, 2012 Correspondence:  Tsuneo Oyama Department of Gastroenterology, Saku Central Hospital, 197 Usuda, Saku,  Nagano 384-0301, Japan Tel: +81-26-782-3131, Fax: +81-26-782-9638, E-mail:  oyama@coral.ocn.ne.jp cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.375FOCUSED REVIEW SERIES: Globalization and Universalization of ESD",Non-OADS,/arxiv_data1/oa_pdf/f2/14/ce-45-375.PMC3521938.pdf
"Key Words :  Endoscopic submucosal dissection; Narrow-band imaging; Magnifying endoscopyOpen Access Received: August 22, 2012    Revised: October 25, 2012 Accepted: October 26, 2012 Correspondence:  Jae Y oung Jang Division of Gastroenterology, Department of Internal Medicine, Kyung Hee Uni - versity School of Medicine, 26 Kyungheedae-ro, Dongdaemun-gu, Seoul 130- 701, KoreaTel: +82-2-958-8150, Fax: +82-2-968-1848, E-mail:  jyjang@khu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.379FOCUSED REVIEW SERIES: Globalization and Universalization of ESD",Non-OADS,/arxiv_data1/oa_pdf/8a/71/ce-45-379.PMC3521939.pdf
"Key Words :  Self-expanding metal stent; Upper gastrointestinal tract; ObstructionOpen Access Received: October 27, 2011    Revised: January 10, 2012 Accepted: January 18, 2012 Correspondence:  Chang-Hun Yang Department of Internal Medicine, Dongguk University College of Medicine,  123 Dongdae-ro, Gyeongju 780-714, Korea Tel: +82-54-770-8206, Fax: +82-54-770-8377 E-mail:  chhyang@dongguk.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.386",Non-OADS,/arxiv_data1/oa_pdf/23/82/ce-45-386.PMC3521940.pdf
"Key Words :  Helicobacter pylori ; Rapid urease test; United testOpen Access Received: November 25, 2011    Revised: June 15, 2012 Accepted: June 16, 2012 Correspondence:  Tae Hyo Kim Department of Internal Medicine and Institute of Health Science, Gyeongsang  National University School of Medicine, 79 Gangnam-ro, Jinju 660-702, Korea Tel: +82-55-750-8726, Fax: +82-55-758-9122 E-mail:  kimthy@medimail.co.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.392 See commentary on page 341-342",Non-OADS,/arxiv_data1/oa_pdf/3d/61/ce-45-392.PMC3521941.pdf
"Key Words :  Billroth II gastrectomy; Endoscopic retrograde cholangiopancreatography; Forward-viewing endoscopeOpen Access Received: November 13, 2011    Revised: March 17, 2012 Accepted: March 29, 2012 Correspondence:  Jae Woo Kim Department of Internal Medicine, Y onsei University Wonju College of Medi - cine, 20 Ilsan-ro, Wonju 220-701, Korea Tel: +82-33-741-1229, Fax: +82-33-741-1228, E-mail:  jawkim96@yonsei.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.397 See commentary on page 343-344",Non-OADS,/arxiv_data1/oa_pdf/90/3c/ce-45-397.PMC3521942.pdf
"Key Words : Bowel preparation; Polyp miss rate; Adenoma miss rate; Colonoscopy; SurveillanceOpen Access Received: December 18, 2011    Revised: April 8, 2012 Accepted: April 24, 2012 Correspondence:  In Kyung Sung Department of Internal Medicine, Konkuk University School of Medicine, 120  Neungdong-ro, Gwangjin-gu, Seoul 143-729, Korea Tel: +82-2-2030-5010, Fax: +82-2-2030-7748, E-mail:  20050051@kuh.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.404 See commentary on page 345-346",Non-OADS,/arxiv_data1/oa_pdf/b0/aa/ce-45-404.PMC3521943.pdf
"Key Words :  Russell body gastritis; Helicobacter pylori ; Mott cell; Polyclonal immunoglobulinOpen Access Received: November 7, 2011    Revised: March 7, 2012 Accepted: March 19, 2012 Correspondence:  Tae Y eong Lee Department of Internal Medicine, Good Samsun Hospital, 326 Gaya-daero,  Sasang-gu, Busan 617-718, Korea Tel: +82-51-322-0900, Fax: +82-51-313-2367, E-mail:  sova123@naver.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.412",Non-OADS,/arxiv_data1/oa_pdf/25/2c/ce-45-412.PMC3521944.pdf
"Key Words :  Esophagus; Intramural hematoma; Endoscopic biopsy; AspirinOpen Access Received:  November 21, 2011    Revised:  July 16, 2012 Accepted:  July 16, 2012 Correspondence:  Min Jeong Kim Division of Gastroenterology, Department of Internal Medicine, KEPCO Medi - cal Center, 308 Uicheon-ro, Dobong-gu, Seoul 132-703, Korea Tel: +82-2-901-3681, Fax: +82-2-901-3684, E-mail:  jfkone@naver.com cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.417 INTRODUCTION Among the acute esophageal injuries, intramural hemato - ma of the esophagus (IHE) is an uncommon clinical entity.",Non-OADS,/arxiv_data1/oa_pdf/8f/2b/ce-45-417.PMC3521945.pdf
"Key Words :  Stomach neoplasms; Signet ring cell; Gastrointestinal stromal tumors; Endosonography; BiopsyOpen Access Received:  December 5, 2011    Revised:  April 29, 2012 Accepted:  May 16, 2012 Correspondence:  Soo Teik Lee Department of Internal Medicine, The Research Institute of Clinical Medi - cine, Chonbuk National University Medical School, 20 Geonji-ro, Deokjin- gu, Jeonju 561-712, Korea Tel: +82-63-250-1684, Fax: +82-63-254-1609, E-mail:  soo@jbnu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.421 INTRODUCTION Gastric cancer with the appearance of a submucosal tumor  is rare.",Non-OADS,/arxiv_data1/oa_pdf/b2/c5/ce-45-421.PMC3521946.pdf
"Key Words :  Duodenum; Duplication cyst; Endoscopic resectionOpen Access Received: December 6, 2011    Revised: February 27, 2012 Accepted: March 5, 2012 Correspondence:  Hyun Seok Y ou Department of Internal Medicine, Pusan National University Hospital, Pusan  National University School of Medicine, 179 Gudeok-ro, Seo-gu, Busan 602- 739, KoreaTel: +82-51-523-3208, Fax: +82-51-523-0075, E-mail:  Yuzu203@hanmail.net cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.425",Non-OADS,/arxiv_data1/oa_pdf/ae/a3/ce-45-425.PMC3521947.pdf
"Key Words :  Sarcoma; Synovial; Retroperitoneal space; Obstructive jaundiceOpen Access Received: February 22, 2012    Revised: March 17, 2012 Accepted: March 17, 2012 Correspondence:  Kwang Ro Joo Department of Gastroenterology, Kyung Hee University Hospital at Gang - dong, Kyung Hee University School of Medicine, 892 Dongnam-ro, Gang - dong-gu, Seoul 134-727, Korea Tel: +82-2-440-6111, Fax: +82-2-440-6295, E-mail:  krjoo@khu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.428",Non-OADS,/arxiv_data1/oa_pdf/07/e7/ce-45-428.PMC3521948.pdf
"Key Words :  Pancreatic pseudocyst; Endosonography; Fine-needle biopsy; ComplicationsOpen Access Received:  March 6, 2012    Revised:  May 4, 2012 Accepted:  July 4, 2012 Correspondence:  Ji Kon Ryu Division of Gastroenterology, Department of Internal Medicine, Seoul Nation - al University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul 110-744,  Korea Tel: +82-2-2072-1962, Fax: +82-2-762-9662, E-mail:  jkryu@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.431 INTRODUCTION Endoscopic ultrasound-guided fine needle aspiration  (EUS-FNA) is well known as a useful diagnostic technique  for pancreatic masses.",Non-OADS,/arxiv_data1/oa_pdf/bb/86/ce-45-431.PMC3521949.pdf
"Key Words :  Choledochal cyst; Pancreatic cyst; CholangiocarcinomaOpen Access Received:  March 13, 2012    Revised:  April 16, 2012 Accepted:  April 20, 2012 Correspondence:  Sang Hyub Lee Division of Gastroenterology, Department of Internal Medicine, Seoul Nation - al University Bundang Hospital, Seoul National University College of Medi - cine, 82 Gumi-ro 173beon-gil, Bundang-gu, Seongnam 463-707, Korea Tel: +82-31-787-7042, Fax: +82-31-787-4051, E-mail:  gidoctor@snubh.org cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.435 INTRODUCTION Choledochal cysts are rare congenital or acquired cystic dil - atations of the intra- or extrahepatic bile ducts and dilatation  of duct.1 It is well accepted that a choledochal cyst is a prema - lignant state.2 Cancer usually occurs within the cyst, and many  authors postulated that malignancy occurs at the site of bile  stasis, irritation, and inflammation.3 Thus, as well as the pre - vention of later development of cancer in cyst, complete exci - sion of the cyst and cholecystectomy with reconstruction is  recommended as the mainstay of treatment.",Non-OADS,/arxiv_data1/oa_pdf/a5/76/ce-45-435.PMC3521950.pdf
"Key Words :  Gastrointestinal hemorrhage; Ileum; Dieulafoy lesion; Single balloon enteroscopyOpen Access Received: October 18, 2011    Revised: January 13, 2012 Accepted: January 25, 2012 Correspondence:  Byoung Wook Bang Division of Gastroenterology, Department of Internal Medicine, Inha Univer - sity Hospital, Inha University School of Medicine, 27 Inhang-ro, Jung-gu,  Incheon 400-711, KoreaTel: +82-32-890-2548, Fax: +82-32-890-2549, E-mail:  bangbu@inha.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.440",Non-OADS,/arxiv_data1/oa_pdf/46/22/ce-45-440.PMC3521951.pdf
"Key Words :  Hypereosinophilic syndrome; Colon; SteroidsOpen Access Received:  October 24, 2011    Revised:  March 13, 2012 Accepted:  March 17, 2012 Correspondence:  Su Jin Hong Department of Internal Medicine, Soonchunhyang University Bucheon Hospi - tal, Soonchunhyang University College of Medicine, 170 Jomaru-ro, Wonmi-gu,  Bucheon 420-767, Korea Tel: +82-32-621-5087, Fax: +82-32-621-5080, E-mail:  sjhong@schmc.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.444 INTRODUCTION Hypereosinophilia is associated with many allergic, infec - tious, neoplastic, and idiopathic diseases, and the disease co- urse can range from self-limited to life-threatening disease.",Non-OADS,/arxiv_data1/oa_pdf/ae/d9/ce-45-444.PMC3521952.pdf
"Key Words :  Stents; Neoplasms; StomaOpen Access Received: November 28, 2011    Revised: February 10, 2012 Accepted: March 10, 2012 Correspondence:  Sung Jae Shin Department of Gastroenterology, Ajou University Hospital, Ajou University  School of Medicine, 164 Worldcup-ro, Y eongtong-gu, Suwon 443-380, Korea Tel: +82-31-219-6939, Fax: +82-31-219-5999, E-mail:  shsj9128@ajou.ac.kr cc This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/ licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution,  and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.448",Non-OADS,/arxiv_data1/oa_pdf/18/6f/ce-45-448.PMC3521953.pdf
"Nucl Med Commun 2012;33:641-647.Lesion Location in Clinical Significance   of Incidental Colorectal FDG UptakeOpen Access Correspondence:  Joseph C. Lee, Department of Nuclear Medicine, The Prince Charles Hospital, Rode Road, Chermside, Qld 4032, Australia Tel: +61-7-3139-4000, Fax: +61-7-3139-4860, E-mail:  Joseph_Lee@health.qld.gov.au cc This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.451LETTER TO THE EDITOR",Non-OADS,/arxiv_data1/oa_pdf/d2/1f/ce-45-451.PMC3521954.pdf
Clin Endosc 2012;45:155-160 http://dx.doi.org/10.5946/ce.2012.45.2.155 The publisher wishes to apologize for incorrectly displaying the author (Jung-Ho Han) name.,Non-OADS,/arxiv_data1/oa_pdf/bb/48/ce-45-453.PMC3521955.pdf
"Copyright © 2012 Korean Society of Gastrointestinal Endoscopy   453Extended Spectrum-β-Lactamase or Carbapenemase Producing  Bacteria Isolated from Patients with Acute Cholangitis Ja Chung Goo1, Mun Hyuk Seong1, Young Kwang Shim1, Hee Seung Lee1, Jung-Ho Han1,  Kyeong Seob Shin2, Jae-Woon Choi3, Sei Jin Youn1 and Seon Mee Park1 Departments of 1Internal Medicine, 2Laboratory Medicine and  3General Surgery, Chungbuk National University College of Medicine, Cheongju, KoreaOpen AccessClin Endosc  2012 ;45:453-453ERRATUM Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.453",Non-OADS,/arxiv_data1/oa_pdf/bb/48/ce-45-453.PMC3521955.pdf
"Clin Endosc 2012 ;45:209-210 http://dx.doi.org/10.5946/ce.2012.45.3.209 The name of the IDEN 2011 member should be Prof. Y oung-Tae Bak (Korea University Guro Hospital, Seoul, Korea) instead of  Prof. Y oung-Tae Kim (Korea University Guro Hospital, Seoul, Korea).",Non-OADS,/arxiv_data1/oa_pdf/37/82/ce-45-454.PMC3521956.pdf
"454  Copyright © 2012 Korean Society of Gastrointestinal Endoscopy   International Digestive Endoscopy Network 2012:   A Patchwork of Networks for the Future Kwang An Kwon1, Il Ju Choi2, Eun Young Kim3, Seok Ho Dong4 and Ki Baik Hahm1 1Department of Gastroenterology, Gachon University Gil Medical Center, Incheon, 2Center for Gastric Cancer, National Cancer Center, Goyang,  3Department of Internal Medicine, Catholic University of Daegu School of Medicine, Daegu, 4Department of Internal Medicine, Kyung Hee University  School of Medicine, Seoul, KoreaOpen AccessClin Endosc  2012 ;45:454-454ERRATUM Print ISSN 2234-2400 / On-line ISSN 2234-2443 http://dx.doi.org/10.5946/ce.2012.45.4.454",Non-OADS,/arxiv_data1/oa_pdf/37/82/ce-45-454.PMC3521956.pdf
"Some available commercial fully-automated assays that  detect Flu A, flu B and/or RSV are: Xpert Flu (Cepheid) that detect Flu A and Flu B and differentiates A(H1N1)pdm09 [48] and Simplexa Flu A/B & RSV kit (Focus Diagnostics) for detection and differentiation of Flu A, Flu B and RSV (http://www.focusdx.com/pdfs/pi/US/MOL2600.pdf).",Non-OADS,/arxiv_data1/oa_pdf/09/61/TOVJ-6-151.PMC3522051.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ea/d2/srep00981.PMC3522068.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Xia, X.H.",Non-OADS,/arxiv_data1/oa_pdf/ea/d2/srep00981.PMC3522068.pdf
"Software package mfinder is available at http://www.weizmann.ac.il/mcb/ UriAlon/ (Accessed Dec. 4, 2012).",OADS,/arxiv_data1/oa_pdf/95/f6/srep00967.PMC3522069.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The author declares no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/95/f6/srep00967.PMC3522069.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Levnajic ´, Z.",Non-OADS,/arxiv_data1/oa_pdf/95/f6/srep00967.PMC3522069.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests : The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/9a/5f/srep00980.PMC3522071.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Boshnjaku, V. et al.",Non-OADS,/arxiv_data1/oa_pdf/9a/5f/srep00980.PMC3522071.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ce/d1/srep00979.PMC3522072.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Kajioka, S. et al.",Non-OADS,/arxiv_data1/oa_pdf/ce/d1/srep00979.PMC3522072.pdf
"[19] The CIRI Human Rights Data Project, Available at:  http://ciri.binghamton.edu/, Revised 2012.",Non-OADS,/arxiv_data1/oa_pdf/2e/a0/CPEMH-8-169.PMC3522089.pdf
Available at SSRN: http://ssrn.com/abstract=980629 or Available at: http://dx.doi.org/10.2139/ssrn.980629.,Non-OADS,/arxiv_data1/oa_pdf/2e/a0/CPEMH-8-169.PMC3522089.pdf
"[22] ISTAT, Sistema di Indicatori terriotoriali, Available at: http://sitis.istat.it/sitis/-html/, 2012.",Non-OADS,/arxiv_data1/oa_pdf/2e/a0/CPEMH-8-169.PMC3522089.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/2e/a0/CPEMH-8-169.PMC3522089.pdf
"This is an open access article licensed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c7/d1/CPEMH-8-175.PMC3522090.pdf
Available from: http://www.cms.gov/Medicare/Medicare- Fee-for-Service-pyment/ClinicalLabFeeSched.,Non-OADS,/arxiv_data1/oa_pdf/50/1b/TOVJ-6-115.PMC3522095.pdf
Available  from: http://www.juntadeandalucia.es/ep-hospitalponientealmeriam  emorias.php?anyo=2012  [12] Per Capita Total Health & Clinical Laboratory Expenditure (2008).,OADS,/arxiv_data1/oa_pdf/50/1b/TOVJ-6-115.PMC3522095.pdf
Available from: http://www.globalh  ealthfacts.org/data/topic/map.aspx?ind=66.,OADS,/arxiv_data1/oa_pdf/50/1b/TOVJ-6-115.PMC3522095.pdf
Available from: http://www.informationdynamics.,OADS,/arxiv_data1/oa_pdf/50/1b/TOVJ-6-115.PMC3522095.pdf
"Briefly, a confluent 6-well plate of hESCs was trypsinized for 5 minutes at 37 uC, neutralized, centrifuged, and resuspended in knockout Dulbecco’s modified Eagle’s medium (DMEM) (Gibco, Grand Island, NY, http://www.invitrogen.com)45, Figure 5 |Combination of SCX with mechanical stress enhances ectopic tendon regeneration in nude mice.",Non-OADS,/arxiv_data1/oa_pdf/ec/66/srep00977.PMC3522101.pdf
"Lentiviral production and infection .Human scleraxis gene (NM_001080514.1) was synthetized by Jin-Si-Te co. (Nanjing, Jiangsu, China) and then subcloned into the pleti-Gateway vector for constructing lentivirus (Invitrogen Inc., Carlsbad, CA, USA, http://www.invitrogen.com) and in packaging cell line Hek293T.",Non-OADS,/arxiv_data1/oa_pdf/ec/66/srep00977.PMC3522101.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ec/66/srep00977.PMC3522101.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Chen, X. et al.",Non-OADS,/arxiv_data1/oa_pdf/ec/66/srep00977.PMC3522101.pdf
"https://www.nscisc.uab.edu/PublicDocument  s/fact_figures_docs/Facts%202012%20Feb%20Final.pdf (Accessed  on: September 5, 2012).",Non-OADS,/arxiv_data1/oa_pdf/6b/99/TOORTHJ-6-548.PMC3522109.pdf
"Available at: http://www.as  iaspinalinju ry.org [Accessed on: September 5th, 2012].",Non-OADS,/arxiv_data1/oa_pdf/6b/99/TOORTHJ-6-548.PMC3522109.pdf
"Available  at: http://emedicine.medscape.com/article/1265682-overview [Acc- essed September 5th, 2012].",Non-OADS,/arxiv_data1/oa_pdf/6b/99/TOORTHJ-6-548.PMC3522109.pdf
"Available at: http://emedicine.medscape.com/article/  93546-overview#a0107 [Accessed on: September 5th, 2012].",Non-OADS,/arxiv_data1/oa_pdf/6b/99/TOORTHJ-6-548.PMC3522109.pdf
"Mutations in ﬁvemitochondrially encoded subunits, ND1, ND4, ND4L, ND5 and ND6, are associated with LHON (http://www.mitomap.org/ MITOMAP).",Non-OADS,/arxiv_data1/oa_pdf/b5/2a/ejhg2012112a.PMC3522193.pdf
"The MnCl 2 dose used was comparable to previous studies.30,31Log signal intensities from MRI scans corresponding to the region immediately superior to the opticchiasm were quantiﬁed using the Image J software 32(http://imagej.nih.gov/ij/) (Supplementary T ext).",OADS,/arxiv_data1/oa_pdf/b5/2a/ejhg2012112a.PMC3522193.pdf
"To view a copy of this license, visit http:// creativecommons.org/licenses/by-nc-nd/3.0/ Supplementary Information accompanies the paper on European Journal of Human Genetics website (http://www.nature.com/ejhg)Mutation-independent gene therapy for LHON N Chadderton et al 68 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/b5/2a/ejhg2012112a.PMC3522193.pdf
Dissertation 2008; http://handle.unsw.edu.au/1959.4/43309.,Non-OADS,/arxiv_data1/oa_pdf/af/d8/ejhg2012101a.PMC3522203.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/Need for a change in policy for DMD ATJM Helderman-van den Enden et al 26 European Journal of Human Genetics",Non-OADS,/arxiv_data1/oa_pdf/af/d8/ejhg2012101a.PMC3522203.pdf
"Moretti and others 440 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/an004e103.PMC3522208.pdf
"Anyway as a control analysis, the stability of the EEG signal was tested asfollows: the power spectra of ten epochs lasting 2 s each wereaveraged both at the beginning at the end of the free-artefactAnalysis of grey matter in thalamus and basal ganglia E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.441",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/an004e103.PMC3522208.pdf
"Voxel-based morphometry The 3D images were processed through the SPM5 softwarepackage (Statistical Parametric Mapping, Version 5; Welcome Department of Imaging Neuroscience, London, UK; http://www.fil.ion.ucl.ac.uk/spm), running on Matlab 7.0.1 (Math-Works).",OADS,/arxiv_data1/oa_pdf/b5/c0/an004e103.PMC3522208.pdf
"Moretti and others 442 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/an004e103.PMC3522208.pdf
"Association between EEG markers and GM changes The increase of a3/a2 ratio is associated with minor atrophy of caudate nuclei, accumbens nuclei in the basal ganglia,Analysis of grey matter in thalamus and basal ganglia E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.443",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/an004e103.PMC3522208.pdf
"Moretti and others 444 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/an004e103.PMC3522208.pdf
"Indeed, the ventral caudate andaccumbens nuclei are related to the regulation of emotional Figure 2 GM density in high versus middle a3/a2 power ratio T-map showing greater regional GM density in patients with high a3/a2 ratio contrasted with patients with middle a3/a2 ratio (P#0.05 uncorrected, the symbol ‘ .’ denotes ‘ major GM density then ’; see also Table 1).Analysis of grey matter in thalamus and basal ganglia E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.445",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/an004e103.PMC3522208.pdf
"Moretti and others 446 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/an004e103.PMC3522208.pdf
Brain Lang http://dx.doi.org/10.1016/j.bandl.2012.08.002.,OADS,/arxiv_data1/oa_pdf/b5/c0/an004e103.PMC3522208.pdf
"Int J Psychophysiol 47:199–216.Analysis of grey matter in thalamus and basal ganglia E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.447",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/an004e103.PMC3522208.pdf
"Moretti and others 448 E2012 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.or g/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b5/c0/an004e103.PMC3522208.pdf
"This is an open access article, published under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5) .",Non-OADS,/arxiv_data1/oa_pdf/ad/e9/JVR-03-022.PMC3522379.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by- nc/3.0/), which permits non- commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a9/a6/des372.PMC3522415.pdf
"NCHS Data Brief 21 [online]Available at: ,http://www.cdc.gov/nchs/data/databriefs/db21.pdf .",OADS,/arxiv_data1/oa_pdf/a9/a6/des372.PMC3522415.pdf
"[online] Available at: ,http://publications.nice.org.uk/fertility-cg11 .",Non-OADS,/arxiv_data1/oa_pdf/a9/a6/des372.PMC3522415.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc/3.0/), which permits non-commercial reuse, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/94/83/dks351.PMC3522447.pdf
Percentage identity and similarity were obtained by sequence alignment using Clustal W at http://npsa-pbil.ibcp.fr/.Table 2.,OADS,/arxiv_data1/oa_pdf/94/83/dks351.PMC3522447.pdf
"coli and to be inhibited by ATPase inhibitors.22 Of the tetracycline ( tet) and oxytetracycline ( otr) resistance genes currently listed in the tetracycline gene nomenclature database (http://faculty.washington.edu/marilynr/), 28 code for active efﬂux, 12 for ribosomal protection, 3 for enzymatic drug inactivation and 1 has an unknown mechanism.",Non-OADS,/arxiv_data1/oa_pdf/94/83/dks351.PMC3522447.pdf
"29 Department of Statistics, Government of Singapore: Key household characteristics and household  income trends 2011. http://www.singstat.gov.sg/pubn/papers/people/pp-s18.pdf (accessed February 17, 2012).",Non-OADS,/arxiv_data1/oa_pdf/85/d0/dee-0002-0529.PMC3522450.pdf
"http://www.hdb.gov.sg/fi10/fi10323p.nsf/w/RentDirectHDBRentDeposit?OpenDocument (accessed April 15, 2010).",Non-OADS,/arxiv_data1/oa_pdf/85/d0/dee-0002-0529.PMC3522450.pdf
http://www.hdb.,Non-OADS,/arxiv_data1/oa_pdf/85/d0/dee-0002-0529.PMC3522450.pdf
"http://www.hpb.gov.sg/ programmes/article.aspx?id=350 (accessed February 28, 2012).",Non-OADS,/arxiv_data1/oa_pdf/85/d0/dee-0002-0529.PMC3522450.pdf
http://www.who.int/classifications/atcddd/(accessed 2012).,OADS,/arxiv_data1/oa_pdf/04/33/dee-0002-0361.PMC3522451.pdf
"Specifically, potential participants were recruited from FTD care-giver support group meetings in Portland, Oreg., and San Francisco, Calif., and information on the study was included in the newsletters and on the website (http://www.theaftd.org/) of the AFTD.",Non-OADS,/arxiv_data1/oa_pdf/1b/be/dee-0002-0516.PMC3522453.pdf
"http://www.ohri.ca/pro-grams/clinical_epidemiology/oxford.asp (accessed November, 2011).",Non-OADS,/arxiv_data1/oa_pdf/e1/2c/dee-0002-0546.PMC3522458.pdf
"Thermodynamic model In case of a trihaem cytochrome, three consecutive reversible steps of one-electron transfer convert the fully reduced state(stage 0, S 0) into the fully oxidized state (stage 3, S3), and therefore four different redox stages can be deﬁned, each groupconsisting of microstates with the same number of oxidizedhaems (see Supplementary Figure S1 at http://www.bioscirep.org/bsr/033/bsr033e002add.htm), as previously described [ 20].",Non-OADS,/arxiv_data1/oa_pdf/14/4e/bsr033e002.PMC3522473.pdf
"In the characterization of the wild-type protein, the chem- ical shifts obtained for the haem methyls 12 1CH 3I,71CH 3III and 121CH 3IV(labelled according to the IUPAC nomenclature; see Supplementary Figure S2 at http://www.bioscirep.org/bsr/033/bsr033e002add.htm) in each oxidation stage in the pHrange 6–9 were ﬁtted simultaneously with visible redox titrationsdata obtained at pH 7 and 8.",Non-OADS,/arxiv_data1/oa_pdf/14/4e/bsr033e002.PMC3522473.pdf
The impact of the mutations on the haem core architecture of the four PpcAM58 mutants was also probed by 2D 1H-NMR; the haem proton resonances were assigned (Supplementary TableS1 at http://www.bioscirep.org/bsr/033/bsr033e002add.htm) andtheir chemical shifts were compared with those of the wild-typecytochrome (see inset in Figure 2 )[13].,OADS,/arxiv_data1/oa_pdf/14/4e/bsr033e002.PMC3522473.pdf
"To illustrate the stepwise oxidation of PpcAM58mutants, 2D-EXSY NMR spectra obtained at pH 8 are shown inSupplementary Figure S3 (at http://www.bioscirep.org/bsr/033/bsr033e002add.htm).",Non-OADS,/arxiv_data1/oa_pdf/14/4e/bsr033e002.PMC3522473.pdf
calculatedfrom approximately 10 4shifts as reported in the Biological Mag- netic Resonance Data Bank (http://www.bmrb.wisc.edu/).,OADS,/arxiv_data1/oa_pdf/14/4e/bsr033e002.PMC3522473.pdf
"L. Morgado and others Figure 6 Molar fractions of the 16 individual microstates of PpcAM58 mutants and wild-type cytochrome at pH 7.5 The molar fractions were calculated as a function of the solution reduction potential using the parameters listed in Table 1.Continuous and broken lines indicate the protonated and deprotonated microstates (described in Supplementary FigureS1 at http://www.bioscirep.org/bsr/033/bsr033e002add.htm), respectively.",OADS,/arxiv_data1/oa_pdf/14/4e/bsr033e002.PMC3522473.pdf
"However, gp64 can be modelled in the pre-fusion conformation based on the available pre-fusion structure of VSV G as, despite large rearrangementsin their relative positions, most of the individual domainsretain their folded structures ([ 35] and Supplementary Fig- ure S1 at http://www.bioscirep.org/bsr/033/bsr033e003add.htm).Domains Ia, Ib and II of the GP64 postfusion structure (PDBcode 3DUZ), deﬁned as described [ 13] were superimposed onto the corresponding domains of the prefusion structure of VSV G(PDB code 2J6J).",Non-OADS,/arxiv_data1/oa_pdf/41/d0/bsr033e003.PMC3522474.pdf
"However, to conﬁrm the relative virus titres, the virusconcentration was also assessed by QPCR (Supplementary Fig-ure S2 at http://www.bioscirep.org/bsr/033/bsr033e003add.htm).For CHO-K1, U2OS and 17.1 cells, all the three mutants gavehigher transduction efﬁciencies than the WT (wild-type) virus(Figure 5 ).",Non-OADS,/arxiv_data1/oa_pdf/41/d0/bsr033e003.PMC3522474.pdf
No attempt was made to distinguish fail-ure to bind from failure to fuse but the virus preparations boundequivalently to the Sf9 cells (see Supplementary Figure S3 at http://www.bioscirep.org/bsr/033/bsr033e003add.htm).,Non-OADS,/arxiv_data1/oa_pdf/41/d0/bsr033e003.PMC3522474.pdf
"LPS caused a time- dependent increase in JNK phosphorylation over the ﬁrsthour of stimulation, which was followed by a gradual de-crease when measured at 6 and 24 h (Supplementary Fig-ure S1 at http://www.bioscirep.org/bsr/033/bsr033e004add.htm).The maximum increase in JNK phosphorylation was observedwith 100 ng/ml LPS, with no further increase achieved with1μg/ml LPS (Supplementary Figure S1).",Non-OADS,/arxiv_data1/oa_pdf/6f/22/bsr033e004.PMC3522475.pdf
Mass data were ana-lysed by ﬂexAnalysis (Bruker Daltonics) and ProteinProspector(http://prospector.ucsf.edu/prospector/mshome.htm).,OADS,/arxiv_data1/oa_pdf/89/be/bsr033e005.PMC3522476.pdf
"Computational analysis DHCR24 promoter analysis of potential transcription-factor-binding sites was performed with the ‘Transcription ElementSearch System’ from the University of Pennsylvania (TESS,http://www.cbil.upenn.edu/tess) [ 31].",OADS,/arxiv_data1/oa_pdf/8a/26/bsr033e006.PMC3522477.pdf
Analysis of full-length cDNA entries in the GenBank®data- base and the Database of Transcriptional Start Sites (DBTSS;http://dbtss.hgc.jp/) revealed multiple other proximal start sitesin the same region ( Figure 2 ).,OADS,/arxiv_data1/oa_pdf/8a/26/bsr033e006.PMC3522477.pdf
Diagrams that describe inmore detail the ‘glucose economy’ and the ‘FA (fatty acid) eco-nomy’ of adipocytes are shown in Supplementary Figures S1 andS2 (at http://www.bioscirep.org/bsr/033/bsr033e007add.htm).,Non-OADS,/arxiv_data1/oa_pdf/2d/b0/bsr033e007.PMC3522478.pdf
Eqn (1.8) in the Supplementary Online data section (at http://www.bioscirep.org/bsr/033/bsr033e007add.htm) was used to calculate glucose utilization.,OADS,/arxiv_data1/oa_pdf/2d/b0/bsr033e007.PMC3522478.pdf
Acute regulation of adipocyte AMPK and validated in the Supplementary Online data section (at http://www.bioscirep.org/bsr/033/bsr033e007add.htm).,Non-OADS,/arxiv_data1/oa_pdf/2d/b0/bsr033e007.PMC3522478.pdf
Eqn (1.1) in the Supplementary Online data section (at http://www.bioscirep.org/bsr/033/bsr033e007add.htm) was then used to derive values for CO 2 formation.,OADS,/arxiv_data1/oa_pdf/2d/b0/bsr033e007.PMC3522478.pdf
"However, as shown in Figure 6 , provision of NEFA appreciably reverses this proportionality –an effect that can be seen over a wide range of glucose con-centrations with or without insulin (Supplementary Figure S8at http://www.bioscirep.org/bsr/033/bsr033e007add.htm).",Non-OADS,/arxiv_data1/oa_pdf/2d/b0/bsr033e007.PMC3522478.pdf
With 1 mM glucose in the absence of insulin where glucosetransport is likely to have appreciable control strength over gluc-ose utilization palmitate substantially decreased the percentageof glucose committed to FA synthesis but the absolute decreasein this process was small (Supplementary Table S1a and FigureS9 at http://www.bioscirep.org/bsr/033/bsr033e007add.htm).,Non-OADS,/arxiv_data1/oa_pdf/2d/b0/bsr033e007.PMC3522478.pdf
0.3 or 0.6 mM) palmitate decreased FA synthesisbut at 2.5 and 5 mM FA synthesis was increased by palmitate inthe absence or presence of insulin (Supplementary Table S2 athttp://www.bioscirep.org/bsr/033/bsr033e007add.htm).,Non-OADS,/arxiv_data1/oa_pdf/2d/b0/bsr033e007.PMC3522478.pdf
Eqn (1.8) from the Supplementary Online data section (at http://www.bioscirep.org/bsr/033/bsr033e007add.htm) was used to calculate glucose utilization.,OADS,/arxiv_data1/oa_pdf/2d/b0/bsr033e007.PMC3522478.pdf
"In addition to inverting the relationship between gluc- ose conversion to FA and GG, calculations leading toSupplementary Figures S10–S13 (available at http://www.bioscirep.org/bsr/033/bsr033e007add.htm) show that palmitatehad other effects on glucose metabolism.",Non-OADS,/arxiv_data1/oa_pdf/2d/b0/bsr033e007.PMC3522478.pdf
Supplementary Figure S14 (availableat http://www.bioscirep.org/bsr/033/bsr033e007add.htm) showsa normalization that allowed comparison of the effects of palmit-ate and adrenaline.,OADS,/arxiv_data1/oa_pdf/2d/b0/bsr033e007.PMC3522478.pdf
As shown in Supplementary Figure S15 (at http://www.bioscirep.org/bsr/033/bsr033e007add.htm) palmitatehad no effect on adipocyte AS160 phosphorylation.,Non-OADS,/arxiv_data1/oa_pdf/2d/b0/bsr033e007.PMC3522478.pdf
"This is an open access article, published under the  terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/2.5) .",Non-OADS,/arxiv_data1/oa_pdf/66/83/JRGS-08-464.PMC3522483.pdf
"MATERIALS AND METHODS Hairpin design In order to generate novel shRNA designs, the sequence of  the PML-RAR α molecular fusion was submitted to shRNA  design modules on both the Ambion (http://www.ambion.",OADS,/arxiv_data1/oa_pdf/66/83/JRGS-08-464.PMC3522483.pdf
com/techlib/misc/siRNA_finder.html) and GenScript  (https://www.genscript.com/ssl-bin/app/rnai) websites.,OADS,/arxiv_data1/oa_pdf/66/83/JRGS-08-464.PMC3522483.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society Biochemical Journal    www.biochemj.org © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/bj4490401.PMC3522501.pdf
"The ﬁnal cell pellet was resuspended c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/bj4490401.PMC3522501.pdf
"Brieﬂy, mammary glands were c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/bj4490401.PMC3522501.pdf
"PBS, or 8 pg/ml or 80 μg/ml oxytocin c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/bj4490401.PMC3522501.pdf
"Similar to our ﬁndings from myoepithelialcells, the incidence of dye transfer between granulosa cells of Cx43 I130T/ +mice was 61 %of the control, whereas coupling in c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/bj4490401.PMC3522501.pdf
"In order to investigate the impact of the I130T Cx43 mutant on mammary gland development in virgin mice, mammary gland c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/bj4490401.PMC3522501.pdf
"Following treatment with 80 μg/ml or 8 pg/ml oxytocin, milk rapidly ﬁlled c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/bj4490401.PMC3522501.pdf
"Together, mammary glands from mutant mice had no observable functional defects in milk production or ejection compared with control mice.DISCUSSION The focus of the present study was two aspects: ﬁrst, to evaluatethe critical role of Cx43 throughout all stages of mammary gland development with emphasis on the importance of Cx43-mediated GJIC; and second, to determine whether a Cx43 ODDD mutant c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/bj4490401.PMC3522501.pdf
"Although it is unknown if the delay in ductal development is a result of dysregulation of Cx43 in the stroma or in the epithelium,extracellular matrix components are able to bind and sequester signalling molecules that affect ductal/branching morphogenesis, c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/bj4490401.PMC3522501.pdf
"Interestingly, cyclin D1-null mice have poor c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/bj4490401.PMC3522501.pdf
"c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/bj4490401.PMC3522501.pdf
"30, 724–733 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/bj4490401.PMC3522501.pdf
"Science 267, 1831–1834 Received 3 July 2012/28 September 2012; accepted 18 October 2012 Published as BJ Immediate Publication 18 October 2012, doi:10.1042/BJ20121070 c/circlecopyrtThe Authors Journal compilation c/circlecopyrt2013 Biochemical Society © 2013 The Author(s) The author(s) has paid for this article to be freely available under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/) which permits unrestricted non-commercial use, distribution and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/98/0f/bj4490401.PMC3522501.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Menstrual Cycle Phase and Duration of Oral Contraception Intake Affect  Olfactory Perception Birgit Derntl1,2,3,*, Veronika Schöpf4,5,*, Kathrin Kollndorfer1,4 and Rupert Lanzenberger6,7 1Institute for Applied Psychology, Faculty of Psychology, University of Vienna, Liebiggasse 5,  1010 Vienna, Austria, 2Department of Psychiatry, Psychotherapy, and Psychosomatics, RWTH  Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany, 3Jülich Aachen Research  Alliance (JARA), Translational Brain Medicine, Aachen, Germany, 4Department of Radiology,  Division of Neuro- and Musculoskeletal Radiology, Medical University Vienna, Währinger  Gürtel 18-20, 1090 Vienna, Austria, 5MR Centre of Excellence, Medical University Vienna,  Lazarettgasse 14, 1090 Vienna, Austria, 6Department of Psychiatry and Psychotherapy,  Medical University Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria and 7Functional,  Molecular and Translational Neuroimaging Lab, Medical University Vienna, Währinger Gürtel 18-20, 1090 Vienna, Austria *These authors contributed equally to the work.",Non-OADS,/arxiv_data1/oa_pdf/b1/15/bjs084.PMC3522517.pdf
"Database URL: http://www.cancerma.org.uk ............................................................................................................................... ............................................................................................................................... ............................... Introduction Cancer is a multi-factorial disease that can arise from alter- ations in expression levels of oncogenes and tumour sup-pressor genes, details of which can be elucidated by meansof expression data ( 1).",Non-OADS,/arxiv_data1/oa_pdf/53/33/bas055.PMC3522872.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/53/33/bas055.PMC3522872.pdf
"Based on the guidelines from Affymetrix/‘simpleaffy’(available at: http://www.bioconductor.org/packages/release/bioc/vignettes/simpleaffy/inst/doc/QCandSimpleaffy.pdf), datasets with scale factors with 3-fold of one another, an ActB 3 0:mid ratio <3 and a GAPDH 30:mid ratio <1.25 were selected.",OADS,/arxiv_data1/oa_pdf/53/33/bas055.PMC3522872.pdf
"The full list of 80 datasets, including the GEO/ArrayExpress accession num- bers as well as the 13 cancer types covered, are availableon the CancerMA website (http://www.cancerma.org.uk/information.html).",OADS,/arxiv_data1/oa_pdf/53/33/bas055.PMC3522872.pdf
"For gene and probe annotation purposes, the Ensembl database ( 15), the HUGO Gene Nomenclature Committee (HGNC) database ( 16) and the annotation files provided by Affymetrix (available at: http://www.affymetrix.com/sup port/technical/annotationfilesmain.affx) were establishedas a local MySQL database.",OADS,/arxiv_data1/oa_pdf/53/33/bas055.PMC3522872.pdf
"To view an example, visit http://www.cancerma.org.uk.Implementation CancerMA is running on an Intel core i7 2.66 Ghz worksta-tion with 12 Gb RAM and installed with CentOS 5.4 GNULinux OS (x86_64).",Non-OADS,/arxiv_data1/oa_pdf/53/33/bas055.PMC3522872.pdf
"For the relational databases, MySQL5.0.77 (available at: http://www.mysql.com) was used.",OADS,/arxiv_data1/oa_pdf/53/33/bas055.PMC3522872.pdf
"TheCancerMA web interface was implemented using: HTML/CSS, Twitter Bootstrapp (available at: http://twitter.github.com/bootstrap/), Javascript/jQuery (available at: http://jquery.com/) and Perl 5.8.8 (available at: http://www.perl.",OADS,/arxiv_data1/oa_pdf/53/33/bas055.PMC3522872.pdf
The CancerMA pipeline was implemented using: R 2.12.1 (available at: http://www.cran.r-project.org) ( 27); the Bioconductor package (available at: http://www.bioconductor.org) ( 28) and Perl 5.8.8 (available at: http:// www.perl.org).,OADS,/arxiv_data1/oa_pdf/53/33/bas055.PMC3522872.pdf
CancerMA is freely available online athttp://www.cancerma.org.uk.,Non-OADS,/arxiv_data1/oa_pdf/53/33/bas055.PMC3522872.pdf
"For a detailed documentation, please refer to theCancerMA help section (http://www.cancerma.org.uk/help.html).",Non-OADS,/arxiv_data1/oa_pdf/53/33/bas055.PMC3522872.pdf
"Web platforms such as Oncomine ( 59), GEO Profiles ( 3), Gene Expression Atlas (available at: http://www.ebi.ac.uk/gxa/) or Gemma ( 60) focus on gene expression profiles across multiple conditions and tissuesbut do not combine the results of the individual studies.",Non-OADS,/arxiv_data1/oa_pdf/53/33/bas055.PMC3522872.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e5/c7/bio-01-12-1169.PMC3522877.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/25/7a/bio-01-12-1178.PMC3522878.pdf
"Statistics Data were analyzed with Statistica 7.0 (StatSoft, http://www.statsoft.com).Physiological variables were measured three times in most individuals, with a three-week interval between measurements (i.e.",OADS,/arxiv_data1/oa_pdf/25/7a/bio-01-12-1178.PMC3522878.pdf
This is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/cd/8f/bio-01-12-1185.PMC3522879.pdf
This is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/b3/6c/bio-01-12-1192.PMC3522880.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/74/de/bio-01-12-1200.PMC3522881.pdf
This is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/dc/29/bio-01-12-1204.PMC3522882.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a0/90/bio-01-12-1215.PMC3522883.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/66/77/bio-01-12-1226.PMC3522884.pdf
"Morphological measurements were made on in-flight images during the middle of the downstroke (Image J, http://rsb.info.nih.gov/ij) following Pennycuick (Pennycuick,1989a).",OADS,/arxiv_data1/oa_pdf/66/77/bio-01-12-1226.PMC3522884.pdf
This is an Open Access article distributed under the terms of theCreative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f2/7e/bio-01-12-1239.PMC3522885.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/0e/d8/bio-01-12-1248.PMC3522886.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share AlikeLicense (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/14/7f/bio-01-12-1258.PMC3522887.pdf
"Volocity 5.2, Image J (NIH, http://rsb.info.nih.gov/ij), and Adobe Photoshop software were used for image capturing and analysis.",OADS,/arxiv_data1/oa_pdf/14/7f/bio-01-12-1258.PMC3522887.pdf
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Share Alike License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/8c/9b/bio-01-12-1264.PMC3522888.pdf
Additional information Reprints and permission information is available online at http://npg.nature.com/ reprintsandpermissions/ Supplementary Information accompanies this paper at http://www.nature.com/ scientificreports www.nature.com/ scientificreports SCIENTIFIC REPORTS | 2 : 987 | DOI: 10.1038/srep00987 6,Non-OADS,/arxiv_data1/oa_pdf/4e/4a/srep00987.PMC3523285.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/How to cite this article: Liu, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/4e/4a/srep00987.PMC3523285.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/7b/85/srep00985.PMC3523286.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Bisri, S.Z.",Non-OADS,/arxiv_data1/oa_pdf/7b/85/srep00985.PMC3523286.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Anttonen, T. et al.",Non-OADS,/arxiv_data1/oa_pdf/a2/89/srep00978.PMC3523287.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/10/48/srep00988.PMC3523288.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Yu, C. & Wang, Q.J.",Non-OADS,/arxiv_data1/oa_pdf/10/48/srep00988.PMC3523288.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/52/97/srep00984.PMC3523289.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/ How to cite this article: Kim, J. et al.",Non-OADS,/arxiv_data1/oa_pdf/52/97/srep00984.PMC3523289.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/ae/f3/srep00983.PMC3523290.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Huang, H. et al.",Non-OADS,/arxiv_data1/oa_pdf/ae/f3/srep00983.PMC3523290.pdf
Additional information Supplementary Information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/75/2c/srep00986.PMC3523291.pdf
"To view a copy of thislicense, visit http://creativecommons.org/licenses/by-nc-nd/3.0/ How to cite this article: Hu, L. et al.",Non-OADS,/arxiv_data1/oa_pdf/75/2c/srep00986.PMC3523291.pdf
"Journal of Visualized Experiments www.jove.com Copyright © 2012  Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported LicenseNovember 2012 |  69  | e4285 | Page 1 of 7Video Article A Visual Description of the Dissection of the Cerebral Surface Vasculature and Associated Meninges and the Choroid Plexus from Rat Brain John F. Bowyer1, Monzy Thomas1, Tucker A. Patterson1, Nysia I. George2, Jeffrey A. Runnells3, Mark S. Levi1 1Division of Neurotoxicology, National Center for Toxicological Research 2Division of Personalized Nutrition and Medicine, National Center for Toxicological Research 3Office of Planning, Finance, and Information Technology, National Center for Toxicological Research Correspondence to: John F. Bowyer at john.bowyer@fda.hhs.gov URL: http://www.jove.com/video/4285 DOI: doi:10.3791/4285 Keywords: Neuroscience, Issue 69, Medicine, Anatomy, Physiology, Toxicology, brain, dissection, choroid plexus, meninges and associated vasculature Date Published: 11/14/2012 Citation: Bowyer, J.F., Thomas, M., Patterson, T.A., George, N.I., Runnells, J.A., Levi, M.S.",Non-OADS,/arxiv_data1/oa_pdf/24/ae/jove-69-4285.PMC3523424.pdf
"Video Link The video component of this article can be found at http://www.jove.com/video/4285/ Protocol Although not shown in the video, rats were first given an overdose of 300 mg/kg of pentobarbital, resulting in anesthesia in less than 3 min, and then killed by decapitation.",Non-OADS,/arxiv_data1/oa_pdf/24/ae/jove-69-4285.PMC3523424.pdf
Available from: URL:   http://emedicine.medscape.com/article/1162720-print.,Non-OADS,/arxiv_data1/oa_pdf/39/da/JRMS-17-101.PMC3523427.pdf
MedlinePlus.Cerebral Amyloid Angiopathy[Online]2011.Available from: URL:   http://www.nlm.nih.gov/medlineplus/ency/article/000719.htm  6.,Non-OADS,/arxiv_data1/oa_pdf/39/da/JRMS-17-101.PMC3523427.pdf
[cited 2011 Jan 30]; Available from URL:  http://www.amar.org.ir/Upload/Modules/Contents /asset0/baravord89/bara vord_esfehan.pdf.,OADS,/arxiv_data1/oa_pdf/66/74/JRMS-17-67.PMC3523440.pdf
[cited 2009  Jan 21]; Available from: URL: http://www.afarineshdaily.ir/afarinesh/News.aspx?NID=20500.,OADS,/arxiv_data1/oa_pdf/a1/75/JRMS-17-83.PMC3523443.pdf
[cited 2008 Feb 10]; Available from: URL:  http://research.mui.ac.ir.,OADS,/arxiv_data1/oa_pdf/a1/75/JRMS-17-83.PMC3523443.pdf
"FDA Advisory Committee Briefing Document: Pharmaceutical Science and Clinical Pharmacology Advisory Committee, March18−19, 2008 ( http://www.fda.gov/ohrms/dockets/ac/08/briefing/ 2008-4351b1-00-index.htm ) 18.",Non-OADS,/arxiv_data1/oa_pdf/20/cc/10637_2011_Article_9789.PMC3523469.pdf
March 2004 ( http://www.fda.gov/ ScienceResearch/SpecialTopics/CriticalPathInitiative/CriticalPathOpportunitiesReports/ucm077262.htm ) 25.,Non-OADS,/arxiv_data1/oa_pdf/20/cc/10637_2011_Article_9789.PMC3523469.pdf
"September 2009 ( http://www.fda.gov/downloads/Drugs/Guidance ComplianceRegulatoryInfor mation/Guidances/ucm079690.pdf ) (accessed April 16, 2010) 26.",Non-OADS,/arxiv_data1/oa_pdf/20/cc/10637_2011_Article_9789.PMC3523469.pdf
"Global Adult Tobacco Survey (GATS) India: 2009–2010 available from: http://www.searo.who.int/LinkFiles/Regional_Tobacco_Surveillance_System_GATS_India.pdf published by IIPS, Mumbai and funded by the Ministry of Health and Family welfare, GOI 2010.",Non-OADS,/arxiv_data1/oa_pdf/33/4e/IJMPO-33-139.PMC3523470.pdf
Available from: http://www.who.int/tobacco/communications/events/wntd/2006/Report_ v8_4May06.pdf [Last accessed on 2011 Jun 17].,OADS,/arxiv_data1/oa_pdf/33/4e/IJMPO-33-139.PMC3523470.pdf
Available from: http://www.mohfw.nic.in/National%20Programme%20for%20Tobacco%20Control.htm [Last accessed on 2010 Nov 06].,Non-OADS,/arxiv_data1/oa_pdf/33/4e/IJMPO-33-139.PMC3523470.pdf
Available from: http://www.healis.org/ [Last accessed on 2011 Nov 17] 21.,Non-OADS,/arxiv_data1/oa_pdf/33/4e/IJMPO-33-139.PMC3523470.pdf
Available from: http://www.phfi.org/ [Last accessed on 2011 Nov 17].,Non-OADS,/arxiv_data1/oa_pdf/33/4e/IJMPO-33-139.PMC3523470.pdf
Available from: http://www.tobaccofreeunion.org/content/en/393/ [Last accessed on 2011 Nov 19].,Non-OADS,/arxiv_data1/oa_pdf/33/4e/IJMPO-33-139.PMC3523470.pdf
Available from: http://whoindia.org/en/section20/section25_925.htm [Last accessed on 2011 Nov 19].,Non-OADS,/arxiv_data1/oa_pdf/33/4e/IJMPO-33-139.PMC3523470.pdf
FAO  available from: http://faostat.fao.org/site/339/default.aspx  [Last accessed on 2011 Nov 19].,OADS,/arxiv_data1/oa_pdf/33/4e/IJMPO-33-139.PMC3523470.pdf
"United  Nations Rome, 2003 available from: http://www.fao.org/ docrep/006/y4997e/y4997e0h.htm#TopOfPage [Last cited  on 2011 Jun 17].",Non-OADS,/arxiv_data1/oa_pdf/33/4e/IJMPO-33-139.PMC3523470.pdf
Available  from: http://www.tobaccoevidence.net/pdf/weurope_ activites/CanaryIsland_HanaandFrank.pdf [Last accessed on 2011 Jun 02].,Non-OADS,/arxiv_data1/oa_pdf/33/4e/IJMPO-33-139.PMC3523470.pdf
Available forom: http://www.itcproject.org/ [Last accessed  on 2011 Nov 17].,Non-OADS,/arxiv_data1/oa_pdf/33/4e/IJMPO-33-139.PMC3523470.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/33/4e/IJMPO-33-139.PMC3523470.pdf
"Available from: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp,http://www.nccn.org/professionals/physician_gls/pdf/nscl.pdf.",Non-OADS,/arxiv_data1/oa_pdf/94/1e/IJMPO-33-146.PMC3523471.pdf
Available from: http://chicago2011.asco.org/Abstracts.aspx.,Non-OADS,/arxiv_data1/oa_pdf/94/1e/IJMPO-33-146.PMC3523471.pdf
Available from: http://chicago2011.asco.org/Abstracts.aspx.,Non-OADS,/arxiv_data1/oa_pdf/94/1e/IJMPO-33-146.PMC3523471.pdf
Available from: http://www.esmo.org/events/milan-2010-congress.html.,Non-OADS,/arxiv_data1/oa_pdf/94/1e/IJMPO-33-146.PMC3523471.pdf
"Abstract 7519 ASCO 2011,  Available from: http://chicago2011.asco.org/Abstracts.aspx.",Non-OADS,/arxiv_data1/oa_pdf/94/1e/IJMPO-33-146.PMC3523471.pdf
Author Help: Online submission of the manuscripts Articles can be submitted online from http://www.journalonweb.com.,Non-OADS,/arxiv_data1/oa_pdf/94/1e/IJMPO-33-146.PMC3523471.pdf
Start a QR-code reading software (see list of free applications from http://tinyurl.com/yzlh2tc) and point the camera to the QR-code printed in the journal.,Non-OADS,/arxiv_data1/oa_pdf/e8/6e/IJMPO-33-182.PMC3523479.pdf
See http://tinyurl.com/2bw7fn3 or http://tinyurl.com/3ysr3me for the free applications.,Non-OADS,/arxiv_data1/oa_pdf/e8/6e/IJMPO-33-182.PMC3523479.pdf
The application can be downloaded from http://itunes.apple.com/us/app/medknow-journals/id458064375?ls=1&mt=8.,Non-OADS,/arxiv_data1/oa_pdf/bd/15/IJMPO-33-185.PMC3523480.pdf
The application can be downloaded from https://market.android.com/details?id=comm.app.medknow.,Non-OADS,/arxiv_data1/oa_pdf/c0/6f/IJMPO-33-192.PMC3523486.pdf
"#Cambridge University Press, 2012 The online version of this article is published within an Open Access environment subject doi:10.1017/S1740925X12000142 to the conditions of the Creative Commons Attribution-NonCommercial-ShareAlike licence ,http://creativecommons.org/ licenses/by-nc-sa/3.0/ ..",Non-OADS,/arxiv_data1/oa_pdf/cb/84/S1740925X12000142a.PMC3523548.pdf
"Further information about the sampling procedure is available at http://www.cdc.gov/nchs/ ahcd/ahcd_scope.htm (accessed November 19, 2011).",OADS,/arxiv_data1/oa_pdf/48/49/wjem-13-344.PMC3523811.pdf
Available at: http://www.cdc.gov/nchs/ahcd/ercharts.htm.,OADS,/arxiv_data1/oa_pdf/48/49/wjem-13-344.PMC3523811.pdf
Available at: http://www.nlm.nih.gov/pubs/ factsheets/mesh.html.,OADS,/arxiv_data1/oa_pdf/48/49/wjem-13-344.PMC3523811.pdf
Available at: http://www.nlm.nih.gov/ mesh/introduction.html.,OADS,/arxiv_data1/oa_pdf/48/49/wjem-13-344.PMC3523811.pdf
Available at: http://www.nlm.nih.gov/mesh/intro_indexing.html.,OADS,/arxiv_data1/oa_pdf/48/49/wjem-13-344.PMC3523811.pdf
Available at: http://www.nlm.nih.gov/pubs/factsheets/online_indexing_system.html.,Non-OADS,/arxiv_data1/oa_pdf/48/49/wjem-13-344.PMC3523811.pdf
Available at: http://www.nlm.nih.gov/pubs/factsheets/jsel.html.,Non-OADS,/arxiv_data1/oa_pdf/48/49/wjem-13-344.PMC3523811.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.form of tobacco has a history of use in Sweden that dates back  several hundred years, although its composition and manufac-turing processes have evolved over time.",Non-OADS,/arxiv_data1/oa_pdf/03/ba/nts123.PMC3524070.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0), which permits unrestricted non-commercial use, distribution, and   reproduction in any medium, provided the original work is properly cited.Nicotine & Tobacco Research, Volume 15, Number 1 (January 2013) 255–261 255",Non-OADS,/arxiv_data1/oa_pdf/03/ba/nts123.PMC3524070.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License  (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction  in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/85/9a/nts190.PMC3524071.pdf
"Retrieved from http://cebp.aacrjournals.org/ Lund, I., & Scheffels, J.",OADS,/arxiv_data1/oa_pdf/85/9a/nts190.PMC3524071.pdf
Retrieved from http://bookshop.rcplondon.ac.uk/ Scientific Committee on Emerging and Newly-Identified Health  Risks.,Non-OADS,/arxiv_data1/oa_pdf/85/9a/nts190.PMC3524071.pdf
"Retrieved from http://ec.europa.eu/health/ archive/ph_risk/committees/04_scenihr/docs/scenihr_o_013.pdf Sponsiello-Wang, Z., Weitkunat, R., & Lee, P .",Non-OADS,/arxiv_data1/oa_pdf/85/9a/nts190.PMC3524071.pdf
"Do not distribute.www.landesbioscience.com  Islets  339Islets 4:5, 339–342; September/October 2012; © 2012 Landes Bioscience SHORT REPORT SHORT REPORT *Correspondence to: Naoaki Sakata; Email: n-sakata@surg1.med.tohoku.ac.jp Submitted: 09/10/12; Revised: 09/23/12; Accepted: 09/27/12http://dx.doi.org/10.4161/islets.22384Introduction In islet transplantation, the failure of insulin independence  is brought about by the loss of islet grafts, caused by instant blood-mediated inflammatory reaction, immune rejection, non-specific inflammation or ischemia of the donor-islets.",Non-OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
T ranspl Int 2012; 25:250-60;  PMID:22188036; http://dx.doi.org/10.1111/j.1432- 2277.2011.01403.x.,OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Nat  Med 2006; 12:144-8; PMID:16380717; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
T ransplantation 2010; 90:1602-6; PMID:21197715;  http://dx.doi.org/10.1097/TP .0b013e3181ffba5e.,OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Am J T ransplant  2009; 9:2816-24; PMID:19845588; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Islets 2011; 3:259- 66; PMID:21795859; http://dx.doi.org/10.4161/ isl.3.5.17058.,OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Magn Reson Med 2004; 52:1228-33;  PMID:15562474; http://dx.doi.org/10.1002/ mrm.20282.,Non-OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Diabetes 2006; 55:2931-8;  PMID:17065328; http://dx.doi.org/10.2337/db06- 0393.9.,Non-OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Am J T ransplant  2009; 9:2372-82; PMID:19681816; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
T ransplantation 2009; 87:1659-66; PMID:19502957; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Am J T ransplant 2008; 8:701-6;  PMID:18294167; http://dx.doi.org/10.1111/j.1600- 6143.2007.02120.x.,OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Radiology  2011; 260:790-8; PMID:21734156; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Radiology 2003; 229:165- 70; PMID:12944593; http://dx.doi.org/10.1148/ radiol.2291021632.,Non-OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Radiology 2005; 234:617-24; PMID:15591436;  http://dx.doi.org/10.1148/radiol.2342031356.,Non-OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Radiology  2011; 258:182-91; PMID:20971778; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Br J Surg 2012; 99:761-6;  PMID:22434330; http://dx.doi.org/10.1002/bjs.8713.,Non-OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Arch Surg 1983; 118:851-8; PMID:6407457; http://dx.doi.org/10.1001/arch - surg.1983.01390070059012.,OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
T ransplantation  2008; 86:1799-802; PMID:19104425; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
Pancreas 2009;  38:1-7; PMID:18665009; http://dx.doi.org/10.1097/ MPA.0b013e3181825c00.,Non-OADS,/arxiv_data1/oa_pdf/06/5e/isl-4-339.PMC3524140.pdf
"Do not distribute.www.landesbioscience.com  Islets  349Islets 4:5, 349–353; September/October 2012; © 2012 Landes Bioscience RESEARCH PAPER RESEARCH PAPER *Correspondence to: Apostolos V. Tsolakis; Email: apostolos.tsolakis@medsci.uu.se Submitted: 09/30/12; Accepted: 10/01/12http://dx.doi.org/10.4161/islets.22416Introduction The pancreatic islets contain five distinct types of hormone  producing cells that have also been characterized ultrastructur - ally.1-3 Endocrine pancreatic tumors (EPTs) are uncommon neo - plasms that may appear sporadically or may be hereditary.",Non-OADS,/arxiv_data1/oa_pdf/18/46/isl-4-349.PMC3524142.pdf
Cell Calcium  1991; 12:229-40; PMID:2059995; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/46/isl-4-349.PMC3524142.pdf
Proteomics  2005; 5:4327-37; PMID:16237735; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/18/46/isl-4-349.PMC3524142.pdf
ACS Chem Biol 2008; 3:38-50; PMID:18205291; http://dx.doi.org/10.1021/ cb700249v.,OADS,/arxiv_data1/oa_pdf/18/46/isl-4-349.PMC3524142.pdf
Adv Protein Chem 2005; 70:37-78; PMID:15837513; http://dx.doi.org/10.1016/S0065- 3233(05)70003-6.,OADS,/arxiv_data1/oa_pdf/18/46/isl-4-349.PMC3524142.pdf
J Struct Biol 2008; 163:258- 69; PMID:18342539; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/18/46/isl-4-349.PMC3524142.pdf
Diabetes 2001;  50(Suppl 1):S169-71; PMID:11272183; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/46/isl-4-349.PMC3524142.pdf
Diabetologia 2009; 52:486-93; PMID:19096824;  http://dx.doi.org/10.1007/s00125-008-1238-y.,Non-OADS,/arxiv_data1/oa_pdf/18/46/isl-4-349.PMC3524142.pdf
Adv Exp Med Biol 2010; 654:1-19; PMID: 20217491; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/18/46/isl-4-349.PMC3524142.pdf
Regul Pept 2002; 107:63-9;  PMID:12137967; http://dx.doi.org/10.1016/S0167- 0115(02)00067-8.,OADS,/arxiv_data1/oa_pdf/18/46/isl-4-349.PMC3524142.pdf
Expert Reviews of Endocrinology and Metabolism 2008; 3:187-205;  http://dx.doi.org/10.1586/17446651.3.2.187.,Non-OADS,/arxiv_data1/oa_pdf/18/46/isl-4-349.PMC3524142.pdf
Mol Cell Proteomics 2008; 7:2019-27; PMID:18669619; http://dx.doi.org/10.1074/mcp.,Non-OADS,/arxiv_data1/oa_pdf/18/46/isl-4-349.PMC3524142.pdf
"build upon earlier work, further exploring how B. pseudomallei kills C. elegans .10The study focuses on the intestinal luminal *Correspondence to: Costi D. Sifri; Email: csifri@virginia.edu Submitted: 10/12/12; Accepted: 10/12/12 http://dx.doi.org/10.4161/viru.22540EDITOR'S CORNER Virulence 3:6, 471 –473; October 1, 2012; G2012 Landes Bioscience www.landesbioscience.com Virulence 471",Non-OADS,/arxiv_data1/oa_pdf/a4/4b/viru-3-471.PMC3524144.pdf
N Engl J Med 2012; 367:1035-44; PMID:22970946; http://dx.doi.org/10.1056/NEJMra1204699 4.,Non-OADS,/arxiv_data1/oa_pdf/a4/4b/viru-3-471.PMC3524144.pdf
Annu Rev Microbiol 2010; 64:495-517; PMID:20528691; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/a4/4b/viru-3-471.PMC3524144.pdf
BMC Microbiol 2010; 10:28; PMID: 20109238; http://dx.doi.org/10.1186/1471-2180-10- 286.,OADS,/arxiv_data1/oa_pdf/a4/4b/viru-3-471.PMC3524144.pdf
Cell Microbiol 2001; 3:381-93; PMID:11422081; http://dx.doi.org/ 10.1046/j.1462-5822.2001.00118.x 7.,OADS,/arxiv_data1/oa_pdf/a4/4b/viru-3-471.PMC3524144.pdf
Mol Microbiol 2002; 44:1185-97; PMID:12068805; http://dx.doi.org/10.1046/j.1365-2958.2002.02957.x 8.,OADS,/arxiv_data1/oa_pdf/a4/4b/viru-3-471.PMC3524144.pdf
PLoS One 2011; 6:e16707; PMID:21408228; http://dx.doi.org/ 10.1371/journal.pone.00167079.,Non-OADS,/arxiv_data1/oa_pdf/a4/4b/viru-3-471.PMC3524144.pdf
Trends Microbiol 2005; 13:119-27; PMID: 15737730; http://dx.doi.org/10.1016/j.tim.2005.01.,OADS,/arxiv_data1/oa_pdf/a4/4b/viru-3-471.PMC3524144.pdf
Virulence 2012; 3:485-96; PMID: 23076282; http://dx.doi.org/10.4161/viru.21808 11.,Non-OADS,/arxiv_data1/oa_pdf/a4/4b/viru-3-471.PMC3524144.pdf
Biochem Biophys Res Commun 2007; 363:438-43; PMID: 17888400; http://dx.doi.org/10.1016/j.bbrc.2007.08.,OADS,/arxiv_data1/oa_pdf/a4/4b/viru-3-471.PMC3524144.pdf
"All larvae infected with strain MGAS315 had distinct signs of Correspondence to: Juliana Campos Junqueira; Email: juliana@fosjc.unesp.br Submitted: 10/08/12; Accepted: 10/09/12 http://dx.doi.org/10.4161/viru.22493Virulence 3:6, 474 –476; October 1, 2012; G2012 Landes Bioscience 474 Virulence Volume 3 Issue 6",Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Antimicrob Agents Chemother 2009; 53:2605-9; PMID:19332683; http://dx.doi.org/10.1128/AAC.01533-08 2.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Infect Immun 2012; 80:1015-24; PMID:22232188; http://dx.doi.org/10.1128/IAI.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Microbes Infect 2007; 9: 729-34; PMID:17400503; http://dx.doi.org/10.1016/ j.micinf.2007.02.0164.,OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
J Bacteriol 2000; 182:3843-5; PMID:10851003; http://dx.doi.org/10.1128/JB.182.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Infect Immun 2003; 71:2404-13; PMID: 12704110; http://dx.doi.org/10.1128/IAI.71.5.2404- 2413.2003 6.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Microbiology 2009; 155:1516-22; PMID: 19383703; http://dx.doi.org/10.1099/mic.0.026823-07.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
J Antimicrob Chemother 2011; 66:1785-90; PMID:21622972; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Infect Immun 2011; 79:2638-45; PMID: 21536798; http://dx.doi.org/10.1128/IAI.01132-10 11.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
J Bacteriol 2010; 192:1122-30; PMID: 20008075; http://dx.doi.org/10.1128/JB.01293-09 12.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Microbes Infect 2010; 12:488-96; PMID:20223293; http://dx.doi.org/ 10.1016/j.micinf.2010.03.001 13.,OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Infect Immun 2005; 73:3842-50; PMID:15972469; http://dx.doi.org/10.1128/IAI.73.7.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Virulence 2010; 1:475-82; PMID:21178491; http://dx.doi.org/10.4161/viru.1.6.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Virulence 2011; 2:413-21; PMID:21921688; http://dx.doi.org/ 10.4161/viru.2.5.17811 16.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Virulence 2011; 2: 521-7; PMID:22186764; http://dx.doi.org/10.4161/ viru.2.6.1852018.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
FEMS Immunol Med Microbiol 2000; 27:163- 9; PMID:10640612; http://dx.doi.org/10.1111/j.,OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Infect Immun 2012; 80:3077-85; PMID:22710873; http://dx.doi.org/10.1128/IAI.00081-12 20.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Infect Immun 2012; 80:2780-90; PMID:22645286; http://dx.doi.org/10.1128/IAI.00510-12 21.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
PLoS One 2011; 6:e24485; PMID:21915338; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Curr Pharm Des 2011; 17:1240-5; PMID:21470117; http://dx.doi.org/10.2174/138161211795703799 23.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
BMC Genomics 2011; 12:308; PMID: 21663692; http://dx.doi.org/10.1186/1471-2164-12- 308 24.,OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
BMC Microbiol 2011; 11: 247; PMID:22053894; http://dx.doi.org/10.1186/ 1471-2180-11-24725.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Comparative analysis of the virulence of invertebrate and mammalian pathogenic bacteria in the oral insect infection model Galleria mellonella .J Invertebr Pathol 2010; 103:24-9; PMID:19800349; http://dx.doi.org/10.1016/j.jip.2009.09.005 26.,OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
J Bacteriol 2008; 190:2306-13; PMID:18223084; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Infect Immun 2007; 75:1861-9; PMID: 17261598; http://dx.doi.org/10.1128/IAI.01473-06 28.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
Antimicrob Agents Chemother 2012; 56:5961-70; PMID:22964249; http://dx.doi.org/10.1128/AAC.,Non-OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
FEMS Microbiol Lett 2011; 317:196-202; PMID:21276046; http://dx.doi.org/10.1111/j.1574-6968.2011.02229.x 31.,OADS,/arxiv_data1/oa_pdf/a3/78/viru-3-474.PMC3524145.pdf
"Early on in the field of host-pathogen interactions, researchers took advantage of*Correspondence to: Birgitte H. Kallipolitis; Email: bhk@bmb.sdu.dk Submitted: 05/30/12; Revised: 08/16/12; Accepted: 08/21/12 http://dx.doi.org/10.4161/viru.21906REVIEW Virulence 3:6, 477 –484; October 1, 2012; G2012 Landes Bioscience www.landesbioscience.com Virulence 477",Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
The enrichment analysis was performed using DAVID v. 6.7 (http://david.abcc.ncifcrf.gov/).71 www.landesbioscience.com Virulence 479,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Cell 1999; 96:47-56; PMID:9989496; http://dx.doi.org/10.1016/ S0092-8674(00)80958-7 2.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Proc Natl Acad Sci U S A 1999; 96: 2408-13; PMID:10051655; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Curr Biol 2010; 20:R965-9; PMID:21093785; http://dx.doi.org/10.1016/j.cub.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Trends Microbiol 2005; 13:119-27; PMID:15737730; http://dx.doi.org/10.1016/j.tim.2005.01.003 5.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Mol Immunol 2004; 41:479-93; PMID:15183927; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Eukaryot Cell 2009; 8:1750-8; PMID:19666778; http://dx.doi.org/10.1128/EC.00163-097.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
PLoS One 2011; 6: e19055; PMID:21602919; http://dx.doi.org/10.1371/ journal.pone.0019055 8.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
PLoS Pathog 2011; 7: e1002074; PMID:21731485; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
PLoS Pathog 2010; 6: e1000982; PMID:20617181; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
PLoS Biol 2008; 6:2736-52; PMID:19071962; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Curr Biol 2002; 12:1209-14; PMID:12176330; http://dx.doi.org/10.1016/S0960- 9822(02)00928-4 13.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Genome Res 2006; 16:1005-16; PMID: 16809667; http://dx.doi.org/10.1101/gr.50823006 15.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
PLoS Genet 2006; 2:e183; PMID:17096597; http://dx.doi.org/10.1371/journal.pgen.0020183 17.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
J Biol Chem 2010; 285:10832-40; PMID:20133945; http://dx.doi.org/10.1074/jbc.M109.091629 18.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Genome Biol 2007; 8:R194; PMID:17875205; http://dx.doi.org/10.1186/ gb-2007-8-9-r194 20.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Biol Direct 2010; 5:11; PMID:20163716; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Dev Comp Immunol 2010; 34:690-8; PMID:20149819; http://dx.doi.org/10.1016/j.dci.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Virulence 2011; 2:120-30; PMID:21389771; http://dx.doi.org/10.4161/viru.2.2.15270 24.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
PLoS One 2010; 5:e15902; PMID:21209831; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
FEBS J 2010; 277:2531-42; PMID: 20553489; http://dx.doi.org/10.1111/j.1742-4658.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Toxicol Sci 2001; 62:61-70; PMID: 11399794; http://dx.doi.org/10.1093/toxsci/62.1.61 27.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Nat Immunol 2009; 10:249-56; PMID: 19198592; http://dx.doi.org/10.1038/ni.1700 28.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
PLoS Pathog 2008; 4:e1000175; PMID:18927620; http://dx.doi.org/10.1371/journal.ppat.1000175 29.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
FEBS J 2005; 272:6179-217; PMID:16336259; http://dx.doi.org/10.1111/j.1742- 4658.2005.05031.x 31.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Glycobiology 1999; 9:1357-69; PMID:10561461; http://dx.doi.org/10.1093/glycob/9.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Immunobiology 2008; 213:237-50; PMID:18406370; http://dx.doi.org/10.1016/j.imbio.2007.12.004 33.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Science 2006; 313:1126-30; PMID: 16931762; http://dx.doi.org/10.1126/science.1127119 34.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
J Mol Biol 1993; 231:539-45; PMID:8510165; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
PLoS Genet 2008; 4:e1000273; PMID:19023415; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
J Biol Chem 1999; 274:10309-15; PMID:10187818; http://dx.doi.org/10.1074/jbc.274.15.10309 37.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Appl Environ Microbiol 2006; 72:5135-7; PMID: 16820523; http://dx.doi.org/10.1128/AEM.00611-0638.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Proc Natl Acad Sci U S A 2010; 107:16411-2; PMID:20823245; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Nature 2005; 438:179-84; PMID:16281027; http://dx.doi.org/10.1038/nature04216 40.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
J Biol Chem 2009; 284: 26493-501; PMID:19635802; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Curr Opin Microbiol 2008; 11:251-6; PMID:18567532; http://dx.doi.org/10.1016/j.mib.2008.05.014 42.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
BMC Evol Biol 2008; 8:114; PMID:18423043; http://dx.doi.org/10.1186/ 1471-2148-8-114 43.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
PLoS One 2011; 6:e16839; PMID:21399680; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Nat Rev Immunol 2010; 10:47-58; PMID:20029447; http://dx.doi.org/ 10.1038/nri2689 45.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Nat Immunol 2004; 5:488-94; PMID:15048112; http://dx.doi.org/10.1038/ni1060 48.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
PLoS Genet 2010; 6:e1000892; PMID: 20369020; http://dx.doi.org/10.1371/journal.pgen.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Immunity 2009; 30:521-32; PMID: 19371715; http://dx.doi.org/10.1016/j.immuni.2009.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Cell Host Microbe 2009; 5:341-52; PMID:19380113; http://dx.doi.org/ 10.1016/j.chom.2009.03.006 53.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
BMC Dev Biol 2010; 10:61; PMID:20529267; http://dx.doi.org/10.1186/1471- 213X-10-61 54.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Science 2007; 317:660-3; PMID:17673661; http://dx.doi.org/ 10.1126/science.1139952 55.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Nature 2003; 424:277-83; PMID:12845331; http://dx.doi.org/10.1038/nature01789 56.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Nat Genet 2006; 38:251-7; PMID:16380712; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
PLoS One 2010; 5:e9494; PMID:20209166; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Science 2003; 300:1921; PMID:12817143; http://dx.doi.org/ 10.1126/science.1080147 59.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Aging Cell 2008; 7:879- 93; PMID:18782349; http://dx.doi.org/10.1111/j.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Proc Natl Acad Sci U S A 2010; 107:2153-8; PMID:20133860; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Cell Host Microbe 2012; 11:375-86; PMID: 22520465; http://dx.doi.org/10.1016/j.chom.2012.02.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Cell Host Microbe 2012; 11: 364-74; PMID:22520464; http://dx.doi.org/10.1016/ j.chom.2012.02.007 63.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Cell 2012; 149:452-66; PMID: 22500807; http://dx.doi.org/10.1016/j.cell.2012.02.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
J Biol Chem 2008; 283:194-201; PMID:17951251; http://dx.doi.org/10.1074/jbc.M70795620066.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
PLoS One 2010; 5: e9010; PMID:20126308; http://dx.doi.org/10.1371/ journal.pone.0009010 67.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Mol Cell 2012; 46:530-41; PMID:22503424; http://dx.doi.org/10.1016/j.molcel.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
RNA 2007; 13: 1090-102; PMID:17526642; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Nat Methods 2011; 8: 849-51; PMID:21874007; http://dx.doi.org/10.1038/ nmeth.1679 71.,OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
Nat Protoc 2009; 4:44-57; PMID:19131956; http://dx.doi.org/10.1038/nprot.,Non-OADS,/arxiv_data1/oa_pdf/21/9d/viru-3-477.PMC3524146.pdf
"Therefore, using a technique previously applied by ourselves and others to study B. anthracis pathogen- esis,16-20we disrupted the B. anthracis Ames luxS gene by inserting *Correspondence to: Joel Bozue; Email: joel.a.bozue@us.army.mil Submitted: 07/03/12; Revised: 08/14/12; Accepted: 08/22/12 http://dx.doi.org/10.4161/viru.21934Virulence 3:6, 504 –509; October 1, 2012; G2012 Landes Bioscience 504 Virulence Volume 3 Issue 6",Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Proc Natl Acad Sci U S A 2003; 100:3007-9; PMID:12631692; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Cell Mol Life Sci 2002; 59:403-9; PMID:11964118; http://dx.doi.org/10.1007/s00018-002-8432-8 4.,OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
JAMA 1999; 281:1735-45; PMID: 10328075; http://dx.doi.org/10.1001/jama.281.18.,OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Infect Immun 2003; 71: 3914-9; PMID:12819077; http://dx.doi.org/10.1128/ IAI.71.7.3914-3919.2003 9.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
J Infect Dis 2005; 191:1881-8; PMID:15871122; http://dx.doi.org/10.1086/429696 10.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Infect Immun 2003; 71:5633-9; PMID:14500483; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Virulence 2010; 1:72-83; PMID:21178420; http://dx.doi.org/10.4161/ viru.1.2.10752 14.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Infect Immun 2003; 71: 3914-9; PMID:12819077; http://dx.doi.org/10.1128/ IAI.71.7.3914-3919.200315.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Nature 2003; 423:81-6; PMID: 12721629; http://dx.doi.org/10.1038/nature01586 16.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Microb Pathog 2005; 38:1-12; PMID:15652290; http://dx.doi.org/10.1016/j.micpath.2004.10.001 17.,OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
J Bacteriol 2007; 189:691-705; PMID:17114257; http://dx.doi.org/10.1128/JB.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Microbiology 2009; 155:1133-45; PMID: 19332815; http://dx.doi.org/10.1099/mic.0.023333-0 19.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Microb Pathog 2004; 37:149-54; PMID:15351038; http://dx.doi.org/10.1016/j.micpath.2004.06.008 20.,OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Infect Immun 2004; 72:4801-9; PMID:15271942; http://dx.doi.org/10.1128/IAI.72.8.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Cell Microbiol 2004; 6:225-33; PMID:14764106; http://dx.doi.org/10.1046/j.1462- 5822.2003.00358.x 25.,OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Vaccine 2001; 19:3241-7; PMID: 11312020; http://dx.doi.org/10.1016/S0264-410X(01) 00021-4 26.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
A LuxS-dependent cell-to-cell language regulates social behavior and development in Bacillus subtilis .J Bacteriol 2006; 188:4442-52; PMID:16740951; http://dx.doi.org/10.1128/JB.00165-06 27.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Annu Rev Cell Dev Biol 2005; 21:319-46; PMID:16212498; http://dx.doi.org/ 10.1146/annurev.cellbio.21.012704.13100128.,OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
J Bacteriol 2006; 188:532-41; PMID: 16385044; http://dx.doi.org/10.1128/JB.188.2.532- 541.2006 29.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Cell 2002; 110: 303-14; PMID:12176318; http://dx.doi.org/10.1016/ S0092-8674(02)00829-2 30.,OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
J Infect Dis 2009; 200:409-16; PMID:19552526; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Infect Immun 2003; 71: 3206-12; PMID:12761100; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
J Bacteriol 2009; 191:7253-9; PMID: 19783624; http://dx.doi.org/10.1128/JB.00727-09 34.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Vet Microbiol 2007; 125:313-22; PMID:17643872; http://dx.doi.org/10.1016/j.vetmic.2007.05.030 35.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Infect Immun 2004; 72:4864-7; PMID: 15271949; http://dx.doi.org/10.1128/IAI.72.8.4864- 4867.2004 36.,Non-OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Proc Natl Acad Sci U S A 1965; 54:704-11; PMID:4956288; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
Microb Pathog 2004; 37:169-75; PMID:15458777; http://dx.doi.org/10.1016/j.micpath.,OADS,/arxiv_data1/oa_pdf/f4/7b/viru-3-504.PMC3524149.pdf
"Cell Host Microbe 2012; 11:325-36; PMID:22520461;   http://dx.doi.org/10.1016/j.chom.2012.03.001 Makoto Fukumatsu,1 Michinaga Ogawa,2 Minsoo Kim,3 Hitomi Mimuro4 and Chihiro Sasakawa1,2,5,*; 1Department of Infectious Disease Control; International  Research Center for Infectious Disease; University of Tokyo; Tokyo, Japan; 2Division of Bacterial Infection; Department of Microbiology and Immunology; Institute of  Medical Science; University of Tokyo; Tokyo, Japan; 3Division of Bacterial Infection Biology; Institute of Medical Science; University of Tokyo; Tokyo, Japan;   4Division of Bacteriology; Department of Infectious Disease Control; International Research Center for Infectious Disease; University of Tokyo; Tokyo, Japan;   5Nippon Institute for Biological Science; Tokyo, Japan; *Email: sasakawa@ims.u-tokyo.ac.jp; http://dx.doi.org/10.4161/viru.21740 as bacterial cell-cell spreading.",OADS,/arxiv_data1/oa_pdf/c2/75/viru-3-515.PMC3524151.pdf
"Nature 2012; 483:623-6; PMID:22407319;   http://dx.doi.org/10.1038/nature10894 Takahito Sanada,1 Minsoo Kim,1 Hitomi Mimuro,2 Hiroshi Ashida,3 Michinaga Ogawa,3 Tsunehiro Mizushima4 and Chihiro Sasakawa1,3,5,*; 1Department of Infectious  Disease Control; International Research Center for Infectious Diseases; University of Tokyo; Tokyo, Japan; 2Division of Bacteriology; Department of Infectious Disease  Control; International Research Center for Infectious Diseases; University of Tokyo; Tokyo, Japan; 3Division of Bacterial Infection; Department of Microbiology and  Immunology; Institute of Medical Science; University of Tokyo; Tokyo, Japan; 4Picobiology Institute; Department of Life Science; Graduate School of Life Science;  University of Hyogo; Hyogo, Japan; 5Nippon Institute for Biological Science; Tokyo, Japan; *Email: sasakawa@ims.u-tokyo.ac.jp;   http://dx.doi.org/10.4161/viru.21451 Upon infection of many bacterial pathogens,  bacterial invasion is quickly sensed by the  innate immune system, resulting in acute  inflammatory responses.",Non-OADS,/arxiv_data1/oa_pdf/c2/75/viru-3-515.PMC3524151.pdf
"Nat Med 2012; 18:816-9; PMID:22522561;   http://dx.doi.org/10.1038/nm.2692 Michael Otto; National Institute of Allergy and Infectious Diseases; The National Institutes of Health; Bethesda, MD USA; Email: motto@niaid.nih.gov;   http://dx.doi.org/10.4161/viru.21523 Why does methicillin-resistant Staphylococcus  aureus (MRSA) remain a dangerous pathogen,  particularly in hospital-associated infections?",Non-OADS,/arxiv_data1/oa_pdf/c2/75/viru-3-515.PMC3524151.pdf
J Virol 2012; 86:9035-43; PMID:22674997; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c2/75/viru-3-515.PMC3524151.pdf
"org/10.1128/JVI.00369-12 Victor C. Huber; Division of Basic Biomedical Sciences; University of South Dakota; Vermillion, SD USA; Email: victor.huber@usd.edu;  http://dx.doi.org/10.4161/viru.21811 The influenza virus genes that will dictate  the severity of the next influenza virus pan-demic currently exist in nature.",Non-OADS,/arxiv_data1/oa_pdf/c2/75/viru-3-515.PMC3524151.pdf
"Meyer*; Department of Molecular Biology; Max Planck Institute for Infection Biology; Berlin, Germany;   *Email: meyer@mpiib-berlin.mpg.de; http://dx.doi.org/10.4161/viru.22183 Both pathogenic and non-pathogenic microbes  express common microbe-associated molecu-lar patterns (MAMPs) that can activate innate  pro-inflammatory responses.",Non-OADS,/arxiv_data1/oa_pdf/c2/75/viru-3-515.PMC3524151.pdf
"Cell Host Microbe 2012; 11:325-36; PMID:22520461;   http://dx.doi.org/10.1016/j.chom.2012.03.001 Makoto Fukumatsu,1 Michinaga Ogawa,2 Minsoo Kim,3 Hitomi Mimuro4 and Chihiro Sasakawa1,2,5,*; 1Department of Infectious Disease Control; International  Research Center for Infectious Disease; University of Tokyo; Tokyo, Japan; 2Division of Bacterial Infection; Department of Microbiology and Immunology; Institute of  Medical Science; University of Tokyo; Tokyo, Japan; 3Division of Bacterial Infection Biology; Institute of Medical Science; University of Tokyo; Tokyo, Japan;   4Division of Bacteriology; Department of Infectious Disease Control; International Research Center for Infectious Disease; University of Tokyo; Tokyo, Japan;   5Nippon Institute for Biological Science; Tokyo, Japan; *Email: sasakawa@ims.u-tokyo.ac.jp; http://dx.doi.org/10.4161/viru.21740 as bacterial cell-cell spreading.",OADS,/arxiv_data1/oa_pdf/53/02/viru-3-518.PMC3524152.pdf
"Nature 2012; 483:623-6; PMID:22407319;   http://dx.doi.org/10.1038/nature10894 Takahito Sanada,1 Minsoo Kim,1 Hitomi Mimuro,2 Hiroshi Ashida,3 Michinaga Ogawa,3 Tsunehiro Mizushima4 and Chihiro Sasakawa1,3,5,*; 1Department of Infectious  Disease Control; International Research Center for Infectious Diseases; University of Tokyo; Tokyo, Japan; 2Division of Bacteriology; Department of Infectious Disease  Control; International Research Center for Infectious Diseases; University of Tokyo; Tokyo, Japan; 3Division of Bacterial Infection; Department of Microbiology and  Immunology; Institute of Medical Science; University of Tokyo; Tokyo, Japan; 4Picobiology Institute; Department of Life Science; Graduate School of Life Science;  University of Hyogo; Hyogo, Japan; 5Nippon Institute for Biological Science; Tokyo, Japan; *Email: sasakawa@ims.u-tokyo.ac.jp;   http://dx.doi.org/10.4161/viru.21451 Upon infection of many bacterial pathogens,  bacterial invasion is quickly sensed by the  innate immune system, resulting in acute  inflammatory responses.",Non-OADS,/arxiv_data1/oa_pdf/53/02/viru-3-518.PMC3524152.pdf
"Nat Med 2012; 18:816-9; PMID:22522561;   http://dx.doi.org/10.1038/nm.2692 Michael Otto; National Institute of Allergy and Infectious Diseases; The National Institutes of Health; Bethesda, MD USA; Email: motto@niaid.nih.gov;   http://dx.doi.org/10.4161/viru.21523 Why does methicillin-resistant Staphylococcus  aureus (MRSA) remain a dangerous pathogen,  particularly in hospital-associated infections?",Non-OADS,/arxiv_data1/oa_pdf/53/02/viru-3-518.PMC3524152.pdf
J Virol 2012; 86:9035-43; PMID:22674997; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/53/02/viru-3-518.PMC3524152.pdf
"org/10.1128/JVI.00369-12 Victor C. Huber; Division of Basic Biomedical Sciences; University of South Dakota; Vermillion, SD USA; Email: victor.huber@usd.edu;  http://dx.doi.org/10.4161/viru.21811 The influenza virus genes that will dictate  the severity of the next influenza virus pan-demic currently exist in nature.",Non-OADS,/arxiv_data1/oa_pdf/53/02/viru-3-518.PMC3524152.pdf
"Meyer*; Department of Molecular Biology; Max Planck Institute for Infection Biology; Berlin, Germany;   *Email: meyer@mpiib-berlin.mpg.de; http://dx.doi.org/10.4161/viru.22183 Both pathogenic and non-pathogenic microbes  express common microbe-associated molecu-lar patterns (MAMPs) that can activate innate  pro-inflammatory responses.",Non-OADS,/arxiv_data1/oa_pdf/53/02/viru-3-518.PMC3524152.pdf
"Cell Host Microbe 2012; 11:325-36; PMID:22520461;   http://dx.doi.org/10.1016/j.chom.2012.03.001 Makoto Fukumatsu,1 Michinaga Ogawa,2 Minsoo Kim,3 Hitomi Mimuro4 and Chihiro Sasakawa1,2,5,*; 1Department of Infectious Disease Control; International  Research Center for Infectious Disease; University of Tokyo; Tokyo, Japan; 2Division of Bacterial Infection; Department of Microbiology and Immunology; Institute of  Medical Science; University of Tokyo; Tokyo, Japan; 3Division of Bacterial Infection Biology; Institute of Medical Science; University of Tokyo; Tokyo, Japan;   4Division of Bacteriology; Department of Infectious Disease Control; International Research Center for Infectious Disease; University of Tokyo; Tokyo, Japan;   5Nippon Institute for Biological Science; Tokyo, Japan; *Email: sasakawa@ims.u-tokyo.ac.jp; http://dx.doi.org/10.4161/viru.21740 as bacterial cell-cell spreading.",OADS,/arxiv_data1/oa_pdf/8e/c6/viru-3-521.PMC3524153.pdf
"Nature 2012; 483:623-6; PMID:22407319;   http://dx.doi.org/10.1038/nature10894 Takahito Sanada,1 Minsoo Kim,1 Hitomi Mimuro,2 Hiroshi Ashida,3 Michinaga Ogawa,3 Tsunehiro Mizushima4 and Chihiro Sasakawa1,3,5,*; 1Department of Infectious  Disease Control; International Research Center for Infectious Diseases; University of Tokyo; Tokyo, Japan; 2Division of Bacteriology; Department of Infectious Disease  Control; International Research Center for Infectious Diseases; University of Tokyo; Tokyo, Japan; 3Division of Bacterial Infection; Department of Microbiology and  Immunology; Institute of Medical Science; University of Tokyo; Tokyo, Japan; 4Picobiology Institute; Department of Life Science; Graduate School of Life Science;  University of Hyogo; Hyogo, Japan; 5Nippon Institute for Biological Science; Tokyo, Japan; *Email: sasakawa@ims.u-tokyo.ac.jp;   http://dx.doi.org/10.4161/viru.21451 Upon infection of many bacterial pathogens,  bacterial invasion is quickly sensed by the  innate immune system, resulting in acute  inflammatory responses.",Non-OADS,/arxiv_data1/oa_pdf/8e/c6/viru-3-521.PMC3524153.pdf
"Nat Med 2012; 18:816-9; PMID:22522561;   http://dx.doi.org/10.1038/nm.2692 Michael Otto; National Institute of Allergy and Infectious Diseases; The National Institutes of Health; Bethesda, MD USA; Email: motto@niaid.nih.gov;   http://dx.doi.org/10.4161/viru.21523 Why does methicillin-resistant Staphylococcus  aureus (MRSA) remain a dangerous pathogen,  particularly in hospital-associated infections?",Non-OADS,/arxiv_data1/oa_pdf/8e/c6/viru-3-521.PMC3524153.pdf
J Virol 2012; 86:9035-43; PMID:22674997; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8e/c6/viru-3-521.PMC3524153.pdf
"org/10.1128/JVI.00369-12 Victor C. Huber; Division of Basic Biomedical Sciences; University of South Dakota; Vermillion, SD USA; Email: victor.huber@usd.edu;  http://dx.doi.org/10.4161/viru.21811 The influenza virus genes that will dictate  the severity of the next influenza virus pan-demic currently exist in nature.",Non-OADS,/arxiv_data1/oa_pdf/8e/c6/viru-3-521.PMC3524153.pdf
"Meyer*; Department of Molecular Biology; Max Planck Institute for Infection Biology; Berlin, Germany;   *Email: meyer@mpiib-berlin.mpg.de; http://dx.doi.org/10.4161/viru.22183 Both pathogenic and non-pathogenic microbes  express common microbe-associated molecu-lar patterns (MAMPs) that can activate innate  pro-inflammatory responses.",Non-OADS,/arxiv_data1/oa_pdf/8e/c6/viru-3-521.PMC3524153.pdf
"Cell Host Microbe 2012; 11:325-36; PMID:22520461;   http://dx.doi.org/10.1016/j.chom.2012.03.001 Makoto Fukumatsu,1 Michinaga Ogawa,2 Minsoo Kim,3 Hitomi Mimuro4 and Chihiro Sasakawa1,2,5,*; 1Department of Infectious Disease Control; International  Research Center for Infectious Disease; University of Tokyo; Tokyo, Japan; 2Division of Bacterial Infection; Department of Microbiology and Immunology; Institute of  Medical Science; University of Tokyo; Tokyo, Japan; 3Division of Bacterial Infection Biology; Institute of Medical Science; University of Tokyo; Tokyo, Japan;   4Division of Bacteriology; Department of Infectious Disease Control; International Research Center for Infectious Disease; University of Tokyo; Tokyo, Japan;   5Nippon Institute for Biological Science; Tokyo, Japan; *Email: sasakawa@ims.u-tokyo.ac.jp; http://dx.doi.org/10.4161/viru.21740 as bacterial cell-cell spreading.",OADS,/arxiv_data1/oa_pdf/5d/c5/viru-3-523.PMC3524154.pdf
"Nature 2012; 483:623-6; PMID:22407319;   http://dx.doi.org/10.1038/nature10894 Takahito Sanada,1 Minsoo Kim,1 Hitomi Mimuro,2 Hiroshi Ashida,3 Michinaga Ogawa,3 Tsunehiro Mizushima4 and Chihiro Sasakawa1,3,5,*; 1Department of Infectious  Disease Control; International Research Center for Infectious Diseases; University of Tokyo; Tokyo, Japan; 2Division of Bacteriology; Department of Infectious Disease  Control; International Research Center for Infectious Diseases; University of Tokyo; Tokyo, Japan; 3Division of Bacterial Infection; Department of Microbiology and  Immunology; Institute of Medical Science; University of Tokyo; Tokyo, Japan; 4Picobiology Institute; Department of Life Science; Graduate School of Life Science;  University of Hyogo; Hyogo, Japan; 5Nippon Institute for Biological Science; Tokyo, Japan; *Email: sasakawa@ims.u-tokyo.ac.jp;   http://dx.doi.org/10.4161/viru.21451 Upon infection of many bacterial pathogens,  bacterial invasion is quickly sensed by the  innate immune system, resulting in acute  inflammatory responses.",Non-OADS,/arxiv_data1/oa_pdf/5d/c5/viru-3-523.PMC3524154.pdf
"Nat Med 2012; 18:816-9; PMID:22522561;   http://dx.doi.org/10.1038/nm.2692 Michael Otto; National Institute of Allergy and Infectious Diseases; The National Institutes of Health; Bethesda, MD USA; Email: motto@niaid.nih.gov;   http://dx.doi.org/10.4161/viru.21523 Why does methicillin-resistant Staphylococcus  aureus (MRSA) remain a dangerous pathogen,  particularly in hospital-associated infections?",Non-OADS,/arxiv_data1/oa_pdf/5d/c5/viru-3-523.PMC3524154.pdf
J Virol 2012; 86:9035-43; PMID:22674997; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5d/c5/viru-3-523.PMC3524154.pdf
"org/10.1128/JVI.00369-12 Victor C. Huber; Division of Basic Biomedical Sciences; University of South Dakota; Vermillion, SD USA; Email: victor.huber@usd.edu;  http://dx.doi.org/10.4161/viru.21811 The influenza virus genes that will dictate  the severity of the next influenza virus pan-demic currently exist in nature.",Non-OADS,/arxiv_data1/oa_pdf/5d/c5/viru-3-523.PMC3524154.pdf
"Meyer*; Department of Molecular Biology; Max Planck Institute for Infection Biology; Berlin, Germany;   *Email: meyer@mpiib-berlin.mpg.de; http://dx.doi.org/10.4161/viru.22183 Both pathogenic and non-pathogenic microbes  express common microbe-associated molecu-lar patterns (MAMPs) that can activate innate  pro-inflammatory responses.",Non-OADS,/arxiv_data1/oa_pdf/5d/c5/viru-3-523.PMC3524154.pdf
"Cell Host Microbe 2012; 11:325-36; PMID:22520461;   http://dx.doi.org/10.1016/j.chom.2012.03.001 Makoto Fukumatsu,1 Michinaga Ogawa,2 Minsoo Kim,3 Hitomi Mimuro4 and Chihiro Sasakawa1,2,5,*; 1Department of Infectious Disease Control; International  Research Center for Infectious Disease; University of Tokyo; Tokyo, Japan; 2Division of Bacterial Infection; Department of Microbiology and Immunology; Institute of  Medical Science; University of Tokyo; Tokyo, Japan; 3Division of Bacterial Infection Biology; Institute of Medical Science; University of Tokyo; Tokyo, Japan;   4Division of Bacteriology; Department of Infectious Disease Control; International Research Center for Infectious Disease; University of Tokyo; Tokyo, Japan;   5Nippon Institute for Biological Science; Tokyo, Japan; *Email: sasakawa@ims.u-tokyo.ac.jp; http://dx.doi.org/10.4161/viru.21740 as bacterial cell-cell spreading.",OADS,/arxiv_data1/oa_pdf/7e/42/viru-3-525.PMC3524155.pdf
"Nature 2012; 483:623-6; PMID:22407319;   http://dx.doi.org/10.1038/nature10894 Takahito Sanada,1 Minsoo Kim,1 Hitomi Mimuro,2 Hiroshi Ashida,3 Michinaga Ogawa,3 Tsunehiro Mizushima4 and Chihiro Sasakawa1,3,5,*; 1Department of Infectious  Disease Control; International Research Center for Infectious Diseases; University of Tokyo; Tokyo, Japan; 2Division of Bacteriology; Department of Infectious Disease  Control; International Research Center for Infectious Diseases; University of Tokyo; Tokyo, Japan; 3Division of Bacterial Infection; Department of Microbiology and  Immunology; Institute of Medical Science; University of Tokyo; Tokyo, Japan; 4Picobiology Institute; Department of Life Science; Graduate School of Life Science;  University of Hyogo; Hyogo, Japan; 5Nippon Institute for Biological Science; Tokyo, Japan; *Email: sasakawa@ims.u-tokyo.ac.jp;   http://dx.doi.org/10.4161/viru.21451 Upon infection of many bacterial pathogens,  bacterial invasion is quickly sensed by the  innate immune system, resulting in acute  inflammatory responses.",Non-OADS,/arxiv_data1/oa_pdf/7e/42/viru-3-525.PMC3524155.pdf
"Nat Med 2012; 18:816-9; PMID:22522561;   http://dx.doi.org/10.1038/nm.2692 Michael Otto; National Institute of Allergy and Infectious Diseases; The National Institutes of Health; Bethesda, MD USA; Email: motto@niaid.nih.gov;   http://dx.doi.org/10.4161/viru.21523 Why does methicillin-resistant Staphylococcus  aureus (MRSA) remain a dangerous pathogen,  particularly in hospital-associated infections?",Non-OADS,/arxiv_data1/oa_pdf/7e/42/viru-3-525.PMC3524155.pdf
J Virol 2012; 86:9035-43; PMID:22674997; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7e/42/viru-3-525.PMC3524155.pdf
"org/10.1128/JVI.00369-12 Victor C. Huber; Division of Basic Biomedical Sciences; University of South Dakota; Vermillion, SD USA; Email: victor.huber@usd.edu;  http://dx.doi.org/10.4161/viru.21811 The influenza virus genes that will dictate  the severity of the next influenza virus pan-demic currently exist in nature.",Non-OADS,/arxiv_data1/oa_pdf/7e/42/viru-3-525.PMC3524155.pdf
"Meyer*; Department of Molecular Biology; Max Planck Institute for Infection Biology; Berlin, Germany;   *Email: meyer@mpiib-berlin.mpg.de; http://dx.doi.org/10.4161/viru.22183 Both pathogenic and non-pathogenic microbes  express common microbe-associated molecu-lar patterns (MAMPs) that can activate innate  pro-inflammatory responses.",Non-OADS,/arxiv_data1/oa_pdf/7e/42/viru-3-525.PMC3524155.pdf
"Detection of Streptococcus pyogenes virulence factors by multiplex PCR Anna L. Borek, Katarzyna Obsza ńska, Waleria Hryniewicz and Izabela Sitkiewicz* Department of Epidemiology and Clinical Microbiology; National Medicines Institute; Warszawa, Poland Keywords: Streptococcus pyogenes , multiplex PCR, virulence factors, Gram-positive pathogens, PCR detection Submitted: 06/15/12 Revised: 07/18/12 Accepted: 07/18/12 http://dx.doi.org/10.4161/viru.21540 *Correspondence to: Izabela Sitkiewicz; Email: iza.sitkiewicz@gmail.comStreptococcus pyogenes (GAS) is a human pathogen that causes mul- tiple infections worldwide.",Non-OADS,/arxiv_data1/oa_pdf/ea/b4/viru-3-529.PMC3524156.pdf
Lancet Infect Dis 2005; 5:685-94; PMID:16253886; http://dx.doi.org/10.1016/S1473-3099(05)70267-X 2.,OADS,/arxiv_data1/oa_pdf/ea/b4/viru-3-529.PMC3524156.pdf
Clin Microbiol Rev 2000; 13:470-511; PMID:10885988; http://dx.doi.org/10.1128/CMR.13.,OADS,/arxiv_data1/oa_pdf/ea/b4/viru-3-529.PMC3524156.pdf
Emerg Infect Dis 2003; 9:1211-8; PMID:14609454; http://dx.doi.org/10.3201/eid0910.0300424.,Non-OADS,/arxiv_data1/oa_pdf/ea/b4/viru-3-529.PMC3524156.pdf
J Infect Dis 2010; 202:20-8; PMID:20497047; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/ea/b4/viru-3-529.PMC3524156.pdf
Int J Med Microbiol 2007; 297: 471-8; PMID:17481952; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ea/b4/viru-3-529.PMC3524156.pdf
"Typing of Streptococcus pyogenes strains using the phage profiling method Anna L. Borek, Katarzyna Obsza ńska, Waleria Hryniewicz and Izabela Sitkiewicz* Department of Epidemiology and Clinical Microbiology; National Medicines Institute; Warszawa, Poland Keywords: Streptococcus pyogenes , prophage detection, ICE detection, typing, multiplex PCR Submitted: 06/15/12 Revised: 08/17/12 Accepted: 08/20/12 http://dx.doi.org/10.4161/viru.21887 *Correspondence to: Izabela Sitkiewicz; Email: iza.sitkiewicz@gmail.comWe recently developed a method that allows fast differentiation between Streptococcus pyogenes (GAS) strains.",Non-OADS,/arxiv_data1/oa_pdf/25/e5/viru-3-534.PMC3524157.pdf
"pyogenes often causes seasonal outbreaks3,4and is respons- ible for infections in hospitals5,6and long- term care facilities.7 Epidemiological investigations of GAS infections and outbreaks usually include classification into one of ~150 serotypes (emm typing8) and sequence type (MLST, http://spyogenes.mlst.net).",Non-OADS,/arxiv_data1/oa_pdf/25/e5/viru-3-534.PMC3524157.pdf
Lancet Infect Dis 2005; 5:685-94; PMID:16253886; http://dx.doi.org/10.1016/S1473-3099(05)70267-X 3.,OADS,/arxiv_data1/oa_pdf/25/e5/viru-3-534.PMC3524157.pdf
J Clin Microbiol 2008; 46:2359-67; PMID:18463210; http://dx.doi.org/10.1128/JCM.00422-08 4.,Non-OADS,/arxiv_data1/oa_pdf/25/e5/viru-3-534.PMC3524157.pdf
J Infect Dis 2012; 206:341-51; PMID:22615319; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/25/e5/viru-3-534.PMC3524157.pdf
Epidemiol Infect 2012; In press; PMID:22717031; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/25/e5/viru-3-534.PMC3524157.pdf
Clin Infect Dis 2007; 45:742-52; PMID:17712760; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/25/e5/viru-3-534.PMC3524157.pdf
PLoS One 2007; 2:e800; PMID:17726530; http://dx.doi.org/10.1371/journal.pone.0000800 11.,OADS,/arxiv_data1/oa_pdf/25/e5/viru-3-534.PMC3524157.pdf
"Multiple locus VNTR fingerprinting (MLVF) of Streptococcus pyogenes Katarzyna Obsza ńska, Anna L. Borek, Waleria Hryniewicz and Izabela Sitkiewicz* Department of Epidemiology and Clinical Microbiology; National Medicines Institute; Warszawa, Poland Keywords: MLVF, typing, Streptococcus pyogenes , multiplex PCR, PCR detection Submitted: 06/15/12 Revised: 10/03/12 Accepted: 10/04/12 http://dx.doi.org/10.4161/viru.22459 *Correspondence to: Izabela Sitkiewicz; Email: iza.sitkiewicz@gmail.comStreptococcus pyogenes (GAS) is a human pathogen that causes mil- lions of infections worldwide.",Non-OADS,/arxiv_data1/oa_pdf/16/6f/viru-3-539.PMC3524158.pdf
Virulence 2012; 3:529-33; PMID: 23076284; http://dx.doi.org/10.4161/viru.215403.,Non-OADS,/arxiv_data1/oa_pdf/16/6f/viru-3-539.PMC3524158.pdf
Virulence 2012; 3:534-38; PMID: 23076280; http://dx.doi.org/10.4161/viru.21887 4.,Non-OADS,/arxiv_data1/oa_pdf/16/6f/viru-3-539.PMC3524158.pdf
"Twenty-two months after #16 tested BLV positive, clinical symp- toms indicative of lymphoma developed Correspondence to: Robert E. Click; Email: mbclicker@msn.com Submitted: 08/16/12; Revised: 09/05/12; Accepted: 09/05/12 http://dx.doi.org/10.4161/viru.22090LETTER TO THE EDITOR Virulence 3:6, 543 –545; October 1, 2012; G2012 Landes Bioscience www.landesbioscience.com Virulence 543",Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
J Comp Pathol 1997; 116:217-61; PMID:9147244; http://dx.doi.org/10.1016/S0021-9975(97)80001-1 2.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
J Clin Microbiol 2007; 45:3883-90; PMID: 17913930; http://dx.doi.org/10.1128/JCM.01371-07 5.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Virulence 2011; 2:337-47; PMID: 21701254; http://dx.doi.org/10.4161/viru.2.4.16137 6.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Virulence 2010; 1:145-55; PMID: 21178433; http://dx.doi.org/10.4161/viru.1.3.108977.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Virulence 2011; 2:131-43; PMID:21460639; http://dx.doi.org/10.4161/viru.2.2.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Vet J 2009; 179:60-9; PMID:17928247; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Lancet Infect Dis 2007; 7:607-13; PMID:17714674; http://dx.doi.org/10.1016/S1473- 3099(07)70211-6 10.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Curr Opin Gastroenterol 2008; 24:17-21; PMID:18043227; http://dx.doi.org/10.1097/MOG.0b013e3282f1dcc412.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Gut Pathog 2009; 1:15; PMID:19602288; http://dx.doi.org/10.1186/1757-4749-1-15 13.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Gut Pathog 2010; 2:21; PMID: 21167058; http://dx.doi.org/10.1186/1757-4749-2-21 14.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Cell Immunol 1972; 3:156-60; PMID:5061825; http://dx.doi.org/ 10.1016/0008-8749(72)90237-7 15.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Cell Immunol 1972; 5:410-8; PMID: 4645593; http://dx.doi.org/10.1016/0008-8749(72) 90067-6 17.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Int J Immunopharmacol 1982; 4:429-36; PMID:6982245; http://dx.doi.org/10.1016/0192-0561(82)90017-0 19.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Virulence 2010; 1:509- 15; PMID:21178502; http://dx.doi.org/10.4161/viru.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Virulence 2010; 1:516- 22; PMID:21178504; http://dx.doi.org/10.4161/viru.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Adv Exp Med Biol 2001; 492:69- 81; PMID:11480676; http://dx.doi.org/10.1007/978- 1-4615-1283-7_7 25.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Amino Acids 2011; 41:7-27; PMID:20306345; http://dx.doi.org/10.1007/ s00726-010-0552-0 27.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Virulence 2010; 1:134-44; PMID:21178432; http://dx.doi.org/ 10.4161/viru.1.3.10896 30.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
Toxicol Appl Pharmacol 2011; 253: 197-202; PMID:21463646; http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/fd/8e/viru-3-543.PMC3524159.pdf
"The inhalation of MAP-contaminated water droplets as a possible route of transmission of MAP from an infected animal ’s feces to humans was first proposed by Hermon-Taylor and Correspondence to: Ellen S. Pierce; Email: ellenpiercemd@gmail.com Submitted: 07/30/12; Revised: 09/07/12; Accepted: 09/07/12 http://dx.doi.org/10.4161/viru.22121Virulence 3:6, 546 –550; October 1, 2012; G2012 Landes Bioscience 546 Virulence Volume 3 Issue 6",Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Gut Pathog 2011; 3:20; PMID:22196128; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Inflamm Bowel Dis 2001; 7:27-33; PMID:11233657; http://dx.doi.org/ 10.1097/00054725-200102000-00004 4.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Inflamm Bowel Dis 2007; 13:254-61; PMID: 17206702; http://dx.doi.org/10.1002/ibd.20029 5.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
"Spokane, Washington, 2011 Feb 6. http://www.spokesman.com/stories/2011/ feb/06/study-tracks-reasons-behind-high-rate-of-illness/ 6.",Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Am J Surg 1983; 145:578-81; PMID:6846693; http://dx.doi.org/10.1016/0002-9610(83)90095-8 7.,OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
"Am J Epidemiol 2006; 164:615-23, discussion 624-8; PMID: 16920784; http://dx.doi.org/10.1093/aje/kwj260 9.",Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Gut Pathog 2009; 1:15; PMID:19602288; http://dx.doi.org/10.1186/1757-4749-1-15 10.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Inflamm Bowel Dis 2006; 12: 936-43; PMID:17012964; http://dx.doi.org/10.1097/ 01.mib.0000231572.88806.b9 11.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
J Comp Pathol 1997; 116:217-61; PMID:9147244; http://dx.doi.org/10.1016/S0021-9975(97)80001-1 12.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Gut Pathog 2010; 2:21; PMID: 21167058; http://dx.doi.org/10.1186/1757-4749-2-21 14.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Gut 1988; 29:346-51; PMID:3356366; http://dx.doi.org/10.1136/gut.29.3.34616.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Appl Environ Microbiol 2003; 69:5685-9; PMID:12957962; http://dx.doi.org/10.1128/AEM.69.9.5685-5689.2003 19.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Microb Pathog 2009; 46:222-30; PMID: 19490829; http://dx.doi.org/10.1016/j.micpath.2009.,OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Appl Environ Microbiol 2001; 67:1225-31; PMID:11229914; http://dx.doi.org/10.1128/AEM.67.3.1225-1231.2001 21.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
J Appl Microbiol 2012; 113:223-32; PMID:22471411; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Appl Environ Microbiol 2010; 76:7367-70; PMID:20817803; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Can J Microbiol 1974; 20: 1051-7; PMID:4837580; http://dx.doi.org/10.1139/ m74-162 24.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
J Appl Microbiol 2009; 107:356-67; PMID: 19228258; http://dx.doi.org/10.1111/j.1365-2672.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Science 1970; 170:626-8; PMID:4919182; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
JAMA 1988; 260:1599-601; PMID:3411741; http://dx.doi.org/10.,OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Lancet 1994; 343:766-7; PMID: 7907734; http://dx.doi.org/10.1016/S0140-6736(94) 91841-4 31.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Proc Natl Acad Sci U S A 2009; 106:16393-9; PMID:19805310; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Limnol Oceanogr 1981; 26:961-4; http://dx.doi.org/10.4319/lo.1981.,OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
BMC Public Health 2010; 10:48; PMID:20113516; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Vet Pathol 1983; 20:274-90; PMID:6879954; http://dx.doi.org/10.1177/030098588302000304 39.,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
PLoS One 2012; 7:e35326; PMID:22496916; http://dx.doi.org/ 10.1371/journal.pone.0035326 www.landesbioscience.com Virulence 549,Non-OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Microbes Infect 2007; 9:1567-73; PMID:18062905; http://dx.doi.org/10.1016/j.micinf.2007.09.001 43.,OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
Dig Dis Sci 2011; 56:2957-62; PMID:21484317; http://dx.doi.org/10.1007/s10620- 011-1699-644.,OADS,/arxiv_data1/oa_pdf/02/45/viru-3-546.PMC3524160.pdf
"3Upstream regulators of the Hippo pathway Fa-Xing y u, Jung- soon Mo and Kun-Liang Guan* department of Pharmacology and Moores Cancer Center; u niversity of California, s an d iego; La Jolla, C a usa *Correspondence to: Kun-Liang Guan; Email: kuguan@ucsd.edu Submitted: 09/09/12; Accepted: 09/10/12http://dx.doi.org/10.4161/cc.22322Comment on: Yu FX, et al.",Non-OADS,/arxiv_data1/oa_pdf/e0/58/cc-11-4097.PMC3524194.pdf
Cell 2012; 150:780-91; PMID:22863277; http://dx.doi.org/10.1016/j.cell.2012.06.037.Figure 1.,OADS,/arxiv_data1/oa_pdf/e0/58/cc-11-4097.PMC3524194.pdf
Genes Dev 2010; 24:862-74;  PMID:20439427; http://dx.doi.org/10.1101/ gad.1909210.,OADS,/arxiv_data1/oa_pdf/e0/58/cc-11-4097.PMC3524194.pdf
Cell 2012; 150:780-91; PMID:22863277;  http://dx.doi.org/10.1016/j.cell.2012.06.037.,OADS,/arxiv_data1/oa_pdf/e0/58/cc-11-4097.PMC3524194.pdf
Chem Biol 2012; 19:955-62;  PMID:22884261; http://dx.doi.org/10.1016/j.chem - biol.2012.07.005.,OADS,/arxiv_data1/oa_pdf/e0/58/cc-11-4097.PMC3524194.pdf
Genes Dev 2012; 26:54-68;  PMID:22215811; http://dx.doi.org/10.1101/ gad.173435.111.,OADS,/arxiv_data1/oa_pdf/e0/58/cc-11-4097.PMC3524194.pdf
EMBO J 2011; 30:2325-35; PMID:21556047; http://dx.doi.org/10.1038/ emboj.2011.157.,Non-OADS,/arxiv_data1/oa_pdf/e0/58/cc-11-4097.PMC3524194.pdf
PLoS Biol 2011; 9:e1000624; PMID:21666802; http://dx.doi.org/10.1371/journal.,OADS,/arxiv_data1/oa_pdf/e0/58/cc-11-4097.PMC3524194.pdf
Development 2011; 138:2337- 46; PMID:21525075; http://dx.doi.org/10.1242/dev.063545.,OADS,/arxiv_data1/oa_pdf/e0/58/cc-11-4097.PMC3524194.pdf
Nature 2011; 474:179-83;  PMID:21654799; http://dx.doi.org/10.1038/ nature10137.,Non-OADS,/arxiv_data1/oa_pdf/e0/58/cc-11-4097.PMC3524194.pdf
"Dorsam RT, Nat Rev Cancer 2007; 7:79-94;  PMID:17251915; http://dx.doi.org/10.1038/nrc2069.",Non-OADS,/arxiv_data1/oa_pdf/e0/58/cc-11-4097.PMC3524194.pdf
Pharmacol Ther 2011; 129:290- 306; PMID:21073897; http://dx.doi.org/10.1016/j.pharmthera.2010.10.007.,Non-OADS,/arxiv_data1/oa_pdf/e0/58/cc-11-4097.PMC3524194.pdf
Emoto K. J Biochem 2011; 150:133-41;  PMID:21697237; http://dx.doi.org/10.1093/jb/ mvr080.,OADS,/arxiv_data1/oa_pdf/e0/58/cc-11-4097.PMC3524194.pdf
"2 A recently discovered  dNTP triphosphohydrolase further limits Out of S-phase Shift of subunits for ribonucleotide reduction Giovanna Pontarin, Paola Ferraro, Peter r eichard* and Vera Bianchi* department of Biology; u niversity of Padova; Padova, i taly *Correspondence to: Peter Reichard and Vera Bianchi; Email: reichard@bio.unipd.it and vbianchi@bio.unipd.it Submitted: 09/12/12; Accepted: 09/13/12http://dx.doi.org/10.4161/cc.22324Comment on: Pontarin G, et al.",Non-OADS,/arxiv_data1/oa_pdf/bf/b3/cc-11-4099.PMC3524195.pdf
Science 1999; 283:689-92;  PMID:9924029; http://dx.doi.org/10.1126/sci - ence.283.5402.689.,OADS,/arxiv_data1/oa_pdf/bf/b3/cc-11-4099.PMC3524195.pdf
Mutat Res 2010; 703:2-10; PMID:20561600; http://dx.doi.org/10.1016/j.mrgentox.2010.06.002.,OADS,/arxiv_data1/oa_pdf/bf/b3/cc-11-4099.PMC3524195.pdf
Nature 2011; 480:379-82;  PMID:22056990; http://dx.doi.org/10.1038/ nature10623.,Non-OADS,/arxiv_data1/oa_pdf/bf/b3/cc-11-4099.PMC3524195.pdf
Annu Rev Biochem 2006; 75:681-706; PMID:16756507; http://dx.doi.org/10.1146/ annurev.biochem.75.103004.142443.,OADS,/arxiv_data1/oa_pdf/bf/b3/cc-11-4099.PMC3524195.pdf
Nature 2000; 404:42-9; PMID:10716435; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/b3/cc-11-4099.PMC3524195.pdf
Oncogene 2000; 19:4283-9; PMID:10980602; http://dx.doi.org/10.1038/ sj.onc.1203774.,OADS,/arxiv_data1/oa_pdf/bf/b3/cc-11-4099.PMC3524195.pdf
Proc Natl Acad Sci USA 2008; 105:17801-6; PMID:18997010; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/b3/cc-11-4099.PMC3524195.pdf
Nat Genet 2007; 39:776-80; PMID:17486094; http://dx.doi.org/10.1038/ng2040.,OADS,/arxiv_data1/oa_pdf/bf/b3/cc-11-4099.PMC3524195.pdf
J Biol Chem 2011; 286:11132- 40; PMID:21297166; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/bf/b3/cc-11-4099.PMC3524195.pdf
Proc Natl Acad Sci USA 2012; 109:13302-7; PMID:22847445; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/bf/b3/cc-11-4099.PMC3524195.pdf
"4 Importantly, nucleus-localized PKM2 functions as a histone kinase Zhimin Lu1,2* 1Brain t umor Center; d epartment of Neuro- oncology and d epartment of Molecular and Cellular o ncology; t he u niversity of t exas M d anderson Cancer Center;   Houston, t X usa ; 2the u niversity of t exas Graduate s chool of Biomedical s ciences at Houston; Houston, t X usa *Correspondence to: Zhimin Lu; Email: zhiminlu@mdanderson.org Submitted: 08/31/12; Accepted: 09/14/12http://dx.doi.org/10.4161/cc.22325Comment on: Yang W, et al.",Non-OADS,/arxiv_data1/oa_pdf/06/2e/cc-11-4101.PMC3524196.pdf
"Cell 2012; 150:685-96; PMID:22901803; http://dx.doi.org/10.1016/j.cell.2012.07.018.PKM2 is involved in controlling gene  transcription.5 Under hypoxic conditions,  PKM2 is hydroxylated at Pro403/408 by prolyl hydroxylase 3, resulting in binding of PKM2 to hypoxia-inducible factor-1 α  (HIF-1 α), which stimulates HIF-1 α- dependent transactivation of glycolytic genes that promote glucose metabolism in cancer cells.",Non-OADS,/arxiv_data1/oa_pdf/06/2e/cc-11-4101.PMC3524196.pdf
Science 2009; 324:1029- 33; PMID:19460998; http://dx.doi.org/10.1126/sci - ence.1160809.,OADS,/arxiv_data1/oa_pdf/06/2e/cc-11-4101.PMC3524196.pdf
Nature 2008; 452:230-3; PMID:18337823; http://dx.doi.org/10.1038/ nature06734.,Non-OADS,/arxiv_data1/oa_pdf/06/2e/cc-11-4101.PMC3524196.pdf
Science 2011; 334:1278-83; PMID:22052977; http://dx.doi.org/10.1126/sci - ence.1211485.,OADS,/arxiv_data1/oa_pdf/06/2e/cc-11-4101.PMC3524196.pdf
Nature 2011; 480:118-22;  PMID:22056988; http://dx.doi.org/10.1038/ nature10598.,OADS,/arxiv_data1/oa_pdf/06/2e/cc-11-4101.PMC3524196.pdf
Cell 2011; 145:732-44; PMID:21620138; http://dx.doi.org/10.1016/j.cell.2011.03.054.,OADS,/arxiv_data1/oa_pdf/06/2e/cc-11-4101.PMC3524196.pdf
Mol Cell 2012; 45:598-609;  PMID:22306293; http://dx.doi.org/10.1016/j.mol - cel.2012.01.001.,OADS,/arxiv_data1/oa_pdf/06/2e/cc-11-4101.PMC3524196.pdf
Lu Z. Chin J Cancer 2012; 31:5-7; PMID:22200182;  http://dx.doi.org/10.5732/cjc.011.10446.,Non-OADS,/arxiv_data1/oa_pdf/06/2e/cc-11-4101.PMC3524196.pdf
Cell 2012; 150:685-96; PMID:22901803; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/06/2e/cc-11-4101.PMC3524196.pdf
"Morris* school of Cancer s ciences; College Medical and d ental s ciences; u niversity of Birmingham; Birmingham, u K *Correspondence to: Joanna R. Morris; Email: j.morris.3@bham.ac.uk Submitted: 09/21/12; Accepted: 09/24/12http://dx.doi.org/10.4161/cc.22395Comment on: Butler LR, et al.",Non-OADS,/arxiv_data1/oa_pdf/a2/4e/cc-11-4103.PMC3524197.pdf
EMBO J 2012; 31:3918-34; PMID:22909820; http://dx.doi.org/10.1038/emboj.2012.232.required for the subsequent accumulation  of repair mediators 53BP1 and BRCA1 (in the BRCA1-A complex).,OADS,/arxiv_data1/oa_pdf/a2/4e/cc-11-4103.PMC3524197.pdf
EMBO J 2012; 31:3918-34;  PMID:22909820; http://dx.doi.org/10.1038/ emboj.2012.232.,Non-OADS,/arxiv_data1/oa_pdf/a2/4e/cc-11-4103.PMC3524197.pdf
DNA Repair (Amst) 2010; 9:1229- 40; PMID:21056014; http://dx.doi.org/10.1016/j.dnarep.2010.09.011.,OADS,/arxiv_data1/oa_pdf/a2/4e/cc-11-4103.PMC3524197.pdf
EMBO J 2012; 31:1865-78;  PMID:22373579; http://dx.doi.org/10.1038/ emboj.2012.47.,Non-OADS,/arxiv_data1/oa_pdf/a2/4e/cc-11-4103.PMC3524197.pdf
Proc Natl Acad Sci U S A 2009; 106:3166-71; PMID:19202061; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a2/4e/cc-11-4103.PMC3524197.pdf
EMBO J 2009; 28:621-31; PMID:19214193; http://dx.doi.org/10.1038/ emboj.2009.27.,Non-OADS,/arxiv_data1/oa_pdf/a2/4e/cc-11-4103.PMC3524197.pdf
Genes Dev 2009; 23:729-39; PMID:19261749; http://dx.doi.org/10.1101/ gad.1770309.,OADS,/arxiv_data1/oa_pdf/a2/4e/cc-11-4103.PMC3524197.pdf
Nat Struct Mol Biol 2010; 17:1260- 2; PMID:20729859; http://dx.doi.org/10.1038/nsmb.1904.,OADS,/arxiv_data1/oa_pdf/a2/4e/cc-11-4103.PMC3524197.pdf
Cell Cycle 2011; 10:4300- 10; PMID:22134242; http://dx.doi.org/10.4161/ cc.10.24.18642.,OADS,/arxiv_data1/oa_pdf/a2/4e/cc-11-4103.PMC3524197.pdf
Genes Dev 2012; 26:1179-95; PMID:22661229; http://dx.doi.org/10.1101/gad.188284.112.Figure 1.,OADS,/arxiv_data1/oa_pdf/a2/4e/cc-11-4103.PMC3524197.pdf
"New observa - tions in budding yeast make it clear that Dmc1, not Rad51, catalyzes homology search and strand exchange for most, if Rad51, the lead in mitotic recombinational   DNA repair, plays a supporting   role in budding yeast meiosis douglas K. Bishop* department of r adiation and Cellular o ncology; d epartment of Molecular Genetics and Cell Biology; u niversity of Chicago; Chicago, i L usa *Correspondence to: Douglas K. Bishop; Email: dbishop@uchicago.edu Submitted: 09/24/12; Accepted: 09/27/12http://dx.doi.org/10.4161/cc.22396Comment on: Cloud V, et al.",Non-OADS,/arxiv_data1/oa_pdf/f1/e8/cc-11-4105.PMC3524198.pdf
"Science 2012; 337:1222-5; PMID:22955832; http://dx.doi.org/10.1126/science.1219379.not all, meiotic recombination events.5 A  separation of function mutant showed that  although Rad51’s ability to form filaments on DNA is required for normal meiotic recombination, its strand exchange activ - ity is fully dispensable.",OADS,/arxiv_data1/oa_pdf/f1/e8/cc-11-4105.PMC3524198.pdf
Cell 1994; 79:1081-92; PMID:7528104;  http://dx.doi.org/10.1016/0092-8674(94)90038-8.,OADS,/arxiv_data1/oa_pdf/f1/e8/cc-11-4105.PMC3524198.pdf
Cell 1997; 90:1123-35;  PMID:9323140; http://dx.doi.org/10.1016/S0092- 8674(00)80378-5.,OADS,/arxiv_data1/oa_pdf/f1/e8/cc-11-4105.PMC3524198.pdf
Genes Cells 1997; 2:615-29; PMID:9427283; http://dx.doi.org/10.1046/j.1365-2443.1997.1480347.x.,OADS,/arxiv_data1/oa_pdf/f1/e8/cc-11-4105.PMC3524198.pdf
Annu Rev Biochem 2008; 77:229-57; PMID:18275380; http://dx.doi.org/10.1146/ annurev.biochem.77.061306.125255.,Non-OADS,/arxiv_data1/oa_pdf/f1/e8/cc-11-4105.PMC3524198.pdf
Science 2012; 337:1222-5; PMID:22955832; http://dx.doi.org/10.1126/sci- ence.1219379.,OADS,/arxiv_data1/oa_pdf/f1/e8/cc-11-4105.PMC3524198.pdf
Genes Dev 2006; 20:1766-75; PMID:16818607; http://dx.doi.org/10.1101/ gad.1422506.,OADS,/arxiv_data1/oa_pdf/f1/e8/cc-11-4105.PMC3524198.pdf
J Biol Chem 2009; 284:11766- 70; PMID:19270307; http://dx.doi.org/10.1074/jbc.C900023200.,OADS,/arxiv_data1/oa_pdf/f1/e8/cc-11-4105.PMC3524198.pdf
Proc Natl Acad Sci USA 2001;  98:8411-8; PMID:11459983; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f1/e8/cc-11-4105.PMC3524198.pdf
Mol Cell Biol 2006; 26:8396-409; PMID:16966380; http://dx.doi.org/10.1128/ MCB.01317-06.,OADS,/arxiv_data1/oa_pdf/f1/e8/cc-11-4105.PMC3524198.pdf
"While mTORC1 is activated by nutrients (amino acids), growth factors and cellular energy, mTORC2 is activated by growth Glutaminolysis feeds mTORC1 raúl V. d urán and Michael N. Hall* Biozentrum; u niversity of Basel; Basel, s witzerland Abbreviations:  2-HG, 2-hydroxyglutarate; α KG, α -ketoglutarate; GDH, glutamate dehydrogenase; GLS, glutaminase; IDH,  isocitrate dehydrogenase; mTOR, mammalian target of rapamycin; TCA, tricarboxylic acid *Correspondence to: Michael N. Hall; Email: m.hall@unibas.ch Submitted: 10/18/12; Accepted: 10/20/12http://dx.doi.org/10.4161/cc.22632Comment on: Durán RV, et al.",Non-OADS,/arxiv_data1/oa_pdf/5f/59/cc-11-4107.PMC3524199.pdf
Mol Cell 2012; 47:349-58; PMID:22749528; http://dx.doi.org/10.1016/j.molcel.2012.05.043.factors alone.,OADS,/arxiv_data1/oa_pdf/5f/59/cc-11-4107.PMC3524199.pdf
Mol Cell 2012; 47:349-58;  PMID:22749528; http://dx.doi.org/10.1016/j.mol- cel.2012.05.043.,OADS,/arxiv_data1/oa_pdf/5f/59/cc-11-4107.PMC3524199.pdf
Cell 2012; 149:274-93;  PMID:22500797; http://dx.doi.org/10.1016/j.cell.2012.03.017.,OADS,/arxiv_data1/oa_pdf/5f/59/cc-11-4107.PMC3524199.pdf
Cell 2006; 124:471-84;  PMID:16469695; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5f/59/cc-11-4107.PMC3524199.pdf
J Biol Chem 1998; 273:14484-94; PMID:9603962; http://dx.doi.org/10.1074/ jbc.273.23.14484.,OADS,/arxiv_data1/oa_pdf/5f/59/cc-11-4107.PMC3524199.pdf
Oncogene 2012; In press;  PMID:23085753; http://dx.doi.org/10.1038/onc.2012.465.,OADS,/arxiv_data1/oa_pdf/5f/59/cc-11-4107.PMC3524199.pdf
Curr Opin Cell Biol 2011; 23:744- 55; PMID:21963299; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5f/59/cc-11-4107.PMC3524199.pdf
Cancer Res 2010; 70:8981-7; PMID:21045145; http://dx.doi.org/10.1158/0008- 5472.CAN-10-1666.,Non-OADS,/arxiv_data1/oa_pdf/5f/59/cc-11-4107.PMC3524199.pdf
Nature 2012; 483:484-8; PMID:22343896; http://dx.doi.org/10.1038/ nature10898.,Non-OADS,/arxiv_data1/oa_pdf/5f/59/cc-11-4107.PMC3524199.pdf
"Genes Dev 2012; 26:2038-49; PMID:22925884; http://dx.doi.org/10.1101/ gad.198200.112 10. van der Vos KE, et al.",OADS,/arxiv_data1/oa_pdf/5f/59/cc-11-4107.PMC3524199.pdf
Nat Cell Biol 2012; 14:829-37; PMID:22820375; http://dx.doi.org/10.1038/ncb2536.,OADS,/arxiv_data1/oa_pdf/5f/59/cc-11-4107.PMC3524199.pdf
"Cell Cycle 2012; 11:3851–60;   PMID:23070521; http://dx.doi.org/10.4161/cc.22027 Marc Diederich; Laboratoire de Biologie Moléculaire et Cellulaire du Cancer; Kirchberg Hospital; Kirchberg, Luxembourg; Email: marc.diederich@lbmcc.lu;   http://dx.doi.org/10.4161/cc.22603 and capsaicin were reported to inhibit epider - mal growth factor receptor (eGFR) cell signal- ing pathways; β-lapachone from the bark of Tabebuia avellanedae induces a reduction of the telomerase RNA level; flavonoids like lute - olin or genistein inhibit mechanisms linked to metastasis formation; angiogenesis is inhib - ited by plumbagin; methyl jasmonate inhibits  cancer cell metabolism by active induction of  hexokinase release; cordycepin inhibits PARP-1-involved base excision repair and finally a  wealth of compounds were shown to inhibit  pro-inflammatory cell signaling mechanisms including NFκB and Jak/STAT.",Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Curr Med Chem 2012;  19:2061-87; PMiD:22414100; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Biotechnol Adv 2011; 29:531-47; PMiD:21371549; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Cell Cycle 2012; 11:3851-60;  PMiD:23070521; http://dx.doi.org/10.4161/cc.22027.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Curr Drug Targets 2011;  12:2034-44; PMiD:21777194; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Cancer Res 2006; 66:8109-15; PMi D:16912188; http://dx.doi.org/10.1158/0008- 5472.CAN-06-0140.,Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Mol Cancer Ther 2010; 9:347-57; PMi D:20124459; http://dx.doi.org/10.1158/1535- 7163.MCT-09-0872.,Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
eMBO Mol Med 2012; 4:515- 27; PMiD:22416035; http://dx.doi.org/10.1002/ emmm.201200229.,Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Blood 2010; 116:4578-87; PMiD:20739657; http://dx.doi.org/10.1182/blood- 2010-01-265769.,Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Cancer Res 2011; 71:2632-42;  PMi D:21300766; http://dx.doi.org/10.1158/0008- 5472.CAN-10-1120.,Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Cell Cycle 2012; 11:3837- 50; PMiD:22983061; http://dx.doi.org/10.4161/ cc.22026.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Proc Natl Acad Sci USA 2011; 108:3406-11; PM iD:21300883; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
"J Clin Oncol 2011; 29:2843-4;  PMiD:21670452; http://dx.doi.org/10.1200/ JCO.2011.35.9208.Predicting PARP inhibitor sensitivity and resistance   Comment on: Oplustilova L, et al.",OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
"Cell Cycle 2012; 11:3837–50;   PMID:22983061; http://dx.doi.org/10.4161/cc.22026 D. Gwyn Bebb1,2 and Susan P .",OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
"Lees-Miller2,3; 1Division of Medical Oncology; Tom Baker Cancer Centre; Calgary, AB Canada; 2Southern Alberta Cancer Research  Institute; Calgary, AB Canada; 3Departments of Biochemistry & Molecular Biology and Oncology; University of Calgary; Calgary, AB Canada;   Email: Gwyn.Bebb@albertahealthservices.ca and leesmill@ucalgary.ca; http://dx.doi.org/10.4161/cc.22604",Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Annu Rev Genet 2011; 45:247- 71; PMiD:21910633; http://dx.doi.org/10.1146/ annurev-genet-110410-132435.,Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Science 2003; 300:1542-8; PMiD:12791985; http://dx.doi.org/10.1126/sci- ence.1083430.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Proc Natl Acad Sci USA 1995;  92:7642-6; PM iD:7644470; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Nature 2001; 412:456-61; PMiD:11473323; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Nature 2010; 467:112-6; PMiD:20811461; http://dx.doi.org/10.1038/ nature09355.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Nature 2010; 467:108-11; PMiD:20811460; http://dx.doi.org/10.1038/ nature09318.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Cancer Res 2012; 72:2802-13; PMi D:22491672; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3152.,Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Cell Cycle 2012; 11:3983-96;  PMiD:22987153; http://dx.doi.org/10.4161/ cc.22215.,Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
"Genes Dev 2012; 26:1393-408; PMiD:22751496; http://dx.doi.org/10.1101/ gad.195248.112.Examining the roles of DNA2 during mammalian end resection Comment on: Karanja KK, et al.",OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
"Cell Cycle 2012; 11:3983–96;   PMID:22987153; http://dx.doi.org/10.4161/cc.22215 Jeremy M. Stark and Binghui Shen; Department of Radiation Biology; City of Hope National Medical Center and Beckman Research Institute; Duarte, CA USA;   Email: jstark@coh.org and bshen@coh.org; http://dx.doi.org/10.4161/cc.22605",OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
"Cell Cycle 2012; 11:4181–90;   PMID:23095642; http://dx.doi.org/10.4161/cc.22413  Swathi V. Iyer and Tomoo Iwakuma*; Department of Cancer Biology; University of Kansas Medical Center; Kansas City, KS USA;  *Email: tiwakuma@kumc.edu; http://dx.doi.org/10.4161/cc.22606 The constitutive photomorphogenesis 9  (COP9) signalosome (CSN) is an evolutionarily conserved multiprotein complex in plants and animals.",OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Cell Cycle 2012; 11:4059–68;   PMID:23095493; http://dx.doi.org/10.4161/cc.22381  Yifan Wang and Binhua P .,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
"Zhou*; Department of Molecular and Cellular Biochemistry and Markey Cancer Center; University of Kentucky School of Medicine;  Lexington, KY USA; *Email: peter.zhou@uky.edu; http://dx.doi.org/10.4161/cc.22607References 1.",Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Annu Rev Cell Dev Biol 2003; 19:261- 86; http://dx.doi.org/10.1146/annurev.cell- bio.19.111301.112449; PMiD:14570571.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Mol Oncol 2012; 6:267-75; http://dx.doi.org/10.1016/j.molonc.2012.01.003;  PMiD:22306028.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Cycle 2011; 10:3057-66; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
FeBS Lett 2012; 586:1390-6; http://dx.doi.org/10.1016/j.febslet.2012.02.049;  PMiD:22673503.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
"J Biol Chem 2004; 279:35510-7; http://dx.doi.org/10.1074/jbc.M404936200;  PMiD:15169778.8. eroles P , et al.",OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Cancer Treat Rev 2012; 38:698- 707; http://dx.doi.org/10.1016/j.ctrv.2011.11.005;  PMiD:22178455.,Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Mol Cancer Res 2007; 5:1-10; http://dx.doi.org/10.1158/1541-7786.MCR-06-0208;  PMiD:17259342.,Non-OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
Nature 2004; 428:77-81; http://dx.doi.org/10.1038/nature02313; PMiD:14999283.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
J Biol Chem 2011; 286:2236-44; http://dx.doi.org/10.1074/jbc.M110.174755;  PMiD:20959462.,OADS,/arxiv_data1/oa_pdf/82/42/cc-11-4109.PMC3524200.pdf
"Cell Cycle 2012; 11:3851–60;   PMID:23070521; http://dx.doi.org/10.4161/cc.22027 Marc Diederich; Laboratoire de Biologie Moléculaire et Cellulaire du Cancer; Kirchberg Hospital; Kirchberg, Luxembourg; Email: marc.diederich@lbmcc.lu;   http://dx.doi.org/10.4161/cc.22603 and capsaicin were reported to inhibit epider - mal growth factor receptor (eGFR) cell signal- ing pathways; β-lapachone from the bark of Tabebuia avellanedae induces a reduction of the telomerase RNA level; flavonoids like lute - olin or genistein inhibit mechanisms linked to metastasis formation; angiogenesis is inhib - ited by plumbagin; methyl jasmonate inhibits  cancer cell metabolism by active induction of  hexokinase release; cordycepin inhibits PARP-1-involved base excision repair and finally a  wealth of compounds were shown to inhibit  pro-inflammatory cell signaling mechanisms including NFκB and Jak/STAT.",Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Curr Med Chem 2012;  19:2061-87; PMiD:22414100; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Biotechnol Adv 2011; 29:531-47; PMiD:21371549; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Cell Cycle 2012; 11:3851-60;  PMiD:23070521; http://dx.doi.org/10.4161/cc.22027.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Curr Drug Targets 2011;  12:2034-44; PMiD:21777194; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Cancer Res 2006; 66:8109-15; PMi D:16912188; http://dx.doi.org/10.1158/0008- 5472.CAN-06-0140.,Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Mol Cancer Ther 2010; 9:347-57; PMi D:20124459; http://dx.doi.org/10.1158/1535- 7163.MCT-09-0872.,Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
eMBO Mol Med 2012; 4:515- 27; PMiD:22416035; http://dx.doi.org/10.1002/ emmm.201200229.,Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Blood 2010; 116:4578-87; PMiD:20739657; http://dx.doi.org/10.1182/blood- 2010-01-265769.,Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Cancer Res 2011; 71:2632-42;  PMi D:21300766; http://dx.doi.org/10.1158/0008- 5472.CAN-10-1120.,Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Cell Cycle 2012; 11:3837- 50; PMiD:22983061; http://dx.doi.org/10.4161/ cc.22026.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Proc Natl Acad Sci USA 2011; 108:3406-11; PM iD:21300883; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
"J Clin Oncol 2011; 29:2843-4;  PMiD:21670452; http://dx.doi.org/10.1200/ JCO.2011.35.9208.Predicting PARP inhibitor sensitivity and resistance   Comment on: Oplustilova L, et al.",OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
"Cell Cycle 2012; 11:3837–50;   PMID:22983061; http://dx.doi.org/10.4161/cc.22026 D. Gwyn Bebb1,2 and Susan P .",OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
"Lees-Miller2,3; 1Division of Medical Oncology; Tom Baker Cancer Centre; Calgary, AB Canada; 2Southern Alberta Cancer Research  Institute; Calgary, AB Canada; 3Departments of Biochemistry & Molecular Biology and Oncology; University of Calgary; Calgary, AB Canada;   Email: Gwyn.Bebb@albertahealthservices.ca and leesmill@ucalgary.ca; http://dx.doi.org/10.4161/cc.22604",Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Annu Rev Genet 2011; 45:247- 71; PMiD:21910633; http://dx.doi.org/10.1146/ annurev-genet-110410-132435.,Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Science 2003; 300:1542-8; PMiD:12791985; http://dx.doi.org/10.1126/sci- ence.1083430.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Proc Natl Acad Sci USA 1995;  92:7642-6; PM iD:7644470; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Nature 2001; 412:456-61; PMiD:11473323; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Nature 2010; 467:112-6; PMiD:20811461; http://dx.doi.org/10.1038/ nature09355.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Nature 2010; 467:108-11; PMiD:20811460; http://dx.doi.org/10.1038/ nature09318.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Cancer Res 2012; 72:2802-13; PMi D:22491672; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3152.,Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Cell Cycle 2012; 11:3983-96;  PMiD:22987153; http://dx.doi.org/10.4161/ cc.22215.,Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
"Genes Dev 2012; 26:1393-408; PMiD:22751496; http://dx.doi.org/10.1101/ gad.195248.112.Examining the roles of DNA2 during mammalian end resection Comment on: Karanja KK, et al.",OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
"Cell Cycle 2012; 11:3983–96;   PMID:22987153; http://dx.doi.org/10.4161/cc.22215 Jeremy M. Stark and Binghui Shen; Department of Radiation Biology; City of Hope National Medical Center and Beckman Research Institute; Duarte, CA USA;   Email: jstark@coh.org and bshen@coh.org; http://dx.doi.org/10.4161/cc.22605",OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
"Cell Cycle 2012; 11:4181–90;   PMID:23095642; http://dx.doi.org/10.4161/cc.22413  Swathi V. Iyer and Tomoo Iwakuma*; Department of Cancer Biology; University of Kansas Medical Center; Kansas City, KS USA;  *Email: tiwakuma@kumc.edu; http://dx.doi.org/10.4161/cc.22606 The constitutive photomorphogenesis 9  (COP9) signalosome (CSN) is an evolutionarily conserved multiprotein complex in plants and animals.",OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Cell Cycle 2012; 11:4059–68;   PMID:23095493; http://dx.doi.org/10.4161/cc.22381  Yifan Wang and Binhua P .,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
"Zhou*; Department of Molecular and Cellular Biochemistry and Markey Cancer Center; University of Kentucky School of Medicine;  Lexington, KY USA; *Email: peter.zhou@uky.edu; http://dx.doi.org/10.4161/cc.22607References 1.",Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Annu Rev Cell Dev Biol 2003; 19:261- 86; http://dx.doi.org/10.1146/annurev.cell- bio.19.111301.112449; PMiD:14570571.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Mol Oncol 2012; 6:267-75; http://dx.doi.org/10.1016/j.molonc.2012.01.003;  PMiD:22306028.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Cycle 2011; 10:3057-66; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
FeBS Lett 2012; 586:1390-6; http://dx.doi.org/10.1016/j.febslet.2012.02.049;  PMiD:22673503.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
"J Biol Chem 2004; 279:35510-7; http://dx.doi.org/10.1074/jbc.M404936200;  PMiD:15169778.8. eroles P , et al.",OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Cancer Treat Rev 2012; 38:698- 707; http://dx.doi.org/10.1016/j.ctrv.2011.11.005;  PMiD:22178455.,Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Mol Cancer Res 2007; 5:1-10; http://dx.doi.org/10.1158/1541-7786.MCR-06-0208;  PMiD:17259342.,Non-OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
Nature 2004; 428:77-81; http://dx.doi.org/10.1038/nature02313; PMiD:14999283.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
J Biol Chem 2011; 286:2236-44; http://dx.doi.org/10.1074/jbc.M110.174755;  PMiD:20959462.,OADS,/arxiv_data1/oa_pdf/67/47/cc-11-4110.PMC3524201.pdf
"Cell Cycle 2012; 11:3851–60;   PMID:23070521; http://dx.doi.org/10.4161/cc.22027 Marc Diederich; Laboratoire de Biologie Moléculaire et Cellulaire du Cancer; Kirchberg Hospital; Kirchberg, Luxembourg; Email: marc.diederich@lbmcc.lu;   http://dx.doi.org/10.4161/cc.22603 and capsaicin were reported to inhibit epider - mal growth factor receptor (eGFR) cell signal- ing pathways; β-lapachone from the bark of Tabebuia avellanedae induces a reduction of the telomerase RNA level; flavonoids like lute - olin or genistein inhibit mechanisms linked to metastasis formation; angiogenesis is inhib - ited by plumbagin; methyl jasmonate inhibits  cancer cell metabolism by active induction of  hexokinase release; cordycepin inhibits PARP-1-involved base excision repair and finally a  wealth of compounds were shown to inhibit  pro-inflammatory cell signaling mechanisms including NFκB and Jak/STAT.",Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Curr Med Chem 2012;  19:2061-87; PMiD:22414100; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Biotechnol Adv 2011; 29:531-47; PMiD:21371549; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Cell Cycle 2012; 11:3851-60;  PMiD:23070521; http://dx.doi.org/10.4161/cc.22027.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Curr Drug Targets 2011;  12:2034-44; PMiD:21777194; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Cancer Res 2006; 66:8109-15; PMi D:16912188; http://dx.doi.org/10.1158/0008- 5472.CAN-06-0140.,Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Mol Cancer Ther 2010; 9:347-57; PMi D:20124459; http://dx.doi.org/10.1158/1535- 7163.MCT-09-0872.,Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
eMBO Mol Med 2012; 4:515- 27; PMiD:22416035; http://dx.doi.org/10.1002/ emmm.201200229.,Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Blood 2010; 116:4578-87; PMiD:20739657; http://dx.doi.org/10.1182/blood- 2010-01-265769.,Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Cancer Res 2011; 71:2632-42;  PMi D:21300766; http://dx.doi.org/10.1158/0008- 5472.CAN-10-1120.,Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Cell Cycle 2012; 11:3837- 50; PMiD:22983061; http://dx.doi.org/10.4161/ cc.22026.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Proc Natl Acad Sci USA 2011; 108:3406-11; PM iD:21300883; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
"J Clin Oncol 2011; 29:2843-4;  PMiD:21670452; http://dx.doi.org/10.1200/ JCO.2011.35.9208.Predicting PARP inhibitor sensitivity and resistance   Comment on: Oplustilova L, et al.",OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
"Cell Cycle 2012; 11:3837–50;   PMID:22983061; http://dx.doi.org/10.4161/cc.22026 D. Gwyn Bebb1,2 and Susan P .",OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
"Lees-Miller2,3; 1Division of Medical Oncology; Tom Baker Cancer Centre; Calgary, AB Canada; 2Southern Alberta Cancer Research  Institute; Calgary, AB Canada; 3Departments of Biochemistry & Molecular Biology and Oncology; University of Calgary; Calgary, AB Canada;   Email: Gwyn.Bebb@albertahealthservices.ca and leesmill@ucalgary.ca; http://dx.doi.org/10.4161/cc.22604",Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Annu Rev Genet 2011; 45:247- 71; PMiD:21910633; http://dx.doi.org/10.1146/ annurev-genet-110410-132435.,Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Science 2003; 300:1542-8; PMiD:12791985; http://dx.doi.org/10.1126/sci- ence.1083430.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Proc Natl Acad Sci USA 1995;  92:7642-6; PM iD:7644470; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Nature 2001; 412:456-61; PMiD:11473323; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Nature 2010; 467:112-6; PMiD:20811461; http://dx.doi.org/10.1038/ nature09355.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Nature 2010; 467:108-11; PMiD:20811460; http://dx.doi.org/10.1038/ nature09318.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Cancer Res 2012; 72:2802-13; PMi D:22491672; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3152.,Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Cell Cycle 2012; 11:3983-96;  PMiD:22987153; http://dx.doi.org/10.4161/ cc.22215.,Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
"Genes Dev 2012; 26:1393-408; PMiD:22751496; http://dx.doi.org/10.1101/ gad.195248.112.Examining the roles of DNA2 during mammalian end resection Comment on: Karanja KK, et al.",OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
"Cell Cycle 2012; 11:3983–96;   PMID:22987153; http://dx.doi.org/10.4161/cc.22215 Jeremy M. Stark and Binghui Shen; Department of Radiation Biology; City of Hope National Medical Center and Beckman Research Institute; Duarte, CA USA;   Email: jstark@coh.org and bshen@coh.org; http://dx.doi.org/10.4161/cc.22605",OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
"Cell Cycle 2012; 11:4181–90;   PMID:23095642; http://dx.doi.org/10.4161/cc.22413  Swathi V. Iyer and Tomoo Iwakuma*; Department of Cancer Biology; University of Kansas Medical Center; Kansas City, KS USA;  *Email: tiwakuma@kumc.edu; http://dx.doi.org/10.4161/cc.22606 The constitutive photomorphogenesis 9  (COP9) signalosome (CSN) is an evolutionarily conserved multiprotein complex in plants and animals.",OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Cell Cycle 2012; 11:4059–68;   PMID:23095493; http://dx.doi.org/10.4161/cc.22381  Yifan Wang and Binhua P .,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
"Zhou*; Department of Molecular and Cellular Biochemistry and Markey Cancer Center; University of Kentucky School of Medicine;  Lexington, KY USA; *Email: peter.zhou@uky.edu; http://dx.doi.org/10.4161/cc.22607References 1.",Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Annu Rev Cell Dev Biol 2003; 19:261- 86; http://dx.doi.org/10.1146/annurev.cell- bio.19.111301.112449; PMiD:14570571.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Mol Oncol 2012; 6:267-75; http://dx.doi.org/10.1016/j.molonc.2012.01.003;  PMiD:22306028.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Cycle 2011; 10:3057-66; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
FeBS Lett 2012; 586:1390-6; http://dx.doi.org/10.1016/j.febslet.2012.02.049;  PMiD:22673503.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
"J Biol Chem 2004; 279:35510-7; http://dx.doi.org/10.1074/jbc.M404936200;  PMiD:15169778.8. eroles P , et al.",OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Cancer Treat Rev 2012; 38:698- 707; http://dx.doi.org/10.1016/j.ctrv.2011.11.005;  PMiD:22178455.,Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Mol Cancer Res 2007; 5:1-10; http://dx.doi.org/10.1158/1541-7786.MCR-06-0208;  PMiD:17259342.,Non-OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
Nature 2004; 428:77-81; http://dx.doi.org/10.1038/nature02313; PMiD:14999283.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
J Biol Chem 2011; 286:2236-44; http://dx.doi.org/10.1074/jbc.M110.174755;  PMiD:20959462.,OADS,/arxiv_data1/oa_pdf/fc/66/cc-11-4111.PMC3524202.pdf
"Cell Cycle 2012; 11:3851–60;   PMID:23070521; http://dx.doi.org/10.4161/cc.22027 Marc Diederich; Laboratoire de Biologie Moléculaire et Cellulaire du Cancer; Kirchberg Hospital; Kirchberg, Luxembourg; Email: marc.diederich@lbmcc.lu;   http://dx.doi.org/10.4161/cc.22603 and capsaicin were reported to inhibit epider - mal growth factor receptor (eGFR) cell signal- ing pathways; β-lapachone from the bark of Tabebuia avellanedae induces a reduction of the telomerase RNA level; flavonoids like lute - olin or genistein inhibit mechanisms linked to metastasis formation; angiogenesis is inhib - ited by plumbagin; methyl jasmonate inhibits  cancer cell metabolism by active induction of  hexokinase release; cordycepin inhibits PARP-1-involved base excision repair and finally a  wealth of compounds were shown to inhibit  pro-inflammatory cell signaling mechanisms including NFκB and Jak/STAT.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Curr Med Chem 2012;  19:2061-87; PMiD:22414100; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Biotechnol Adv 2011; 29:531-47; PMiD:21371549; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Cell Cycle 2012; 11:3851-60;  PMiD:23070521; http://dx.doi.org/10.4161/cc.22027.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Curr Drug Targets 2011;  12:2034-44; PMiD:21777194; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Cancer Res 2006; 66:8109-15; PMi D:16912188; http://dx.doi.org/10.1158/0008- 5472.CAN-06-0140.,Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Mol Cancer Ther 2010; 9:347-57; PMi D:20124459; http://dx.doi.org/10.1158/1535- 7163.MCT-09-0872.,Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
eMBO Mol Med 2012; 4:515- 27; PMiD:22416035; http://dx.doi.org/10.1002/ emmm.201200229.,Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Blood 2010; 116:4578-87; PMiD:20739657; http://dx.doi.org/10.1182/blood- 2010-01-265769.,Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Cancer Res 2011; 71:2632-42;  PMi D:21300766; http://dx.doi.org/10.1158/0008- 5472.CAN-10-1120.,Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Cell Cycle 2012; 11:3837- 50; PMiD:22983061; http://dx.doi.org/10.4161/ cc.22026.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Proc Natl Acad Sci USA 2011; 108:3406-11; PM iD:21300883; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
"J Clin Oncol 2011; 29:2843-4;  PMiD:21670452; http://dx.doi.org/10.1200/ JCO.2011.35.9208.Predicting PARP inhibitor sensitivity and resistance   Comment on: Oplustilova L, et al.",OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
"Cell Cycle 2012; 11:3837–50;   PMID:22983061; http://dx.doi.org/10.4161/cc.22026 D. Gwyn Bebb1,2 and Susan P .",OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
"Lees-Miller2,3; 1Division of Medical Oncology; Tom Baker Cancer Centre; Calgary, AB Canada; 2Southern Alberta Cancer Research  Institute; Calgary, AB Canada; 3Departments of Biochemistry & Molecular Biology and Oncology; University of Calgary; Calgary, AB Canada;   Email: Gwyn.Bebb@albertahealthservices.ca and leesmill@ucalgary.ca; http://dx.doi.org/10.4161/cc.22604",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Annu Rev Genet 2011; 45:247- 71; PMiD:21910633; http://dx.doi.org/10.1146/ annurev-genet-110410-132435.,Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Science 2003; 300:1542-8; PMiD:12791985; http://dx.doi.org/10.1126/sci- ence.1083430.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Proc Natl Acad Sci USA 1995;  92:7642-6; PM iD:7644470; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Nature 2001; 412:456-61; PMiD:11473323; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Nature 2010; 467:112-6; PMiD:20811461; http://dx.doi.org/10.1038/ nature09355.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Nature 2010; 467:108-11; PMiD:20811460; http://dx.doi.org/10.1038/ nature09318.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Cancer Res 2012; 72:2802-13; PMi D:22491672; http://dx.doi.org/10.1158/0008- 5472.CAN-11-3152.,Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Cell Cycle 2012; 11:3983-96;  PMiD:22987153; http://dx.doi.org/10.4161/ cc.22215.,Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
"Genes Dev 2012; 26:1393-408; PMiD:22751496; http://dx.doi.org/10.1101/ gad.195248.112.Examining the roles of DNA2 during mammalian end resection Comment on: Karanja KK, et al.",OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
"Cell Cycle 2012; 11:3983–96;   PMID:22987153; http://dx.doi.org/10.4161/cc.22215 Jeremy M. Stark and Binghui Shen; Department of Radiation Biology; City of Hope National Medical Center and Beckman Research Institute; Duarte, CA USA;   Email: jstark@coh.org and bshen@coh.org; http://dx.doi.org/10.4161/cc.22605",OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
"Cell Cycle 2012; 11:4181–90;   PMID:23095642; http://dx.doi.org/10.4161/cc.22413  Swathi V. Iyer and Tomoo Iwakuma*; Department of Cancer Biology; University of Kansas Medical Center; Kansas City, KS USA;  *Email: tiwakuma@kumc.edu; http://dx.doi.org/10.4161/cc.22606 The constitutive photomorphogenesis 9  (COP9) signalosome (CSN) is an evolutionarily conserved multiprotein complex in plants and animals.",OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Cell Cycle 2012; 11:4059–68;   PMID:23095493; http://dx.doi.org/10.4161/cc.22381  Yifan Wang and Binhua P .,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
"Zhou*; Department of Molecular and Cellular Biochemistry and Markey Cancer Center; University of Kentucky School of Medicine;  Lexington, KY USA; *Email: peter.zhou@uky.edu; http://dx.doi.org/10.4161/cc.22607References 1.",Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Annu Rev Cell Dev Biol 2003; 19:261- 86; http://dx.doi.org/10.1146/annurev.cell- bio.19.111301.112449; PMiD:14570571.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Mol Oncol 2012; 6:267-75; http://dx.doi.org/10.1016/j.molonc.2012.01.003;  PMiD:22306028.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Cycle 2011; 10:3057-66; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
FeBS Lett 2012; 586:1390-6; http://dx.doi.org/10.1016/j.febslet.2012.02.049;  PMiD:22673503.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
"J Biol Chem 2004; 279:35510-7; http://dx.doi.org/10.1074/jbc.M404936200;  PMiD:15169778.8. eroles P , et al.",OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Cancer Treat Rev 2012; 38:698- 707; http://dx.doi.org/10.1016/j.ctrv.2011.11.005;  PMiD:22178455.,Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Mol Cancer Res 2007; 5:1-10; http://dx.doi.org/10.1158/1541-7786.MCR-06-0208;  PMiD:17259342.,Non-OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
Nature 2004; 428:77-81; http://dx.doi.org/10.1038/nature02313; PMiD:14999283.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
J Biol Chem 2011; 286:2236-44; http://dx.doi.org/10.1074/jbc.M110.174755;  PMiD:20959462.,OADS,/arxiv_data1/oa_pdf/a1/8c/cc-11-4112.PMC3524203.pdf
"Cell Cycle 2012; 11:3851–60;   PMID:23070521; http://dx.doi.org/10.4161/cc.22027 Marc Diederich; Laboratoire de Biologie Moléculaire et Cellulaire du Cancer; Kirchberg Hospital; Kirchberg, Luxembourg; Email: marc.diederich@lbmcc.lu;   http://dx.doi.org/10.4161/cc.22603 and capsaicin were reported to inhibit epider - mal growth factor receptor (eGFR) cell signal- ing pathways; β-lapachone from the bark of Tabebuia avellanedae induces a reduction of the telomerase RNA level; flavonoids like lute - olin or genistein inhibit mechanisms linked to metastasis formation; angiogenesis is inhib - ited by plumbagin; methyl jasmonate inhibits  cancer cell metabolism by active induction of  hexokinase release; cordycepin inhibits PARP-1-involved base excision repair and finally a  wealth of compounds were shown to inhibit  pro-inflammatory cell signaling mechanisms including NFκB and Jak/STAT.",Non-OADS,/arxiv_data1/oa_pdf/57/d3/cc-11-4113.PMC3524204.pdf
Curr Med Chem 2012;  19:2061-87; PMiD:22414100; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/57/d3/cc-11-4113.PMC3524204.pdf
Biotechnol Adv 2011; 29:531-47; PMiD:21371549; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/57/d3/cc-11-4113.PMC3524204.pdf
Cell Cycle 2012; 11:3851-60;  PMiD:23070521; http://dx.doi.org/10.4161/cc.22027.,OADS,/arxiv_data1/oa_pdf/57/d3/cc-11-4113.PMC3524204.pdf
Curr Drug Targets 2011;  12:2034-44; PMiD:21777194; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/57/d3/cc-11-4113.PMC3524204.pdf
Cancer Res 2006; 66:8109-15; PMi D:16912188; http://dx.doi.org/10.1158/0008- 5472.CAN-06-0140.,Non-OADS,/arxiv_data1/oa_pdf/57/d3/cc-11-4113.PMC3524204.pdf
